Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353492	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1493	"liver: 1224.7"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 1548.5"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;RH-30: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	NA	NA	200000000000	51000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016673: AB_1611892, HPA044252: AB_2678876"	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.1	1224.7	0.1	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.0	2.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.9	0.3	0.8	0.0	0.1	0.1	0.7	1.3	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.3	0.4	0.0	0.6	0.2	0.0	0.0	0.9	0.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	10.2	12.8	14.1	0.7	50.2	8.8	2.2	16.2	12.0	3.4	52.0	64.3	0.7	27.1	10.6	22.0	2.1	1.0	71.2	0.0	7.9	0.9	0.6	5.0	52.6	10.9	1.2	56.2	2.2	9.2	15.6	20.3	5.1	2.1	17.7	10.8	43.2	1548.5	25.1	8.4	1.7	0.1	20.3	110.9	66.0	2.1	1.2	49.4	115.6	0.0	60.8	3.1	15.5	0.0	8.7	5.4	0.0	1.2	94.4	11.1	0.0	2.0	15.0	5.5	26.3	29.2	43.8	4.1	7.9	1.5	3.7	1.9	52.6	0.7	0.2	0.6
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 144.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	23.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.5	144.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.0	0.0	26.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1678.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Group enriched"	"Detected in some"	5	"AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	170000000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	451.5	182.3	157.5	149.8	158.5	5.6	295.3	169.3	223.5	227.2	163.3	257.0	141.2	306.2	244.1	218.3	228.4	452.4	312.8	149.8	175.0	311.4	1250.0	1678.3	98.2	192.9	167.6	101.7	91.5	153.7	135.3	445.2	193.0	293.8	316.3	129.9	131.8	226.7	147.8	71.5	182.7	520.0	196.2	240.6	171.6	58.9	190.7	53.9	202.7	285.6	59.2	847.0	160.2	192.7	0.3	0.0	772.0	0.0	223.5	16.2	2.0	93.1	25.5	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	10.1	649.8	0.0	0.8	0.8	36.9	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.2	2.0	3.3	0.0	0.1	1.8	0.9	0.8	0.0	0.3	0.3	0.7	1.8	0.0	230.1	3.2	0.0	0.3	0.3	0.1	6.7	1.5	0.5	0.7	0.3	0.7	0.2	0.5	15.4	0.0	0.1	0.0	1.5	0.0	0.8	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	157.5	158.5	169.3	223.5	149.8	175.0	192.9	167.6	193.0	196.2	190.7	192.7	1319.0	12.8	85.6	5.2	9.0	19.5	2.3	0.0	12.0	5.5	10.8	95.5	106.1	22.8	6.8	1.8	8.4	2.5	8.1	0.0	0.0	0.2	18.8	8.3	54.7	797.7	0.0	45.9	3.2	5.5	2.9	241.3	9.2	14.7	27.8	2.5	526.1	910.1	233.0	681.4	2.9	0.0	0.0	123.1	41.4	36.8	77.3	130.7	23.2	355.1	37.8	6.1	1.0	5.5	4.7	0.2	0.0	141.4	11.2	4.7	0.0	0.3	4.4	21.2	335.2	22.1	328.0	2.7	8.8	8.2	14.1	4.1	13.0	73.3	0.0	3.6
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2;liver: 121.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.6	0.4	0.2	0.7	0.4	0.8	3.0	0.5	0.3	0.5	0.1	0.6	39.1	0.4	0.2	0.3	0.7	24.4	0.2	0.3	0.2	18.5	121.7	0.5	0.7	0.4	0.3	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.2	0.2	0.2	1.4	0.7	0.7	0.3	0.8	0.4	0.7	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.2	0.4	0.3	0.4	0.2	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.8	0.7	1.1	1.0	0.8	5.7	13.2	0.3	0.6	0.3	1.5	2.9	2.6	0.7	0.7	27.4	134.2	7.4	0.0	0.8	0.9	1.0	17.2	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.7	1.0	4.6	0.4	7.9	0.3	0.7	0.7	6.4	0.4	0.8	0.0	5.6	0.1	0.0	0.4	0.7	0.7	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"intestine: 47.8;liver: 62.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 60.3;Paneth cells: 23.9;Proximal enterocytes: 30.9"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	54	"Hep G2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	47.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	62.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	5.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.6	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	60.3	0.0	0.0	3.2	2.5	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.8	0.0	23.9	0.0	0.0	0.0	30.9	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882988	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"intestine: 31.5;liver: 63.4"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 32.0;Proximal enterocytes: 13.8"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"Hep G2: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.0	0.4	0.1	0.3	0.1	0.0	0.2	1.1	0.0	0.0	0.2	29.8	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.4	0.3	63.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	31.5	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.1	0.2	0.4	0.3	0.1	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.8	0.6	1.8	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.7	0.6	0.0	2.7	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	32.0	0.0	0.0	2.8	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0
ABLIM1	"ABLIM, LIMAB1, limatin"	ENSG00000099204	"Actin binding LIM protein 1"	O14639	10	114431113-114768061	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 875.6;Cardiomyocytes: 592.5;Peritubular cells: 413.0;Squamous epithelial cells: 481.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 139.1"	"Group enriched"	"Detected in many"	7	"B-cells: 52.2;NK-cells: 63.6;T-cells: 139.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 164.1;OE19: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038951, HPA038952"	Approved		Supported	Cytosol		NA	NA		6000	"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA038951: AB_10673017, HPA038952: AB_10670915"	"unprognostic (2.25e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.23e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.87e-2)"	73.3	93.4	71.0	35.7	67.6	13.6	54.8	277.3	59.4	44.4	76.2	46.7	37.3	37.3	26.7	205.6	51.3	33.5	268.6	58.5	78.3	54.7	28.3	54.5	50.0	90.5	65.1	233.6	32.1	42.3	22.0	31.5	74.9	24.0	57.8	110.1	98.2	26.5	75.1	97.5	34.2	29.3	85.2	20.1	120.7	41.3	67.0	56.8	112.9	111.6	89.1	42.0	89.4	73.2	48.2	34.7	120.2	27.2	1.1	0.4	1.5	9.6	3.2	2.4	6.7	49.0	76.7	61.8	128.7	11.1	18.1	101.4	41.1	66.2	3.1	21.2	35.5	0.5	96.0	128.8	0.5	24.6	0.4	1.5	164.1	18.1	52.1	50.3	47.5	21.4	0.2	93.3	0.5	17.5	5.0	10.8	47.0	159.5	38.4	2.1	29.3	80.3	38.4	105.6	41.7	51.4	40.4	59.2	21.0	60.0	30.7	0.3	32.1	0.1	43.1	1.1	18.3	0.5	0.3	140.0	2.3	54.0	0.9	11.9	0.2	0.8	28.6	0.2	55.5	40.9	53.9	32.8	0.4	52.2	139.1	91.0	2.4	63.6	0.3	0.4	33.7	48.1	71.0	67.6	277.3	59.4	58.5	78.3	90.5	65.1	74.9	85.2	67.0	73.2	218.9	317.3	36.0	875.6	47.1	86.8	42.2	35.7	306.2	54.5	27.6	29.5	592.5	51.5	97.1	53.3	18.8	1.5	43.2	59.8	35.2	37.8	110.7	88.4	32.7	107.3	16.8	7.4	236.0	54.5	0.8	126.1	225.3	30.9	1.3	119.6	55.6	51.4	0.6	58.9	326.0	101.7	16.2	1.3	18.4	133.7	227.7	9.4	21.4	213.6	4.3	54.7	27.8	50.3	9.2	59.6	34.7	413.0	22.7	49.8	46.7	42.1	79.3	96.7	0.0	155.8	22.0	3.9	4.7	481.0	189.4	0.7	62.8	53.6	51.4	164.0
AC026464.3		ENSG00000260371	"Novel protein"		16	69335091-69356306	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"																						0.7	1.0	0.1	0.5	0.6	0.4	0.2	0.1	1.1	0.3	0.8	1.6	0.4	0.8	0.0	1.0	0.3	0.0	0.0	0.7	0.5	0.5	0.7	0.4	0.5	0.7	0.9	1.1	2.6	1.7	0.1	0.1	0.8	0.3	0.0	0.5	0.0	0.9	2.3	0.1	0.8	0.0	0.1	0.9	0.7	1.1	0.7	2.6	0.0	2.1	0.7	1.4	0.1	0.8	1.2	7.9	2.0	3.7	0.3	6.0	0.0	0.5	4.0	4.3	4.7	2.1	3.3	0.9	1.7	0.6	2.2	2.7	2.6	2.7	1.8	0.0	1.5	0.1	4.5	5.6	2.3	1.1	1.8	0.0	0.0	1.3	3.1	1.8	1.3	0.8	0.6	3.2	6.5	1.7	4.9	0.0	3.8	3.1	0.0	3.8	1.0	0.9	3.8	0.7	2.0	0.9	0.0	2.4	0.0	2.7	2.8	6.4	0.0	2.6	0.9	0.7	3.2	3.3	4.0	5.8	3.4	1.2	2.9	0.1	0.5	0.4	0.8	0.3	0.0	0.9	0.6	0.7	0.4	1.3	0.9	0.5	0.6	2.0	1.1	0.1	0.6	0.4	0.1	0.6	0.1	1.1	0.7	0.5	0.7	0.9	0.8	0.1	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC136475.9		ENSG00000288681	"Novel protein"		11	308408-315272	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	7	"brain: 4.1"	"Cell type enhanced"	"Detected in single"		"dendritic cells: 1.1"					"Group enriched"	"Detected in some"	6	"cerebral cortex: 4.1;hippocampal formation: 1.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 473.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 473.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.1;MCF7: 1.2;NB-4: 1.0;U-698: 2.7"															NA	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"																					0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	4.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0		0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	2.7	0.0	0.0	0.0	151.8	6.4	206.0	16.5	41.9	20.0	12.0	24.2	8.8	6.0	13.3	10.6	29.8	473.0	87.7	53.0	2.8	6.4	170.9	0.1	0.0	0.3	4.1	1.7	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.4"									"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	92.3	47.7	10.0	7.0	10.3	5.6	48.9	9.2	12.4	17.1	12.2	42.2	24.7	42.9	10.7	10.9	24.1	6.1	94.5	10.1	9.5	49.4	118.9	17.3	4.7	8.8	9.4	11.7	12.8	22.4	8.3	4.4	8.2	17.8	11.1	4.1	17.8	11.1	114.0	13.1	24.5	22.8	9.2	11.4	22.5	12.0	13.0	3.7	14.5	50.0	3.3	31.2	13.3	9.0	22.8	25.0	4.9	22.1	21.3	7.9	1.0	13.7	31.5	21.9	28.6	18.1	12.6	0.1	9.7	7.0	10.3	12.7	0.0	1.2	11.4	33.1	31.6	16.0	7.6	62.4	14.5	0.1	43.3	19.5	0.0	7.6	0.1	21.0	9.5	0.0	0.0	0.1	18.7	7.4	2.5	18.2	7.5	2.3	37.8	37.2	21.9	0.3	8.0	9.5	21.6	27.3	33.1	24.3	29.6	2.1	51.1	12.7	17.0	17.9	47.2	11.8	13.0	0.0	0.1	9.5	15.8	0.1	18.2	3.5	5.9	3.1	22.1	7.0	15.8	15.0	20.2	16.6	21.9	12.4	17.8	19.9	0.2	15.3	6.5	13.6	31.3	13.6	10.0	10.3	9.2	12.4	10.1	9.5	8.8	9.4	8.2	9.2	13.0	9.0	4.3	0.0	6.4	3.3	6.6	1.7	1.0	5.9	16.5	1.1	5.2	4.2	50.0	7.2	3.0	7.3	10.4	6.1	3.0	20.1	13.7	20.9	1.5	1.4	1.9	4.0	15.7	8.4	2.9	33.2	3.2	7.0	11.7	2.1	13.4	1.9	4.2	27.7	14.9	1.7	3.1	15.5	10.2	3.8	1.6	1.1	5.9	5.6	5.4	1.0	18.5	5.5	7.2	3.0	1.7	21.8	8.6	8.2	7.9	0.4	27.5	36.5	3.3	4.9	6.6	1.4	9.8	0.3	4.8	8.5	0.4	8.2	5.8	1.7	18.8	0.4
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1061.1;Late spermatids: 2128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	41.2	104.0	43.1	45.5	47.6	91.9	64.7	43.9	54.0	43.4	63.9	61.4	64.0	46.6	69.3	43.3	57.9	45.4	57.3	49.4	47.1	78.1	106.4	46.8	66.2	43.4	44.2	59.2	94.1	73.9	59.2	61.7	44.3	52.1	64.7	72.7	71.1	44.2	76.6	41.3	60.7	41.5	44.9	44.7	67.1	46.1	45.3	66.2	63.7	74.9	61.9	47.5	36.4	50.2	78.3	112.5	177.4	97.4	76.1	77.1	142.2	92.6	97.7	91.9	80.8	151.7	78.5	48.8	70.7	85.1	114.6	76.5	169.4	97.0	82.3	118.7	157.9	142.3	99.0	348.5	105.7	162.5	80.4	78.7	90.5	81.9	102.3	95.5	105.8	176.9	145.1	95.1	110.9	103.1	178.5	161.3	214.1	204.7	111.7	118.2	176.1	114.5	144.2	110.5	191.6	191.3	56.0	137.6	196.3	115.0	82.1	89.8	88.9	101.3	65.2	84.0	142.6	123.8	261.2	150.4	120.0	138.9	123.7	65.4	61.6	57.2	88.8	75.2	118.1	106.6	100.4	103.2	57.3	97.2	118.1	115.2	10.9	121.5	80.2	65.3	117.6	115.0	43.1	47.6	43.9	54.0	49.4	47.1	43.4	44.2	44.3	44.9	45.3	50.2	62.5	44.8	96.7	9.1	102.6	79.2	105.3	173.4	51.8	53.1	118.8	130.0	84.9	131.5	119.6	68.0	8.4	207.1	101.3	81.9	270.1	226.7	1061.1	113.1	56.2	70.6	82.5	291.5	20.4	169.0	279.7	74.2	54.6	85.5	70.3	95.9	56.0	115.8	141.1	28.6	21.0	125.1	126.1	72.0	66.3	2128.2	94.4	74.6	81.8	16.9	117.8	92.2	152.4	19.6	26.0	174.4	109.2	92.2	106.4	187.0	174.2	306.6	128.1	56.9	92.1	42.5	87.0	122.6	137.4	87.4	91.2	187.7	86.0	124.4	143.9	148.3
ACSM2A	"A-923A4.1, ACSM2, MGC150530"	ENSG00000183747	"Acyl-CoA synthetase medium chain family member 2A"	Q08AH3	16	20451461-20487669	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1182	"kidney: 277.2;liver: 363.3"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 708.7;Proximal tubular cells: 372.5"	"Group enriched"	"Detected in some"	479	"liver cancer: 22.7;renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.9"									HPA057699	Supported					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA057699: AB_2683506"	"unprognostic (1.17e-4)"						"prognostic favorable (1.41e-5)"				"unprognostic (5.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.09e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	277.2	363.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	4.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	21.5	0.0	7.3	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	2.7	0.0	13.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	708.7	0.0	0.0	0.2	0.0	0.0	18.3	0.0	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	372.5	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.0	0.1	0.3	1.7	0.0	0.0	0.1
ACSM2B	"ACSM2, HXMA, HYST1046"	ENSG00000066813	"Acyl-CoA synthetase medium chain family member 2B"	Q68CK6	16	20536226-20576427	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	173	"kidney: 414.1;liver: 523.5"	"Group enriched"	"Detected in some"	20	"Hepatocytes: 1036.1;Proximal tubular cells: 441.9"	"Group enriched"	"Detected in some"	449	"liver cancer: 30.9;renal cancer: 17.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;Hep G2: 5.5;U-937: 1.9"									HPA057699	Supported					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA057699: AB_2683506"	"unprognostic (1.34e-2)"						"prognostic favorable (3.31e-4)"				"unprognostic (7.13e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"		0.4	0.5	0.4	0.0	1.0	0.2	0.3	2.7	1.6	0.1	0.1	0.8	0.3	0.3	0.3	0.3	0.4	0.5	0.6	0.6	0.8	414.1	523.5	0.4	0.2	0.7	0.5	0.4	0.2	0.2	0.1	0.1	0.7	0.2	0.0	0.5	0.1	0.0	0.9	0.8	0.1	0.1	0.1	0.3	0.6	0.9	0.4	0.1	1.0	0.0	0.1	0.0	0.1	0.8	0.5	0.0	2.9	0.7	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.7	0.5	0.0	1.4	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.4	0.1	0.7	5.5	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.5	0.0	0.0	0.4	0.3	0.5	0.6	0.7	0.0	0.0	0.6	0.1	0.0	0.1	0.9	0.5	1.4	0.0	0.5	0.1	1.1	0.2	0.0	0.0	0.5	0.0	0.4	0.3	0.2	0.3	0.2	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.0	2.7	1.6	0.6	0.8	0.7	0.5	0.7	0.1	0.4	0.8	0.5	0.0	0.0	0.0	6.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	7.3	0.0	0.0	0.0	0.2	35.2	0.1	0.8	0.0	0.0	2.2	1.8	24.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.7	1036.1	0.1	0.0	0.0	0.0	0.0	23.2	0.4	0.7	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	441.9	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	2.7	0.1	0.0	0.0
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261210	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 46.5;Astrocytes: 167.8;Early spermatids: 52.9;Hepatocytes: 53.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"basophil: 7.0;neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.3;ASC TERT1: 16.1;Hep G2: 42.6;hTERT-RPE1: 14.0;RH-30: 19.1;SK-BR-3: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	22.7	14.5	5.2	1.5	5.1	0.1	7.3	5.2	5.3	8.3	9.3	2.2	0.7	9.1	12.1	1.5	8.0	8.1	6.8	4.7	4.9	25.9	40.0	6.4	1.5	5.5	6.4	16.7	2.0	13.7	4.4	4.0	5.2	5.7	1.0	4.8	12.1	5.5	3.5	1.7	1.5	6.3	4.9	2.1	1.4	2.3	6.5	1.1	8.8	5.7	1.1	2.8	5.0	5.5	0.0	0.2	3.4	0.0	14.3	16.1	0.1	2.2	11.0	1.7	1.9	0.4	0.1	0.0	0.0	5.0	5.2	0.1	0.0	0.0	1.0	0.0	2.2	0.0	0.0	42.6	4.8	0.1	0.0	10.8	0.0	0.5	0.0	14.0	0.4	0.0	0.0	0.0	7.8	1.0	0.1	0.2	4.8	0.0	0.0	0.0	19.1	2.7	0.1	0.1	3.1	0.0	0.0	18.0	0.1	7.1	7.9	0.5	0.0	2.8	2.7	0.2	1.2	0.1	0.1	0.1	3.5	0.0	3.4	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	5.2	5.1	5.2	5.3	4.7	4.9	5.5	6.4	5.2	4.9	6.5	5.5	1.3	22.4	46.5	167.8	0.2	0.9	9.5	0.0	2.2	37.8	5.6	3.0	21.8	14.3	3.2	12.9	4.2	1.5	0.1	0.1	5.9	6.4	52.9	3.9	14.8	1.5	0.0	0.0	1.5	2.9	0.8	12.1	0.0	2.7	0.0	8.8	1.8	53.6	0.7	28.6	1.6	0.1	0.0	3.2	0.6	9.4	23.9	0.8	0.0	35.6	0.1	16.4	0.0	16.6	0.7	0.1	0.1	23.7	0.0	3.0	1.1	31.7	3.7	5.3	6.6	18.6	9.9	4.6	0.6	0.4	0.1	0.5	0.6	13.2	1.2	3.7
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983340-51989197	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"intestine: 181.5;kidney: 449.9;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 128.0"									"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		23000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	19.2	24.0	5.6	7.3	5.7	8.8	20.7	6.4	7.3	13.9	11.6	30.6	181.5	4.3	21.8	10.7	13.0	10.7	14.5	5.1	6.0	449.9	274.9	9.2	7.2	6.5	5.9	4.8	8.7	28.2	4.7	9.7	6.6	14.3	30.5	1.9	16.4	11.1	20.2	8.2	138.2	6.9	6.7	8.1	23.6	3.2	6.1	5.1	21.0	34.6	9.2	12.5	7.1	6.6	15.9	26.2	13.2	34.1	28.9	39.4	40.5	12.6	28.2	29.4	14.9	41.2	67.9	7.2	12.2	22.0	13.2	20.0	14.7	81.2	11.5	21.8	10.7	25.3	13.9	128.0	49.7	19.8	21.0	48.0	67.2	25.4	69.1	25.8	11.5	14.6	47.1	23.9	29.9	35.2	0.6	38.9	23.4	92.1	39.3	8.0	14.1	63.5	74.5	50.8	16.9	18.2	12.6	62.6	29.5	7.5	42.3	27.9	7.1	22.0	21.9	24.8	18.8	61.7	16.9	12.1	28.1	42.9	29.0	9.1	15.7	0.4	10.7	15.1	5.7	7.4	2.6	4.5	21.2	6.1	4.1	4.7	0.0	20.4	6.4	2.8	3.8	9.7	5.6	5.7	6.4	7.3	5.1	6.0	6.5	5.9	6.6	6.7	6.1	6.6	0.5	3.2	3.2	0.0	4.9	0.6	1.0	1.9	17.1	0.2	2.7	1.3	0.2	1.5	2.5	5.5	0.0	3.9	0.3	31.6	9.8	16.6	0.2	0.2	0.9	0.9	2.4	15.8	0.0	8.3	4.5	4.3	32.6	0.6	7.0	0.2	1.1	13.1	1.9	0.0	0.0	11.2	4.1	1.9	0.3	0.8	0.6	4.2	0.0	0.0	9.3	0.8	1.0	0.0	0.0	16.4	23.3	0.0	14.9	0.6	144.8	92.0	1.7	1.1	0.0	0.6	2.0	0.1	0.2	18.5	0.4	4.1	2.6	1.0	14.5	0.4
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 703.8"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 325.5;Proximal tubular cells: 92.4"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 44.7"	"Not detected"	"Not detected"							"HPA067946, HPA069081"	Enhanced					NA	NA		3400000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	8.2	41.5	0.3	0.0	0.3	9.2	7.7	0.0	0.0	0.0	52.3	703.8	0.2	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.1	0.1	8.6	0.0	0.0	0.1	0.0	1.8	22.6	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	9.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.3	15.7	1.1	5.5	0.0	0.0	0.0	7.8	7.9	0.3	0.0	11.2	0.3	0.4	12.1	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.0	7.1	325.5	0.0	0.0	0.1	8.9	8.2	5.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	31.1	92.4	15.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	12.7	0.1
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Tryptophan catabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 118.3;Proximal tubular cells: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.4;intermediate monocyte: 16.7;memory B-cell: 5.4;myeloid DC: 7.6;non-classical monocyte: 11.0;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in all"	5	"B-cells: 5.4;dendritic cells: 7.6;monocytes: 16.7"	"Cell line enhanced"	"Detected in all"		"Hep G2: 186.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	14.6	7.6	52.8	11.7	76.1	10.8	65.5	67.3	66.2	15.2	35.5	15.8	17.9	15.3	13.9	18.7	22.9	19.0	22.5	52.6	60.5	88.8	173.2	27.1	12.0	74.4	71.3	31.9	59.3	9.1	9.1	26.7	66.8	28.3	18.8	4.0	38.7	18.4	19.2	32.9	15.5	13.4	56.6	14.6	22.1	13.2	68.6	8.9	15.0	14.4	13.4	13.2	19.0	114.8	21.3	29.4	25.4	23.3	27.9	32.5	13.7	29.8	16.8	20.4	24.5	31.5	17.2	65.8	19.2	22.8	11.9	17.8	43.5	26.0	28.5	41.9	34.6	53.2	35.2	186.5	24.4	44.4	26.2	43.8	26.9	23.9	31.0	33.5	38.8	19.6	54.7	22.4	16.0	20.9	34.0	67.2	20.9	51.1	49.8	38.3	25.9	79.2	27.9	19.3	56.2	41.5	25.5	75.5	24.4	25.1	22.8	42.3	19.3	31.2	20.5	19.9	21.4	33.8	24.2	68.0	25.7	21.5	8.2	1.7	6.4	0.8	0.7	16.7	1.2	5.4	1.1	1.2	7.6	2.1	0.6	0.6	1.8	1.9	11.0	5.1	1.1	1.8	52.8	76.1	67.3	66.2	52.6	60.5	74.4	71.3	66.8	56.6	68.6	114.8	17.9	16.0	16.0	0.7	9.7	26.4	19.8	11.5	79.6	1.2	44.7	34.3	13.2	58.6	12.1	64.4	4.2	12.9	2.1	15.1	17.6	11.5	0.2	21.3	14.5	16.7	13.1	11.3	7.7	8.5	11.2	18.6	23.9	23.8	2.5	9.5	17.9	118.3	10.1	1.7	4.0	26.8	10.2	20.9	20.7	2.7	22.4	21.9	30.2	6.5	8.8	1.6	2.1	3.0	74.2	7.8	27.6	21.8	25.4	15.7	17.8	105.8	14.7	1.7	0.0	15.2	18.1	1.5	13.3	52.1	41.1	11.5	4.3	21.6	30.6	14.5
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AGFG2	"HRBL, RABR"	ENSG00000106351	"ArfGAP with FG repeats 2"	O95081	7	100539203-100568220	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"salivary gland: 289.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatic stellate cells: 57.5;Hepatocytes: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019689, HPA073562"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA019689: AB_1855074, HPA073562: "	"unprognostic (7.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.64e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.03e-6)"	"unprognostic (7.83e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.90e-3)"	"unprognostic (9.31e-2)"	12.8	35.6	16.7	5.1	20.1	5.0	11.2	10.8	15.8	11.6	6.8	18.9	10.3	21.9	5.3	30.8	16.4	11.1	9.8	22.0	14.7	14.0	53.9	7.8	9.0	19.4	12.0	30.2	18.8	7.4	17.7	2.2	14.1	13.3	9.9	2.2	289.4	13.4	6.2	26.0	13.4	7.6	11.1	29.1	13.5	12.1	15.5	4.4	10.7	5.6	6.4	11.7	12.5	12.3	10.8	17.2	2.2	5.1	15.1	7.8	3.0	5.1	13.6	7.9	8.2	15.1	9.6	6.8	16.5	6.0	34.8	8.8	2.4	5.2	3.5	24.1	6.7	2.1	8.3	33.1	6.1	2.2	11.7	13.0	3.9	6.4	7.1	4.9	21.6	4.4	6.4	9.2	6.5	9.5	8.8	8.0	1.5	30.0	7.1	4.3	2.5	6.1	4.6	5.7	3.1	3.8	9.9	14.0	4.6	3.4	4.0	3.0	5.5	9.8	6.7	24.5	5.4	5.6	31.4	2.6	7.4	6.5	5.7	2.2	0.0	2.2	1.7	0.2	1.5	0.3	1.7	2.0	0.1	0.6	0.5	0.7	0.4	0.5	0.0	0.4	1.4	0.6	16.7	20.1	10.8	15.8	22.0	14.7	19.4	12.0	14.1	11.1	15.5	12.3	16.9	0.0	3.9	15.0	3.2	2.0	7.4	2.3	8.6	1.6	4.3	3.6	9.1	34.3	3.1	25.8	2.1	1.8	4.9	25.8	11.7	13.4	1.7	2.8	3.2	13.4	26.5	5.9	6.2	11.6	1.6	3.6	10.2	4.2	2.5	7.2	57.5	37.0	1.5	3.3	4.8	12.0	2.0	5.4	3.1	2.3	5.6	1.3	3.6	3.7	7.1	4.0	7.2	3.0	2.5	7.2	9.6	9.1	7.3	3.6	11.1	2.8	1.0	1.7	13.1	1.5	5.6	14.5	14.5	9.2	5.4	0.8	12.6	6.8	15.2	6.9
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 133.9;liver: 62.1;skeletal muscle: 34.2"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.6	1.5	0.5	1.1	9.2	17.9	0.5	0.3	0.5	0.3	0.5	0.1	1.1	1.3	133.9	62.1	0.2	4.0	0.7	0.6	0.1	0.6	2.2	0.3	0.2	0.8	0.5	6.8	0.4	4.6	0.1	34.2	0.4	13.4	0.7	0.4	1.6	1.8	0.7	0.9	2.1	0.5	6.1	4.1	0.8	0.1	1.2	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.6	1.5	1.1	1.3	0.7	0.6	0.8	0.4	0.9	1.2	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230690776-230745576	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1603.7"	"Group enriched"	"Detected in many"	9	"Cholangiocytes: 985.1;Hepatocytes: 2244.9"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 646.2;THP-1: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	65000000000		"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	11.7	14.6	252.9	2.6	259.8	0.4	4.4	267.5	243.6	9.7	138.2	5.6	2.5	3.2	1.9	2.6	6.0	92.7	154.7	236.0	242.1	52.5	1603.7	5.1	1.0	352.4	314.4	3.5	7.9	6.0	25.8	0.7	304.9	16.3	3.6	26.4	4.9	2.2	43.6	2.0	9.7	5.8	340.5	1.3	4.9	4.1	273.5	1.7	13.2	25.8	0.1	7.0	4.5	322.4	0.2	0.4	0.2	0.2	15.6	0.0	0.9	0.6	0.2	0.0	0.0	80.6	0.1	0.3	0.7	0.2	0.7	0.7	0.0	0.0	0.0	11.4	0.2	0.2	0.3	646.2	1.9	1.0	0.5	26.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	5.5	0.7	0.0	0.2	0.6	0.6	0.1	0.2	0.3	2.4	0.1	0.1	0.3	0.9	0.6	0.4	0.1	5.5	0.1	0.0	243.6	0.1	0.4	1.3	0.4	1.2	3.5	47.0	0.4	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.9	259.8	267.5	243.6	236.0	242.1	352.4	314.4	304.9	340.5	273.5	322.4	0.8	0.0	1.7	140.0	11.3	0.6	1.1	0.0	0.0	4.7	0.8	0.3	60.0	985.1	0.6	3.7	35.5	0.1	0.0	0.0	25.4	169.8	62.2	0.3	0.4	5.5	0.0	50.8	0.3	10.0	0.2	27.2	0.5	0.1	0.0	0.0	39.3	2244.9	2.1	3.3	1.5	1.1	0.0	56.9	0.4	48.5	4.1	0.9	8.8	5.6	0.6	75.1	0.0	3.5	6.8	13.7	1.2	3.4	0.0	26.2	24.2	146.9	0.1	49.8	13.1	7.2	94.1	0.4	0.4	0.0	0.0	0.7	3.9	0.0	0.4	1.9
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	315	"liver: 2199.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.9	2199.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4302	"liver: 5817.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 1242.5"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	78	"Hep G2: 2287.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	1.3	5817.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	1.0	2287.3	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	3.5	0.0	0.0	1.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.2	4.3	0.2	0.1	0.9	0.0	32.0	0.6	0.6	2.4	0.1	0.0	0.1	0.0	0.0	28.2	1242.5	1.3	0.0	0.1	0.0	0.0	32.4	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.0	0.0	0.0	0.1
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 173.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cytosol"	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.92e-4)"	39.6	13.5	7.5	6.3	8.1	1.9	31.2	7.3	8.0	6.9	8.6	12.9	9.3	7.8	9.0	13.3	6.8	5.0	17.0	6.9	7.7	10.4	21.9	9.3	5.1	8.2	7.3	7.9	5.0	3.2	5.6	4.1	6.9	9.9	7.1	2.4	7.6	7.7	9.8	5.6	11.5	5.0	6.2	7.7	9.9	3.9	8.3	2.4	14.6	7.3	3.6	12.0	6.3	6.5	26.5	45.2	1.1	11.3	26.2	9.8	0.3	10.4	25.5	21.0	23.6	35.3	49.8	3.8	25.8	14.5	27.5	27.9	12.7	3.8	5.9	50.8	1.9	0.2	27.3	173.3	56.1	0.3	6.4	13.3	8.4	33.8	7.2	13.2	9.5	1.7	20.5	21.9	11.0	33.5	1.2	1.3	4.5	21.2	14.6	0.8	4.2	12.4	11.4	19.2	3.6	0.8	19.1	16.6	29.8	1.8	0.7	7.2	12.0	0.5	25.3	15.6	30.8	16.2	32.7	7.3	14.0	0.9	13.9	1.0	0.5	0.5	1.8	0.5	1.5	1.7	0.6	1.5	0.4	1.5	0.8	1.3	0.5	4.0	0.5	0.2	1.3	0.7	7.5	8.1	7.3	8.0	6.9	7.7	8.2	7.3	6.9	6.2	8.3	6.5	11.6	6.4	14.1	7.2	5.0	2.3	15.0	8.4	2.8	5.7	5.5	4.7	13.8	8.6	10.5	18.4	0.0	13.9	1.4	53.1	3.9	40.7	24.1	6.0	7.7	4.8	12.0	7.0	8.2	21.9	3.0	11.2	14.3	6.2	11.4	22.3	1.8	25.0	10.2	1.7	5.2	7.1	14.2	3.3	3.3	47.0	5.3	6.7	8.8	4.7	34.4	4.8	1.0	5.5	3.5	40.8	22.7	4.5	17.0	14.6	28.7	22.6	9.5	2.1	19.7	11.8	12.8	6.2	3.9	5.1	1.4	18.6	3.8	8.8	13.7	20.4
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143341058	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 235.8"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 245.4;Proximal tubular cells: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	42.0	29.8	43.7	10.4	44.6	31.6	30.0	43.3	46.1	17.6	48.2	23.0	46.6	14.4	33.0	34.1	34.4	24.5	54.1	44.1	49.1	102.0	235.8	19.9	10.7	45.0	43.4	34.7	31.0	31.0	36.6	11.9	46.4	22.7	18.8	33.9	19.8	24.1	23.7	16.8	45.9	15.2	47.1	20.1	20.8	15.7	51.0	6.8	42.9	32.5	14.8	29.4	26.1	52.5	32.6	25.2	20.6	56.9	29.7	22.3	7.6	28.3	57.1	26.8	61.9	37.5	81.5	20.0	40.5	66.1	41.7	42.0	26.5	79.2	64.2	67.2	63.0	5.6	35.6	157.3	40.8	46.0	2.7	32.9	76.7	35.7	129.6	88.2	10.9	30.8	4.0	67.6	59.3	45.6	14.2	9.8	40.8	37.4	27.6	20.2	61.6	36.6	100.6	77.6	75.5	42.4	35.5	33.2	17.2	36.0	31.7	96.0	3.0	25.2	27.8	22.7	33.4	99.6	95.1	2.1	59.7	9.5	26.9	12.0	6.2	9.6	6.6	29.3	15.1	9.6	12.4	10.6	33.0	5.6	13.1	10.0	11.3	11.8	35.4	2.9	9.7	9.2	43.7	44.6	43.3	46.1	44.1	49.1	45.0	43.4	46.4	47.1	51.0	52.5	40.8	16.0	27.7	114.9	22.0	25.0	51.8	82.5	27.9	68.3	69.9	65.4	73.7	72.9	66.9	51.5	25.0	79.6	8.6	12.6	52.8	60.3	22.4	99.8	25.9	32.8	39.5	29.3	204.3	31.5	10.5	42.2	26.0	83.1	36.8	90.9	36.8	229.6	32.7	53.8	245.4	33.3	59.0	40.1	42.3	7.0	32.0	37.2	55.2	100.2	18.2	74.3	8.2	105.1	172.9	25.8	65.2	38.4	47.7	35.3	232.9	261.5	69.1	36.9	32.9	41.7	50.8	5.6	17.3	53.1	45.7	108.1	18.5	61.5	42.4	53.2
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 183.5;liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 242.6;Proximal tubular cells: 595.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.1;myeloid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	Yes		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	24.7	1.9	19.5	6.6	21.0	4.9	26.6	17.8	20.8	6.1	17.5	19.7	4.3	7.0	4.2	23.4	7.6	13.7	51.7	21.4	21.2	183.5	104.0	2.8	1.6	19.0	22.8	4.6	1.2	18.3	4.7	8.3	22.8	16.2	14.0	21.9	9.6	12.7	1.7	27.4	6.6	21.4	18.5	1.2	15.0	11.3	22.7	5.7	2.5	38.8	3.3	19.1	11.8	21.1	73.2	5.0	5.6	23.9	51.6	48.7	12.0	12.1	15.0	25.6	70.8	108.1	8.6	39.1	31.0	19.0	32.1	46.1	18.8	89.9	101.9	33.0	21.5	37.9	21.9	208.6	2.5	29.9	4.6	27.2	49.6	25.1	73.0	42.2	0.9	12.2	48.0	0.6	39.6	31.2	1.1	1.3	24.6	1.0	42.5	0.2	41.0	7.1	37.8	3.2	20.5	15.4	21.6	1.5	16.7	25.8	29.7	12.9	4.2	42.4	36.2	3.3	20.9	39.5	18.8	2.1	68.7	10.9	2.5	0.9	3.1	0.0	0.1	0.6	0.2	0.2	0.1	0.2	2.7	0.1	0.1	0.1	0.4	0.3	0.1	0.4	0.0	0.8	19.5	21.0	17.8	20.8	21.4	21.2	19.0	22.8	22.8	18.5	22.7	21.1	11.2	0.0	0.5	51.2	4.7	49.7	23.6	44.2	63.7	24.5	48.9	44.7	105.7	52.9	14.3	31.3	2.1	2.2	0.6	15.8	56.7	18.6	3.4	30.1	8.2	19.6	5.4	13.9	17.1	12.1	21.1	11.4	27.5	52.2	0.0	36.4	11.7	242.6	3.3	16.8	7.7	8.7	24.4	7.8	9.2	5.8	4.1	6.9	24.9	3.7	5.7	32.7	0.0	9.5	2.5	31.9	4.3	9.4	0.4	38.7	18.8	595.5	12.3	6.5	6.6	5.6	18.8	1.8	9.5	43.1	74.3	4.9	3.6	0.7	23.1	20.4
AKAP1	"AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17"	ENSG00000121057	"A-kinase anchoring protein 1"	Q92667	17	57085092-57121346	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.8"	"Group enriched"	"Detected in all"	9	"Early spermatids: 584.7;Late spermatids: 2219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008620, HPA008691, CAB019286"	Supported		Supported	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119"	"unprognostic (5.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.86e-9)"	"unprognostic (6.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	40.6	15.5	31.6	17.8	35.2	6.9	35.2	29.1	35.2	23.7	17.2	76.1	54.8	24.5	19.7	36.4	31.5	18.0	82.6	28.5	26.5	26.2	49.9	19.6	10.8	26.7	27.1	20.0	22.2	48.1	17.1	7.1	26.9	34.7	48.9	34.7	33.6	24.8	207.8	27.3	55.8	26.3	21.9	11.3	55.4	112.9	29.8	11.4	36.3	137.9	9.5	46.8	25.5	28.0	46.1	54.3	80.7	27.5	18.2	12.8	46.8	19.0	18.3	24.2	16.8	61.2	42.2	74.1	52.3	14.5	26.5	74.6	50.1	44.4	24.7	40.6	63.5	63.1	51.4	118.1	19.4	59.9	23.8	11.7	41.8	26.2	39.2	14.4	25.7	22.9	42.3	28.6	14.8	39.8	76.1	24.1	28.7	97.9	61.7	58.2	32.8	61.0	17.1	61.9	58.9	40.3	15.8	45.1	23.9	16.6	31.4	61.4	18.8	24.3	24.2	28.3	45.0	28.9	36.9	55.8	14.0	47.5	19.7	1.6	1.0	0.4	2.6	2.0	2.3	1.8	2.0	2.1	2.3	1.2	4.0	2.1	0.1	3.3	0.5	4.0	1.7	1.3	31.6	35.2	29.1	35.2	28.5	26.5	26.7	27.1	26.9	21.9	29.8	28.0	34.5	35.3	49.9	26.4	16.6	22.6	23.5	11.9	32.5	33.0	29.4	42.3	154.9	28.6	32.1	5.5	47.9	21.5	10.6	89.1	1.9	16.3	584.7	16.8	12.6	16.4	45.9	12.6	14.9	16.3	13.8	12.2	54.0	37.8	3.8	21.0	11.4	60.2	9.5	37.0	26.3	86.6	8.2	9.0	9.5	2219.5	19.6	10.9	7.2	4.7	8.7	8.2	3.1	10.6	9.6	12.7	68.5	13.9	13.2	32.3	65.6	7.4	6.5	77.1	46.0	17.9	54.4	18.3	14.9	44.9	19.7	6.8	11.5	13.3	117.6	17.0
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 623.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2;lung cancer: 53.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	185.7	14.3	12.3	13.5	16.5	5.8	116.2	16.0	11.5	12.9	6.9	23.2	25.3	6.6	6.6	103.9	11.5	65.7	135.5	10.9	18.7	45.4	623.2	28.9	4.7	22.1	18.4	15.5	23.3	0.8	9.7	1.7	23.2	17.3	12.2	11.5	73.7	12.5	120.4	35.3	23.4	8.7	19.6	4.1	142.9	13.0	22.2	4.6	46.7	27.3	7.8	71.1	31.3	20.3	0.0	429.6	2.4	426.7	2988.3	358.2	0.2	13.7	95.9	5.4	4.1	8.4	0.5	0.0	6.1	97.7	72.5	3.6	1.6	22.4	2.5	0.1	0.2	12.6	65.6	5415.7	30.0	1.8	0.0	183.9	27.3	44.2	26.7	0.4	10.2	2.9	95.8	0.4	74.7	2.4	0.1	0.4	1.2	2297.1	1.5	0.1	0.8	4.2	24.3	81.4	0.4	1.7	23.8	0.7	0.8	1.3	0.5	7.8	85.3	36.0	2.3	97.6	4.5	1.6	0.5	0.3	129.3	12.1	0.9	1.5	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.2	12.3	16.5	16.0	11.5	10.9	18.7	22.1	18.4	23.2	19.6	22.2	20.3	21.6	67.3	34.4	2.0	2.4	21.2	27.8	253.8	262.4	3.1	7.6	1.0	3.2	284.5	144.5	62.5	0.0	0.1	0.2	5.9	13.7	67.0	24.0	3.3	1.7	17.1	1.8	52.6	3.4	328.0	0.1	176.3	139.1	4.6	4.5	0.8	21.0	597.7	0.4	0.0	3.1	6.8	20.3	16.1	15.6	9.9	151.6	3.3	106.7	13.1	4.6	51.5	0.0	4.5	0.5	120.2	3.6	147.4	0.4	41.3	20.2	61.9	72.2	4.5	0.0	16.4	24.3	1.9	1.1	229.3	20.5	0.1	2.1	6.4	20.3	306.0
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 341.5;liver: 481.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	341.5	20.8	9.8	10.0	11.6	1.0	205.6	10.7	12.9	17.4	8.1	37.1	29.6	5.6	3.3	202.5	8.6	98.1	83.8	7.2	16.6	43.0	481.9	23.5	2.1	18.7	13.7	10.4	11.8	1.1	8.1	0.8	17.1	11.7	13.3	15.2	116.5	12.9	286.9	42.5	33.7	9.2	11.5	2.1	137.0	11.8	16.8	4.4	38.3	36.5	9.3	253.9	47.0	9.7	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	11.6	10.7	12.9	7.2	16.6	18.7	13.7	17.1	11.5	16.8	9.7	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"liver: 426.9"	"Group enriched"	"Detected in some"	31	"Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		61000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.1	0.2	0.0	0.1	0.2	5.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	426.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	110.3	0.4	0.0	0.2	0.2	0.0	3.2	0.4	126.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	1.6	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 711.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		950000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	33.3	67.9	45.3	17.5	48.0	25.0	33.8	47.4	44.2	57.2	66.2	46.4	81.1	34.7	22.4	47.8	48.4	29.1	39.1	45.9	46.1	76.7	62.7	24.6	25.3	48.8	49.4	45.7	47.9	32.7	32.6	19.0	44.9	31.6	27.5	16.0	31.4	27.7	55.4	37.1	56.8	22.6	49.2	28.3	42.7	33.1	48.2	31.3	28.6	39.6	20.5	29.6	38.5	54.1	65.3	40.2	43.3	40.2	67.0	64.7	28.8	47.6	57.6	65.0	58.2	51.5	53.6	46.8	49.6	64.2	36.6	50.8	48.7	71.5	30.5	37.5	77.4	29.4	37.5	83.3	51.9	32.9	22.9	64.8	55.5	50.0	30.6	61.5	55.8	60.2	43.6	42.6	67.7	64.9	64.2	31.9	12.4	90.8	50.1	66.7	54.0	83.2	64.2	28.3	80.9	30.2	51.8	46.1	84.6	24.6	91.9	112.7	44.2	40.6	42.7	44.0	36.2	51.4	34.8	57.9	87.6	74.4	58.5	0.7	82.2	40.6	61.4	69.7	71.7	63.8	54.4	54.2	113.5	57.6	61.7	54.1	9.5	69.4	54.1	98.8	78.9	73.7	45.3	48.0	47.4	44.2	45.9	46.1	48.8	49.4	44.9	49.2	48.2	54.1	47.6	16.0	22.3	15.3	42.6	24.3	73.2	56.4	37.5	33.1	94.6	98.8	27.7	98.7	31.7	77.3	6.2	167.5	52.8	95.0	254.3	64.0	94.6	85.8	35.8	35.3	99.7	33.4	8.6	36.2	99.8	67.9	44.9	33.4	10.2	62.5	43.2	90.6	104.6	21.9	7.5	97.9	46.8	58.4	34.2	57.6	77.3	47.6	53.4	5.6	64.6	128.7	63.8	5.5	9.2	39.4	131.5	67.7	36.3	39.3	273.8	711.5	61.0	30.1	46.0	57.8	54.4	56.3	24.9	76.0	34.1	102.6	40.4	88.4	136.4	62.3
AL034430.1		ENSG00000285508	"Novel protein"		20	10413520-10431922	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 8.2;heart muscle: 8.2"	"Cell type enhanced"	"Detected in single"		"granulocytes: 1.3"					"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 86.5"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"																					4.8	2.2	0.0	5.6	0.0	8.2	0.0	0.0	0.4	0.0	0.0	2.7	1.9	0.6	0.0	2.8	0.0	0.2	8.2	0.0	0.0	0.3	2.2	0.0	1.9	0.0	0.0	0.0	4.0	0.0		1.1	0.0	1.7	0.6	0.0	2.3	0.0	0.0	0.3	1.8	0.0	0.0	0.3	4.7	3.2	0.0	0.0	0.0	0.0	0.3	3.7		0.0	27.4	18.8	6.8	9.6	0.0	2.8	14.1	16.0	7.1	11.1	12.5	14.7	34.0	7.2	11.8	5.4	21.9	19.8	0.0	22.4	23.2	2.4	6.1	6.7	16.5	86.5	5.6	27.5	8.7	2.6	0.0	4.3	13.9	2.1	17.2	1.7	20.4	22.6	17.2	16.8	3.3	39.1	16.1	0.0	18.9	11.8	21.3	20.3	11.0	25.3	3.5	4.4	14.6	28.0	43.1	12.8	14.3	12.7	12.7	20.3	22.3	16.1	24.7	8.2	11.2	17.7	9.0	14.4	19.5	33.3	16.7	22.0	3.9	22.4	5.8	8.7	5.2	8.1	16.7	7.8	4.2	6.4	16.6	5.0	19.2	45.0	7.3	4.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AL035461.3		ENSG00000286235	"Novel protein"		20	5950949-6039856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.0"									"HPA045141, HPA066433"			Approved	Nucleoplasm,Cytosol		NA	NA					"Cluster 37: Hep G2 - Hepatocyte cell processes"		Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "																		0.9	0.9	0.1	1.0	0.1	0.4	2.6	0.1	0.3	1.8	0.1	1.5	1.4	1.3	1.5	1.4	1.3	0.8	1.5	0.1	0.1	1.5	1.1	1.2	1.4	0.1	0.1	1.6	0.8	1.4		1.8	0.1	1.7	2.6	2.2	0.5	1.5	0.3	0.7	1.6	2.1	0.1	0.9	1.0	2.0	0.1	2.3	1.2	2.9	2.4	1.0		0.1	0.5	5.4	5.0	2.4	5.4	4.7	0.7	1.2	4.5	4.3	4.7	7.3	3.0	1.6	0.1	3.7	3.2	0.4	8.4	6.6	7.1	0.3	0.0	7.2	2.5	18.0	0.8	2.4	1.1	2.8	1.7	4.1	4.0	3.7	2.4	3.0	0.4	2.0	5.2	2.0	3.5	0.7	2.7	6.9	0.1	2.2	3.2	1.8	4.0	4.9	2.6	2.1	0.0	10.8	1.2	6.7	1.4	5.6	0.0	1.6	0.8	0.8	1.2	0.1	0.2	0.9	1.4	4.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL121758.1		ENSG00000270299	"Novel protein"		20	646626-675800	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;Hep G2: 4.3;Karpas-707: 2.7;SK-BR-3: 2.6;TIME: 2.5;U-266/84: 2.7"															NA	NA					"Cluster 37: Hep G2 - Hepatocyte cell processes"					"unprognostic (2.38e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.42e-3)"	"unprognostic (4.14e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.03e-2)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	2.0	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	3.2	0.0	0.0	0.2	0.0	0.3	0.1	2.4	0.2	4.3	0.0	0.3	1.3	0.0	0.0	0.2	0.0	0.1	0.0	1.9	0.3	2.7	0.0	0.0	0.0	0.0	1.3	1.2	0.1	0.0	0.7	1.0	0.0	0.1	0.4	1.0	0.6	2.6	0.5	0.4	0.4	0.5	2.5	0.2	0.4	0.0	0.7	0.2	2.7	0.1	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL121845.2		ENSG00000273047	"Novel transcript, LIME1-SLC2A4RG readthrough"		20	63738270-63740398	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	6	"liver: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.0"	"Group enriched"	"Detected in many"	31	"dendritic cells: 6.0;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.7;HHSteC: 1.2;JURKAT: 1.6;OE19: 2.2;U-266/70: 1.2;U-698: 2.7"															NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"											"unprognostic (3.96e-2)"						"unprognostic (1.60e-1)"					0.8	0.0	0.2	0.0	0.3	0.1	0.6	0.3	1.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.1	6.8	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.2	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.9	0.1	3.3	4.2	0.0	0.1	2.2	1.3	0.1	0.0	0.1	6.0	3.3	0.6	0.2	0.3	0.3	1.0	0.2	0.2	0.5	0.2	0.3	0.3	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL132780.3		ENSG00000259132	"Novel protein"		14	22946270-22982258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.9;MCF7: 23.7"									HPA029803	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA029803: AB_10601428"																		3.0	4.8	9.5	2.8	9.6	4.7	2.5	9.1	13.9	4.0	9.0	5.6	3.9	2.6	6.8	4.2	4.7	4.2	8.1	9.6	9.4	7.7	6.9	4.0	6.4	10.1	9.4	6.9	12.8	2.3	3.1	2.8	9.9	4.7	4.0	2.0	3.7	2.1	5.8	6.1	4.2	1.8	9.5	10.2	5.4	3.4	9.8	4.7	3.4	1.5	2.6	3.5	3.0	10.2	4.0	13.0	4.4	0.8	7.1	7.1	6.1	0.0	5.6	3.7	4.1	2.9	0.0	0.0	1.9	9.4	1.3	0.6	2.9	3.9	2.1	0.0	1.6	0.0	7.7	38.9	4.1	4.2	0.1	4.3	8.1	3.5	8.3	8.5	6.9	12.7	0.0	5.6	3.4	23.7	6.2	16.8	2.2	6.4	5.1	5.7	3.9	4.4	14.1	10.8	4.4	1.9	0.0	2.8	1.4	4.7	4.6	7.9	0.1	5.4	2.6	0.6	4.4	4.7	9.4	7.1	0.4	1.7	3.1	0.3	2.8	1.2	1.7	2.5	0.6	1.6	1.0	1.0	2.8	2.3	1.8	1.0	5.8	0.5	1.6	1.4	2.4	1.5	9.5	9.6	9.1	13.9	9.6	9.4	10.1	9.4	9.9	9.5	9.8	10.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392702-38398661	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.7;smooth muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 183.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	21.2	10.4	3.2	31.4	3.2	2.9	8.9	4.1	4.0	8.5	6.4	61.5	22.9	57.7	5.7	32.7	34.9	29.0	14.7	2.7	4.8	59.2	172.7	7.3	5.1	3.5	3.3	12.6	11.3	8.5	2.5	5.2	4.3	36.9	35.5	1.5	11.1	54.5	55.8	6.3	24.8	128.0	3.4	7.2	28.2	8.3	4.0	5.1	15.4	35.9	5.6	85.1	10.5	4.1	72.2	65.5	19.8	31.8	27.6	32.5	15.8	33.6	16.9	27.8	28.3	44.2	13.7	45.2	19.7	47.4	42.0	10.0	66.0	71.4	27.4	50.8	28.5	22.4	44.7	132.2	20.0	36.0	24.0	39.0	15.3	22.6	19.5	56.6	26.8	10.6	65.6	42.8	42.8	27.3	0.1	14.4	59.1	183.3	29.0	14.9	119.9	34.5	25.1	31.7	43.3	19.9	25.7	16.7	19.4	20.6	15.9	27.9	18.2	31.9	52.4	26.9	42.5	6.5	13.2	17.8	16.4	36.0	22.1	0.3	4.2	0.2	6.7	9.2	9.6	5.5	6.5	6.1	9.5	2.6	5.1	6.2	1.0	8.0	11.9	1.2	5.0	5.3	3.2	3.2	4.1	4.0	2.7	4.8	3.5	3.3	4.3	3.4	4.0	4.1	3.3	9.6	1.7	0.0	3.7	1.0	5.7	9.4	2.2	1.2	3.7	4.2	6.6	85.8	3.8	16.5	2.1	2.0	1.2	12.8	17.6	64.1	0.6	2.3	6.4	4.7	15.6	12.8	0.5	6.9	46.6	6.6	8.2	3.4	8.9	12.8	8.9	128.1	7.2	0.0	1.1	25.5	6.1	4.1	2.4	2.2	6.5	4.2	0.0	0.0	5.5	2.1	0.0	0.5	0.5	15.0	7.7	6.8	3.7	6.1	10.3	165.0	0.3	0.7	0.0	6.0	16.1	0.6	0.8	2.1	1.0	1.8	3.3	91.7	71.7	2.8
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 200.4;liver: 436.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	70.8	16.1	73.9	3.9	88.9	11.7	21.6	73.8	95.9	12.6	106.5	6.8	1.6	9.8	4.7	36.3	8.3	5.5	33.0	68.2	73.8	200.4	436.6	6.2	3.4	72.9	82.8	7.3	4.6	23.0	9.7	13.2	70.0	29.5	2.7	6.5	9.1	27.1	74.2	19.2	4.7	7.1	65.6	7.5	12.5	3.2	92.4	11.7	7.1	74.8	4.2	19.3	16.8	66.1	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	73.9	88.9	73.8	95.9	68.2	73.8	72.9	82.8	70.0	65.6	92.4	66.1	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078328	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 10947.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 10517.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	173	"Hep G2: 1398.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		47000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.7	0.2	0.1	0.0	0.1	0.0	6.4	0.3	0.4	0.2	0.3	0.3	2.3	0.1	0.4	0.3	0.4	160.4	0.5	0.1	0.1	11.0	10947.9	0.3	0.0	0.1	0.1	0.2	125.3	0.0	0.2	0.4	0.1	0.2	0.5	0.2	0.1	0.0	0.2	0.3	0.7	0.0	0.1	3.1	2.6	1.0	0.1	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	1.8	0.0	1.8	2.1	0.2	0.9	0.5	0.0	0.0	0.0	3.2	0.0	3.0	1.0	1398.1	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.3	0.0	0.9	3.1	0.0	0.2	8.1	0.4	5.9	0.6	1.7	0.0	2.8	1.1	0.0	0.1	0.0	0.2	1.0	0.0	0.8	0.0	0.4	1.0	0.3	1.5	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.0	19.1	1.5	0.6	0.0	2.2	0.0	1.9	0.4	0.2	2585.0	0.6	1.8	0.0	0.1	0.0	0.6	3.9	216.5	30.4	0.2	0.1	10.0	2.4	219.2	0.1	28.2	0.8	0.1	0.0	1.0	0.0	0.0	181.3	10517.4	0.7	0.0	0.1	1.6	0.0	243.7	0.5	59.4	0.6	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	14.9	1.7	0.0	0.0	0.6	0.6	13.7	0.0	0.0	0.0	0.0	0.5	0.6	0.2	1.1	0.4	1.4	14.3	0.0	1.2	0.3
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416778-49422685	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0"									HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	12.8	9.8	1.2	10.3	8.8	5.6	10.7	11.7	11.8	13.1	12.2	13.8	6.8	8.2	3.5	10.1	5.8	21.6	9.4	9.6	23.2	49.1	5.4	2.1	9.8	10.2	12.5	19.5	14.2	11.9	2.3	9.8	11.3	11.8	6.5	10.6	8.5	3.1	4.8	12.1	3.7	9.9	6.3	11.1	3.0	10.0	3.8	5.8	4.2	1.5	8.0	6.4	9.9	0.1	0.7	1.4	0.4	0.6	0.0	17.1	0.0	0.4	0.1	0.3	0.5	0.6	0.0	0.2	0.4	0.0	0.3	0.1	0.7	0.1	0.3	0.0	0.0	0.5	47.5	1.8	0.0	0.0	0.6	1.8	0.0	0.7	1.3	0.6	0.2	0.0	0.0	0.2	0.4	0.1	0.1	8.0	0.0	0.2	0.0	0.5	1.0	0.8	0.4	0.0	14.9	0.2	0.0	1.1	9.0	0.1	0.3	0.6	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.2	0.0	1.7	0.0	0.5	0.0	0.0	4.2	0.2	1.2	0.9	0.1	7.9	0.5	0.3	0.0	1.3	9.8	10.3	10.7	11.7	9.4	9.6	9.8	10.2	9.8	9.9	10.0	9.9	1.2	3.2	9.2	11.4	3.6	2.8	12.1	3.1	3.4	17.4	1.2	1.3	21.8	14.3	6.3	0.0	20.9	25.6	1.4	13.8	0.0	0.8	2.5	0.7	1.6	3.2	12.7	8.8	8.7	0.7	8.8	4.5	15.8	1.0	7.6	2.0	3.9	42.4	5.0	8.4	8.5	18.4	2.0	3.8	2.9	1.6	10.5	2.6	5.4	7.5	1.8	26.0	7.2	6.0	6.6	0.6	18.9	6.4	1.1	6.7	33.3	1.1	6.6	19.3	6.6	5.2	3.1	1.9	0.3	2.2	2.7	10.3	3.8	1.0	31.6	10.9
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3018.1"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.6	3.0	3.6	6.0	3.5	1.0	37.8	3.5	4.9	38.2	5.6	32.6	23.2	23.4	17.9	9.8	30.5	28.5	16.9	3.6	4.9	18.4	3018.1	18.5	3.5	4.5	4.2	58.1	30.8	5.3	5.0	3.8	4.3	32.7	45.7	2.2	52.6	13.3	6.2	27.4	27.1	10.4	4.5	7.4	58.2	10.2	3.7	1.5	8.8	10.5	4.1	24.8	31.4	4.8	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.5	3.5	4.9	3.6	4.9	4.5	4.2	4.3	4.5	3.7	4.8	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 409.8"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 151.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"Hep G2: 37.0;MCF7: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	350000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	35.7	0.8	1.1	0.2	1.0	0.1	22.5	0.1	1.7	1.2	0.0	1.4	0.4	0.9	1.6	0.3	0.8	0.4	1.8	0.9	0.6	4.0	409.8	0.4	0.1	0.7	0.6	1.1	0.9	0.0	0.3	0.1	0.5	0.8	0.0	0.1	1.3	0.1	0.8	0.9	1.2	0.1	0.3	0.4	0.7	0.5	1.1	0.0	1.0	0.0	0.0	1.1	1.0	0.9	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	1.3	37.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	21.2	0.0	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.0	0.3	0.0	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	1.7	0.9	0.6	0.7	0.6	0.5	0.3	1.1	0.9	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.4	0.2	0.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	2.7	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	4.6	151.2	0.1	0.0	0.0	0.0	0.0	4.4	0.0	1.9	0.9	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.1
ANKRD65		ENSG00000235098	"Ankyrin repeat domain 65"	E5RJM6	1	1418420-1421769	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 65.0;Glandular and luminal cells: 88.4;Respiratory ciliated cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"myeloid DC: 3.5;plasmacytoid DC: 7.8"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 7.8"	"Group enriched"	"Detected in some"	8	"Hep G2: 35.9;RT4: 34.5;SCLC-21H: 46.3"	"Not detected"	"Not detected"							HPA065720	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA065720: AB_2685545"	"unprognostic (2.17e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.64e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.76e-2)"	6.0	1.0	24.6	3.2	29.5	0.2	10.3	25.6	25.9	8.8	18.5	14.2	2.3	7.6	5.9	15.6	36.7	2.9	4.1	22.0	25.2	6.0	1.5	11.2	9.1	31.0	28.5	8.5	15.2	1.4	2.3	6.9	29.4	19.9	1.7	2.5	16.1	21.9	3.1	7.0	6.3	4.0	24.0	1.6	9.9	7.3	25.7	7.8	4.3	3.3	7.2	21.1	9.4	34.8	1.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.5	0.9	0.0	4.5	0.3	4.3	0.0	0.5	0.4	0.0	0.0	35.9	0.8	0.1	0.0	0.4	5.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.2	0.1	0.0	0.3	4.6	0.0	0.0	34.5	46.3	0.5	0.2	0.0	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.2	24.6	29.5	25.6	25.9	22.0	25.2	31.0	28.5	29.4	24.0	25.7	34.8	11.8	22.4	29.0	5.5	0.1	2.2	12.9	14.1	13.1	8.5	5.9	32.5	0.7	14.3	20.1	1.8	0.0	26.0	0.0	0.0	9.8	19.0	0.0	65.0	20.5	11.7	1.8	2.7	4.4	30.7	0.8	13.3	3.1	88.4	8.8	2.9	1.4	0.8	2.2	8.4	2.0	0.0	14.2	1.0	3.3	0.9	20.8	1.5	3.6	1.0	1.2	16.6	0.0	3.5	20.5	11.0	0.1	29.0	0.1	6.3	0.0	0.5	51.8	3.1	0.0	25.7	3.6	0.3	0.3	10.7	3.1	16.8	1.1	0.7	0.0	10.8
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 12.3;kidney: 5.9;liver: 13.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	2.1	0.2	0.0	0.0	8.9	9.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.1	0.2	0.0	0.0	0.7	0.1	12.3	0.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;prostate: 69.6;stomach 1: 28.1"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 53.4"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.2;Hep G2: 2.3;OE19: 2.5"	"Low region specificity"	"Detected in many"							HPA078464	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.3	0.3	0.2	1.0	0.7	3.6	0.2	0.2	1.0	0.3	0.0	16.3	10.7	0.5	0.0	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.0	1.2	0.2	0.5	0.4	0.0	0.2	0.1	0.4	69.6	10.1	0.0	4.9	0.2	0.0	0.2	14.7	0.1	0.3	0.3	28.1	0.2	0.8	0.0	0.2	0.0	0.0	0.2	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.2	1.0	0.2	0.2	1.2	0.2	0.4	0.3	0.8	1.6	1.2	0.0	0.0	1.6	0.7	0.3	0.8	0.8	1.2	0.2	1.9	2.7	1.6	0.0	0.2	0.0	0.0	0.6	0.1	2.6	0.0	2.7	0.1	0.8	0.7	2.1	3.0	0.0	4.8	4.2	5.6	2.0	80.0	1.9	0.0	12.4	2.9	3.9	1.5	0.0	2.7	53.4	0.0	1.3	0.0	0.0	3.4	0.7	1.8	7.5	0.0	1.4	0.0	1.0	6.9	6.4	1.9	2.2	0.5	11.9	3.6	2.8	0.0	0.6	0.0	0.8	1.0	0.1	1.7	0.1	0.0	0.7	0.3	2.6	2.4	0.8
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 subunit mu 2"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 162.0;Proximal tubular cells: 373.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.3;neutrophil: 7.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 172.8;Hep G2: 313.8;MCF7: 268.3;OE19: 156.7;RT4: 164.9;U-2 OS: 166.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA054999: AB_2682666"	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	3.4	0.1	0.8	6.4	0.3	0.9	32.9	0.6	0.8	27.1	0.3	67.1	64.0	6.6	61.8	51.9	46.6	22.7	0.4	0.5	0.4	76.3	1.5	19.2	0.4	0.7	0.6	0.3	55.9	62.4	34.8	16.2	0.4	30.8	63.4	0.1	41.5	24.0	0.3	42.1	54.8	3.0	0.3	0.6	59.1	9.6	0.7	4.2	58.8	0.3	9.5	23.4	19.1	0.6	144.2	71.1	0.4	10.4	0.0	0.0	65.0	0.2	0.0	2.3	1.6	172.8	82.1	0.4	64.7	1.2	43.4	97.6	0.1	109.0	3.2	0.6	1.0	6.7	48.5	313.8	1.3	0.3	0.8	0.2	81.6	3.9	0.1	5.0	0.0	0.4	0.3	0.6	1.2	268.3	0.6	1.8	31.4	156.7	0.0	2.4	9.3	0.7	2.7	164.9	67.3	0.2	0.0	120.0	0.6	34.6	123.3	0.4	0.0	0.4	166.7	0.9	2.2	0.4	0.9	1.4	0.2	0.4	0.2	4.3	0.4	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.6	0.0	1.4	0.2	0.0	2.7	0.8	0.3	0.6	0.8	0.5	0.4	0.7	0.6	0.4	0.3	0.7	0.6	0.4	28.9	34.8	0.0	1.9	6.9	19.2	68.9	13.1	0.0	49.3	30.0	0.5	47.1	64.2	86.5	0.0	123.0	0.5	112.2	137.0	141.3	43.4	52.4	5.4	1.7	74.4	0.0	0.3	115.8	101.0	1.5	73.4	57.7	2.5	0.0	0.7	0.0	9.8	0.0	0.2	95.5	97.6	0.8	0.0	19.9	1.5	2.6	3.6	0.0	1.7	0.0	0.0	0.0	0.2	130.2	125.6	0.7	0.0	37.6	162.0	373.6	61.5	0.0	0.0	0.0	6.2	16.9	4.1	39.1	13.1	66.1	2.8	0.0	131.4	48.3
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837622	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 19248.5"	"Group enriched"	"Detected in many"	21	"Hepatocytes: 27332.1;Proximal enterocytes: 18348.1"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	17	"Hep G2: 3460.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	110000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	3.2	1.4	1.2	3.6	1.2	0.0	2.1	1.1	1.4	0.8	0.8	7.4	1709.3	3.5	0.4	1.1	6.1	1.7	67.2	1.0	1.1	3.7	19248.5	2.7	3.2	1.1	1.1	23.1	2.5	0.0	4.2	1.6	1.1	1.1	0.2	0.1	0.7	1.0	0.8	1.0	4053.7	2.1	1.1	9.0	14.6	384.5	1.2	0.9	3.7	0.2	0.1	0.5	1.5	1.2	0.0	0.0	0.6	0.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	203.4	0.3	3.1	6.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	7.3	1.9	3460.4	0.0	16.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	0.3	15.0	1.2	1.2	0.1	0.5	15.0	20.3	0.0	2.6	5.7	20.7	8.9	0.0	0.0	3.9	0.0	0.1	2.6	0.0	0.4	2.1	0.1	1.2	0.2	4.9	0.0	5.5	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.5	0.0	0.2	0.0	1.2	0.6	0.1	1.2	1.2	1.1	1.4	1.0	1.1	1.1	1.1	1.1	1.1	1.2	1.2	2.0	3.2	3.3	0.3	49.7	0.1	0.5	0.2	0.6	0.5	0.9	0.9	37.0	479.0	1.3	0.0	0.0	0.6	5.1	0.4	0.0	0.1	36.9	15.2	4.3	50.3	1.8	541.9	0.5	1.1	4.2	5.8	17.9	1.7	2.5	419.2	458.7	27332.1	3.3	0.0	0.8	458.8	0.0	681.2	2.0	149.7	22.4	2.1	0.0	0.0	0.0	0.3	3.1	0.0	0.3	0.3	458.2	4.9	1.0	0.1	18348.1	9.0	0.4	0.6	6.6	1.6	13.0	39.8	11.2	0.0	0.6	4.2	35.7	1051.7	175.7	0.3
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1388	"liver: 36012.6"	"Cell type enriched"	"Detected in some"	75	"Hepatocytes: 50065.8"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 16822.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	92000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	3.8	1.1	0.7	0.7	0.6	25.9	1.8	0.5	1.4	0.9	1.0	0.7	0.0	0.7	0.1	1.0	1.9	0.0	2.0	0.6	0.8	9.5	36012.6	2.1	0.3	1.1	0.8	0.7	2.0	0.0	1.2	1.3	1.1	0.6	0.5	0.0	0.6	0.0	0.6	0.9	0.9	0.0	0.8	7.7	1.9	1.2	0.7	0.4	0.8	0.0	0.3	0.4	0.8	1.0	0.0	0.6	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1814.4	0.0	3.6	0.0	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	5.8	10.0	16822.4	0.0	19.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.7	0.7	1.5	0.0	1.1	1.3	14.6	0.3	0.0	11.3	0.8	0.0	7.8	0.0	0.2	5.2	0.1	0.0	4.1	0.0	0.1	0.0	0.0	3.8	0.0	5.2	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.6	0.5	1.4	0.6	0.8	1.1	0.8	1.1	0.8	0.7	1.0	0.0	0.0	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	480.4	0.0	0.0	0.0	0.8	0.0	0.1	1.9	0.0	1.7	0.0	0.0	22.5	0.0	323.6	0.0	0.6	6.4	0.2	0.0	0.0	0.0	0.0	425.9	50065.8	4.7	0.0	0.0	0.2	0.0	665.8	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	9.8	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	5.6	26.0	0.0	0.0	0.0
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	216	"liver: 582.1"	"Cell type enriched"	"Detected in some"	88	"Hepatocytes: 1249.5"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	55	"Hep G2: 35.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	114000000	21000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	582.1	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	35.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.4	1249.5	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	143	"intestine: 304.3;liver: 1191.0"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 2967.4;Proximal enterocytes: 1585.9"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 1079.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	2.7	0.0	0.1	0.2	0.2	0.1	0.9	0.1	0.1	0.7	0.2	0.4	181.4	0.2	0.0	0.1	0.1	0.5	5.2	0.1	0.3	0.3	1191.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.5	304.3	0.2	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1079.8	0.0	0.6	0.1	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	277.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	1.6	3.5	0.0	104.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	52.8	2967.4	0.1	0.0	0.2	30.8	0.0	69.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.5	0.0	0.0	1585.9	0.6	0.0	0.0	0.0	1.1	0.2	0.5	0.3	0.0	0.0	0.0	3.9	0.9	14.5	0.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 16232.1"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 33405.9"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 5.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 576.4;HSkMC: 332.9;K-562: 151.6;SK-MEL-30: 268.0"	"Low region specificity"	"Detected in all"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	15000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	59.2	1998.1	90.3	28.1	133.0	52.2	87.1	83.3	338.1	29.0	73.6	29.1	13.1	11.0	42.0	5.9	21.2	31.0	10.9	75.3	109.8	14.6	16232.1	289.9	140.1	133.2	152.8	56.4	21.4	16.3	23.6	41.7	121.9	14.4	16.7	15.1	35.5	2.2	22.2	73.1	49.1	4.0	92.7	254.9	22.7	18.7	139.2	37.4	36.3	6.1	33.9	23.5	11.3	169.4	2.7	26.5	12.0	5.0	37.1	38.2	111.5	1.3	1.7	4.8	7.3	55.6	49.9	8.4	9.4	1.0	3.2	1.8	15.6	1.9	2.3	0.4	63.5	36.8	4.2	576.4	32.9	27.5	18.1	332.9	2.8	4.8	1.8	9.2	1.3	1.8	151.6	0.8	1.7	3.6	1.5	2.0	112.4	10.4	5.6	6.2	16.0	0.8	7.3	2.0	5.3	3.3	18.9	0.3	268.0	37.7	2.2	98.4	4.2	0.4	1.7	0.2	1.7	4.5	5.4	8.2	0.7	7.4	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.3	90.3	133.0	83.3	338.1	75.3	109.8	133.2	152.8	121.9	92.7	139.2	169.4	22.9	115.4	214.4	2.3	40.6	17.0	4.1	5.8	6.2	2.5	49.8	92.8	0.8	453.2	55.8	1.8	0.0	31.7	1.6	2.4	49.0	4.6	1.2	6.6	128.4	68.9	2.4	768.8	0.3	4.0	341.3	93.0	19.4	5.0	142.6	30.6	432.6	33405.9	4789.8	0.0	0.5	3.2	4.1	867.7	27.3	22.8	270.9	620.5	30.2	3.7	124.5	276.0	0.0	0.0	0.0	3.2	0.3	259.5	1.3	4.2	0.6	16.6	24.4	9.9	19.7	1628.8	24.4	2.0	3.2	3.7	17.8	71.6	46.7	1226.7	2.1	5.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27649.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			4.1	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.4	0.0	7.2	907.0	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.2	27649.0	1.4	0.9	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.2	1106.7	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360568-56362857	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	344	"liver: 416.7"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 341.9"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	18000000000	2200000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.3	0.1	0.2	0.2	0.1	0.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	416.7	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.4	4.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.7	0.3	0.2	0.0	0.3	0.1	0.3	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.3	8.6	0.0	0.0	2.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.4	0.0	16.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	5.0	341.9	0.0	0.0	0.0	0.1	0.0	10.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	563	"liver: 17965.3"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.9	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.6	0.2	0.0	31.9	17965.3	5.6	0.3	0.2	0.1	0.2	10.9	0.0	0.2	0.4	0.1	0.2	0.7	0.2	0.1	0.3	0.1	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
APOM	"G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 390.7"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 665.9;Proximal tubular cells: 681.1"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 38.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	8200000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	4.9	5.3	0.6	0.1	0.6	2.5	5.2	1.0	0.9	3.7	0.5	3.8	0.6	3.9	1.0	4.1	4.1	0.5	3.5	0.6	0.7	93.7	390.7	2.6	0.6	0.7	0.7	6.2	6.0	0.7	4.7	0.1	0.7	3.8	0.4	0.4	3.5	0.5	7.2	6.4	9.0	0.4	0.7	4.1	5.3	16.0	0.6	1.2	5.5	0.6	1.1	3.3	3.3	0.8	0.5	0.3	0.6	0.7	0.6	0.8	0.0	0.4	1.1	0.4	0.9	3.2	1.0	1.4	0.2	1.1	0.2	0.6	0.4	0.6	0.8	0.8	0.7	0.8	0.3	38.2	1.3	1.7	0.1	1.2	0.4	0.3	1.0	0.5	0.3	0.9	1.2	0.4	1.1	1.1	1.1	0.9	0.5	0.6	0.2	0.8	0.4	1.5	1.1	0.6	0.5	0.2	0.4	0.0	0.5	0.2	1.5	1.2	0.4	0.2	0.1	0.3	0.3	1.1	1.2	1.5	0.2	1.8	0.1	3.0	0.6	0.6	0.3	0.3	0.5	1.1	0.4	0.3	0.5	0.5	0.5	0.6	0.4	0.3	0.7	0.3	0.7	0.3	0.6	0.6	1.0	0.9	0.6	0.7	0.7	0.7	0.7	0.7	0.6	0.8	1.5	0.0	7.4	2.3	9.0	6.4	6.7	6.7	9.1	1.5	6.6	12.4	1.6	12.8	3.0	14.7	4.2	2.0	1.6	4.1	76.3	4.3	60.2	5.2	3.1	2.0	4.2	11.4	0.3	6.9	0.9	4.3	5.1	1.6	5.1	1.8	8.9	665.9	5.4	0.0	0.4	4.9	2.0	14.5	4.2	38.4	9.3	6.1	5.4	0.0	2.5	14.6	1.0	0.5	1.3	6.4	4.9	6.4	7.4	4.2	81.4	681.1	4.6	2.5	0.0	6.2	3.1	33.1	6.6	5.3	6.5	1.2	5.6	4.6	6.5	6.1
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610356	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.6;liver: 16.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.0;Hepatocytes: 35.9;Late spermatids: 65.0;Muller glia cells: 30.7;Proximal enterocytes: 33.2;Spermatocytes: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;GAMG: 12.3;Hep G2: 13.6;OE19: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	13.2	3.4	0.7	3.0	0.6	1.2	4.6	3.3	0.8	1.0	2.3	28.6	0.8	1.0	0.4	0.8	1.2	0.8	2.6	3.4	6.0	16.1	0.5	0.8	3.3	3.1	6.0	4.0	0.5	1.5	0.8	3.5	4.0	2.1	5.6	0.7	0.4	0.9	0.9	25.3	0.4	2.7	0.9	2.4	8.1	3.0	0.1	1.5	0.2	0.1	0.8	0.6	3.0	1.0	3.4	1.4	2.2	3.1	0.8	1.3	1.6	0.8	1.6	0.7	8.2	1.6	1.6	0.7	0.8	12.3	0.9	0.6	0.1	0.8	4.7	1.2	1.3	1.3	13.6	1.0	2.8	1.4	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.9	1.0	1.9	1.7	0.9	2.0	1.4	7.8	3.1	1.3	3.3	0.6	0.9	1.2	1.3	0.9	2.1	0.5	0.8	1.1	1.5	0.3	0.9	1.2	3.7	2.4	1.0	1.0	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.6	0.2	0.0	0.7	0.0	0.0	0.0	0.2	3.4	3.0	4.6	3.3	2.6	3.4	3.3	3.1	3.5	2.7	3.0	3.0	0.6	0.0	0.0	3.9	0.8	0.1	0.9	0.4	1.8	7.5	2.1	1.3	0.7	7.2	0.2	1.8	0.0	7.5	0.6	10.8	0.0	1.1	42.0	1.2	0.8	0.5	4.2	0.0	13.5	4.0	11.4	1.5	3.6	0.8	4.5	17.1	0.4	35.9	1.2	0.0	14.6	2.9	0.0	0.6	0.4	65.0	15.5	0.5	1.8	1.0	0.0	30.7	0.0	9.0	9.9	2.5	5.5	11.3	0.3	1.4	33.2	19.9	0.2	5.0	0.0	0.5	1.2	56.0	6.4	0.4	0.1	15.9	0.7	21.4	6.4	0.4
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228932	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	641	"intestine: 330.0;pancreas: 1280.1"	"Group enriched"	"Detected in some"	45	"Distal enterocytes: 1005.1;Paneth cells: 379.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.4;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.3	0.2	0.6	0.4	0.7	0.4	0.3	0.7	0.8	0.5	0.3	330.0	0.2	0.5	0.0	0.1	0.3	0.0	0.2	0.7	0.5	0.2	0.7	0.1	0.0	0.4	0.4	0.6	1280.1	0.0	0.1	0.1	0.4	0.3	160.3	0.1	0.1	0.3	0.1	0.4	0.2	1.2	0.4	0.1	0.8	0.5	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.8	0.7	0.5	0.4	0.4	0.4	0.4	0.6	0.6	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1005.1	0.0	0.1	1.4	0.2	1.3	0.1	13.1	0.0	0.8	11.0	0.1	0.0	0.0	0.3	8.9	0.4	0.0	0.0	0.1	1.7	0.6	15.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	379.5	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.4	1.7	0.2	12.9	0.1
ARHGEF10L	"FLJ10521, KIAA1626"	ENSG00000074964	"Rho guanine nucleotide exchange factor 10 like"	Q9HCE6	1	17539698-17697874	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	41	"classical monocyte: 18.8;intermediate monocyte: 18.0;myeloid DC: 13.4;non-classical monocyte: 4.8"	"Group enriched"	"Detected in many"	48	"dendritic cells: 13.4;monocytes: 18.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026426, HPA026440, HPA028115"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285"	"unprognostic (4.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (8.13e-5)"	"unprognostic (3.61e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.21e-3)"	22.2	10.5	11.9	11.4	10.9	1.7	16.5	38.7	11.4	24.2	13.8	29.4	15.9	16.2	4.6	28.1	16.0	11.9	30.2	10.3	12.2	32.5	87.5	13.0	4.5	19.4	18.5	10.4	43.9	17.0	7.9	5.9	19.4	18.4	12.9	4.0	25.9	19.5	66.2	40.9	21.7	8.7	10.9	9.7	20.8	3.7	17.7	1.6	18.0	35.5	4.3	24.6	21.7	9.3	8.0	9.1	11.3	3.9	19.1	6.3	7.6	5.4	10.6	6.3	5.3	9.5	23.6	0.0	9.8	10.2	8.8	6.0	1.6	2.9	1.2	0.2	2.9	0.0	9.5	26.9	4.2	0.0	0.0	8.5	5.5	3.9	1.1	12.7	1.2	0.0	0.0	0.2	17.8	7.7	0.0	0.2	4.9	12.2	0.0	0.0	4.5	3.0	13.4	16.4	16.5	12.2	4.2	2.9	12.3	3.2	11.0	9.5	0.0	5.5	6.5	6.5	2.3	0.0	2.5	0.0	8.5	0.2	3.0	0.0	18.8	0.0	0.0	18.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	7.6	11.9	10.9	38.7	11.4	10.3	12.2	19.4	18.5	19.4	10.9	17.7	9.3	1.3	3.2	7.4	82.6	1.0	5.7	5.3	7.2	5.2	16.1	13.7	12.3	36.4	20.0	13.9	31.3	2.1	0.7	0.1	41.6	9.8	19.8	15.9	3.4	4.2	2.1	37.8	2.7	16.7	20.3	0.6	8.5	17.9	6.5	0.0	3.9	2.5	43.7	26.0	10.1	23.8	45.5	8.2	8.6	26.4	8.9	5.0	18.6	3.6	19.7	9.6	14.6	0.0	24.6	7.1	11.7	24.9	6.8	0.2	5.9	13.6	18.3	9.4	5.4	13.1	10.8	18.3	11.9	1.6	8.0	8.7	1.0	0.6	0.3	46.1	12.1
ARHGEF3	"DKFZP434F2429, GEF3, STA3, XPLN"	ENSG00000163947	"Rho guanine nucleotide exchange factor 3"	Q9NR81	3	56727418-57079329	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 157.8;NK-cells: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 88.8;RPMI-8226: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034715, HPA064945"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA034715: AB_10600780, HPA064945: AB_2685389"	"unprognostic (1.84e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (8.25e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (9.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.99e-2)"	"prognostic favorable (1.96e-7)"	"unprognostic (8.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-2)"	16.8	43.2	11.2	20.6	14.8	9.8	13.8	14.4	17.4	16.0	30.9	14.3	6.4	38.0	12.5	19.0	23.2	22.3	12.7	25.9	10.8	25.3	5.2	24.8	29.3	11.2	9.1	20.6	29.1	52.3	21.6	21.3	10.7	14.8	13.5	8.2	21.5	15.3	8.0	12.6	9.6	34.5	7.6	21.5	15.8	14.3	11.6	36.1	14.2	8.5	28.7	17.2	11.6	12.8	24.2	8.4	1.2	7.7	2.7	2.2	16.5	2.6	2.2	2.6	3.4	4.1	22.3	12.6	2.5	4.7	25.3	12.1	7.2	30.8	3.0	18.4	3.5	10.3	5.2	88.8	6.6	0.0	10.9	9.7	19.9	2.3	3.5	23.6	25.5	13.3	2.9	27.2	5.9	3.7	34.8	1.3	2.3	19.5	12.9	0.2	9.2	92.2	19.8	13.2	1.4	3.8	15.3	11.2	6.9	8.5	2.9	10.6	11.8	1.3	6.0	5.4	4.0	35.0	14.2	45.1	21.7	12.2	10.9	20.6	23.0	3.7	96.1	25.5	72.5	26.0	73.6	85.0	13.9	16.9	59.3	73.5	8.3	39.7	32.2	5.9	67.4	76.0	11.2	14.8	14.4	17.4	25.9	10.8	11.2	9.1	10.7	7.6	11.6	12.8	22.7	16.0	22.4	30.0	24.2	11.1	8.6	16.3	32.5	9.5	7.6	9.9	9.8	2.8	12.6	23.9	4.2	11.4	57.5	4.8	11.7	11.0	22.6	10.1	7.0	40.3	9.6	14.1	157.8	10.2	7.9	13.5	36.2	16.5	13.9	4.8	22.9	0.1	7.6	0.0	70.8	1.3	2.0	38.1	8.2	14.1	17.7	18.7	10.6	63.7	19.9	9.0	137.0	68.3	80.0	7.5	1.4	24.0	22.1	11.2	0.2	7.3	9.5	1.2	0.0	8.0	4.4	3.3	2.6	37.9	14.9	11.9	64.3	3.2	3.2	13.4
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540233	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.1;skeletal muscle: 34.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.2;Cardiomyocytes: 3.2;Early spermatids: 2.3;Late spermatids: 2.0;Respiratory ciliated cells: 2.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.9;Hep G2: 7.9;SCLC-21H: 4.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.5;hypothalamus: 31.7"	"Region enriched"	"Detected in single"	10	"midbrain: 4.3"	HPA055240	Uncertain					NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055240: AB_2682753"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.1	47.1	1.8	0.2	2.3	0.6	0.4	2.3	2.1	0.1	1.5	0.1	0.3	0.1	0.2	0.3	0.3	0.2	1.9	1.8	2.4	0.2	1.5	0.6	0.3	2.5	3.8	0.2	0.7	0.0	8.4	2.1	2.6	0.2	0.1	1.3	0.6	0.2	34.2	0.3	0.4	0.1	1.8	0.3	0.6	0.3	2.2	0.2	0.3	10.5	0.1	0.0	0.0	2.8	0.2	4.9	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	4.7	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.3	2.3	2.1	1.8	2.4	2.5	3.8	2.6	1.8	2.2	2.8	0.1	0.0	0.5	7.2	0.0	0.1	0.1	0.5	0.0	0.0	0.4	0.1	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	2.0	0.6	0.0	0.0	1.0	0.0	0.0	1.0	1.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.7	0.1	0.9	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.1
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins, Predicted secreted proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1092.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1107.9"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 41.2;monocytes: 115.2"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 493.2"	"Region enriched"	"Detected in all"	9	"cerebellum: 44.1"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA		10000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	2.6	1.5	7.7	3.7	7.8	2.5	1.8	17.0	10.9	1.6	7.0	1.2	2.2	1.3	0.6	1.7	1.8	2.9	1.1	7.9	7.6	1.4	1092.3	3.9	1.3	8.0	8.2	1.1	0.9	7.0	2.9	0.5	8.3	1.7	0.5	4.8	0.9	0.3	1.5	4.4	1.4	1.3	6.0	4.8	1.4	26.5	7.8	0.4	5.8	0.4	0.3	1.7	1.5	8.7	0.3	0.7	9.2	4.2	0.0	0.2	0.8	0.8	0.9	0.9	1.6	16.8	0.5	0.3	1.1	0.2	0.4	0.2	0.3	0.2	0.4	0.3	0.8	1.2	1.4	493.2	0.1	0.8	1.7	1.2	0.2	0.5	0.1	0.6	8.4	7.4	1.1	0.6	0.5	0.4	0.7	1.2	1.7	0.2	0.4	0.9	3.5	0.2	0.1	0.7	0.6	3.5	0.7	0.3	0.6	1.5	0.5	0.2	1.2	0.9	3.4	0.7	0.4	0.2	0.3	0.5	0.6	0.4	0.3	10.0	115.2	0.4	0.2	55.5	1.1	0.5	0.2	0.2	41.2	0.5	0.3	0.4	3.3	0.5	14.9	1.8	0.3	36.7	7.7	7.8	17.0	10.9	7.9	7.6	8.0	8.2	8.3	6.0	7.8	8.7	6.0	0.0	4.7	2.9	2.6	3.2	1.7	2.0	3.4	37.8	5.6	6.0	1.5	55.8	2.0	3.7	160.6	3.6	2.9	1.4	3.9	0.9	235.4	4.2	3.6	13.2	15.6	16.8	4.6	0.2	3.7	1.9	3.6	16.5	0.0	5.1	27.5	1107.9	39.9	15.2	4.8	2.3	2.0	97.4	11.9	115.8	2.5	52.6	0.0	1.9	77.2	3.6	0.0	2.0	0.6	0.3	1.3	1.2	0.0	0.9	0.2	6.8	1.6	42.3	0.0	0.8	1.9	6.5	9.7	9.9	4.8	12.4	1.4	1.6	1.3	2.4
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"liver: 840.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 878.6"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 528.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	1.5	0.3	0.8	7.9	1.0	7.0	0.5	0.9	1.3	0.4	1.3	0.5	0.3	0.3	0.1	0.5	0.6	17.6	0.5	0.8	1.0	1.2	840.7	2.5	0.9	1.0	1.1	0.2	0.5	0.1	0.2	0.5	1.2	0.4	0.4	0.0	0.5	0.2	0.2	5.2	0.6	1.3	1.0	6.8	0.5	0.5	1.4	0.5	0.3	0.1	1.0	2.0	0.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	528.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.0	110.0	0.8	0.1	11.2	0.2	0.0	0.0	0.0	64.1	0.0	0.1	0.0	1.7	0.1	0.1	1.6	0.3	31.8	0.8	1.0	0.9	1.3	0.8	1.0	1.0	1.1	1.2	1.0	1.4	1.2	0.0	0.0	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	150.2	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.4	0.0	0.0	1.3	7.1	19.6	1.9	0.0	0.2	0.1	0.0	0.1	2.5	0.0	16.1	878.6	8.4	0.0	0.1	0.1	0.0	41.1	7.7	0.7	0.0	19.6	0.0	0.0	15.3	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.4	1.4	0.0	0.0	0.1
ASPHD1		ENSG00000174939	"Aspartate beta-hydroxylase domain containing 1"	Q5U4P2	16	29900375-29919864	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 138.6;choroid plexus: 79.3;pituitary gland: 36.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 27.1;Enteroendocrine cells: 29.4;Excitatory neurons: 25.1;Gastric mucus-secreting cells: 32.1;Inhibitory neurons: 22.6;Oligodendrocytes: 29.3;Pancreatic endocrine cells: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 61.7;Hep G2: 79.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045175	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA045175: AB_10959899"	"unprognostic (1.58e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.34e-3)"	"unprognostic (6.96e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.37e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (5.55e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.03e-2)"	5.5	5.1	113.3	0.7	119.8	0.1	0.8	106.3	138.6	1.3	79.3	1.3	2.5	3.0	0.1	0.4	1.3	14.8	0.8	108.6	101.7	4.4	0.7	1.1	0.2	113.3	113.9	1.3	9.1	0.8	36.4	0.2	111.9	1.5	0.9	2.3	4.9	0.5	0.2	0.3	1.7	1.4	110.4	0.3	20.9	5.9	110.1	0.0	0.1	0.2	0.2	0.8	0.4	117.6	3.3	14.5	0.0	16.7	0.0	2.4	0.9	15.8	5.1	18.0	12.9	35.1	61.7	6.2	39.4	10.5	13.0	2.4	2.0	4.2	3.4	1.0	2.4	3.1	50.9	79.1	29.1	0.7	40.5	18.3	3.9	26.7	2.7	19.4	0.7	11.3	0.2	13.1	4.3	32.1	0.9	0.6	23.0	13.7	13.8	1.2	0.0	2.5	18.4	0.4	47.3	19.3	0.2	26.1	5.2	0.3	10.0	11.9	1.2	7.5	13.2	0.4	4.5	1.1	0.4	0.6	23.7	41.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.3	119.8	106.3	138.6	108.6	101.7	113.3	113.9	111.9	110.4	110.1	117.6	0.7	0.0	5.1	4.9	0.1	0.6	4.8	2.5	0.0	19.2	4.3	3.9	0.3	27.1	0.5	1.8	4.2	0.0	0.0	2.6	1.9	17.3	1.9	0.7	9.4	0.9	29.4	0.0	25.1	20.2	0.4	7.8	32.1	1.4	1.3	0.5	0.0	0.2	4.0	6.7	22.6	4.2	6.1	0.0	0.3	1.2	0.3	0.9	1.8	5.6	0.0	1.7	0.0	9.0	29.3	29.3	0.3	0.7	0.1	8.1	1.7	3.7	0.3	10.2	0.0	0.2	2.5	1.2	1.0	0.0	0.6	0.3	0.2	4.8	4.2	2.8
ASPSCR1	"ASPL, ASPS, TUG, UBXD9, UBXN9"	ENSG00000169696	"ASPSCR1 tether for SLC2A4, UBX domain containing"	Q9BZE9	17	81976807-82017406	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"Hep G2: 298.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026749	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA026749: AB_1845114"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.01e-2)"	16.5	20.4	16.6	8.4	17.0	15.0	16.9	16.5	20.4	16.2	17.7	16.0	13.6	15.6	7.9	16.8	14.0	7.7	26.1	16.2	15.5	27.3	57.9	17.3	12.2	20.1	16.6	13.4	22.8	14.8	30.6	12.9	18.3	21.6	4.6	5.7	18.3	6.7	44.3	20.5	18.1	5.2	14.7	20.7	22.7	30.0	17.2	8.3	25.9	5.8	6.4	16.0	14.2	21.5	19.3	33.3	13.0	17.9	7.5	9.3	55.4	17.7	12.6	19.3	19.5	20.3	21.3	19.2	18.1	12.4	16.3	9.8	12.0	13.1	6.2	12.9	41.0	21.4	28.7	298.1	25.5	19.1	29.9	10.9	13.9	9.5	6.6	10.0	19.5	16.0	22.0	25.0	11.6	65.0	16.9	41.8	15.5	32.8	23.5	19.2	18.7	39.4	18.0	17.0	32.4	34.8	14.6	42.2	35.2	12.3	27.2	41.4	16.6	35.7	24.5	26.4	22.8	20.2	12.5	21.6	19.2	19.3	21.3	24.0	11.7	8.6	6.6	8.0	3.7	9.0	10.0	8.8	14.7	9.0	7.7	5.8	2.7	8.0	10.4	9.3	5.3	5.6	16.6	17.0	16.5	20.4	16.2	15.5	20.1	16.6	18.3	14.7	17.2	21.5	13.9	9.6	44.7	19.9	24.1	13.4	23.7	24.4	23.3	23.3	19.6	15.6	13.6	27.1	19.8	14.7	41.7	73.7	25.8	29.3	39.2	24.2	49.1	16.2	14.9	16.1	25.0	17.9	12.4	26.2	222.6	17.5	46.9	20.1	21.5	31.0	12.8	56.1	44.7	50.5	12.1	31.5	20.3	26.7	18.6	96.0	11.8	21.7	19.6	1.9	23.8	57.8	19.6	10.6	14.1	17.6	25.8	17.7	27.3	24.9	42.5	58.3	18.5	39.4	13.1	14.7	37.4	41.7	51.0	20.3	14.3	59.4	18.4	23.6	33.3	23.1
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported	Supported	Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	16.8	20.2	15.6	15.2	17.6	16.4	19.5	23.3	25.7	25.7	4.1	15.1	13.0	21.8	21.6	14.3	18.9	17.8	12.1	19.3	15.5	22.5	27.8	15.4	19.7	16.2	14.9	26.0	18.9	24.0	13.9	20.4	17.2	18.3	15.7	21.8	17.9	17.7	12.5	10.0	13.6	18.1	12.3	17.6	14.3	21.0	13.3	30.2	32.3	23.1	21.1	18.8	13.0	19.8	14.1	12.1	35.1	23.4	30.6	32.3	16.1	22.3	38.1	26.6	38.1	26.6	25.4	21.1	23.9	26.6	31.2	13.3	26.9	13.5	41.2	26.6	15.6	29.3	19.8	58.3	34.4	27.8	29.7	24.4	29.8	34.4	40.5	35.0	37.0	19.4	24.4	31.6	30.1	10.5	45.2	34.4	32.7	23.6	27.2	38.3	16.1	32.5	39.1	11.8	29.3	23.9	27.9	8.6	33.0	28.2	19.3	30.4	23.5	30.8	16.1	16.9	13.6	30.3	48.9	26.9	24.2	26.0	21.2	35.5	16.9	20.1	20.1	15.1	24.3	16.6	17.0	20.9	21.9	14.1	19.6	21.5	10.8	19.8	19.1	12.1	24.4	18.0	15.6	17.6	23.3	25.7	19.3	15.5	16.2	14.9	17.2	12.3	13.3	19.8	43.4	16.0	13.2	47.7	33.5	33.0	15.4	15.6	52.9	22.7	34.0	24.4	22.5	20.0	15.5	23.9	10.4	14.1	37.4	16.5	13.7	12.1	115.4	19.5	30.5	33.8	16.3	20.8	86.6	7.0	13.0	32.2	18.3	28.4	29.8	27.1	17.2	27.0	18.9	40.4	71.3	14.4	18.3	23.3	30.2	153.0	32.6	23.6	30.2	54.4	20.4	32.3	24.7	75.9	84.9	11.9	9.1	28.6	38.8	15.6	11.5	21.6	19.3	27.3	13.1	31.5	33.9	36.3	17.6	30.4	25.3	6.3	32.9	23.7	16.1	13.6
ATP6V0E2	"ATP6V0E2L, C7orf32"	ENSG00000171130	"ATPase H+ transporting V0 subunit e2"	Q8NHE4	7	149872968-149891204	"Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"brain: 328.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 123.7;Horizontal cells: 114.4;Muller glia cells: 173.0;Proximal tubular cells: 102.9"	"Cancer enhanced"	"Detected in all"		"glioma: 89.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 148.8;SCLC-21H: 169.4"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (8.72e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.26e-7)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.48e-3)"	21.8	30.0	270.4	11.4	284.5	5.7	17.7	242.5	309.4	9.5	149.4	33.6	7.6	9.3	9.2	10.5	21.9	9.4	117.7	328.6	256.5	57.0	118.0	12.9	23.3	305.6	287.9	10.4	22.7	41.5	134.9	4.1	324.6	44.3	8.0	50.4	66.1	30.7	16.4	14.8	19.0	9.9	236.5	24.0	33.8	8.1	300.3	30.9	55.5	15.6	13.5	12.1	8.8	235.7	26.2	72.2	29.6	96.3	11.9	1.9	18.5	13.4	18.2	36.0	36.8	25.7	32.1	53.5	55.2	17.9	37.5	22.9	63.2	22.6	15.4	69.4	70.2	16.7	21.0	148.8	17.8	12.3	35.3	4.1	23.1	39.8	2.4	27.9	30.2	66.3	18.3	25.5	2.6	45.0	8.8	28.2	25.7	33.7	50.6	57.8	1.2	24.7	28.4	28.0	169.4	96.0	17.4	60.0	41.9	7.2	33.9	8.1	5.7	10.4	11.0	109.6	50.3	35.4	49.2	26.5	65.9	21.4	34.4	4.4	9.0	2.2	45.9	17.5	41.7	19.6	56.5	53.4	18.5	17.8	71.9	66.6	1.5	38.6	22.2	8.5	92.9	31.6	270.4	284.5	242.5	309.4	328.6	256.5	305.6	287.9	324.6	236.5	300.3	235.7	3.7	16.0	11.3	35.6	14.1	4.2	4.1	3.4	0.6	123.7	31.1	23.5	29.6	21.5	8.5	27.6	25.0	19.5	23.2	1.9	54.8	45.5	0.4	13.6	1.9	6.7	22.2	9.5	39.9	12.8	4.8	8.8	10.2	20.9	10.8	21.9	11.4	65.1	24.7	114.4	62.3	26.2	22.4	10.2	4.1	1.6	5.3	9.9	44.4	14.0	6.4	173.0	27.8	34.7	34.2	5.6	0.7	11.3	4.5	15.0	0.9	102.9	6.7	78.9	6.6	8.7	10.0	0.9	13.2	6.9	4.4	5.1	38.1	6.6	2.5	5.6
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44788170	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 16.4;fallopian tube: 8.3;intestine: 27.4"	"Cell type enriched"	"Detected in some"	25	"Paneth cells: 1290.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-698: 1.8"					"Low region specificity"	"Detected in many"			HPA058564	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.2	1.9	1.2	0.7	1.1	0.7	0.5	2.2	1.3	1.6	16.4	27.4	9.1	0.7	3.0	0.2	8.3	0.2	0.3	0.8	1.7	0.5	0.6	1.9	0.6	1.9	3.3	0.5	0.3	0.3	2.7	0.2	1.5	0.4	16.0	1.1	0.3	0.5	0.4	2.2	8.1	0.5	1.3	0.5	0.4	0.7	1.6	0.5	0.6	0.1	0.4	0.3	0.2	1.0	0.0	0.2	0.3	0.4	0.1	0.1	1.1	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.5	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.2	0.0	0.8	2.5	0.1	0.0	0.3	0.2	0.3	0.1	0.2	0.6	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.8	0.3	0.1	0.1	0.1	0.2	0.4	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	1.8	0.4	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.8	0.6	0.7	0.0	0.5	0.2	0.5	0.1	0.3	0.0	0.3	0.6	0.1	1.2	1.1	2.2	1.3	0.8	1.7	1.9	3.3	1.5	1.3	1.6	1.0	0.2	0.0	0.0	0.0	0.8	0.3	0.8	3.4	0.0	0.8	0.4	1.0	0.5	0.0	4.2	5.5	0.0	0.3	0.4	31.2	1.9	0.7	0.0	26.7	0.5	0.2	2.4	0.0	1.9	0.8	0.2	0.6	0.5	1.2	0.0	0.3	0.4	0.0	0.3	0.0	4.3	3.2	0.0	0.0	0.9	0.2	0.9	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.6	1290.4	0.4	0.4	0.7	6.1	1.0	50.1	0.2	0.0	1.2	0.8	0.7	1.6	0.0	0.6	0.3	1.4	0.4	9.1	0.5
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 778.9;liver: 1141.8"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 604.2;Proximal tubular cells: 996.1"	"Group enriched"	"Detected in some"	4	"liver cancer: 90.6;renal cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.6;NTERA-2: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		10000000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.7	0.3	0.3	0.0	0.8	0.0	0.5	0.0	0.5	0.3	0.1	0.6	1.2	0.2	1.8	0.1	0.2	0.2	0.2	0.5	0.3	778.9	1141.8	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	3.2	0.3	0.3	0.5	0.4	0.0	0.0	11.6	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.5	0.3	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	4.3	0.0	16.5	0.0	0.0	0.0	0.0	78.2	0.0	0.5	0.1	0.8	0.8	0.0	13.5	0.9	0.0	0.1	0.1	8.2	0.2	0.0	0.1	8.9	604.2	0.0	0.0	0.2	0.4	0.0	12.2	0.0	0.5	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.6	0.0	0.0	0.0	996.1	0.0	0.4	0.0	0.2	0.1	0.2	1.0	0.0	0.0	0.1	4.2	0.5	0.1	0.3
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069767-79090069	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 333.1;liver: 429.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Hepatocytes: 201.2;Proximal tubular cells: 408.6"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 17.5;Hep G2: 78.2;hTEC/SVTERT24-B: 46.0;U-87 MG: 18.6"	"Not detected"	"Not detected"							HPA044573	Enhanced					NA	NA		1900000	"Cluster 17: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	31.3	16.6	5.6	3.0	6.0	0.3	15.5	4.5	5.0	8.5	14.2	15.7	1.7	12.1	37.6	7.6	7.6	7.4	13.6	4.9	7.3	333.1	429.9	3.1	1.3	5.2	7.0	7.8	1.8	0.5	12.3	0.4	6.2	12.0	2.4	1.3	2.1	14.4	10.2	2.4	6.1	13.0	4.7	0.6	9.1	3.8	6.9	0.9	18.8	4.8	1.0	18.1	3.8	4.7	0.0	0.2	0.1	0.1	8.5	6.0	2.8	7.8	17.5	4.0	7.7	0.0	0.1	0.1	0.1	9.7	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.4	0.4	78.2	6.6	0.4	0.1	7.3	0.0	46.0	0.0	7.9	0.0	0.0	0.4	0.4	1.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.2	2.2	0.1	0.5	0.0	0.1	0.5	0.1	0.2	0.0	0.3	0.1	0.3	0.1	0.1	0.1	0.3	18.6	0.4	0.1	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.3	0.0	0.1	0.0	0.0	5.6	6.0	4.5	5.0	4.9	7.3	5.2	7.0	6.2	4.7	6.9	4.7	1.4	6.4	0.5	6.2	1.2	0.8	0.4	0.1	0.0	1.5	0.2	0.1	4.4	1.5	0.0	46.0	2.1	0.2	0.0	0.0	95.9	0.1	0.5	0.4	11.7	2.9	1.2	2.7	4.1	0.0	0.4	17.3	0.0	0.4	0.0	4.5	2.5	201.2	0.3	0.0	0.6	0.1	0.0	4.4	1.2	1.3	27.4	2.5	0.0	11.2	0.3	4.2	0.0	2.0	0.6	0.0	0.0	37.2	0.1	0.4	0.0	408.6	0.1	1.2	6.6	6.2	3.1	0.4	0.5	0.1	1.0	0.3	2.2	30.0	0.0	1.0
BMP4	BMP2B	ENSG00000125378	"Bone morphogenetic protein 4"	P12644	14	53949736-53958761	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 47.3;Fibroblasts: 65.2;Hepatic stellate cells: 52.8;Pancreatic endocrine cells: 40.1;Skeletal myocytes: 51.0;Syncytiotrophoblasts: 34.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 28.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	12	"monocytes: 1.9;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 120.1;CAPAN-2: 298.6;Hep G2: 326.0;OE19: 219.1;SuSa: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006863, HPA066235"	Uncertain				"Secreted to blood"	NA	NA	162000000		"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB006863: , HPA066235: AB_2685641"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.45e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.24e-1)"	14.0	13.4	3.0	6.1	3.2	0.1	13.4	7.0	4.5	21.0	32.4	25.6	17.0	8.9	2.5	12.9	9.7	14.4	16.3	3.1	2.8	9.0	4.2	13.4	9.6	3.6	3.3	23.8	3.4	2.7	4.7	44.4	3.9	21.9	28.9	2.7	10.5	18.7	11.5	15.3	19.2	9.0	3.2	6.5	23.8	2.0	3.9	3.4	8.5	17.7	4.2	27.4	23.5	4.7	15.6	40.0	2.1	1.8	0.5	0.4	0.6	7.9	34.0	20.1	15.5	120.1	298.6	0.0	97.2	0.1	2.2	73.2	8.6	1.0	10.7	4.1	5.9	0.2	8.3	326.0	19.4	0.0	1.0	0.0	2.8	9.5	0.5	61.1	59.3	6.8	0.0	0.3	9.7	6.9	5.3	0.3	13.9	219.1	3.4	0.2	10.5	0.3	28.5	1.3	0.1	0.3	0.0	1.1	0.9	168.2	38.8	1.5	2.9	0.6	87.1	0.3	1.4	0.2	0.1	1.0	0.1	0.1	4.3	0.0	0.6	0.0	0.1	1.1	0.0	0.0	0.9	0.2	0.1	0.0	1.3	0.4	0.0	0.0	1.9	0.0	0.0	0.3	3.0	3.2	7.0	4.5	3.1	2.8	3.6	3.3	3.9	3.2	3.9	4.7	7.6	9.6	7.3	1.0	0.6	27.5	4.0	16.1	47.3	0.3	8.0	10.4	5.7	14.3	6.0	5.5	0.0	29.3	0.1	1.0	3.9	5.5	2.5	0.7	18.9	18.2	0.0	2.7	1.3	0.2	18.9	65.2	0.5	0.7	1.3	0.9	52.8	2.0	3.7	0.0	0.4	5.3	2.0	0.6	5.9	1.0	10.5	0.4	3.6	1.9	0.0	0.5	0.0	1.0	0.3	40.1	4.0	1.5	0.1	2.3	0.6	2.4	5.8	1.5	0.0	51.0	10.5	1.4	2.2	7.5	17.5	34.8	1.0	1.4	4.0	1.4
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007704-33023703	"Plasma proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"salivary gland: 2294.3"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 6.1;Breast myoepithelial cells: 9.1;Early spermatids: 4.8;Late spermatids: 9.3;Prostatic glandular cells: 7.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	582	"Hep G2: 232.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		36000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favorable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.4	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	99.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	1.8	0.0	0.0	2294.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	9.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6
BRMS1L	"BRMS1, FLJ39177, MGC11296"	ENSG00000100916	"BRMS1 like transcriptional repressor"	Q5PSV4	14	35826338-35932325	"Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046623	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA046623: AB_2679724"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.56e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.04e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (6.55e-5)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (6.87e-6)"	6.2	10.1	8.3	3.8	9.0	2.6	6.2	7.6	11.2	6.0	5.4	5.1	3.2	6.3	5.5	6.4	5.1	4.2	11.6	8.9	7.8	8.9	6.1	4.8	3.0	7.4	8.2	7.2	3.0	9.8	4.4	7.3	7.9	6.5	3.6	8.2	4.2	6.2	13.6	5.9	3.1	7.0	7.7	3.5	4.3	5.3	8.2	3.5	7.2	13.7	3.9	5.8	5.4	9.4	10.1	10.1	17.1	9.9	15.2	19.1	25.5	10.3	9.9	15.7	15.3	6.5	8.3	8.1	10.3	14.4	7.4	12.6	13.7	18.7	22.3	9.0	16.8	7.4	10.1	28.6	10.7	3.7	5.9	13.4	12.5	12.1	10.2	8.2	11.4	4.7	3.6	6.3	17.7	13.5	4.3	6.0	6.8	14.2	14.8	4.4	19.1	6.2	12.7	11.4	5.1	13.1	12.0	13.7	12.2	13.0	15.7	5.2	7.0	14.9	9.1	8.6	10.2	5.8	8.2	5.0	3.7	8.1	9.2	0.0	0.5	0.3	1.0	1.2	0.8	0.7	1.0	1.3	0.3	0.5	1.4	1.2	0.0	0.4	1.4	0.9	1.4	0.7	8.3	9.0	7.6	11.2	8.9	7.8	7.4	8.2	7.9	7.7	8.2	9.4	11.6	9.6	13.9	13.7	10.5	18.6	10.2	10.4	19.9	18.5	8.4	7.1	19.2	2.8	10.6	7.3	4.2	19.3	15.7	2.3	7.9	4.9	3.5	6.7	13.0	11.2	4.8	1.3	21.2	6.9	15.4	15.3	6.1	6.3	14.7	6.9	6.8	6.3	5.1	16.8	22.3	3.8	12.2	2.8	9.5	3.2	11.1	3.9	8.8	6.5	6.6	21.4	3.1	20.6	26.2	4.4	3.0	9.8	8.8	14.0	1.7	19.2	6.7	17.5	19.7	17.5	20.0	6.5	16.6	12.6	16.2	22.4	11.4	11.8	3.7	7.1
C14orf119	FLJ20671	ENSG00000179933	"Chromosome 14 open reading frame 119"	Q9NWQ9	14	23095505-23100456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003638	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	Cytosol	"HPA003638: AB_2243669"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.26e-3)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.63e-1)"	41.5	49.2	26.7	34.3	28.6	15.5	46.9	30.3	32.0	41.1	34.7	42.8	33.6	40.1	42.3	45.6	33.2	27.5	36.6	26.8	29.7	49.4	37.2	38.1	34.2	30.3	29.6	33.6	31.6	35.3	38.4	33.7	30.6	30.6	51.3	25.5	36.2	38.5	32.9	30.9	41.2	48.8	29.7	47.1	41.0	25.2	31.5	40.4	33.9	31.1	50.8	47.5	33.9	32.2	53.9	52.5	77.4	47.2	166.8	144.3	62.1	88.5	129.9	114.1	134.6	41.9	81.3	40.9	44.8	144.2	138.0	89.9	74.6	117.4	157.6	65.2	36.5	61.6	41.4	180.8	130.7	93.2	91.9	177.0	104.1	96.3	70.5	104.0	126.6	72.7	41.9	44.4	127.2	77.8	44.3	72.1	48.7	124.5	79.2	38.6	57.5	47.0	130.8	85.9	37.1	33.8	73.7	68.6	81.0	85.5	46.4	53.2	103.0	54.0	47.0	81.6	40.6	41.5	52.6	50.5	49.4	58.3	49.2	317.0	160.8	302.7	122.6	106.0	140.9	143.9	138.9	137.3	150.7	121.0	144.0	142.6	94.5	131.0	74.4	102.2	188.7	203.2	26.7	28.6	30.3	32.0	26.8	29.7	30.3	29.6	30.6	29.7	31.5	32.2	50.9	48.1	47.7	4.2	41.9	26.5	89.0	144.5	23.9	28.6	41.9	50.5	23.7	34.3	75.9	31.3	8.4	89.0	53.5	44.1	129.1	95.9	22.6	39.0	45.2	56.2	28.3	65.4	3.8	84.3	105.5	42.9	30.5	33.2	54.4	39.6	46.4	29.6	107.8	20.2	4.4	57.4	81.4	38.9	32.1	15.1	64.0	53.1	48.0	5.6	93.2	36.1	58.7	2.0	11.5	97.0	42.4	48.5	31.4	59.8	61.5	100.3	48.3	21.5	32.9	18.6	47.1	52.7	25.6	33.5	34.0	143.1	46.5	81.3	51.7	83.2
C17orf100	LOC388327	ENSG00000256806	"Chromosome 17 open reading frame 100"	A8MU93	17	6651762-6693202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.9;Late spermatids: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.0;SH-SY5Y: 9.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA046824			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA046824: AB_2679825"	"unprognostic (9.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.54e-3)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-2)"	"unprognostic (9.44e-2)"	"unprognostic (7.65e-2)"	0.9	1.6	4.1	1.7	4.9	0.5	1.5	3.3	4.8	1.9	2.2	1.6	3.0	1.6	2.2	4.3	2.0	1.1	0.6	3.5	4.5	2.4	3.6	1.2	3.2	3.2	3.7	1.3	4.5	3.5	9.5	0.8	3.2	2.5	1.5	5.3	2.8	1.0	0.6	7.3	3.0	0.8	3.4	2.9	2.4	5.5	4.1	1.7	3.3	0.8	1.2	1.9	2.3	3.9	1.1	2.1	4.6	1.5	0.7	1.3	2.2	0.6	3.4	1.4	2.7	3.2	1.5	1.3	2.3	1.1	3.6	4.1	0.9	2.2	2.0	5.6	6.3	1.2	2.4	10.0	1.6	0.2	3.2	1.8	2.1	0.7	1.5	4.1	0.8	6.7	1.6	1.2	1.8	2.4	1.4	2.1	0.6	1.9	1.4	2.6	0.8	2.0	2.9	1.0	4.8	9.4	2.9	0.3	3.4	1.4	2.5	0.3	1.3	1.3	2.6	0.8	1.1	1.7	1.2	0.8	1.1	0.4	3.1	3.9	0.9	4.0	1.2	1.3	1.6	2.3	2.2	1.4	1.6	2.5	2.5	1.4	0.8	1.4	1.3	0.5	1.5	0.9	4.1	4.9	3.3	4.8	3.5	4.5	3.2	3.7	3.2	3.4	4.1	3.9	1.7	0.0	1.7	0.0	3.2	2.8	5.4	4.8	8.0	3.8	4.9	5.0	0.4	0.0	4.9	0.0	2.1	1.7	0.6	3.8	1.9	4.1	32.9	3.0	3.0	1.8	7.7	1.3	1.4	3.2	1.8	1.6	4.1	2.9	8.9	4.7	0.0	0.0	1.2	1.7	1.4	7.1	10.2	0.0	1.3	48.7	0.9	0.7	1.8	1.0	1.2	5.1	1.0	1.5	2.2	3.3	2.6	1.9	0.9	4.5	9.0	2.1	2.4	5.8	6.6	1.9	3.0	16.4	4.6	7.0	3.0	1.5	1.7	3.8	3.9	5.1
C20orf204	"DKFZp434G015, FLJ27267, LINC00176, NCRNA00176, PRR17"	ENSG00000196421	"Chromosome 20 open reading frame 204"	A0A1B0GTL2	20	64034344-64039962	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.5;Breast glandular cells: 1.3;Endometrial stromal cells: 2.0;Endothelial cells: 4.3;Glandular and luminal cells: 1.8;T-cells: 1.1"	"Cancer enriched"	"Detected in some"	6	"ovarian cancer: 7.2"	"Region enriched"	"Detected in single"	7	"cerebellum: 4.0"	"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 5.8;naive CD8 T-cell: 4.7;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	9	"T-cells: 5.8"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 49.0"	"Low region specificity"	"Detected in single"													NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.84e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.43e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.49e-6)"	"unprognostic (5.83e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.79e-4)"	0.3	0.1	0.3	0.1	0.3	0.0	0.3	4.0	0.4	0.5	0.0	0.2	0.0	0.3	0.0	0.4	0.8	0.0	0.3	0.2	0.3	0.5	0.2	0.2	0.0	0.2	0.4	0.4	0.3	0.1	0.9	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.2	0.2	0.7	0.0	0.2	0.3	0.1	0.6	0.2	1.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.2	0.0	0.0	49.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.8	0.0	0.0	5.8	4.7	0.2	0.6	0.0	0.0	1.4	0.4	0.3	0.3	4.0	0.4	0.2	0.3	0.2	0.4	0.5	0.2	0.2	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.8	2.0	4.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 4761.3"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 4512.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 1213.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"non-classical monocyte: 13.3"	"Lineage enriched"	"Detected in many"	4	"monocytes: 13.3"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 357.8;EFO-21: 738.6;Hep G2: 795.3;HSkMC: 534.8;SiHa: 209.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	200000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	585.2	286.5	46.0	194.3	53.7	1.5	213.9	47.8	46.0	237.5	31.5	128.9	22.9	82.9	41.1	76.4	350.3	354.9	221.6	36.5	81.8	51.4	4761.3	176.0	68.2	143.3	99.2	228.1	182.7	17.9	21.8	17.7	116.4	35.4	76.5	11.7	155.6	57.4	36.6	51.4	156.4	123.0	89.9	7.1	107.9	41.1	103.4	34.1	92.4	52.0	126.4	363.3	101.3	121.9	65.0	23.0	0.0	0.1	10.8	36.0	74.7	5.2	357.8	6.8	12.6	3.6	49.5	1.9	738.6	0.3	54.2	46.6	0.2	43.1	6.9	24.0	0.5	3.1	31.2	795.3	16.3	6.2	9.1	534.8	12.8	60.8	27.3	9.5	0.0	0.0	2.1	0.8	0.2	1.0	0.6	1.6	1.5	0.7	0.1	0.4	5.0	0.3	32.1	6.2	0.5	0.5	209.5	0.1	0.5	0.1	17.2	8.8	3.5	5.7	7.4	4.8	3.6	1.6	4.8	4.5	75.1	4.5	0.3	1.7	1.3	0.6	0.3	2.5	0.2	0.5	0.2	0.1	0.7	0.5	0.2	0.2	3.0	1.3	13.3	0.5	0.1	0.9	46.0	53.7	47.8	46.0	36.5	81.8	143.3	99.2	116.4	89.9	103.4	121.9	36.4	76.9	473.9	0.7	29.4	27.5	14.7	141.5	0.6	0.7	19.5	23.4	14.5	783.5	422.5	16.5	0.0	1.4	2.0	0.2	5.9	494.1	45.9	23.0	63.5	26.2	0.0	209.9	0.4	136.7	1.4	482.2	17.9	57.7	5.1	0.1	124.9	4512.2	34.4	0.0	0.5	0.9	20.3	164.5	44.8	97.5	226.2	45.1	35.6	70.3	14.6	1.2	0.0	0.5	0.6	376.4	0.2	10.9	3.9	13.3	1.9	53.6	177.5	4.6	6.6	20.1	49.1	4.0	7.7	5.2	21.9	2.7	15.0	0.1	0.4	38.2
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104233-207144972	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 1918.6"	"Group enriched"	"Detected in many"	14	"Alveolar cells type 1: 493.6;Alveolar cells type 2: 660.8;Hepatocytes: 1020.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"neutrophil: 29.5"	"Lineage enriched"	"Detected in single"	137	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 37.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	NA	NA	30800000000	28000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	1.4	0.7	0.4	2.5	0.2	0.1	4.5	0.7	0.2	6.3	0.0	1.7	0.0	4.5	0.0	0.1	1.0	3.2	0.2	0.1	0.7	0.6	1918.6	173.3	0.3	0.4	0.2	1.5	9.6	0.2	0.1	0.7	0.5	0.1	0.8	0.0	1.1	0.0	0.0	0.0	0.8	0.1	0.1	1.2	0.4	0.3	0.3	0.0	0.1	0.0	1.1	0.1	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	37.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	7.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.7	0.2	0.1	0.7	0.4	0.2	0.5	0.1	0.3	0.4	0.0	493.6	660.8	0.0	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.4	0.2	41.5	22.5	0.0	0.0	0.0	0.0	3.2	0.0	11.2	0.3	18.0	7.6	1.9	0.0	21.5	0.7	18.7	0.0	1.1	0.0	48.8	3.8	0.0	22.1	1020.8	0.2	0.0	1.4	0.3	0.0	39.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.6	32.0	0.0	0.0	0.3	0.1	0.1	3.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	3.9	16.7	0.2	1.4
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050275	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 433.7"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 538.3"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 28.4;Hep G2: 30.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	39000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	2.9	1.7	2.5	1.1	3.4	2.2	2.5	2.4	2.6	3.0	3.5	2.8	3.9	2.7	2.7	1.6	3.0	1.5	1.3	2.2	2.6	4.8	433.7	7.0	2.1	2.9	2.9	3.3	14.9	2.6	3.1	0.9	3.2	3.2	1.6	3.5	1.4	2.2	0.5	3.8	3.9	1.9	2.8	1.5	5.8	1.6	2.8	1.2	2.0	1.2	1.7	2.6	2.1	4.5	1.6	28.4	6.4	11.3	8.0	9.2	0.2	3.4	3.5	0.9	2.0	0.8	2.8	4.1	0.1	1.8	3.8	11.0	0.3	0.3	1.5	0.9	0.0	1.8	1.5	30.4	1.5	1.0	0.7	4.1	0.5	2.0	3.7	1.8	1.0	1.6	0.7	3.8	2.2	5.6	0.4	0.2	1.7	7.0	10.9	2.5	2.8	0.4	1.7	0.8	1.6	6.5	1.6	0.0	2.7	4.4	2.2	3.7	1.3	2.8	0.2	7.5	3.4	2.3	1.8	1.7	2.2	3.8	6.8	0.0	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	3.4	2.4	2.6	2.2	2.6	2.9	2.9	3.2	2.8	2.8	4.5	0.8	6.4	28.6	30.0	3.5	1.0	1.0	0.5	1.8	4.8	2.2	1.3	0.8	32.9	7.1	1.8	0.0	0.1	0.1	0.4	1.9	0.2	1.8	1.1	2.2	1.4	0.0	12.0	7.3	0.4	0.0	2.9	2.0	0.8	0.0	3.1	7.5	538.3	1.9	6.7	9.4	1.0	0.0	16.3	1.0	2.8	3.1	3.5	0.0	6.5	2.3	3.2	2.1	25.6	25.4	0.7	3.8	9.1	0.1	0.7	1.0	6.8	3.8	2.6	0.0	4.0	1.6	7.5	2.5	2.0	1.3	0.0	1.4	2.8	2.0	0.6
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854797-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	195	"liver: 635.7"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 296.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		6400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	635.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	296.4	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929207-56966140	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	156	"liver: 840.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 295.1"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		6700000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	840.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	1.0	0.0	0.1	0.0	5.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	7.1	295.1	0.1	0.0	0.1	0.0	0.0	7.6	0.0	11.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0
C9orf24	"bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1"	ENSG00000164972	"Chromosome 9 open reading frame 24"	Q8NCR6	9	34379019-34397810	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.2;choroid plexus: 105.6;fallopian tube: 108.7;testis: 90.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 744.6;Endometrial ciliated cells: 841.0;Late spermatids: 3115.3;Respiratory ciliated cells: 1312.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053008	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"HPA053008: AB_2682015"	"unprognostic (3.62e-3)"	"unprognostic (9.06e-3)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.90e-2)"	1.2	0.6	20.6	0.3	26.6	0.0	0.7	19.5	29.8	7.8	105.6	3.2	1.9	0.7	0.0	0.4	108.7	0.3	17.5	20.8	22.8	3.4	0.3	18.4	0.2	35.9	39.2	0.4	0.9	0.1	10.6	0.2	29.8	1.6	0.7	1.2	1.9	0.4	1.4	0.6	5.4	0.5	33.0	0.2	1.4	90.6	22.3	0.3	0.6	1.7	0.3	0.9	0.4	25.5	0.2	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.3	0.0	0.4	1.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.2	0.6	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.4	0.1	20.6	26.6	19.5	29.8	20.8	22.8	35.9	39.2	29.8	33.0	22.3	25.5	0.4	6.4	15.1	11.4	0.3	2.2	3.3	67.3	2.2	1.4	1.6	1.8	37.0	1.5	116.4	7.3	0.0	0.6	0.1	11.3	72.4	1.1	744.6	841.0	6.1	2.1	12.1	0.0	11.3	1.5	0.3	3.5	0.5	9.8	8.8	0.2	1.4	4.1	0.4	0.0	12.6	13.4	81.4	1.0	1.0	3115.3	10.5	2.7	0.0	1.0	0.0	2.2	1.0	4.0	5.4	0.2	7.3	7.2	0.5	4.5	142.5	13.7	1312.6	0.9	32.9	0.5	25.5	21.0	6.9	0.4	1.0	0.5	1.6	0.0	20.5	2.4
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936580	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"liver: 24.2"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 39.0"	"Cancer enriched"	"Detected in single"	26	"liver cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"Hep G2: 25.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (1.91e-1)"	"unprognostic (8.64e-3)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.76e-2)"	0.0	0.0	0.5	0.1	0.5	0.1	0.1	0.6	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	24.2	0.1	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.5	0.5	0.6	0.5	0.6	0.5	0.5	0.5	0.2	0.0	3.4	0.3	0.3	0.4	2.5	0.0	0.0	1.7	0.2	0.3	2.1	0.0	1.3	1.8	4.2	0.4	0.5	0.1	0.0	0.0	0.3	0.6	0.4	5.4	0.0	2.7	0.8	0.0	0.3	1.0	0.0	0.8	6.3	0.2	1.1	39.0	0.1	3.3	0.6	0.2	0.0	1.4	1.6	0.8	0.3	1.5	0.0	2.8	0.2	0.8	2.1	0.0	0.5	0.0	0.0	1.2	0.1	1.9	0.2	0.3	1.5	3.8	0.0	4.1	1.1	0.4	0.4	0.0	0.3	0.3	1.2	1.7	0.1	1.8
CAMK2N1	CaMKIINalpha	ENSG00000162545	"Calcium/calmodulin dependent protein kinase II inhibitor 1"	Q7Z7J9	1	20482391-20486210	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 461.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 640.5;Intestinal goblet cells: 431.4;Paneth cells: 367.7;Proximal tubular cells: 519.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;MAIT T-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 212.1;CAPAN-2: 199.1;Hep G2: 165.6;SK-BR-3: 159.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075200	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA075200: "	"unprognostic (1.67e-1)"	"unprognostic (2.70e-3)"	"unprognostic (9.71e-3)"	"unprognostic (3.13e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (1.37e-7)"	"prognostic unfavorable (5.49e-4)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.31e-2)"	20.1	61.6	340.5	9.3	322.3	0.5	19.8	172.0	461.3	32.5	115.4	85.0	80.4	27.8	38.1	27.8	22.3	27.4	22.3	354.6	206.5	86.2	53.8	67.9	1.9	224.8	222.4	30.2	8.8	42.4	37.7	11.6	215.9	35.8	77.0	32.6	30.4	40.8	7.1	12.0	86.9	22.7	226.7	12.2	19.5	4.7	265.4	2.0	10.8	9.9	7.0	27.3	24.3	348.6	63.1	17.5	15.0	212.1	28.4	52.6	2.2	52.6	119.0	9.5	4.8	20.1	199.1	6.3	14.7	21.7	7.7	103.2	4.6	90.0	5.9	11.7	3.8	1.3	0.9	165.6	31.4	0.1	6.2	8.4	41.2	5.6	21.2	19.6	16.4	4.3	6.3	0.5	105.8	17.4	0.2	0.5	2.8	109.7	3.9	5.6	9.4	0.4	59.3	93.5	57.6	16.2	28.5	159.6	16.3	10.2	30.6	0.6	5.0	34.9	46.1	48.5	21.1	0.1	0.1	2.5	119.5	13.5	22.0	0.0	0.0	0.0	1.6	0.0	1.1	0.5	0.5	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	340.5	322.3	172.0	461.3	354.6	206.5	224.8	222.4	215.9	226.7	265.4	348.6	28.3	3.2	1.1	35.6	7.6	9.3	11.7	2.3	0.6	248.6	96.5	104.5	20.8	178.7	2.5	248.3	6.2	0.5	10.1	640.5	229.0	20.1	0.8	6.2	45.6	20.0	299.2	8.0	132.5	40.8	2.9	65.1	9.2	12.0	1.3	4.6	9.3	201.6	0.3	85.8	108.7	431.4	14.2	1.9	12.1	3.9	62.7	5.6	39.2	26.2	0.6	81.1	0.0	27.6	249.1	141.5	367.7	94.0	3.5	37.7	183.2	519.2	1.2	35.6	131.5	86.2	96.4	0.8	2.8	1.0	7.5	2.1	14.7	0.8	223.5	50.3
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 178.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	9.8	15.2	20.7	8.4	21.1	7.0	17.0	21.7	25.8	11.2	20.6	11.4	11.0	6.5	9.0	15.5	10.9	5.2	12.5	21.1	22.3	26.0	41.9	9.6	6.6	21.1	21.3	10.6	19.4	7.8	16.8	6.7	21.5	17.4	10.5	8.7	9.6	7.7	8.4	11.0	13.9	5.9	20.7	21.2	11.4	11.4	21.0	4.6	15.6	4.2	9.7	12.7	9.8	21.8	37.7	40.1	14.0	17.3	20.8	9.5	16.4	26.0	17.6	20.2	20.6	5.2	33.6	51.2	16.2	15.3	29.1	27.2	64.1	21.3	38.2	8.4	15.4	14.4	69.3	91.0	16.2	32.8	8.9	16.9	23.9	18.7	14.8	25.0	37.3	19.4	20.5	36.9	21.1	45.8	16.4	34.2	16.3	64.4	42.4	28.1	19.2	49.9	32.4	23.9	18.1	18.3	21.2	16.1	8.0	24.5	76.4	21.3	10.6	9.1	33.6	27.7	30.2	12.0	34.8	11.8	37.4	35.9	35.3	1.7	11.8	8.8	3.2	15.0	3.7	5.3	5.3	4.6	12.4	3.0	4.8	4.0	7.8	2.8	9.8	5.2	4.4	10.6	20.7	21.1	21.7	25.8	21.1	22.3	21.1	21.3	21.5	20.7	21.0	21.8	17.8	41.7	51.8	13.4	58.4	65.1	31.8	24.6	178.7	37.7	59.4	36.7	33.6	25.8	38.5	20.2	68.8	44.0	10.6	33.2	21.5	33.1	10.5	17.4	8.4	22.8	16.8	25.9	60.6	39.0	23.0	20.1	49.5	15.4	10.1	16.3	16.4	48.0	15.9	35.3	60.8	32.6	12.2	25.1	36.6	4.6	21.1	27.5	30.2	20.6	45.2	13.5	7.2	37.2	32.2	33.7	51.1	17.3	143.5	32.3	76.9	42.7	27.8	62.4	6.6	10.4	18.8	35.2	25.5	119.4	85.5	50.5	29.6	12.3	34.2	30.5
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36001553	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 83.0;liver: 31.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 35.4;OE19: 28.7"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	3270000	11000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.2	0.4	0.1	7.8	0.1	0.1	0.4	0.1	0.3	0.3	0.0	59.7	37.6	0.1	0.0	0.2	9.6	9.2	0.0	0.1	0.1	10.0	31.6	2.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	83.0	0.0	0.1	0.1	0.0	0.1	62.0	1.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	4.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	7.2	5.0	0.0	0.0	0.0	0.0	262.6	0.0	0.0	0.0	12.2	0.1	0.7	71.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	8.9	0.0	2.5	40.2	0.1	0.0	0.0	208.3	2.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	380.6	0.0	0.0	0.0	461.4	61.3	76.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	138.2	0.2
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"liver: 120.3"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 262.0"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 10.1"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	2780000	23000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.2	0.1	0.5	0.0	0.2	0.5	0.2	0.2	0.0	0.0	0.3	120.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.0	2.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	262.0	0.0	0.0	0.0	0.2	0.0	4.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139696	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 35.8"	"Group enriched"	"Detected in many"	4	"B-cells: 44.0;Late spermatids: 26.4;T-cells: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 77.4;T-cells: 74.5"	"Group enriched"	"Detected in some"	6	"Hep G2: 9.4;OE19: 3.2"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"			"CAB006820: , HPA014488: AB_1846639"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.39e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.74e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	0.5	0.2	0.5	11.4	0.5	2.5	2.2	0.2	0.7	0.9	0.1	1.9	2.8	0.4	0.6	1.4	0.6	2.1	0.1	0.6	0.3	0.5	0.6	1.2	18.1	0.3	0.3	0.2	0.1	0.1	0.0	0.1	0.3	1.0	2.2	1.4	0.6	0.3	0.1	2.4	6.6	0.4	0.2	12.5	3.6	2.7	0.5	3.6	0.6	0.1	35.8	4.4	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.3	0.0	0.2	9.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.4	0.3	0.2	0.4	4.5	0.0	74.5	69.0	30.7	11.6	17.5	77.4	0.3	0.2	0.7	1.5	0.1	2.1	58.7	6.9	0.5	0.5	0.2	0.7	0.6	0.3	0.3	0.3	0.3	0.2	0.5	0.4	0.7	0.0	4.2	1.0	44.0	1.0	0.3	0.0	0.0	0.8	2.1	1.1	0.0	0.0	1.9	0.0	2.1	0.1	3.0	0.0	1.9	0.2	8.6	0.8	0.3	1.0	0.0	0.4	1.8	0.2	0.0	0.9	4.1	0.3	2.5	0.2	1.1	0.8	0.1	0.0	1.1	2.0	0.0	0.0	7.3	26.4	0.0	5.5	1.8	0.0	3.7	0.5	0.0	1.0	0.3	0.1	0.1	0.4	5.5	0.2	4.6	0.4	0.9	3.8	0.0	0.7	0.5	2.2	0.4	0.1	0.4	0.1	40.1	0.1	0.8	0.1
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 275.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.1"	"Low region specificity"	"Detected in all"			"HPA012569, HPA017053"	Enhanced					NA	NA		8800000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.0	0.1	0.8	4.5	0.4	0.2	0.0	0.1	0.7	0.0	0.0	23.2	275.8	0.1	0.0	0.1	0.6	5.0	0.0	1.2	0.4	10.1	30.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.1	238.3	1.1	0.0	0.1	12.4	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.5	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	0.7	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	8.6	0.0	1.8	0.0	0.0	0.3	167.0	0.0	4.0	182.4	3.2	0.1	0.2	33.6	0.0	3.9	1.0	0.0	0.0	55.0	0.1	0.0	0.0	0.0	15.3	0.0	0.0	4.2	42.7	0.0	0.6	0.0	680.0	1.5	0.5	0.0	1.0	0.0	1.6	0.0	1.5	0.5	15.3	215.0	2.2	0.1	0.0	611.4	13.7	0.7	0.3	0.0	0.0	0.1	3.8	2.0	0.0	0.0	0.1	0.7	3.5	19.8	0.0
CDIP1	"C16orf5, CDIP, LITAFL"	ENSG00000089486	"Cell death inducing p53 target 1"	Q9H305	16	4510669-4538828	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4;RPMI-8226: 68.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049352	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	Centrosome	Nucleoplasm	"HPA049352: AB_2680724"	"unprognostic (6.38e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (9.05e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.43e-2)"	"unprognostic (3.51e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.65e-2)"	19.6	43.2	27.2	5.0	30.0	2.1	18.4	21.2	65.1	26.8	0.0	24.6	14.5	30.0	1.0	22.3	24.6	7.9	57.3	26.6	21.3	49.7	44.1	14.5	5.4	22.3	21.3	34.0	37.9	7.1	65.2	5.3	25.4	25.3	2.5	6.9	14.0	10.9	41.1	17.9	26.0	7.0	15.0	20.1	21.5	28.7	29.3	11.5	24.2	8.4	4.0	20.3	20.1	36.2	10.6	3.6	14.0	3.0	1.7	0.0	0.4	14.9	2.3	11.5	10.6	22.6	2.2	0.7	12.2	10.8	4.6	0.8	12.8	41.9	3.0	27.6	25.8	40.7	12.9	59.4	10.5	20.5	21.0	10.5	44.7	10.2	3.4	3.4	9.6	13.1	1.2	9.1	14.5	1.3	15.0	19.2	19.9	10.6	10.1	50.1	12.8	68.3	3.0	0.5	27.9	13.6	24.2	1.4	16.6	7.2	4.4	13.4	0.8	5.5	16.3	7.7	0.7	27.5	29.1	37.9	0.5	16.7	4.7	4.5	5.8	14.4	11.7	9.0	6.9	6.4	4.1	7.3	5.7	5.7	9.0	6.8	5.0	12.0	17.7	6.6	7.0	5.9	27.2	30.0	21.2	65.1	26.6	21.3	22.3	21.3	25.4	15.0	29.3	36.2	27.1	16.0	7.0	28.7	19.4	29.6	21.5	25.4	38.1	63.5	7.7	14.4	26.5	7.2	9.0	16.5	12.5	1.8	16.3	12.1	52.8	13.0	90.9	1.5	18.7	20.3	9.6	7.2	23.5	9.2	1.6	15.4	7.7	2.9	22.9	11.3	25.7	18.5	19.6	70.7	26.4	6.1	14.2	12.2	11.7	25.4	18.0	17.5	14.2	8.4	7.1	41.4	45.3	9.5	14.7	8.2	13.2	16.6	24.1	13.3	39.6	65.0	0.9	16.1	6.6	8.4	11.3	21.1	27.7	15.2	14.9	6.7	22.9	13.7	6.7	11.5
CDR2	"CDR62, Yo"	ENSG00000140743	"Cerebellar degeneration related protein 2"	Q01850	16	22345936-22437165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 70.2;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.4;NK-cells: 2.5;T-cells: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018151, HPA023870"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA018151: AB_1846457, HPA023870: AB_1846459"	"unprognostic (7.89e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.38e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.67e-3)"	19.1	12.0	9.5	19.0	17.7	23.9	14.6	13.6	10.9	18.8	32.0	22.5	28.6	17.8	10.3	12.1	15.9	22.2	14.3	9.8	9.5	25.0	22.9	21.6	25.4	8.6	7.6	14.9	13.9	13.2	21.8	15.0	8.5	20.7	19.3	74.0	15.7	23.1	5.9	10.6	22.1	27.2	5.0	18.7	17.5	62.0	10.5	28.2	49.0	5.6	19.3	29.2	14.0	8.3	38.9	26.8	22.8	24.2	55.2	47.4	23.9	36.4	57.0	36.7	48.4	35.3	25.9	33.3	19.3	62.4	22.2	36.5	49.2	20.8	43.0	26.2	25.1	25.3	29.4	111.0	63.4	27.6	49.6	35.6	18.8	36.2	40.3	46.3	46.2	42.6	25.1	53.3	35.4	28.0	27.8	20.0	32.4	32.3	22.0	40.1	29.4	49.5	45.7	24.8	17.5	12.5	24.8	51.9	36.4	25.7	15.4	13.7	31.9	36.2	22.9	34.5	32.9	27.6	49.7	46.9	23.8	27.1	31.7	8.4	0.8	1.2	1.6	0.7	3.6	0.9	5.3	3.4	0.9	0.6	4.1	3.5	0.7	2.5	0.9	1.1	6.5	1.7	9.5	17.7	13.6	10.9	9.8	9.5	8.6	7.6	8.5	5.0	10.5	8.3	18.2	3.2	5.1	3.6	8.7	34.0	17.3	4.3	15.4	8.9	27.4	9.1	3.5	10.0	7.0	9.2	14.6	1.7	12.7	22.0	1.9	8.7	36.7	6.9	10.0	13.9	6.6	17.2	8.0	7.1	10.8	19.6	19.4	12.0	0.0	9.6	10.0	9.5	9.4	8.4	10.5	16.1	6.1	5.0	11.5	8.8	6.8	7.4	10.6	2.8	4.0	10.1	4.1	3.5	2.2	13.8	12.2	10.9	24.9	19.4	22.4	12.4	4.9	70.2	6.6	9.7	15.8	50.9	16.1	8.7	24.3	1.4	25.8	2.7	7.8	14.8
CDRT4	FLJ36674	ENSG00000239704	"CMT1A duplicated region transcript 4"	Q8N9R6	17	15436015-15503608	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"Early spermatids: 65.8;Late spermatids: 202.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 10.1;NB-4: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021590	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA021590: AB_1848906"	"unprognostic (5.46e-6)"	"unprognostic (9.47e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.74e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-5)"	"unprognostic (2.00e-3)"	"unprognostic (1.74e-6)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (4.18e-1)"	"unprognostic (9.27e-2)"	5.8	18.7	14.1	1.7	12.9	6.1	9.3	14.3	12.0	19.3	13.2	10.6	0.9	8.8	23.7	10.8	20.7	3.2	5.7	12.2	13.9	16.5	10.0	8.8	5.0	11.7	13.5	20.4	19.8	1.5	48.0	2.5	11.6	20.1	4.6	11.8	15.9	3.8	1.8	21.8	11.9	2.3	8.4	15.9	11.4	15.3	14.7	3.2	23.5	0.8	2.9	9.0	12.8	12.0	2.5	2.2	2.8	1.0	2.4	1.7	2.9	0.9	2.5	1.1	1.0	1.4	0.7	0.0	1.2	1.4	0.2	0.8	3.0	2.4	1.7	0.5	0.4	0.4	2.0	10.1	0.7	0.9	3.9	1.9	3.6	1.6	4.0	4.3	2.6	1.0	0.5	1.6	2.1	0.4	1.0	8.0	0.9	0.4	0.8	0.4	0.0	0.0	2.9	2.0	0.4	1.3	0.8	0.4	0.8	6.2	1.1	2.0	2.4	0.3	1.1	1.0	1.0	2.2	0.9	0.1	0.0	0.0	0.3	0.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	14.1	12.9	14.3	12.0	12.2	13.9	11.7	13.5	11.6	8.4	14.7	12.0	0.4	0.0	1.1	0.0	0.3	0.1	0.2	0.2	0.0	1.4	0.6	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.0	0.8	65.8	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	2.5	1.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	202.7	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.6	1.8	0.0	0.0	0.4	0.4	0.0	3.7	1.5	0.0	0.3	0.2	1.0	0.7	0.0	0.0	0.1	0.2	0.5	1.0	0.3
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"CEA cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 246.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 335.2;Distal enterocytes: 731.7;Paneth cells: 585.4;Prostatic glandular cells: 244.9;Urothelial cells: 618.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"eosinophil: 43.6;neutrophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 43.6"	"Group enriched"	"Detected in many"	5	"CAPAN-2: 30.6;Hep G2: 101.0;OE19: 80.9;RT4: 59.2;SK-MEL-30: 67.4"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	11.9	10.6	1.3	31.1	0.8	74.5	13.3	3.2	1.8	16.4	0.0	246.3	53.3	11.1	3.9	64.9	6.0	7.4	4.0	1.9	0.0	31.9	60.5	6.8	4.3	0.4	0.1	1.1	2.4	1.7	3.8	33.1	0.5	20.2	141.2	0.6	58.9	10.3	2.7	3.3	51.0	13.1	0.0	7.9	19.9	3.7	0.2	2.3	3.1	3.1	21.5	37.0	29.2	0.0	0.6	5.6	0.3	0.3	0.0	0.0	14.4	0.0	0.2	1.0	0.5	2.3	30.6	1.7	12.2	0.0	3.2	0.8	0.0	7.9	0.4	0.1	0.5	0.3	0.2	101.0	1.7	0.2	13.3	0.0	0.1	0.1	0.1	0.0	0.7	1.4	0.0	5.0	0.0	3.2	0.3	0.2	0.9	80.9	1.7	2.6	0.0	1.3	0.6	59.2	0.5	0.2	0.0	0.2	67.4	7.3	0.3	0.0	2.1	0.3	1.2	1.4	0.5	1.8	0.0	3.7	0.2	0.4	1.0	0.8	0.0	43.6	0.1	1.7	0.3	3.3	0.9	0.4	0.2	0.8	0.6	0.2	26.3	0.1	3.3	0.1	2.7	0.6	1.3	0.8	3.2	1.8	1.9	0.0	0.4	0.1	0.5	0.0	0.2	0.0	16.7	6.4	8.2	1.0	6.0	1.3	335.2	10.4	2.8	6.0	16.3	12.7	1.8	7.2	14.7	0.0	4.2	2.0	0.7	731.7	0.0	21.3	3.5	5.0	5.2	22.3	17.3	0.4	1.7	16.1	9.4	2.9	12.8	28.7	8.9	4.6	41.4	37.7	1.4	5.0	1.4	46.1	4.1	5.9	3.1	0.2	0.0	2.6	7.2	0.0	0.9	1.3	2.1	0.5	0.6	58.7	585.4	0.7	0.2	244.9	97.5	11.1	3.9	6.4	0.0	2.7	3.1	4.3	3.9	9.2	1.0	0.7	5.5	2.2	33.2	618.9
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2517.1"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	94.9	14.1	0.9	3.2	1.2	27.0	43.6	0.8	1.8	26.6	3.7	82.3	24.0	60.4	7.5	41.1	54.6	272.9	66.1	1.0	1.4	6.7	2517.1	167.8	1.8	2.3	1.2	20.3	8.8	0.7	3.7	8.5	1.5	39.2	12.3	2.9	41.4	36.4	5.2	14.0	27.4	40.4	1.0	41.0	56.1	7.8	1.1	2.5	9.9	9.4	1.0	57.7	17.7	1.1	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.9	1.2	0.8	1.8	1.0	1.4	2.3	1.2	1.5	1.0	1.1	1.1	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242654-147295765	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	14.4	14.9	19.2	11.9	20.4	17.1	14.6	20.0	28.0	14.6	17.8	16.4	14.4	19.1	9.4	12.7	17.3	6.7	10.8	18.6	18.9	16.5	33.7	17.5	13.1	19.7	19.6	10.9	13.1	19.8	20.1	9.4	19.3	16.4	15.1	4.9	11.6	8.9	12.8	14.4	19.3	16.1	20.3	27.1	15.8	19.5	20.0	14.9	10.6	11.2	11.1	13.1	11.7	20.9	40.0	34.0	28.0	21.2	25.1	21.4	29.6	38.7	31.4	30.4	29.1	30.6	29.2	49.9	15.4	33.9	21.9	37.7	31.2	35.3	30.6	53.6	40.6	43.8	27.5	87.0	31.5	58.9	24.0	25.6	15.1	30.2	31.1	27.9	34.1	51.5	56.0	19.8	44.3	42.2	39.8	43.1	46.9	80.0	47.4	48.8	35.1	41.1	32.2	30.7	16.6	36.4	32.4	39.2	30.8	46.3	21.7	99.3	34.5	19.2	33.2	18.2	49.0	14.9	22.4	37.9	46.7	19.6	33.3	11.3	8.7	3.2	8.7	7.9	8.1	11.7	7.4	6.6	20.3	14.2	6.9	7.9	0.4	10.0	9.2	17.5	5.4	8.2	19.2	20.4	20.0	28.0	18.6	18.9	19.7	19.6	19.3	20.3	20.0	20.9	7.7	12.8	15.6	45.7	27.1	11.5	10.0	8.8	15.9	7.2	12.5	8.5	6.5	11.5	16.4	5.5	6.2	21.7	17.1	15.4	21.5	10.0	21.2	6.4	12.5	11.1	9.0	43.7	48.3	8.2	19.1	12.6	21.4	9.8	21.5	25.1	5.3	33.7	21.8	1.7	40.8	16.7	16.2	16.1	20.7	25.6	7.2	25.5	16.0	36.5	15.9	14.5	12.3	60.8	80.7	10.3	14.4	11.3	14.4	10.8	13.0	12.9	16.1	9.3	6.6	11.9	12.5	38.3	27.4	20.9	10.4	11.8	13.4	18.8	19.7	9.1
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846419	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 37.6;liver: 35.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Hepatocytes: 51.8;Proximal enterocytes: 70.1;Proximal tubular cells: 87.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 3.1;T-reg: 1.3"	"Group enriched"	"Detected in many"	17	"granulocytes: 3.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.4;Hep G2: 35.8;OE19: 25.3;T-47d: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036633, HPA058130"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.6	2.8	13.6	1.8	14.3	0.6	7.3	12.5	11.4	3.7	16.5	8.9	8.4	2.7	1.4	0.9	2.6	2.7	2.4	11.3	10.9	37.6	35.8	2.4	1.0	14.5	13.9	1.3	16.4	8.3	7.8	0.4	10.1	5.8	9.2	1.5	15.0	1.0	3.9	2.4	14.7	0.9	10.3	0.5	8.0	6.9	15.9	0.2	2.6	1.2	1.2	0.4	0.9	12.0	0.4	4.6	1.2	0.1	0.0	0.0	5.2	0.3	0.5	0.0	0.0	11.4	0.8	0.4	0.8	0.8	0.1	0.0	7.4	0.0	0.0	0.0	4.0	0.0	1.7	35.8	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	5.7	0.7	0.0	6.9	0.0	0.1	7.2	25.3	0.8	0.0	1.8	8.2	5.1	4.0	3.0	4.0	1.8	0.1	0.0	0.9	11.2	0.1	0.0	0.0	0.8	0.2	1.0	1.0	1.6	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	13.6	14.3	12.5	11.4	11.3	10.9	14.5	13.9	10.1	10.3	15.9	12.0	0.6	3.2	6.8	19.6	1.3	6.6	5.6	1.1	1.2	23.8	23.5	19.8	11.3	52.9	5.9	11.0	14.6	3.7	0.4	16.6	7.9	19.4	28.9	3.2	11.0	1.4	47.9	0.0	2.4	13.8	2.3	2.3	21.4	9.4	7.0	2.2	1.4	51.8	0.3	1.7	3.5	38.9	0.0	1.9	2.5	46.2	5.9	2.6	3.6	1.0	0.1	18.8	0.0	27.2	5.2	8.0	15.1	15.4	5.3	19.8	70.1	87.8	3.8	13.4	0.0	1.0	3.4	15.1	2.3	0.7	5.3	0.8	2.4	2.0	45.4	2.2
CHMP4A	"C14orf123, HSPC134, VPS32A"	ENSG00000254505	"Charged multivesicular body protein 4A"	Q9BY43	14	24209615-24213830	"Metabolic proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA068473	Approved					NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA068473: AB_2685994"	"unprognostic (4.33e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.74e-4)"	"unprognostic (2.02e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.90e-2)"	58.8	39.5	73.9	49.3	77.3	38.5	51.4	74.2	109.3	39.1	68.5	59.2	39.4	33.6	79.0	50.5	45.2	35.8	46.9	71.2	73.4	52.4	53.5	36.1	72.6	76.6	75.6	30.8	42.5	72.9	23.0	33.9	76.5	51.0	64.5	15.5	31.5	60.6	20.1	51.6	43.6	51.6	76.8	51.5	45.8	16.5	78.1	70.4	43.4	27.4	84.9	47.7	32.0	77.7	48.7	100.5	43.8	49.1	75.4	67.9	59.7	52.9	62.6	53.0	60.7	46.6	114.9	79.0	48.5	80.6	49.8	56.4	47.5	84.7	58.8	142.6	25.6	64.7	91.6	207.4	131.8	101.1	69.9	69.1	121.6	43.9	168.4	60.8	72.3	84.6	68.2	119.7	107.1	136.1	98.0	93.5	29.0	123.3	83.0	71.9	37.5	86.7	99.3	128.4	28.4	34.3	112.7	101.8	73.8	49.8	65.7	90.2	49.4	33.0	40.0	42.7	47.2	117.1	133.2	86.4	31.2	71.7	71.3	144.3	152.2	103.4	123.4	195.6	132.9	182.8	131.8	138.5	179.9	169.3	101.6	109.9	42.6	138.4	193.6	190.0	185.2	171.6	73.9	77.3	74.2	109.3	71.2	73.4	76.6	75.6	76.5	76.8	78.1	77.7	74.2	16.0	33.3	13.4	78.6	52.6	76.0	154.8	18.8	31.8	66.7	65.7	2.1	92.9	86.3	62.5	64.6	93.4	111.4	50.0	97.8	116.0	11.0	49.1	52.5	58.8	39.2	53.7	14.3	82.3	84.0	39.3	25.5	53.2	76.5	41.1	67.5	73.1	162.5	25.2	12.6	69.9	99.7	94.8	90.3	19.1	66.8	80.1	69.4	11.2	202.6	64.7	178.2	12.1	15.5	76.0	66.7	48.5	44.8	76.1	144.9	159.3	72.2	24.2	98.6	40.6	58.1	20.4	18.3	32.3	78.8	120.7	102.8	43.8	79.7	70.4
CHPF	"CHSY2, CSS2"	ENSG00000123989	"Chondroitin polymerizing factor"	Q8IZ52	2	219538948-219543809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 163.7;Extravillous trophoblasts: 182.7;Syncytiotrophoblasts: 310.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035123	Approved		Supported	Vesicles,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		570000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Vesicles, Centrosome"	"HPA035123: AB_10602799"	"unprognostic (1.13e-3)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.65e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.37e-1)"	"unprognostic (6.59e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.96e-4)"	29.9	45.7	26.9	12.5	24.9	1.7	22.3	25.8	34.2	59.1	36.7	21.9	26.7	55.9	13.7	27.3	30.2	24.2	134.8	38.4	31.2	41.1	97.8	42.8	6.5	34.0	30.4	127.4	138.9	24.6	128.3	40.6	32.1	58.6	4.7	8.5	56.1	25.6	16.3	26.2	23.2	12.6	27.4	16.6	40.9	97.5	33.2	3.6	52.8	3.9	4.5	34.3	30.0	34.0	67.5	13.0	9.6	81.0	36.0	55.8	109.7	66.4	55.4	18.5	16.8	36.8	57.5	20.7	139.0	64.6	63.3	84.1	6.3	40.3	2.9	32.3	22.5	7.4	18.0	161.9	49.8	6.6	42.1	75.0	69.2	18.8	17.9	66.7	0.1	7.1	47.2	49.6	17.7	105.5	1.0	17.6	39.8	22.8	50.6	0.1	30.4	41.6	22.4	29.7	23.4	36.0	32.1	30.7	94.3	17.9	10.5	22.6	1.6	67.9	37.1	81.9	35.2	58.9	19.9	9.7	62.1	6.7	70.4	1.7	0.0	6.5	1.9	0.1	2.4	1.0	1.5	1.3	0.0	0.1	1.7	0.6	0.0	1.9	0.0	9.5	1.2	0.7	26.9	24.9	25.8	34.2	38.4	31.2	34.0	30.4	32.1	27.4	33.2	34.0	2.1	0.0	15.2	16.0	16.5	14.5	23.2	52.8	17.1	14.6	40.0	29.6	30.5	22.8	31.2	75.4	10.4	163.7	21.7	15.9	9.8	58.1	4.1	14.0	22.2	2.9	43.0	3.2	4.3	80.4	182.7	56.0	25.5	42.4	10.2	27.4	4.2	64.0	18.5	43.7	9.2	57.8	36.7	2.4	9.1	7.1	24.8	2.3	67.6	5.6	1.8	56.8	9.2	5.5	3.7	65.6	32.7	63.2	123.6	42.3	60.7	20.6	14.6	11.5	26.3	19.3	27.1	11.9	6.3	14.2	11.1	310.3	9.7	46.3	14.3	33.0
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 130.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 31.2;Excitatory neurons: 28.2;Fibroblasts: 16.4;Hepatocytes: 36.4;Inhibitory neurons: 37.5;Skeletal myocytes: 19.1;Smooth muscle cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.8;Hep G2: 11.8;MCF7: 2.5;SuSa: 4.0;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	NA	NA		350000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	11.1	12.2	13.9	2.1	13.9	0.0	9.9	19.0	21.2	40.0	9.1	7.6	1.6	32.9	3.2	3.3	15.0	2.5	11.2	15.1	9.4	18.8	130.0	7.2	1.5	10.1	9.9	16.3	17.1	1.1	6.0	2.4	10.2	9.7	0.8	0.0	3.8	5.2	4.4	5.4	6.0	4.6	10.3	9.7	7.8	1.1	9.7	0.2	7.7	2.7	0.3	7.2	15.4	13.6	0.0	0.0	0.3	1.1	0.1	0.1	1.4	0.3	0.0	0.2	0.1	2.8	0.0	0.0	1.1	0.3	1.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	11.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	4.0	1.4	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	13.9	19.0	21.2	15.1	9.4	10.1	9.9	10.2	10.3	9.7	13.6	2.6	0.0	0.0	11.8	0.4	2.7	0.0	0.0	0.6	2.9	2.1	1.8	3.1	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.6	31.2	2.6	0.0	0.0	28.2	3.1	0.0	16.4	1.1	4.5	0.0	0.9	3.3	36.4	0.7	0.0	37.5	0.2	0.0	3.2	3.1	0.0	3.7	0.4	1.8	4.7	0.0	0.0	0.0	7.1	2.5	1.1	0.0	2.2	0.0	0.1	0.0	4.0	0.0	0.5	6.6	19.1	16.4	0.3	0.3	0.3	1.1	0.1	0.7	0.1	0.0	0.3
CILK1	"ICK, KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Ciliogenesis associated kinase 1"	Q9UPZ9	6	53001279-53061824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.0;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 33.9;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	7.9	17.9	10.2	4.9	11.0	2.7	10.7	8.4	9.7	8.9	5.1	8.7	9.8	8.0	5.5	8.6	7.4	6.9	8.5	6.8	7.8	4.5	7.5	6.3	5.2	9.4	11.6	9.5	5.0	7.3	1.7	12.1	8.8	9.9	10.7	17.4	17.9	7.3	4.0	8.7	10.4	7.4	8.8	5.6	12.9	4.5	14.9	10.1	6.3	5.0	6.2	6.5	5.8	12.8	7.8	2.9	14.6	10.0	8.9	14.0	17.0	6.9	12.4	10.8	12.3	4.1	2.4	5.7	4.0	21.0	3.5	5.0	17.6	7.1	14.2	19.9	7.0	4.2	3.3	22.3	4.5	5.2	5.4	12.5	7.6	4.6	5.3	7.7	10.2	12.1	8.1	22.6	24.9	6.7	5.6	6.4	5.6	27.0	6.3	8.8	6.5	7.5	4.5	5.6	23.6	10.6	6.7	16.3	9.6	14.2	9.5	10.9	8.5	17.2	8.0	6.5	17.1	6.3	4.8	2.2	3.5	5.0	8.5	2.8	1.0	2.2	1.7	0.8	1.5	1.2	1.2	1.4	1.0	1.5	1.4	1.2	0.5	1.1	0.9	1.4	1.7	0.8	10.2	11.0	8.4	9.7	6.8	7.8	9.4	11.6	8.8	8.8	14.9	12.8	6.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	20.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	33.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	58.1	0.8	0.0	0.0	0.0
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"choroid plexus: 19.8;kidney: 39.1;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.8	0.1	0.1	0.0	0.1	0.1	1.1	0.4	0.5	0.0	19.8	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.0	39.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.6	0.3	0.0	0.0	0.8	0.7	0.2	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.5	1.3	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	31	"retina: 297.9"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 407.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.3"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA		11000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.4	1.0	2.7	0.5	6.1	3.9	2.3	2.0	4.0	1.5	7.2	0.9	0.5	1.4	0.5	1.2	1.8	2.0	0.3	3.1	4.2	5.3	0.5	1.4	0.7	3.0	3.4	4.9	1.3	3.6	3.9	0.6	3.1	8.5	0.1	297.9	2.3	1.1	0.2	0.7	1.4	0.1	3.1	0.1	3.1	2.6	4.3	1.7	6.8	0.0	0.0	0.8	0.1	9.5	3.6	5.4	10.1	6.8	0.0	0.0	6.1	3.9	0.3	0.0	0.0	4.2	2.1	4.3	1.0	0.0	3.6	1.5	0.0	0.6	0.0	3.6	9.3	7.3	2.9	34.3	0.0	2.5	1.3	0.3	0.0	0.0	0.0	1.7	0.4	10.5	10.5	12.3	0.0	1.2	4.4	7.8	0.7	4.4	2.4	8.8	4.8	15.5	1.1	1.1	8.8	6.2	4.0	2.5	3.4	8.0	3.3	1.0	0.8	4.0	5.7	2.8	2.0	6.9	13.3	9.7	3.2	4.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	0.0	2.7	6.1	2.0	4.0	3.1	4.2	3.0	3.4	3.1	3.1	4.3	9.5	0.1	0.0	2.6	0.3	0.1	0.0	3.8	1.5	2.8	29.6	2.8	5.0	0.2	0.0	1.7	0.0	20.9	0.8	0.0	0.1	1.9	0.4	0.7	2.5	0.3	2.0	0.0	0.0	5.2	0.2	0.1	0.4	0.0	3.2	0.0	3.5	0.0	0.0	0.2	16.8	3.8	0.0	0.0	0.0	0.3	0.8	0.9	0.2	0.0	1.0	0.0	58.1	0.0	0.0	4.9	0.0	0.0	1.2	0.0	5.5	0.0	0.5	2.4	407.5	6.6	0.0	0.3	10.6	8.6	0.2	0.1	0.4	0.1	17.3	0.1	1.6
CNBD2	"C20orf152, CNMPD1, dJ954P9.1"	ENSG00000149646	"Cyclic nucleotide binding domain containing 2"	Q96M20	20	35954564-36030700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 173.9;Late spermatids: 99.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA043182	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA043182: AB_10794389"	"unprognostic (1.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.59e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.82e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.85e-2)"	2.5	4.4	6.3	1.8	6.6	8.8	3.9	6.9	7.7	2.8	6.9	4.2	3.8	3.1	12.5	3.1	2.8	1.6	4.0	6.2	6.6	7.7	5.5	2.4	4.1	6.7	6.6	2.7	7.0	5.7	5.0	1.7	6.5	3.7	2.8	15.8	4.2	2.5	23.7	5.8	4.6	1.9	6.6	5.7	3.8	25.9	6.6	4.3	4.6	16.8	3.3	2.8	2.5	6.9	2.2	3.3	4.4	4.4	3.7	1.8	2.9	0.5	1.9	3.5	3.2	8.2	4.7	3.9	1.5	2.7	2.6	3.5	3.4	5.9	3.5	1.5	5.4	5.8	10.7	17.1	3.0	3.2	1.4	3.5	5.4	2.7	2.9	1.7	5.4	6.2	1.7	19.0	2.2	5.7	3.4	8.7	1.1	3.1	4.9	3.2	3.2	13.8	4.8	1.9	9.6	4.1	2.0	5.6	4.4	1.2	2.6	5.3	2.3	2.4	4.1	1.6	0.4	15.9	10.0	9.9	2.4	5.5	0.7	2.1	0.4	0.1	1.5	2.0	0.3	1.0	0.6	0.7	0.2	2.1	0.7	0.4	0.6	3.7	0.8	0.4	3.4	0.5	6.3	6.6	6.9	7.7	6.2	6.6	6.7	6.6	6.5	6.6	6.6	6.9	8.3	0.0	6.5	7.8	11.7	0.3	9.3	0.1	8.6	10.8	18.3	23.5	0.6	14.3	3.1	11.0	22.9	7.0	32.1	13.6	29.4	4.4	173.9	7.8	6.5	5.5	12.7	8.6	4.1	5.5	7.1	4.5	11.2	6.1	1.3	4.7	8.2	9.7	8.0	23.5	6.7	16.2	0.0	13.8	0.4	99.0	6.5	7.9	0.0	3.7	4.6	21.1	9.2	7.5	5.9	3.3	13.9	3.0	20.8	6.9	19.1	19.5	2.2	39.7	19.7	7.1	5.9	20.2	16.4	18.4	0.1	4.9	20.5	5.8	10.3	7.0
CNNM3	ACDP3	ENSG00000168763	"Cyclin and CBS domain divalent metal cation transport mediator 3"	Q8NE01	2	96816245-96835382	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016711	Supported		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016711: AB_1847394"	"unprognostic (1.50e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.32e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.31e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-2)"	7.8	8.9	8.0	6.7	10.1	7.0	7.9	15.0	9.5	8.4	8.0	10.5	17.3	8.5	5.2	5.6	10.9	9.4	5.7	7.5	7.1	7.5	20.0	9.1	9.1	9.2	9.0	10.3	26.6	21.4	8.0	10.2	8.5	8.9	8.8	13.1	12.4	9.0	45.1	8.5	14.2	5.8	6.9	9.5	12.4	11.3	8.6	11.4	8.4	6.1	7.2	8.3	7.6	12.5	10.4	9.2	8.7	13.4	10.2	5.4	24.3	6.8	5.5	6.4	6.3	25.3	16.4	11.7	23.3	5.2	7.4	11.8	12.6	8.8	4.8	11.3	29.4	15.3	12.9	28.1	8.9	14.0	11.2	4.5	11.8	8.1	7.3	8.7	7.9	9.6	14.1	19.8	2.7	13.0	12.8	17.4	11.6	15.6	11.5	15.6	11.6	14.4	11.3	12.7	26.5	17.0	8.7	14.2	8.2	13.3	13.5	10.2	3.7	5.6	16.1	9.2	9.8	17.8	18.1	8.6	3.5	13.2	6.0	1.6	0.8	3.5	2.6	0.6	1.6	1.8	1.6	2.1	0.3	2.1	1.5	1.5	3.3	1.5	1.4	1.8	2.2	0.8	8.0	10.1	15.0	9.5	7.5	7.1	9.2	9.0	8.5	6.9	8.6	12.5	4.1	9.6	4.8	9.1	5.4	1.3	2.7	1.1	0.6	17.5	4.9	5.0	15.6	8.6	3.0	0.0	8.4	5.0	8.9	4.7	0.0	5.0	7.3	5.3	4.4	3.7	4.2	5.7	5.7	4.3	2.6	4.3	5.6	12.6	0.0	11.7	6.4	17.4	2.6	33.7	9.5	7.6	4.1	3.4	0.6	1.3	2.5	1.9	3.6	4.7	2.3	6.4	6.2	18.1	19.6	2.7	1.9	4.1	6.4	7.1	8.4	1.9	2.8	13.5	13.1	5.7	4.5	5.9	6.3	2.8	1.6	1.6	6.9	11.5	8.2	3.4
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Disease related genes, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 710.2;Proximal tubular cells: 729.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031966, HPA071122"	Approved		Enhanced	Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA031966: AB_10602115, HPA071122: "	"unprognostic (1.20e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favorable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	64.8	73.0	122.8	30.8	122.9	15.3	63.7	128.2	160.5	71.5	125.8	110.8	106.0	55.6	172.3	128.4	73.7	42.9	102.4	125.6	124.5	223.4	158.9	45.7	41.0	124.6	125.4	55.8	172.6	106.8	59.7	38.9	127.2	84.9	89.7	34.9	66.1	66.7	119.6	58.0	81.1	41.5	125.8	50.5	128.5	25.2	125.5	42.7	57.9	94.3	49.8	60.5	78.6	125.3	66.8	219.9	99.4	54.7	89.5	75.8	61.0	51.1	77.2	119.2	107.3	87.5	81.8	3.9	141.0	62.5	112.4	63.5	77.3	124.8	111.9	65.1	202.8	44.7	96.3	280.8	63.4	61.0	52.0	77.4	92.0	112.7	64.2	61.0	96.1	31.6	72.9	55.5	106.9	108.9	20.2	132.9	45.7	135.9	78.5	79.4	145.1	113.6	122.6	90.2	73.8	61.9	52.2	54.9	91.5	85.3	170.3	78.5	59.3	129.6	67.5	55.4	69.0	65.1	76.3	36.2	97.3	60.1	89.8	206.7	209.6	141.5	136.2	208.1	143.5	218.9	140.0	138.3	178.8	187.5	128.4	126.2	22.7	187.5	177.7	120.3	191.1	245.9	122.8	122.9	128.2	160.5	125.6	124.5	124.6	125.4	127.2	125.8	125.5	125.3	55.4	28.9	68.7	7.5	44.5	36.8	52.2	192.7	50.7	36.5	99.9	110.9	263.9	173.0	113.8	266.7	20.9	153.9	30.3	233.8	710.2	136.5	13.2	203.0	70.0	65.4	79.9	54.3	8.1	239.8	177.5	72.5	103.5	154.6	35.5	77.5	69.3	390.1	121.6	45.4	9.2	205.9	195.3	75.3	33.4	18.8	55.9	54.8	88.9	6.5	86.0	94.7	63.8	6.6	11.8	134.7	201.6	45.1	73.2	79.0	221.7	729.1	145.2	37.0	39.5	46.2	88.0	48.4	52.1	242.0	55.5	102.2	43.4	97.6	258.9	67.7
COPG1	COPG	ENSG00000181789	"COPI coat complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		57000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	84.7	111.0	66.6	59.0	68.2	59.4	79.8	69.5	80.7	100.4	93.0	107.6	86.7	75.5	157.4	86.8	70.0	53.8	95.5	70.3	73.7	82.7	149.5	84.4	54.8	74.3	71.5	77.9	162.4	96.3	139.0	81.9	77.4	107.7	109.8	33.4	130.7	72.7	75.7	74.4	86.7	72.2	66.4	81.9	114.0	46.5	73.2	53.5	83.3	43.2	67.1	67.2	72.2	73.2	167.8	83.2	119.1	104.0	272.8	219.0	126.9	266.3	251.8	179.5	225.2	153.9	101.2	91.1	150.8	380.7	145.6	98.4	99.5	157.2	193.6	112.0	41.4	151.9	103.2	252.6	247.9	116.4	156.4	230.9	135.6	143.8	235.0	196.1	164.3	68.9	54.2	213.6	219.2	253.4	68.7	117.7	71.3	243.6	100.9	73.3	111.8	178.3	227.3	136.7	74.1	86.1	204.2	150.3	255.9	129.8	167.1	167.6	223.9	96.9	91.7	207.2	104.2	165.7	86.1	158.9	236.4	86.9	190.0	79.1	49.9	37.2	44.1	59.2	53.6	24.9	39.8	43.9	57.0	26.9	30.0	36.2	37.2	57.0	57.3	52.2	43.8	56.2	66.6	68.2	69.5	80.7	70.3	73.7	74.3	71.5	77.4	66.4	73.2	73.2	16.6	16.0	31.5	7.8	19.2	8.8	16.9	35.4	12.0	9.2	18.9	8.6	23.3	17.2	34.6	27.6	4.2	55.6	19.7	77.0	43.0	44.5	10.4	26.2	27.7	22.8	38.6	22.9	14.1	46.5	63.1	32.5	53.0	36.9	15.2	28.6	28.9	56.5	39.0	5.0	14.8	75.1	22.4	31.2	14.8	4.7	41.0	21.6	23.2	7.5	36.5	12.7	18.6	4.5	11.8	40.8	44.6	31.2	68.4	24.4	64.5	39.5	32.6	7.1	19.7	20.2	33.3	24.3	17.0	16.4	10.2	72.2	19.4	27.7	44.6	20.6
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067614-19080095	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubiquinone biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 40.4;neutrophil: 126.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 126.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	10.2	13.6	10.7	7.0	11.2	4.8	13.4	10.9	11.6	10.8	12.5	14.1	12.4	15.6	12.3	12.4	15.5	10.7	23.4	11.0	10.8	14.1	12.3	10.0	8.3	10.6	11.3	20.0	10.3	24.4	9.7	10.0	11.1	17.7	13.2	14.0	10.4	14.7	45.8	7.9	11.8	11.6	10.4	10.0	12.8	20.9	11.3	10.3	16.2	44.9	8.4	10.3	8.8	13.1	23.5	24.8	21.1	12.4	11.6	12.2	17.7	13.5	11.0	18.0	18.5	15.9	19.1	17.8	63.9	10.4	19.4	24.5	29.6	16.9	13.0	15.2	29.9	9.5	22.8	49.3	14.4	22.9	20.1	10.3	14.6	16.8	12.2	14.8	14.8	20.9	26.4	16.2	12.9	42.4	24.0	18.4	16.1	9.1	13.1	29.0	23.3	22.8	15.7	15.5	30.4	17.4	12.6	27.4	16.2	10.2	25.2	30.7	16.3	19.0	10.9	14.1	19.7	15.0	26.2	19.7	20.4	13.1	12.5	40.4	11.4	17.8	9.9	10.6	9.4	16.3	8.9	8.7	12.6	15.3	12.2	10.8	126.5	12.9	12.3	15.6	6.2	5.6	10.7	11.2	10.9	11.6	11.0	10.8	10.6	11.3	11.1	10.4	11.3	13.1	13.3	16.0	12.6	6.2	35.5	11.0	26.3	20.9	13.6	31.2	18.3	21.1	21.8	31.5	14.9	16.5	39.6	21.2	28.7	38.1	45.0	25.2	14.8	23.7	16.2	16.1	24.0	4.8	6.0	18.0	17.9	14.9	32.1	23.2	25.4	31.1	20.7	11.1	23.3	20.2	8.8	39.0	30.5	29.4	12.9	8.5	18.6	18.8	10.6	4.7	11.6	39.5	8.2	5.0	9.4	13.2	30.4	13.9	11.6	17.8	71.5	23.7	24.4	53.9	19.7	20.0	20.2	81.3	53.1	12.8	12.4	32.2	23.9	38.2	39.8	24.0
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1484.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1332.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	86	"Hep G2: 173.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		8500000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.5	0.1	3.1	0.7	0.1	0.6	1.8	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	4.8	0.0	0.5	1.4	0.4	1484.1	17.6	0.1	1.7	2.0	0.0	0.5	0.0	0.0	0.0	2.5	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.4	0.1	0.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	173.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.1	0.6	1.8	0.5	1.4	1.7	2.0	2.5	0.3	2.2	5.1	0.0	3.2	27.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	190.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.0	0.0	10.7	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	15.7	1332.7	0.1	0.0	5.3	0.0	0.0	22.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884021	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 308.9;epididymis: 128.6;pituitary gland: 65.6"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 36.6;Excitatory neurons: 44.7;Horizontal cells: 95.9;Inhibitory neurons: 35.9;Late spermatids: 32.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"A549: 496.4;Hep G2: 323.4;SCLC-21H: 201.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	0.7	28.3	239.7	1.0	136.0	0.0	0.1	78.2	291.5	0.0	0.0	3.5	2.1	0.0	128.6	0.1	0.0	0.0	0.2	308.9	62.3	0.1	0.2	1.3	0.0	62.2	98.8	0.2	9.0	0.1	65.6	0.0	50.2	0.2	1.4	19.4	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.0	5.0	3.0	19.6	0.1	0.2	0.0	0.0	0.1	0.5	157.7	0.0	496.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	323.4	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.3	2.1	15.2	0.1	0.0	0.0	0.6	0.0	0.2	201.3	16.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.7	136.0	78.2	291.5	308.9	62.3	62.2	98.8	50.2	0.0	19.6	157.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.2	36.6	0.0	44.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	35.9	1.0	0.0	0.0	0.0	32.9	0.9	0.0	0.0	4.7	0.0	1.1	0.0	5.5	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339768-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 218.6"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 171.8"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"Hep G2: 61.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.4	3.0	0.7	0.4	0.6	1.5	0.2	0.6	1.1	0.2	0.0	0.2	0.0	0.4	0.4	0.1	0.2	0.4	1.0	0.7	0.8	14.7	218.6	0.2	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.4	0.2	0.2	0.2	1.1	0.2	0.1	0.1	0.6	0.2	0.2	0.0	1.2	0.4	0.7	0.4	0.1	0.3	0.0	0.2	0.1	0.0	1.1	0.2	0.1	0.3	0.3	0.1	0.8	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.3	0.8	0.4	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.6	61.8	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.5	0.6	0.0	0.3	0.2	0.3	0.3	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.2	1.4	1.6	0.2	2.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.7	0.8	0.2	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	171.8	0.2	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12803887	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 105.2;monocytes: 127.4;Syncytiotrophoblasts: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 674.2"	"Group enriched"	"Detected in all"	28	"dendritic cells: 168.5;granulocytes: 674.2;monocytes: 320.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 144.2;HMC-1: 129.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: AB_2677774"	"prognostic unfavorable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	12.5	9.4	9.1	19.3	14.1	14.0	8.2	13.0	11.4	11.0	7.3	13.3	21.3	7.9	5.1	25.2	7.1	11.2	10.1	8.3	13.3	33.7	34.4	13.7	11.7	14.0	13.1	7.6	4.8	3.9	4.1	18.5	14.4	11.1	14.8	3.7	13.1	8.6	8.2	6.5	21.4	12.9	11.3	29.8	8.7	15.5	12.2	9.2	13.2	9.6	16.6	11.5	8.8	17.3	5.0	29.7	3.3	7.7	12.0	25.3	0.5	54.1	14.5	28.4	23.1	14.5	15.2	7.3	54.6	39.6	12.5	0.4	0.0	13.5	29.3	17.0	8.2	62.5	4.2	144.2	7.4	0.1	129.9	25.4	3.0	2.5	20.2	0.1	43.1	9.9	22.1	4.3	70.4	6.3	5.6	29.1	8.7	2.4	4.2	11.9	18.8	15.6	43.0	9.4	15.3	10.0	0.2	48.5	20.0	15.3	10.5	13.7	65.0	40.6	8.5	0.2	0.1	0.1	1.0	11.6	9.1	31.7	8.8	57.1	224.0	146.1	9.1	320.0	7.8	10.8	7.6	10.0	168.5	8.4	2.4	5.7	674.2	13.5	320.8	41.1	13.8	129.7	9.1	14.1	13.0	11.4	8.3	13.3	14.0	13.1	14.4	11.3	12.2	17.3	12.3	9.6	16.7	8.1	8.7	4.6	3.4	4.9	4.6	3.3	4.7	4.7	10.7	10.0	11.4	14.7	8.4	105.2	18.5	9.2	60.7	43.1	3.6	5.3	13.5	16.7	6.0	31.7	13.1	12.8	15.6	12.6	4.1	9.4	54.4	8.1	7.5	45.8	47.1	10.1	10.2	9.3	6.1	80.3	30.7	4.1	15.5	59.0	7.2	30.0	127.4	13.5	8.2	21.1	70.9	31.9	18.3	24.0	4.4	3.2	40.6	66.0	13.4	6.1	26.3	17.6	11.9	2.5	9.9	14.8	4.5	131.9	8.3	13.6	15.4	1.7
CPSF4L		ENSG00000187959	"Cleavage and polyadenylation specific factor 4 like"	A6NMK7	17	73248449-73262352	"Predicted intracellular proteins"		RNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Skeletal myocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 3.0"	"Region enriched"	"Detected in single"	36	"cerebellum: 10.2"	"Low region specificity"	"Detected in many"			HPA044047	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"		"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044047: AB_10961638"	"unprognostic (7.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.57e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.03e-8)"	"unprognostic (6.71e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.4	0.9	0.5	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.5	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.3;testis: 25.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Distal tubular cells: 9.8;Granulosa cells: 12.5;Late spermatids: 7.9;Oligodendrocyte precursor cells: 6.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	16	"myeloid DC: 44.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 44.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.8;HEK 293: 3.3;HeLa: 3.5;Hep G2: 6.5;NTERA-2: 5.7;RPMI-8226: 4.6;THP-1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036198	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.8	0.6	10.1	1.7	10.2	2.6	0.9	11.3	16.5	2.4	8.1	1.1	2.0	1.3	1.6	0.7	2.0	0.6	24.3	10.1	10.4	5.3	10.4	0.6	5.4	9.4	9.4	2.1	1.6	2.1	2.3	0.2	9.4	5.7	0.4	2.5	0.8	8.0	0.4	1.8	3.5	0.6	9.0	7.9	0.8	25.7	10.0	1.6	2.0	0.0	5.9	1.1	1.4	10.4	0.0	0.8	0.2	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.6	2.8	0.1	0.0	0.0	3.3	0.0	3.5	6.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.6	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.7	0.9	0.0	1.7	0.0	2.3	0.0	0.0	44.6	2.6	0.0	0.0	0.8	0.3	2.3	0.4	0.0	1.8	10.1	10.2	11.3	16.5	10.1	10.4	9.4	9.4	9.4	9.0	10.0	10.4	0.2	0.0	0.0	9.4	2.8	0.6	0.3	0.0	0.0	0.9	0.1	0.8	3.2	5.7	0.1	0.0	0.0	0.0	0.1	0.3	9.8	1.1	3.9	1.1	0.2	0.2	0.0	0.8	4.7	0.2	0.0	0.2	0.0	0.1	0.0	12.5	0.0	2.9	0.2	0.0	3.5	0.1	0.0	0.9	3.4	7.9	1.2	0.7	0.0	1.0	1.4	0.5	1.0	6.6	3.4	0.3	0.1	0.0	0.1	0.1	0.7	4.5	0.3	0.8	0.0	0.3	0.4	5.3	1.6	0.0	0.0	0.0	0.3	1.0	0.4	0.1
CRLS1	"C20orf155, CLS1, dJ967N21.6, GCD10"	ENSG00000088766	"Cardiolipin synthase 1"	Q9UJA2	20	6006093-6040053	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 169.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 264.2;Hepatocytes: 208.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 237.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (1.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (8.02e-4)"	50.1	55.1	14.7	16.9	14.9	28.4	33.2	14.4	17.9	24.0	16.7	32.3	59.2	18.9	19.9	18.5	24.1	19.9	82.8	14.5	14.7	57.8	169.5	27.1	16.5	15.5	15.9	21.2	37.4	28.3	15.8	17.9	15.3	32.6	32.9	15.5	27.5	25.8	86.0	15.1	40.9	23.7	15.3	14.5	46.5	27.8	16.9	16.9	27.2	79.5	18.3	25.8	17.7	15.4	71.7	46.5	27.9	40.0	83.1	74.9	34.5	43.6	50.9	38.8	46.8	61.5	44.4	75.8	31.4	52.6	73.3	45.0	54.6	70.9	57.6	21.9	39.9	99.5	17.0	237.4	59.6	99.7	32.4	44.6	59.4	41.5	73.5	36.8	57.3	40.3	76.4	31.6	44.2	25.9	63.6	90.1	55.4	154.8	42.4	42.3	44.6	80.7	61.8	22.1	50.3	43.4	44.8	98.7	78.1	27.5	35.8	59.6	39.2	45.9	33.4	48.7	59.0	33.8	79.1	79.9	17.6	79.5	43.9	0.0	1.2	0.6	1.2	0.9	2.2	2.3	0.7	0.8	1.3	1.1	1.4	0.8	0.0	1.7	0.5	1.6	0.8	0.4	14.7	14.9	14.4	17.9	14.5	14.7	15.5	15.9	15.3	15.3	16.9	15.4	18.8	22.4	47.6	22.2	26.4	33.8	41.4	19.4	31.9	12.9	35.8	27.7	108.0	64.3	16.2	36.8	4.2	45.1	19.5	36.3	64.6	27.9	264.2	29.7	26.2	22.7	28.6	58.0	37.0	28.8	64.1	33.8	52.0	29.7	14.7	31.6	22.5	208.7	34.2	11.8	28.7	50.7	4.1	40.0	24.1	99.5	30.4	31.9	26.6	32.8	28.9	40.5	25.7	39.7	34.3	28.4	49.1	24.5	41.8	117.7	75.7	141.0	15.0	12.9	13.1	29.2	25.6	23.0	18.4	37.7	27.8	36.3	23.3	32.3	82.9	48.6
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"kidney: 85.6;retina: 55.5"	"Cell type enriched"	"Detected in single"	5	"Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	148	"Hep G2: 38.0"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.9"					"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	85.6	6.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYAA2		ENSG00000276076	"Crystallin alpha A2"	A0A140G945	21	6560714-6564489	"Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	136	"kidney: 125.7;liver: 42.1;retina: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	207	"Hep G2: 37.5"									"HPA037737, HPA038430"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"		Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	125.7	42.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 594.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 176.9;melanoma: 85.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 151.5;neutrophil: 126.3"	"Group enriched"	"Detected in many"	21	"granulocytes: 126.3;monocytes: 151.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	23.1	50.3	45.2	15.7	59.0	1.3	21.8	57.0	59.3	27.6	75.6	27.6	77.8	19.8	11.6	11.9	34.0	19.1	30.7	42.2	49.3	46.4	594.4	71.7	24.6	63.0	56.1	32.6	8.3	18.5	29.6	6.2	62.7	41.8	20.7	22.5	40.4	29.5	37.9	17.5	81.9	13.2	50.6	13.0	13.8	12.6	58.8	23.6	12.6	49.2	28.0	24.3	23.2	69.2	0.2	0.0	2.7	0.2	4.6	3.3	0.4	1.9	11.7	3.9	7.8	13.7	0.8	0.0	4.3	7.6	0.2	0.1	0.0	0.0	1.7	1.4	1.0	0.0	0.4	299.6	16.2	0.4	0.3	54.7	0.5	0.1	0.0	12.8	5.9	0.0	0.3	0.1	8.3	0.0	0.0	0.2	2.3	0.3	0.5	0.1	2.4	0.5	78.5	0.2	0.2	0.2	0.1	0.0	103.6	2.4	1.6	2.2	5.9	0.0	0.2	0.1	6.0	0.0	0.0	0.1	0.1	0.3	42.9	0.0	151.5	0.4	0.2	17.1	0.3	0.7	0.2	0.5	6.5	0.0	0.1	0.0	126.3	0.0	1.2	0.8	0.0	44.1	45.2	59.0	57.0	59.3	42.2	49.3	63.0	56.1	62.7	50.6	58.8	69.2	10.6	3.2	28.9	33.6	0.9	5.2	52.4	8.5	21.6	15.3	12.7	18.8	5.1	17.2	11.3	3.7	27.1	0.7	0.5	37.0	9.8	12.1	1.0	12.6	4.3	10.3	24.5	8.4	2.2	12.0	0.7	35.4	2.6	14.8	2.5	1.9	19.6	404.3	148.9	10.1	3.9	20.0	4.1	18.2	5.1	1.0	47.5	104.3	49.8	15.0	92.4	28.7	0.0	26.7	108.5	9.7	44.0	26.7	0.0	43.3	206.3	76.9	21.4	14.1	0.0	12.8	7.2	0.7	0.1	3.2	3.1	1.2	2.3	1.2	30.3	20.4
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130865	"Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 320.0"	"Group enriched"	"Detected in many"	35	"Hepatocytes: 512.8;Proximal enterocytes: 465.2"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.8"					"Low region specificity"	"Detected in many"			HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.2	0.0	0.3	0.3	0.1	0.8	0.2	0.1	0.3	0.3	3.7	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.3	320.0	0.1	0.1	0.2	0.0	0.2	0.8	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.2	11.7	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.3	0.6	0.0	1.1	5.5	0.7	0.5	0.7	1.3	2.8	7.3	1.1	1.4	0.4	2.8	0.7	1.8	2.1	0.1	0.6	2.9	1.9	0.7	3.1	0.8	0.6	0.6	1.2	0.0	6.5	0.6	0.1	0.3	4.1	1.4	0.0	0.7	5.7	512.8	0.1	11.8	9.4	7.6	0.0	5.6	0.0	13.6	0.0	0.4	0.0	0.0	0.1	0.7	0.0	5.0	4.9	0.7	11.3	1.5	0.4	0.6	465.2	0.5	1.3	2.3	0.0	0.4	2.1	0.8	0.4	0.6	1.1	0.4	1.0	0.1	3.4	0.3
CYP2W1	"FLJ20359, MGC34287"	ENSG00000073067	"Cytochrome P450 family 2 subfamily W member 1"	Q8TAV3	7	983181-989640	"Predicted intracellular proteins"	"Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 19.1;intestine: 6.1;skin 1: 10.5"	"Cell type enriched"	"Detected in some"	7	"Enteroendocrine cells: 98.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 25.3;stomach cancer: 15.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 13.5;Hep G2: 49.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (7.09e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.85e-4)"	0.1	19.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.4	0.0	0.9	6.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.3	1.0	0.1	2.1	0.5	0.2	0.3	0.2	0.0	10.5	1.0	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	2.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	4.0	2.3	1.5	0.0	0.6	0.0	0.0	0.5	0.0	2.6	0.0	0.0	1.1	0.0	3.7	0.0	0.1	0.1	0.1	0.0	0.3	98.5	0.0	0.0	0.9	0.6	10.2	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	13.6	0.0	0.0	0.9	0.0	1.8	0.3	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.1	3.3	0.0	0.1	1.2	1.1	0.0	3.3	0.6	0.0	0.8	0.3	0.2	0.1	0.0	4.4	1.9	0.2	4.4	11.4	3.7
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99705036-99735196	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 304.9"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 85.8;Hepatocytes: 60.5"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.3;Hep G2: 2.5;HHSteC: 1.4"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.2	0.9	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.2	0.5	0.3	0.3	0.1	0.0	6.5	0.0	0.0	0.1	8.5	304.9	2.4	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.1	85.8	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.3	60.5	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.8	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	1.3	0.0	0.2
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.2;kidney: 40.9;liver: 166.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.1	0.1	0.1	1.1	0.2	0.1	0.3	0.1	0.5	2.2	79.9	0.0	25.8	0.2	0.0	3.3	0.0	0.2	0.1	40.9	166.7	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	6.6	0.9	0.0	0.0	0.1	0.0	0.8	80.2	0.0	0.3	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
DAD1	OST2	ENSG00000129562	"Defender against cell death 1"	P61803	14	22564907-22589224	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028882	Uncertain		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Endoplasmic reticulum"	"HPA028882: AB_10602214"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (9.43e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.37e-3)"	204.0	229.3	209.2	159.1	224.4	129.0	224.0	236.2	259.4	229.6	252.2	197.7	165.8	184.3	473.8	187.0	230.5	190.8	202.6	211.4	238.0	296.8	275.7	183.4	169.6	240.2	218.7	174.5	200.2	254.1	201.6	141.8	238.7	145.5	209.9	86.2	286.3	205.5	156.6	137.2	173.8	206.6	237.2	165.3	197.0	150.7	219.2	211.6	272.8	197.5	191.0	200.0	163.4	252.0	373.3	344.7	274.6	375.8	740.2	529.9	238.3	387.0	473.0	340.5	478.1	219.6	520.1	233.7	242.1	453.1	381.4	330.0	291.1	375.7	543.3	319.8	265.1	228.5	180.9	886.0	514.5	321.2	315.8	395.8	498.7	356.0	454.4	383.1	506.2	220.9	176.4	532.1	509.9	459.3	153.6	391.4	169.7	816.1	557.8	211.7	232.4	306.7	503.2	306.1	211.5	263.4	294.9	416.1	445.9	328.7	251.4	323.1	381.1	291.8	232.2	358.2	248.3	391.2	502.6	308.5	263.8	225.5	431.0	532.4	421.9	460.9	528.4	371.9	518.9	527.2	543.8	501.4	401.0	477.1	564.8	497.6	481.5	437.2	332.3	783.9	560.3	941.8	209.2	224.4	236.2	259.4	211.4	238.0	240.2	218.7	238.7	237.2	219.2	252.0	357.9	160.3	161.7	15.0	183.9	198.3	188.3	581.8	149.7	25.1	201.0	274.6	173.8	187.3	315.2	255.6	27.1	260.9	204.6	174.8	215.2	525.4	196.8	270.3	242.9	267.8	135.7	130.2	10.6	415.2	383.1	276.5	145.2	255.6	302.6	150.8	187.7	231.9	350.3	21.9	11.0	242.3	360.1	146.2	224.8	101.5	214.3	166.8	330.8	8.4	217.3	216.8	198.8	18.1	42.5	396.8	160.7	199.0	408.6	172.5	244.8	420.8	393.7	42.6	151.2	141.5	291.0	300.3	128.1	179.6	215.8	289.0	211.7	266.6	183.8	174.4
DAO	"DAAO, DAMOX"	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 71.4;kidney: 90.3;liver: 149.9"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 46.1;Proximal tubular cells: 86.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Group enriched"	"Detected in some"	10	"cerebellum: 66.4;pons and medulla: 20.2"	"Low region specificity"	"Detected in all"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.1	0.0	0.9	0.0	6.9	0.0	0.0	71.4	1.6	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	90.3	149.9	0.2	0.0	41.9	14.8	0.0	0.2	0.0	0.0	0.0	29.5	0.0	2.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	44.0	0.1	0.1	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.9	71.4	1.6	0.8	3.3	41.9	14.8	29.5	44.0	4.3	59.1	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.7	0.0	4.6	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	46.1	0.2	0.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	86.8	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.2	0.0
DCAF11	"GL014, PRO2389, WDR23"	ENSG00000100897	"DDB1 and CUL4 associated factor 11"	Q8TEB1	14	24114195-24125242	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 201.2;Hepatocytes: 156.0;Proximal enterocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003583, HPA031157"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003583: AB_2667001, HPA031157: AB_10603002"	"unprognostic (1.50e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.23e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-1)"	"prognostic favorable (3.50e-13)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.68e-1)"	15.4	41.6	21.5	13.4	21.7	39.5	17.1	19.7	23.0	15.4	19.9	24.5	29.3	17.1	23.2	29.8	15.6	13.6	38.1	22.3	19.9	35.8	107.2	17.5	15.6	21.0	20.3	23.1	59.7	28.2	25.6	9.2	19.8	23.6	16.6	17.6	25.9	17.5	62.3	20.1	37.5	11.7	19.2	28.9	34.3	16.5	22.0	19.0	26.4	50.0	16.1	20.3	16.2	21.1	12.5	18.3	12.3	10.9	10.7	8.8	16.6	9.1	10.7	16.0	19.5	12.0	21.3	19.4	10.3	12.2	13.3	16.1	15.8	9.6	7.4	23.1	9.5	15.6	19.7	67.3	14.3	27.7	31.0	5.3	23.1	6.7	16.7	13.1	12.3	31.6	15.0	23.0	9.7	39.2	23.7	28.5	7.2	35.0	17.0	25.1	16.0	28.2	12.2	28.1	22.1	17.0	5.3	29.9	13.4	12.7	15.4	19.6	5.1	12.5	10.0	13.6	13.2	38.6	36.2	25.3	6.0	17.7	10.9	14.0	13.8	20.5	13.8	15.8	11.7	12.1	12.5	13.5	17.1	11.5	12.2	11.4	11.7	23.0	13.9	8.6	16.7	15.2	21.5	21.7	19.7	23.0	22.3	19.9	21.0	20.3	19.8	19.2	22.0	21.1	18.2	28.9	45.4	10.4	30.5	8.8	22.2	18.7	31.3	34.1	34.8	20.7	41.2	44.3	23.9	38.6	47.9	34.6	34.2	76.1	46.9	41.6	19.3	22.0	10.8	15.2	28.9	201.2	9.2	46.2	31.5	14.1	29.0	22.5	12.6	26.5	22.1	156.0	37.4	16.8	6.9	40.7	20.3	27.0	12.8	26.6	9.0	24.1	17.8	9.4	39.2	38.8	55.6	7.1	9.7	31.9	34.6	14.7	26.6	25.0	147.9	56.0	22.3	29.4	26.3	15.9	14.5	23.7	12.4	32.6	11.4	50.5	31.2	60.7	49.0	22.7
DDRGK1	"C20orf116, dJ1187M17.3, UFBP1"	ENSG00000198171	"DDRGK domain containing 1"	Q96HY6	20	3190350-3204685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013373, HPA013705"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA013373: AB_2091955, HPA013705: AB_2668872"	"unprognostic (2.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.10e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.01e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.90e-2)"	44.6	89.1	43.2	23.8	44.6	24.8	45.5	38.9	65.7	50.8	36.7	43.3	43.4	43.5	20.0	46.0	49.0	22.4	38.4	42.3	36.8	51.2	77.9	51.6	23.6	39.7	38.8	48.9	84.1	54.7	36.6	25.9	39.5	45.7	19.2	43.2	61.7	32.2	58.2	53.0	44.9	19.9	33.5	36.3	63.0	34.8	37.5	18.6	51.3	14.1	17.0	43.5	44.6	48.4	108.5	133.3	32.3	60.6	71.7	27.2	46.6	67.2	31.9	40.6	44.1	105.7	76.7	64.3	53.6	37.5	77.9	118.2	33.5	100.6	14.8	44.0	62.8	54.4	45.6	186.1	97.9	62.1	56.6	42.8	96.2	77.8	55.2	44.8	37.5	45.3	77.0	74.8	26.4	59.2	42.9	115.5	40.1	73.6	60.8	55.9	28.7	98.6	66.7	99.8	71.4	44.1	69.2	192.7	65.6	19.2	82.0	37.6	57.2	64.9	28.8	46.3	104.2	55.8	67.7	27.3	18.0	51.6	38.9	23.1	36.9	45.6	33.3	25.3	32.7	26.9	35.0	35.6	36.8	26.3	30.8	30.5	9.5	24.6	23.2	57.3	36.2	25.9	43.2	44.6	38.9	65.7	42.3	36.8	39.7	38.8	39.5	33.5	37.5	48.4	57.3	44.8	53.9	19.9	35.1	26.3	68.8	119.0	44.3	47.9	77.1	72.3	31.3	91.5	114.3	69.9	64.6	127.5	50.9	105.8	19.6	147.0	42.2	54.8	42.6	54.1	53.4	26.5	28.6	178.8	65.1	49.3	54.0	79.0	27.3	34.8	50.0	125.6	119.3	52.2	13.9	72.2	154.6	60.9	36.0	21.1	55.9	54.2	39.2	7.5	67.8	73.7	64.9	6.0	28.4	145.0	125.3	68.8	60.5	75.7	216.3	80.5	81.6	108.3	65.7	39.1	115.6	38.7	23.6	64.0	38.8	146.0	44.7	70.0	92.7	75.0
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401858-412487	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 165.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 129.2;Proximal enterocytes: 81.3;Proximal tubular cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes	Microtubules	"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	13.0	34.8	5.5	1.6	5.7	5.8	11.8	5.5	8.1	9.6	5.4	18.5	20.6	10.0	2.0	12.0	9.2	2.1	12.4	6.0	6.6	35.8	165.1	6.8	1.2	5.6	5.5	8.6	21.2	1.7	8.4	2.4	5.5	11.9	2.8	0.5	9.5	7.1	32.3	10.5	17.4	1.5	5.5	6.8	13.8	11.4	6.1	1.8	6.3	7.2	1.0	10.7	8.1	6.1	2.4	22.5	3.4	14.7	4.1	6.3	7.7	7.0	5.7	6.0	6.7	16.2	16.2	6.1	12.2	7.5	3.7	3.5	2.1	6.4	1.3	12.4	5.7	2.3	10.3	37.6	17.7	4.9	11.1	9.1	4.8	4.2	5.5	6.1	6.9	9.5	4.3	7.9	5.5	27.7	3.2	10.2	8.0	9.0	7.5	5.8	1.3	12.2	6.9	6.3	4.3	8.5	11.3	15.9	8.8	1.3	21.9	10.1	10.8	5.1	5.8	7.5	5.6	6.7	7.1	2.6	7.0	10.2	16.1	0.0	3.8	0.1	2.7	5.1	1.5	1.8	1.1	1.5	5.1	1.7	2.6	1.5	0.2	2.9	2.5	7.8	0.9	2.6	5.5	5.7	5.5	8.1	6.0	6.6	5.6	5.5	5.5	5.5	6.1	6.1	9.6	12.8	16.2	5.2	4.3	3.8	7.3	5.6	10.2	2.0	14.9	15.6	8.3	20.0	7.4	20.2	0.0	34.3	5.7	53.8	39.2	37.3	2.6	7.1	8.1	9.4	12.5	29.5	2.3	38.9	7.1	9.9	38.7	9.6	12.7	15.8	7.5	129.2	12.9	3.3	2.7	30.6	6.1	7.3	5.7	6.3	6.5	6.0	5.4	0.0	10.0	7.0	5.2	3.0	2.8	25.3	37.2	6.8	3.8	6.4	81.3	159.1	7.7	3.0	0.0	7.7	8.3	3.8	6.3	12.6	6.0	12.6	3.5	25.8	38.8	5.1
DEXI	MYLE	ENSG00000182108	"Dexi homolog"	O95424	16	10928891-10942468	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA041511	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"	Cytosol	"HPA041511: AB_10796675"	"unprognostic (4.14e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.47e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.83e-2)"	34.7	82.2	52.6	10.8	54.2	5.5	29.3	59.3	60.1	35.3	44.3	46.8	14.6	34.5	23.4	25.0	34.1	11.2	101.6	43.0	54.0	33.1	91.3	27.3	12.5	58.7	55.6	34.6	29.8	20.9	38.0	13.0	62.2	39.1	7.9	6.2	23.5	20.3	128.4	27.6	24.9	15.5	51.8	30.5	34.0	14.8	67.9	11.6	28.4	58.7	10.5	33.5	28.9	45.5	18.1	25.9	13.6	24.1	54.1	29.5	12.5	27.2	28.0	17.4	16.5	12.2	18.5	21.4	39.9	31.0	19.0	22.9	16.2	29.3	14.9	50.4	36.4	10.7	17.1	52.3	30.9	18.3	19.3	30.2	33.1	17.1	19.7	28.2	25.3	29.7	24.5	20.8	19.6	31.9	22.9	19.9	19.1	22.3	26.5	21.2	18.0	32.8	21.9	13.3	28.0	24.7	26.0	28.2	22.6	11.4	22.5	31.6	28.1	17.5	18.7	41.9	18.0	27.2	22.6	6.2	15.4	38.7	20.2	1.3	0.5	7.2	4.6	0.6	4.2	0.5	4.0	5.4	0.3	4.1	4.7	4.6	0.5	3.0	0.2	2.0	3.3	1.0	52.6	54.2	59.3	60.1	43.0	54.0	58.7	55.6	62.2	51.8	67.9	45.5	23.3	6.4	12.1	10.1	12.4	33.3	40.5	9.7	21.6	18.8	19.1	26.0	0.0	41.5	5.9	27.6	12.5	28.1	11.5	8.5	76.3	24.8	8.1	10.5	21.4	27.1	14.9	15.6	8.0	36.2	21.4	33.8	10.7	7.4	1.3	30.4	46.1	106.3	41.2	23.5	13.3	14.5	14.2	15.5	15.8	14.9	75.2	14.6	16.0	8.4	10.7	57.0	18.6	3.5	6.7	31.2	10.1	85.7	14.9	70.7	17.8	70.9	8.8	14.8	19.7	29.9	26.1	3.8	3.7	18.4	32.5	11.6	19.2	38.4	17.5	39.0
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"adrenal gland: 3.4;brain: 12.2;pituitary gland: 6.1"	"Cell type enriched"	"Detected in some"	6	"NK-cells: 13.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 12.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 19.8"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"	0.0	3.4	1.3	0.0	5.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.8	2.3	0.0	0.0	0.0	6.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	5.1	0.0	2.9	0.1	4.5	0.8	2.3	1.1	0.4	12.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.1	0.0	13.4	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299780	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 68.9;liver: 61.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000599, HPA076886"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655, HPA076886: "	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.18e-5)"	"prognostic favorable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	12.4	14.8	2.0	2.8	2.1	4.4	13.3	2.3	2.8	17.6	2.7	16.3	21.5	11.5	5.8	68.9	9.4	5.3	5.4	2.0	2.4	15.0	61.2	9.7	4.4	2.4	2.1	7.0	7.7	13.5	8.8	3.5	2.3	10.1	6.6	1.2	26.2	7.4	2.9	40.7	19.8	5.7	2.3	10.5	11.4	5.5	2.1	4.8	11.7	2.8	9.5	8.9	25.4	2.7	16.6	4.0	4.2	1.7	9.4	10.0	1.1	5.9	12.7	13.4	14.6	1.7	15.7	7.7	2.5	9.3	2.2	14.0	3.2	26.5	6.6	5.4	3.6	2.4	9.1	27.2	4.5	4.8	1.9	8.9	15.9	3.4	2.5	11.2	10.2	6.5	4.9	7.4	11.4	7.0	1.8	1.8	0.7	13.4	6.1	6.0	3.0	10.8	10.5	6.4	3.8	2.7	8.2	11.1	3.0	3.0	5.8	1.4	4.0	1.1	2.6	1.7	2.0	4.1	3.5	3.8	4.9	4.1	1.3	15.1	9.0	18.4	6.5	10.2	7.2	9.9	7.2	6.2	11.1	6.3	7.0	4.0	5.9	5.0	6.2	6.8	12.3	5.2	2.0	2.1	2.3	2.8	2.0	2.4	2.4	2.1	2.3	2.3	2.1	2.7	17.8	22.4	17.1	8.5	18.4	32.9	26.9	89.9	28.5	12.3	32.4	27.3	19.0	50.1	36.1	35.0	18.8	48.3	26.2	59.6	39.2	27.1	21.7	14.2	6.7	17.1	19.2	16.2	6.9	30.4	9.5	16.5	19.4	18.0	6.3	14.6	14.6	105.4	28.1	15.2	9.2	39.8	40.7	14.6	18.0	34.8	20.2	17.0	46.2	4.7	15.2	16.5	24.7	7.1	14.2	64.1	50.3	20.7	21.8	17.9	178.8	74.8	22.6	47.7	26.3	10.4	16.3	27.3	14.0	80.5	45.7	26.1	23.4	13.7	41.3	35.9
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 1330.8;pituitary gland: 772.9;placenta: 1631.2"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1;testis cancer: 25.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 163.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.7"	"Group enriched"	"Detected in many"	5	"hypothalamus: 41.2;midbrain: 156.8"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		NA	NA		2600000		"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavorable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			3.1	1330.8	3.4	6.1	1.9	0.1	7.1	0.0	0.8	9.4	0.3	0.2	1.8	0.7	0.2	2.6	3.1	2.2	45.7	0.5	163.3	0.6	1.8	0.8	0.5	15.4	38.7	277.2	21.2	0.0	772.9	1631.2	81.7	1.4	0.0	0.0	26.9	0.0	17.5	1.2	1.3	0.2	2.1	1.1	1.0	40.9	14.7	1.7	0.2	83.1	0.0	1.0	1.5	0.9	0.0	0.0	120.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	12.6	0.3	419.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	1.4	0.1	0.0	0.5	33.7	473.8	0.0	0.1	0.0	2.9	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	1.9	0.0	0.8	0.5	163.3	15.4	38.7	81.7	2.1	14.7	0.9	0.4	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.3	1.0	2.6	0.0	0.0	0.0	0.0	55.2	0.2	0.0	0.0	4.8	7.1	0.0	0.0	6.7	0.0	0.0	0.0	576.5	45.3	699.3	0.0	0.0	0.0	0.8	0.0	0.0	84.3	0.0	0.0	0.0	0.0	0.0	0.3	35.0	1357.0	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	172.6	0.0	1.3	0.0	0.2	0.0	0.0	59.2	2360.1	3.0	13.5	69.9	0.0	0.4	105.8	0.8	63.2	0.0	0.2
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69400888-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;parathyroid gland: 12.5;retina: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 230.4;Excitatory neurons: 236.8;Inhibitory neurons: 259.1;Oligodendrocyte precursor cells: 178.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;Hep G2: 11.1;RPMI-8226: 10.5;SCLC-21H: 4.7;SH-SY5Y: 10.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	"Focal adhesion sites, Cytosol"		"HPA041099: AB_2677299, HPA063534: AB_2685032"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	1.1	0.7	8.8	0.7	10.3	0.1	0.5	0.9	14.0	1.8	0.0	0.6	0.3	1.5	0.5	0.7	0.7	3.2	6.2	17.8	10.6	4.9	2.4	2.4	0.5	10.9	11.6	2.2	0.2	12.5	0.7	5.9	9.7	1.3	0.5	22.3	0.8	2.1	0.1	0.5	0.5	2.5	4.1	0.9	0.7	1.5	6.5	0.1	2.2	0.6	0.5	3.1	1.1	5.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.0	11.1	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.5	0.0	0.0	4.7	10.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	4.0	0.6	0.0	1.5	0.3	0.0	0.0	3.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.3	0.9	14.0	17.8	10.6	10.9	11.6	9.7	4.1	6.5	5.8	0.5	0.0	0.0	9.8	0.0	0.3	0.1	0.0	0.0	230.4	0.1	0.0	9.1	0.0	1.3	0.0	14.6	0.0	1.2	0.0	1.9	0.0	45.3	0.4	13.3	1.5	0.0	0.0	236.8	0.0	0.0	6.7	0.0	0.3	0.0	17.2	0.0	0.9	0.0	10.1	259.1	0.0	0.0	0.3	0.8	30.6	1.5	2.1	0.0	8.4	0.1	6.9	2.1	178.4	6.4	0.0	0.0	6.8	0.7	0.1	0.0	9.6	0.0	14.6	0.0	0.4	5.5	0.9	1.1	0.1	0.6	0.0	1.2	4.9	0.0	0.1
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 377.4;kidney: 255.9;pancreas: 440.7"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		370000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.6	2.3	0.0	1.8	0.0	0.4	0.5	0.0	0.2	4.1	0.0	1.7	85.5	0.6	0.9	0.3	0.6	3.9	0.3	0.0	0.3	255.9	0.5	0.9	2.8	0.2	1.1	0.8	440.7	0.0	0.5	0.8	0.6	0.5	0.5	0.3	1.2	1.0	0.0	2.2	377.4	0.3	0.3	4.5	1.6	46.5	0.9	0.9	0.8	0.0	0.9	2.2	0.9	0.0	0.0	0.9	0.2	0.0	1.7	0.2	4.4	0.0	0.0	0.0	0.0	8.5	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.6	0.0	0.0	33.1	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	1.1	3.4	0.0	0.0	0.0	3.0	0.0	0.1	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	1.4	0.0	0.0	0.2	0.1	0.0	46.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.1	0.6	0.3	0.9	0.0	0.1	3.2	1.8	0.0	9.2	0.5	0.0	0.0	0.0	5.8	1.7	0.0	0.3	0.0	0.6	23.9	0.0	0.2	0.0	2.0	56.7	0.5	13.2	0.2	0.2	7.0	8.9	0.0	0.3	192.1	0.8	8.9	1.1	0.1	1.3	0.7	1.1	0.0	0.5	0.0	0.3	142.3	0.0	0.3	0.3	45.2	289.8	4.8	5.4	0.0	1.0	0.1	0.0	0.0	0.1	27.4	187.4	1217.5	61.2	0.0	4683.5	829.6	0.0	0.2	6.6	0.0	0.7	17.3	2.8	0.0	0.3	0.4	2.5	0.2	151.7	0.0
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526281	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 16.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.3;Gastric mucus-secreting cells: 13.7;Intestinal goblet cells: 17.3;Paneth cells: 13.9;Proximal enterocytes: 44.2;Undifferentiated cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.8;Hep G2: 18.4;hTCEpi: 6.1;OE19: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039158, HPA046763"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"		"HPA039158: AB_10960125, HPA046763: "	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.4	0.0	6.3	16.4	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	5.6	0.0	0.4	0.0	0.0	1.1	13.9	0.5	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	1.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.1	5.8	0.1	0.0	0.0	0.5	0.2	18.4	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	15.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.9	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.5	0.1	4.5	4.6	0.4	0.1	0.0	0.3	1.5	3.5	0.0	2.1	1.6	0.0	17.3	0.0	0.0	0.0	0.2	0.1	0.0	2.4	0.0	0.6	0.0	0.8	0.6	13.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	13.9	0.0	0.4	0.0	44.2	0.0	5.0	0.9	0.0	0.1	0.1	0.6	0.3	3.1	0.0	1.1	0.1	0.0	12.5	0.2
DRC7	"C16orf50, CCDC135, CFAP50, DKFZp434I099, FAP50"	ENSG00000159625	"Dynein regulatory complex subunit 7"	Q8IY82	16	57694793-57731805	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 11.4;fallopian tube: 21.1;testis: 46.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 119.1;Late spermatids: 134.4;Spermatocytes: 48.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"basophil: 10.9"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 10.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.0;HMC-1: 1.6;JURKAT: 1.8;NB-4: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (4.04e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.11e-2)"	"prognostic favorable (3.61e-4)"	"unprognostic (9.96e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.34e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.53e-2)"	0.1	0.0	2.2	0.3	2.0	1.0	0.0	1.2	1.1	1.0	11.4	0.0	0.0	0.6	0.8	0.0	21.1	0.7	0.0	2.4	2.7	0.8	0.3	1.9	0.1	6.1	9.3	0.2	1.2	0.7	1.0	0.1	4.5	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.1	4.1	0.2	0.2	46.1	2.8	0.2	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.7	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.3	0.3	1.6	0.6	0.0	0.2	0.0	0.6	0.2	1.8	0.7	0.0	0.0	0.0	0.3	1.4	0.1	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.7	0.8	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	10.9	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	2.2	2.0	1.2	1.1	2.4	2.7	6.1	9.3	4.5	4.1	2.8	2.9	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.4	119.1	25.1	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	134.4	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.8	21.9	0.0	0.0	0.1	0.1	48.2	4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1
DTD2	"C14orf126, MGC9912"	ENSG00000129480	"D-aminoacyl-tRNA deacylase 2"	Q96FN9	14	31446036-31457506	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001117	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA001117: AB_2666204"	"unprognostic (2.56e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.28e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (5.74e-6)"	8.6	6.3	4.7	4.9	6.8	2.3	7.1	5.2	6.5	4.0	5.2	4.8	3.9	5.2	5.0	5.7	4.9	3.5	3.1	5.3	5.3	5.8	8.1	5.8	5.5	5.5	5.9	5.3	6.3	6.1	4.4	4.3	5.9	5.7	5.4	5.0	6.0	3.9	1.6	5.6	3.7	5.5	4.9	4.9	4.0	4.0	6.2	5.0	6.2	1.6	5.5	4.7	3.8	8.1	11.4	9.5	8.1	10.6	14.6	12.3	5.5	10.3	10.0	8.0	7.1	5.2	10.7	21.6	6.8	11.8	8.6	10.8	13.0	11.6	13.6	11.7	5.7	6.2	6.5	29.0	15.7	12.6	7.3	14.0	12.9	7.1	15.9	6.7	11.8	12.8	12.3	9.9	10.7	13.7	18.3	11.3	11.0	19.6	9.7	12.3	6.0	11.3	15.0	9.8	12.1	8.0	16.8	21.6	12.4	6.9	19.8	6.5	8.6	8.7	7.7	7.1	9.1	12.3	24.5	20.7	3.8	11.4	14.3	2.5	2.6	1.0	2.0	2.2	2.9	2.7	3.0	2.2	3.7	3.2	4.5	3.0	1.5	3.7	1.2	2.2	1.6	2.8	4.7	6.8	5.2	6.5	5.3	5.3	5.5	5.9	5.9	4.9	6.2	8.1	2.9	9.6	9.0	10.1	7.6	5.2	5.7	5.1	13.1	5.9	6.1	4.3	4.8	15.7	4.9	3.7	8.4	9.1	4.9	3.3	3.9	5.7	4.4	6.8	7.2	3.8	3.0	8.0	9.2	6.2	6.3	6.2	5.1	3.0	1.3	5.9	3.9	11.6	5.1	5.0	12.7	6.7	14.2	5.5	3.7	6.6	7.5	4.0	3.6	2.8	4.8	9.5	7.2	35.2	40.2	5.2	3.9	8.2	7.1	6.0	3.3	9.7	6.2	9.2	0.0	7.4	6.8	10.1	2.7	16.2	5.4	2.7	5.4	10.3	7.2	4.2
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 247.2;testis: 53.7;tongue: 122.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 428.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	10	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;EFO-21: 5.0;Hep G2: 11.0;K-562: 4.3;LHCN-M2: 9.5;RH-30: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	0.1	0.0	0.1	5.8	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.3	3.7	0.1	0.0	17.3	0.1	0.5	0.1	0.1	0.3	0.0	0.2	0.7	0.0	0.0	0.2	0.1	0.0	1.3	1.0	0.0	0.0	3.5	0.0	247.2	0.5	0.0	0.0	0.1	0.5	0.0	53.7	0.1	0.2	0.1	122.5	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	4.3	0.0	9.5	0.5	0.0	0.0	0.6	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.5	0.2	0.7	1.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	1.1	3.4	0.0	0.0	0.1	12.2	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	428.1	0.0	0.0	0.6	0.0	0.0	0.1	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	94.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.1	0.1	0.0	0.0	0.2	0.0	0.0	21.7	0.6	10.4	3.3	6.3	2.0	3.0	0.1	0.0	0.0	0.2
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 56.9;placenta: 72.6"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.0	4.1	0.0	3.3	0.0	0.2	1.7	3.8	0.1	1.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	4.0	1.9	56.9	1.1	0.0	0.0	2.1	2.5	0.8	0.5	0.7	0.0	72.6	2.2	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	1.9	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.7	0.1	2.6	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.3	1.7	3.8	4.0	1.9	2.1	2.5	2.2	1.9	2.8	2.6	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
EAPP	"BM036, C14orf11, FLJ20578"	ENSG00000129518	"E2F associated phosphoprotein"	Q56P03	14	34515938-34539711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002916	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA002916: AB_1078715"	"unprognostic (8.76e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (9.34e-4)"	"unprognostic (1.81e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.64e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (3.24e-2)"	37.3	35.8	26.3	24.6	27.0	89.2	51.0	29.7	35.5	33.3	27.1	50.8	35.7	35.0	44.7	29.0	39.4	28.1	29.0	27.1	28.6	42.4	50.2	29.5	37.2	25.9	26.5	49.7	26.7	54.7	21.6	35.2	26.3	33.7	51.7	37.1	36.4	31.2	37.0	46.9	45.6	29.2	28.1	31.3	29.3	23.5	27.1	49.1	45.5	29.3	37.1	31.1	30.0	30.0	37.7	45.1	41.3	24.4	47.8	48.7	64.1	33.8	51.6	41.5	43.1	21.6	48.6	39.1	46.6	41.5	24.7	34.5	30.8	45.1	48.3	49.1	27.1	28.7	31.6	91.7	65.1	51.5	30.4	56.3	56.7	23.8	60.9	54.6	41.7	54.1	28.9	42.0	39.1	88.0	71.4	41.5	24.3	69.4	50.0	44.8	49.5	39.5	50.2	50.3	33.1	36.5	47.8	45.6	76.4	39.4	79.7	32.3	45.2	21.4	18.1	28.1	22.0	52.8	63.1	41.5	20.1	28.0	27.6	139.9	61.9	134.3	65.3	57.8	79.1	107.7	81.9	75.0	54.9	101.0	82.7	75.8	140.2	100.6	80.9	47.8	124.4	80.0	26.3	27.0	29.7	35.5	27.1	28.6	25.9	26.5	26.3	28.1	27.1	30.0	59.8	22.4	53.3	17.0	78.6	46.4	67.2	145.0	74.6	75.6	60.0	70.1	35.4	60.1	78.8	82.8	31.3	125.3	76.3	91.8	174.1	86.6	20.9	82.0	59.6	57.8	66.0	66.7	20.5	84.5	76.5	67.6	26.5	54.8	73.5	98.7	57.5	109.0	58.8	25.2	21.3	112.8	87.5	50.6	33.9	14.9	89.5	47.5	90.7	16.9	71.3	122.0	87.6	17.6	23.1	59.8	102.5	94.4	46.8	61.4	131.5	164.8	102.0	75.7	72.3	69.9	78.7	103.3	38.3	63.8	66.5	189.4	74.2	101.2	98.0	58.2
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039472	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 84.3;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	5	"monocytes: 1.2;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 5.2;Hep G2: 17.9;OE19: 5.1;RPMI-8226: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Secreted - unknown location"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Lipid droplets"	"HPA037972: AB_2675761, HPA037973: AB_2675762"	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	4.2	8.5	2.4	0.7	3.0	0.1	2.8	2.2	2.6	4.9	5.2	2.6	0.5	3.0	3.2	1.5	3.8	2.0	10.4	2.1	2.4	3.7	2.1	3.2	0.8	3.2	2.8	4.9	4.2	9.7	1.3	1.8	3.0	3.4	1.1	0.3	2.2	2.2	1.7	4.2	1.1	2.1	2.3	1.4	3.8	1.2	3.1	1.2	6.0	2.0	0.6	2.3	3.9	4.6	0.0	0.6	0.3	2.8	0.5	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	5.2	0.2	0.2	0.5	3.8	1.4	0.0	0.0	4.5	0.0	0.0	17.9	1.0	0.0	1.1	1.8	1.3	0.0	0.9	0.0	0.5	3.5	0.0	4.9	0.0	1.2	0.0	0.0	2.8	5.1	0.3	0.0	1.2	6.0	0.1	0.0	1.5	0.0	0.1	0.3	0.1	2.0	0.3	0.1	0.5	1.7	2.2	2.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.1	2.4	3.0	2.2	2.6	2.1	2.4	3.2	2.8	3.0	2.3	3.1	4.6	3.3	3.2	0.5	21.2	0.3	3.8	2.6	2.0	6.8	0.2	0.9	1.5	12.1	0.0	1.1	5.5	0.0	0.2	0.1	1.0	0.0	1.3	21.3	4.6	1.2	2.2	1.8	0.0	17.9	1.3	0.2	6.0	5.6	12.2	0.0	0.5	11.0	1.2	4.1	0.0	9.6	0.6	0.0	4.8	1.2	9.2	4.7	2.8	1.8	84.3	0.1	1.3	0.0	30.2	45.9	1.1	0.1	2.2	0.2	2.3	0.4	3.1	1.3	0.1	6.6	10.7	5.4	1.7	3.5	3.2	4.1	0.0	2.1	0.4	0.9	1.5
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.6;fallopian tube: 19.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.3	0.4	0.8	0.1	1.0	0.8	0.3	1.7	1.1	1.1	12.6	0.1	0.0	0.3	0.8	0.0	19.7	0.2	0.3	1.4	1.5	0.8	1.2	1.7	0.1	4.9	7.0	1.0	0.6	1.7	3.6	0.1	3.2	3.0	0.0	1.6	0.2	0.2	0.0	0.1	0.3	0.0	3.6	0.4	0.7	6.9	2.4	0.2	1.2	0.0	0.2	0.0	0.1	1.0	0.1	0.7	0.2	0.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.7	1.1	1.4	1.5	4.9	7.0	3.2	3.6	2.4	1.0	0.2	3.2	1.7	0.3	0.5	0.5	0.1	0.8	0.0	0.4	0.7	0.4	1.3	1.5	1.8	0.0	2.1	0.0	0.3	0.1	0.0	0.2	29.6	31.9	0.7	0.5	0.0	0.0	2.7	0.2	0.1	0.5	3.1	1.9	0.0	0.1	0.0	1.1	0.1	5.0	0.8	0.3	2.0	0.0	0.0	20.1	0.3	0.3	0.0	0.0	0.1	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	46.0	5.6	0.0	0.5	0.6	6.8	2.7	0.7	0.3	0.0	0.3	0.3	0.0	0.2
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1285873-1301431	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.3;liver: 12.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Cardiomyocytes: 4.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 5.0;Paneth cells: 2.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5;stomach cancer: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 6.2;Hep G2: 13.5;NTERA-2: 6.8;OE19: 6.0;REH: 6.8;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.0	0.0	1.6	1.5	1.7	0.0	0.0	1.2	1.3	0.1	0.3	9.9	9.9	0.0	0.0	0.4	0.0	3.5	0.0	1.4	2.0	0.4	12.9	0.0	0.0	1.7	3.0	0.0	0.1	0.2	0.3	0.2	1.1	0.0	4.4	0.6	0.0	0.0	0.2	0.1	12.3	0.0	1.9	0.0	0.2	0.6	3.1	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.2	10.3	3.1	0.0	0.0	3.7	0.2	0.0	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.0	0.0	4.8	0.0	0.0	0.0	1.4	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.1	6.8	6.0	0.0	6.8	1.0	0.1	0.0	0.4	0.0	13.3	0.7	0.0	0.2	3.5	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.6	1.7	1.2	1.3	1.4	2.0	1.7	3.0	1.1	1.9	3.1	1.4	0.1	0.0	0.0	1.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.0
EIF3C	"eIF3-p110, EIF3S8"	ENSG00000184110	"Eukaryotic translation initiation factor 3 subunit C"	Q99613	16	28688558-28735727	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 101.4;Cardiomyocytes: 157.0;Club cells: 91.1;Respiratory ciliated cells: 168.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034045, HPA047097, HPA049495, HPA050112"	Supported		Supported	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020"	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-3)"	174.0	99.7	86.7	113.5	94.3	149.8	185.7	77.4	92.6	136.9	83.2	189.7	148.6	138.0	51.7	159.7	185.9	86.7	135.3	98.1	89.2	172.8	143.1	104.6	124.8	87.4	91.6	236.4	219.6	227.9	86.8	122.8	92.8	115.2	166.1	94.8	187.6	112.9	360.1	188.3	145.0	149.0	80.2	116.2	124.4	140.8	84.2	91.0	175.7	291.9	189.0	144.8	104.2	89.3	182.1	321.5	419.3	481.5	368.0	453.1	627.7	444.1	380.9	587.7	425.4	620.6	333.9	461.7	556.7	322.2	366.5	214.5	361.4	618.1	650.0	188.4	376.0	518.9	466.8	860.4	471.9	791.3	344.6	521.4	367.4	370.4	582.8	253.6	679.5	439.3	595.7	394.5	314.5	783.0	622.0	299.2	652.8	304.0	491.2	638.8	612.7	447.0	317.8	406.4	379.1	573.2	396.8	531.0	478.0	263.3	551.6	356.6	570.3	372.3	370.1	180.4	299.9	325.8	279.0	860.7	378.7	320.4	398.7	54.5	198.1	90.2	122.0	204.0	140.6	114.3	131.8	129.1	213.2	113.9	127.4	120.5	14.3	163.8	220.5	98.3	147.2	267.3	86.7	94.3	77.4	92.6	98.1	89.2	87.4	91.6	92.8	80.2	84.2	89.3	5.0	67.3	101.4	1.0	9.6	11.9	10.0	3.9	15.4	7.0	5.3	3.0	157.0	5.7	91.1	5.5	41.7	3.7	6.2	4.6	1.9	3.3	2.8	8.7	7.7	16.0	6.0	17.5	1.4	3.5	3.1	33.2	10.2	12.9	39.1	7.3	7.9	4.8	3.1	0.0	1.5	5.9	2.0	5.0	8.4	3.5	6.5	12.6	5.4	5.6	3.9	1.9	2.1	4.5	1.0	4.1	5.2	5.3	21.4	5.7	7.1	5.2	168.1	16.2	0.0	6.9	18.5	3.9	4.6	16.9	13.8	5.6	11.2	6.1	6.3	8.8
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.6;Distal tubular cells: 50.9;Ductal cells: 28.7;Extravillous trophoblasts: 36.9;Hofbauer cells: 34.0;Proximal tubular cells: 41.6;Syncytiotrophoblasts: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	8.5	15.2	24.8	13.8	25.6	18.2	9.8	24.3	27.3	9.3	20.5	13.6	12.2	9.9	19.4	19.7	13.2	7.7	11.9	26.0	26.2	17.9	16.5	9.3	19.2	22.2	23.2	6.9	10.5	15.8	27.8	9.1	23.9	9.5	11.8	15.9	11.2	7.8	14.0	13.9	10.6	10.6	22.9	14.6	10.8	11.6	25.1	22.2	22.4	15.2	18.0	10.8	11.1	23.6	25.4	48.2	25.9	28.2	15.7	21.1	56.2	26.8	27.8	32.0	24.2	32.5	32.6	45.3	46.8	28.3	30.1	25.9	20.9	39.3	17.3	35.5	37.5	40.7	28.4	76.2	29.9	40.2	49.9	19.5	35.1	32.2	43.6	17.6	41.9	79.0	45.2	30.9	29.7	48.5	37.6	57.9	29.4	61.5	38.1	43.6	26.6	61.6	39.6	35.7	54.5	62.6	18.5	31.7	30.1	13.8	29.0	36.9	29.9	25.3	13.1	21.2	36.9	34.9	88.0	37.8	30.0	40.8	24.1	22.2	15.2	12.8	19.7	17.9	19.6	16.8	16.1	20.6	27.4	20.6	17.6	18.8	6.5	22.2	16.7	30.3	22.2	18.6	24.8	25.6	24.3	27.3	26.0	26.2	22.2	23.2	23.9	22.9	25.1	23.6	5.6	3.2	9.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	8.5	7.0	0.0	0.0	6.2	20.2	0.0	48.6	7.0	0.0	50.9	28.7	0.0	14.9	7.5	7.0	0.0	0.0	0.0	16.0	36.9	5.0	0.0	11.5	3.8	13.7	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	16.5	0.0	0.0	0.0	0.0	20.7	0.0	0.0	2.3	0.0	0.0	41.6	4.4	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	26.7	5.7	24.5	0.0	0.0
EMC9	"C14orf122, CGI-112, FAM158A"	ENSG00000100908	"ER membrane protein complex subunit 9"	Q9Y3B6	14	24138959-24141591	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 63.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078254	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA078254: "	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.99e-1)"	10.4	30.2	9.5	2.7	9.5	6.0	10.4	9.7	10.9	11.4	11.7	14.9	9.9	11.0	4.8	14.5	11.5	2.5	17.6	9.5	10.4	22.2	26.8	10.1	4.2	9.9	9.1	13.3	20.8	5.0	31.9	3.0	10.1	19.5	3.4	12.5	14.4	5.2	39.6	16.6	14.4	3.1	8.8	17.3	13.8	16.3	9.6	6.1	14.4	18.4	3.6	13.2	11.9	9.1	14.1	32.6	9.0	25.0	4.7	2.5	8.3	8.7	7.0	12.5	12.5	14.2	10.5	11.6	7.5	7.0	9.7	12.6	7.4	13.8	7.4	9.3	18.0	2.7	13.2	63.3	5.8	10.3	5.7	3.4	5.6	6.8	11.9	10.0	14.1	16.3	2.7	14.9	9.9	33.0	10.2	8.8	10.4	14.3	23.7	6.4	22.3	12.1	9.8	16.7	15.7	12.7	16.3	28.9	7.7	4.4	16.1	5.2	7.1	5.4	15.0	8.0	14.7	18.7	17.7	13.5	8.4	4.4	8.8	0.8	4.2	3.5	3.7	2.3	4.2	4.6	5.1	5.0	4.3	4.8	2.5	3.4	0.4	3.4	2.1	10.2	7.5	3.5	9.5	9.5	9.7	10.9	9.5	10.4	9.9	9.1	10.1	8.8	9.6	9.1	14.1	0.0	7.0	3.9	17.3	18.1	10.4	24.7	24.5	46.4	23.3	23.1	19.7	17.2	15.5	23.9	18.8	33.0	17.3	22.1	56.7	17.6	83.3	12.6	12.3	12.3	21.0	32.6	6.1	11.7	24.2	16.6	6.1	12.9	5.1	24.2	8.6	26.1	30.5	11.8	6.6	29.6	24.4	14.0	19.6	155.7	11.5	11.4	16.0	3.7	15.4	21.2	9.2	4.0	3.2	9.7	14.0	21.8	21.6	17.9	75.9	61.0	18.6	54.4	13.1	15.5	18.5	20.9	5.6	18.1	23.9	24.5	13.4	32.0	30.9	10.3
EML4	"C2orf2, ELP120, ROPP120"	ENSG00000143924	"EMAP like 4"	Q9HC35	2	42169353-42332548	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 186.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036687, HPA036688, HPA065337"	Enhanced		Supported	Microtubules,Cytosol		NA	NA		25000	"Cluster 13: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Microtubules	Cytosol	"HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	11.2	13.7	1.5	32.4	2.5	41.1	14.1	1.0	1.4	11.7	3.9	23.6	38.8	11.1	4.6	11.1	9.9	19.9	4.6	1.6	1.0	19.4	38.1	24.3	28.3	2.2	1.6	8.9	24.3	13.8	4.3	35.6	1.6	9.7	23.7	10.3	21.0	8.0	2.4	18.3	36.5	14.1	2.0	28.3	20.9	20.4	3.7	14.9	21.5	3.9	30.0	27.3	5.7	2.8	45.1	76.7	43.7	34.9	15.6	25.4	47.7	27.3	21.4	29.7	28.5	80.8	55.1	41.1	18.5	26.9	45.6	22.7	38.0	26.3	51.3	80.8	31.8	37.7	23.5	186.3	19.7	28.8	37.1	27.9	9.8	39.4	26.5	14.4	20.9	14.0	37.9	40.3	32.5	26.4	27.3	7.7	44.8	57.8	21.9	27.8	69.2	24.3	24.2	64.3	42.9	86.3	26.9	27.7	20.8	39.6	14.4	11.4	24.6	30.1	39.9	24.3	24.9	44.9	33.3	34.6	26.3	27.0	21.6	5.6	4.7	9.9	9.0	13.7	19.0	13.9	15.0	14.8	4.1	9.1	12.8	9.6	12.3	11.9	14.6	5.3	22.3	7.6	1.5	2.5	1.0	1.4	1.6	1.0	2.2	1.6	1.6	2.0	3.7	2.8	47.0	60.9	107.3	37.9	137.6	67.3	74.3	60.5	75.1	35.1	53.5	45.7	7.0	51.5	60.9	40.5	47.9	143.0	120.8	57.0	17.6	34.0	33.1	33.4	50.1	50.8	102.3	20.8	54.2	75.4	47.5	55.3	76.0	86.6	48.1	80.7	43.9	61.9	65.6	16.8	60.0	69.3	34.6	40.3	56.6	31.0	23.9	74.8	16.0	119.9	38.4	35.1	47.4	62.8	32.9	38.1	58.9	23.0	139.5	65.4	51.3	41.3	28.6	47.3	6.6	25.0	47.6	46.5	39.4	73.4	79.7	118.9	223.8	42.0	85.0	96.4
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 32.1;intestine: 44.5"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	86	"basophil: 30.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 30.6"	"Group enriched"	"Detected in some"	18	"HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"spinal cord: 2.6"	HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		1100000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	1.2	6.2	0.4	1.1	0.4	0.1	6.6	0.9	0.5	32.1	0.2	9.3	16.2	3.8	1.2	0.5	2.3	1.3	0.1	0.3	0.5	10.0	5.0	0.9	0.5	0.5	0.6	0.5	0.1	0.3	0.1	0.1	0.5	2.4	8.4	0.3	18.1	15.6	0.1	0.6	44.5	0.8	0.4	0.3	0.5	0.8	0.5	9.6	0.3	0.2	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.4	0.0	14.6	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.5	0.3	0.5	0.5	0.6	0.5	0.4	0.5	0.4	0.4	0.0	1.1	5.2	0.2	0.0	2.6	0.7	1.2	0.2	1.0	0.6	0.3	0.0	2.5	0.0	0.0	0.0	0.2	9.2	1.9	0.0	1.6	160.0	46.3	1.4	0.0	2.1	2.1	0.0	0.1	0.5	0.0	387.2	36.0	0.1	0.7	1.7	0.1	0.0	4.1	1.5	0.0	0.6	1.1	0.4	1.2	1.5	1.8	2.8	0.0	0.1	1.0	3.5	0.9	0.0	1.9	0.7	0.3	2.7	53.3	9.1	5.4	0.1	0.0	0.2	1.0	2.5	0.8	0.0	0.6	0.1	2.2	0.1	4.9	1.1
ENTPD2	"CD39L1, NTPDase-2"	ENSG00000054179	"Ectonucleoside triphosphate diphosphohydrolase 2"	Q9Y5L3	9	137048107-137054061	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.7"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 192.3;Paneth cells: 35.5;Peritubular cells: 96.7;Proximal enterocytes: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 24.3;hTCEpi: 12.7;MCF7: 16.7;OE19: 26.6;SK-BR-3: 21.6;T-47d: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017676	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA017676: AB_1848179"	"unprognostic (1.64e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.71e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (3.51e-6)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.51e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.12e-3)"	1.0	0.8	17.5	0.9	13.0	0.2	5.0	13.3	14.8	5.9	4.3	6.8	12.2	1.8	1.6	3.3	6.1	4.5	3.4	12.5	28.1	4.7	0.9	0.4	0.1	15.9	31.7	0.7	1.8	0.9	3.0	0.7	17.1	7.3	3.8	1.0	5.5	1.6	2.0	10.2	7.8	1.0	16.7	0.1	6.1	3.5	26.4	0.2	0.6	3.4	0.3	1.2	3.6	14.5	6.5	1.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.0	1.2	1.9	0.0	1.4	0.0	0.0	5.1	0.5	3.7	0.0	0.0	0.2	0.0	0.8	24.3	0.0	0.0	0.3	0.0	12.7	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	26.6	3.6	0.0	1.1	2.5	2.8	0.6	3.5	0.1	0.3	21.6	0.0	0.1	23.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	13.0	13.3	14.8	12.5	28.1	15.9	31.7	17.1	16.7	26.4	14.5	1.1	0.0	0.0	19.2	0.5	1.7	1.9	2.8	4.0	0.2	8.0	13.2	0.5	11.5	1.8	0.0	0.0	0.3	0.0	26.2	0.0	6.2	1.4	12.1	1.5	1.2	25.2	0.0	0.2	4.3	1.1	1.5	5.1	2.8	0.0	0.0	0.4	1.1	0.2	0.0	0.1	9.4	6.1	0.0	0.0	6.2	192.3	0.3	5.4	1.9	0.6	6.8	0.0	0.5	0.1	6.0	35.5	96.7	0.0	4.4	61.8	8.6	3.2	0.1	0.0	0.4	4.1	1.2	4.4	1.8	1.4	1.0	0.2	0.0	16.0	1.5
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720468-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 2.9;Exocrine glandular cells: 4.2;Extravillous trophoblasts: 14.0;Hepatocytes: 19.5;Pancreatic endocrine cells: 3.7;Syncytiotrophoblasts: 2.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.6;Hep G2: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010336	Supported				"Secreted to blood"	NA	NA	12300			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.3	2.9	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.4	0.1	0.4	3.1	47.2	0.1	0.0	0.2	0.1	0.2	8.3	0.0	0.0	0.0	0.2	0.5	0.0	0.2	1.4	0.5	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.2	14.0	0.0	0.0	0.0	0.0	0.1	1.4	19.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	2.9	0.0	0.0	0.0	0.0
EPOP	"C17orf96, LOC100170841, PRR28"	ENSG00000273604	"Elongin BC and polycomb repressive complex 2 associated protein"	A6NHQ4	17	38671703-38674957	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4;testis: 10.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 19.3;Breast myoepithelial cells: 13.6;Glandular and luminal cells: 6.4;Syncytiotrophoblasts: 13.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.5;basal ganglia: 8.8;cerebral cortex: 10.4;hippocampal formation: 7.7;white matter: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 47.9;Hep G2: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055190, HPA056555"	Enhanced		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA055190: AB_2682731, HPA056555: AB_2683172"	"unprognostic (9.08e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.78e-10)"	"unprognostic (8.97e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	1.6	2.2	4.5	1.7	8.8	0.5	1.1	0.9	10.4	0.9	0.5	0.8	0.3	1.2	0.8	1.9	1.1	0.9	1.2	7.7	0.9	1.6	3.8	1.1	2.7	1.4	1.7	0.8	3.7	4.8	0.8	1.3	1.6	1.4	0.4	2.2	0.8	0.9	0.6	3.3	0.9	0.7	1.3	1.1	1.3	10.0	1.7	1.5	0.6	0.3	3.5	2.9	0.7	5.4	9.2	10.8	6.8	47.9	1.5	0.4	11.7	1.9	0.7	2.1	3.3	10.8	3.3	17.1	11.6	1.2	6.1	7.3	22.6	4.6	3.7	18.2	17.1	3.8	1.5	57.3	3.1	2.1	9.0	1.0	8.0	2.3	4.6	4.4	1.6	18.8	12.0	25.9	1.4	14.4	15.8	5.1	1.5	6.0	9.6	37.3	3.9	37.8	1.3	2.4	10.4	15.8	6.0	7.8	2.1	11.0	11.4	7.2	2.7	2.0	2.0	2.2	1.8	13.5	16.1	21.7	3.9	25.4	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	8.8	0.9	10.4	7.7	0.9	1.4	1.7	1.6	1.3	1.7	5.4	4.4	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	19.3	13.6	0.0	0.0	1.3	1.8	0.0	1.7	3.5	0.0	0.0	4.2	0.0	3.4	4.8	1.8	0.0	0.0	0.0	4.0	1.5	1.0	0.0	6.4	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.1	0.6	0.8	0.0	0.0
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443156-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 42.5;kidney: 16.6"	"Group enriched"	"Detected in some"	10	"Proximal enterocytes: 189.7;Proximal tubular cells: 90.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 2.6;Hep G2: 6.2;THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.4	0.1	0.3	42.5	0.6	0.0	0.2	0.5	0.3	2.0	0.0	0.0	16.6	0.0	1.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.3	0.0	1.7	0.2	39.2	0.0	0.1	0.6	0.2	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	13.7	0.2	3.7	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	189.7	90.2	0.0	0.0	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.0	0.3	0.1	3.0	0.0
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026309	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 743.8;pancreas: 678.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1242.3;Basal prostatic cells: 1428.1;Hepatocytes: 722.3;Suprabasal keratinocytes: 732.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 2.0"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 558.4;LHCN-M2: 442.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076543			Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	143.6	41.7	13.8	31.0	15.3	1.8	127.6	33.0	20.5	87.0	42.2	61.5	33.3	78.1	18.3	51.2	75.8	131.1	53.3	16.7	20.3	157.3	743.8	82.8	17.6	31.9	16.7	148.5	678.8	88.0	112.1	125.6	17.4	53.1	23.4	36.3	76.1	26.0	225.9	124.6	47.2	88.5	28.6	9.5	125.0	16.5	18.7	18.4	113.4	30.2	12.5	86.9	75.5	20.9	86.1	49.7	20.8	28.2	192.6	143.0	215.7	81.9	23.8	15.0	17.5	22.2	218.9	1.4	47.9	27.6	102.5	18.2	5.8	144.7	68.2	2.6	16.1	1.3	15.1	260.1	558.4	0.9	3.3	195.8	142.7	49.4	118.7	208.4	38.3	3.6	6.1	0.7	442.5	36.8	0.3	5.5	50.0	66.3	121.7	7.4	233.8	1.4	69.3	27.0	14.3	8.5	16.2	36.5	26.0	145.6	25.4	2.0	54.4	57.7	33.9	49.0	116.6	1.3	1.1	1.5	222.0	3.8	54.4	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.1	0.3	0.4	0.0	0.0	2.0	0.1	0.2	0.0	13.8	15.3	33.0	20.5	16.7	20.3	31.9	16.7	17.4	28.6	18.7	20.9	93.0	221.2	108.7	22.5	9.2	1242.3	1428.1	228.6	249.8	9.8	186.3	115.9	52.1	177.3	198.7	27.6	14.6	87.6	25.7	161.9	31.3	99.1	24.0	209.6	74.4	29.8	109.5	21.5	18.4	111.2	51.0	130.1	56.6	336.3	14.5	3.9	32.5	722.3	10.0	3.3	16.5	70.2	59.0	11.7	95.0	63.9	51.9	17.9	71.2	8.4	0.6	40.0	3.1	13.0	30.9	144.9	127.2	38.4	6.6	382.2	78.1	131.1	86.3	9.9	6.6	113.9	93.3	21.1	21.8	152.6	732.9	259.0	33.5	4.9	82.7	543.4
ETFB		ENSG00000105379	"Electron transfer flavoprotein subunit beta"	P38117	19	51345169-51366388	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1105.3;Proximal enterocytes: 710.7;Proximal tubular cells: 1118.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 53.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1693.9;OE19: 770.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	159.1	171.5	121.1	44.0	134.4	70.2	115.3	134.8	145.5	55.7	123.0	97.6	136.3	48.9	16.9	140.7	53.3	62.7	387.8	112.8	120.6	144.5	493.6	50.4	58.2	129.8	124.8	55.2	81.9	106.3	73.1	39.0	125.7	55.2	41.2	24.1	172.2	37.9	280.7	79.0	129.7	31.7	119.9	64.5	90.0	53.6	132.4	81.4	70.3	280.3	36.9	65.6	69.0	137.0	118.9	304.3	41.3	113.9	129.4	150.4	65.6	82.4	61.0	63.5	63.1	257.3	192.1	121.5	80.2	129.8	33.8	104.0	83.3	171.1	19.2	182.0	323.3	98.1	188.9	1693.9	141.8	92.1	67.6	235.3	50.3	86.1	88.2	79.2	54.9	115.0	146.6	130.2	83.2	243.7	95.2	86.2	26.7	770.2	372.0	104.5	114.4	224.6	88.5	135.7	91.7	44.5	184.5	49.9	94.4	29.4	130.3	86.3	77.8	65.9	67.6	71.4	73.3	195.8	130.0	109.8	335.0	135.1	172.5	127.7	190.1	119.6	104.3	212.3	137.4	281.6	156.0	134.2	225.3	303.1	163.6	136.0	97.8	205.3	165.7	265.1	225.7	140.5	121.1	134.4	134.8	145.5	112.8	120.6	129.8	124.8	125.7	119.9	132.4	137.0	90.9	80.1	93.8	15.3	75.6	65.0	114.9	196.4	55.2	77.1	129.9	170.1	243.8	234.4	122.5	121.4	31.3	240.7	58.7	440.9	571.3	188.0	139.2	67.5	70.2	76.2	168.4	120.0	4.1	140.5	206.6	93.8	128.9	48.2	88.8	63.2	144.9	1105.3	217.5	43.7	4.2	335.2	158.7	147.7	73.4	354.4	107.5	86.9	286.4	5.6	95.2	158.8	50.4	7.1	18.9	155.4	339.4	114.3	69.9	74.9	710.7	1118.7	118.8	67.9	98.6	87.4	144.5	71.0	52.8	135.3	63.6	160.1	74.0	217.3	354.4	140.3
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 160.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 113.6;Hepatocytes: 195.1;Leydig cells: 215.9;Peritubular cells: 236.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.4;BJ hTERT+: 11.5;CACO-2: 12.7;fHDF/TERT166: 13.1;Hep G2: 59.6;HHSteC: 11.5;SH-SY5Y: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA		13000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	21.3	8.5	1.1	1.5	1.2	0.0	11.7	2.5	2.0	53.8	1.4	5.6	10.9	13.2	16.4	8.9	23.9	10.9	40.7	1.1	1.8	4.1	160.0	14.4	3.2	2.6	1.5	27.9	7.1	0.2	4.5	4.4	2.5	12.8	2.0	0.9	5.1	7.1	6.8	20.7	11.9	2.7	1.3	3.2	8.6	10.1	1.4	1.4	8.3	6.6	1.3	11.9	25.8	1.1	0.1	0.0	2.5	0.4	8.0	8.1	0.1	14.4	11.5	0.8	0.3	12.7	0.1	0.1	0.5	13.1	1.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	59.6	11.5	0.0	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	1.5	0.1	0.0	0.3	0.0	1.3	0.2	0.3	0.1	0.0	0.0	0.2	1.0	27.9	0.1	0.5	0.1	0.6	0.6	0.1	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	2.5	2.0	1.1	1.8	2.6	1.5	2.5	1.3	1.4	1.1	7.0	0.0	0.0	1.3	0.6	15.7	0.1	0.0	0.0	1.1	0.4	0.3	9.1	4.3	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.1	2.9	1.9	45.9	3.8	17.9	2.7	1.3	0.0	0.4	113.6	6.1	1.0	1.3	2.2	7.9	195.1	1.4	6.7	1.4	5.0	0.0	4.8	25.0	9.6	215.9	1.3	19.6	5.6	0.6	4.5	0.0	0.5	0.1	0.3	6.5	236.2	0.0	0.3	28.3	6.4	0.0	1.2	52.6	14.5	40.9	2.3	1.2	0.5	15.3	1.1	1.9	2.4	2.2	0.4
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 243.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 27.6;Hepatocytes: 75.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.2	17.1	0.2	0.1	0.0	0.0	13.1	0.0	0.2	0.0	27.6	243.2	8.4	0.0	0.0	0.3	0.3	58.9	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	27.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	2.5	1.8	0.0	0.0	0.2	0.3	11.7	2.3	0.0	0.0	0.0	0.1	0.0	5.3	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.7	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1518	"liver: 1217.3"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 991.0"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 281.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	1217.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.2	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	281.0	0.0	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.0	37.5	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	21.8	991.0	0.0	0.0	0.2	0.2	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.1
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FAM177A1	C14orf24	ENSG00000151327	"Family with sequence similarity 177 member A1"	Q8N128	14	35044907-35113130	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 637.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053222, HPA055440"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA		170000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Nucleoplasm	"HPA053222: AB_2682083, HPA055440: AB_2682817"	"unprognostic (6.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (4.64e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.91e-1)"	45.3	43.2	36.8	30.0	50.1	49.6	38.2	45.3	46.5	44.2	36.9	81.5	57.2	29.4	29.6	49.7	26.8	37.7	78.1	39.0	51.3	61.3	77.0	68.6	20.2	52.4	50.6	28.2	49.4	30.6	47.4	27.3	49.1	63.1	71.5	31.3	43.4	36.1	48.3	41.3	54.6	42.3	45.0	23.6	42.5	86.2	47.0	21.6	48.0	32.8	23.2	46.7	37.7	57.0	63.4	51.2	38.0	31.3	64.6	64.6	46.7	101.3	55.8	52.4	57.1	52.2	82.6	25.1	68.1	98.9	71.1	65.8	47.1	58.5	66.7	73.5	28.8	19.5	63.8	179.5	79.4	30.7	44.9	58.5	75.3	63.5	49.5	76.7	60.6	46.7	47.7	79.8	102.5	91.5	38.0	28.1	30.9	100.9	65.2	21.9	52.7	35.9	95.2	68.7	52.1	45.9	119.3	94.2	81.3	75.2	87.2	23.9	71.3	67.5	59.2	76.6	53.2	59.3	79.8	31.2	42.3	20.5	68.0	79.9	43.9	79.2	31.0	36.7	36.5	45.0	40.3	35.7	34.8	35.8	31.7	31.4	167.5	32.6	31.9	50.8	60.0	30.4	36.8	50.1	45.3	46.5	39.0	51.3	52.4	50.6	49.1	45.0	47.0	57.0	126.7	240.4	176.3	6.5	87.4	160.7	199.4	200.4	83.6	35.8	119.0	118.4	147.8	67.2	168.1	104.8	27.1	71.0	322.2	329.3	119.3	121.9	637.1	235.5	86.6	116.4	133.8	36.0	10.7	249.6	118.0	80.5	107.0	426.4	82.3	43.1	82.5	235.6	75.5	23.5	13.4	189.5	144.5	61.1	130.9	505.9	54.0	85.4	149.4	8.4	125.1	45.3	48.4	9.0	28.4	364.6	220.1	53.0	133.3	211.4	273.7	347.2	177.8	45.5	46.0	65.2	106.2	189.3	106.8	93.1	171.5	123.3	215.7	30.4	224.2	229.5
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.3;choroid plexus: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	3.1	1.6	33.3	1.3	36.3	0.2	4.7	37.3	43.3	3.6	30.5	3.5	3.0	2.5	3.0	1.4	3.2	1.8	2.5	34.3	33.0	6.7	6.3	9.9	3.5	31.9	32.4	4.5	3.2	4.8	11.0	23.0	32.4	3.9	0.9	16.3	3.3	2.8	0.9	1.7	1.6	1.6	29.1	0.6	1.7	16.9	32.6	0.6	7.0	2.2	3.5	2.4	2.1	34.5	0.1	0.3	11.8	0.9	0.3	0.3	0.0	0.6	0.4	0.5	0.9	2.0	1.1	0.9	0.0	0.2	5.3	0.0	3.4	0.0	0.2	1.3	11.1	0.1	0.9	7.9	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.3	0.0	11.6	10.4	0.7	0.3	0.3	0.4	0.1	6.0	0.6	1.3	0.0	0.1	0.0	0.1	0.1	8.5	8.0	0.7	0.6	1.8	2.2	2.1	1.4	0.3	0.8	0.5	0.2	2.9	4.9	3.3	0.3	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	33.3	36.3	37.3	43.3	34.3	33.0	31.9	32.4	32.4	29.1	32.6	34.5	21.0	48.1	103.0	261.2	0.7	2.4	5.9	0.4	11.4	35.2	3.8	8.8	6.4	2.8	17.7	3.7	29.2	61.4	0.6	0.4	17.6	1.0	22.9	2.0	2.0	5.3	6.0	0.4	66.9	1.1	18.9	11.8	1.5	0.8	6.3	8.9	1.8	4.0	5.6	13.5	55.5	0.6	0.0	0.3	1.8	9.2	3.7	1.0	0.0	34.7	0.0	11.1	0.0	88.4	20.6	0.3	1.2	7.2	2.7	1.6	0.4	3.1	37.3	28.4	6.6	45.2	4.1	61.8	16.0	4.2	3.4	266.4	5.8	1.4	0.7	2.0
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552573-20555020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 21.0;brain: 21.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Distal tubular cells: 3.9;Excitatory neurons: 2.6;Fibroblasts: 3.8;Inhibitory neurons: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;BJ hTERT+: 2.4;fHDF/TERT166: 4.9;Hep G2: 3.7;SCLC-21H: 4.3;SiHa: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050813	Approved		Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA050813: AB_2681244"	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	1.6	21.0	12.2	0.2	10.7	0.0	0.3	11.0	12.5	0.6	2.4	0.9	0.1	1.0	3.0	0.3	0.9	0.2	3.9	13.5	13.5	5.0	0.4	0.3	0.0	16.6	21.7	0.3	0.5	0.0	0.8	0.6	13.8	0.7	0.1	0.4	0.5	0.1	0.9	0.2	0.3	0.8	9.9	0.8	0.3	0.5	18.8	0.1	1.2	1.4	0.0	0.7	0.4	10.2	0.0	1.7	0.2	3.3	0.1	0.1	0.0	0.3	2.4	0.4	0.0	0.1	0.0	0.0	0.2	4.9	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.1	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	10.7	11.0	12.5	13.5	13.5	16.6	21.7	13.8	9.9	18.8	10.2	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.1	1.9	1.6	0.0	0.0	2.6	0.0	0.1	3.8	0.0	0.2	0.0	0.0	1.8	0.0	0.1	0.0	7.5	0.0	0.0	0.6	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.3	0.1	0.9	0.7	0.0	0.0	0.1	0.1	0.1	0.0
FBXO31	"FBX14, Fbx31, FBXO14, MGC15419"	ENSG00000103264	"F-box protein 31"	Q5XUX0	16	87326987-87392142	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 65.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030150	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA030150: AB_10670559"	"unprognostic (4.85e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.16e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.26e-3)"	33.7	12.8	6.8	6.0	8.5	5.7	24.3	39.0	14.5	14.9	0.0	20.9	8.6	21.7	4.4	10.2	16.8	6.2	18.2	11.9	13.4	5.3	15.9	8.7	6.4	8.3	5.5	15.0	13.1	8.2	19.4	4.9	11.1	10.2	5.8	8.1	11.1	10.7	65.3	17.0	15.9	11.1	2.7	5.2	11.5	18.7	9.5	5.7	8.7	36.8	4.6	21.8	13.0	7.6	7.0	13.1	4.3	11.7	21.6	12.9	12.5	12.0	11.9	11.6	6.1	11.9	5.8	16.3	12.9	12.7	5.9	10.6	8.3	10.0	7.7	7.5	15.5	5.5	8.7	34.1	12.1	5.3	4.4	15.4	8.3	15.2	14.3	7.6	7.2	8.3	15.9	6.3	6.3	10.1	13.0	7.3	8.4	7.3	11.5	16.1	5.1	7.0	5.2	4.9	20.0	9.7	26.7	5.4	8.3	3.1	8.5	4.6	10.1	11.2	8.5	10.8	9.6	14.4	12.0	20.1	9.0	9.8	7.0	0.5	0.1	0.0	0.2	0.1	0.4	0.6	0.4	0.6	0.1	0.3	0.4	0.5	0.2	0.0	0.2	0.2	1.1	0.4	6.8	8.5	39.0	14.5	11.9	13.4	8.3	5.5	11.1	2.7	9.5	7.6	61.3	0.0	4.6	13.1	7.3	14.7	5.1	3.3	17.1	13.8	6.4	6.7	20.6	2.8	2.1	5.5	33.3	10.8	4.6	19.3	0.0	3.6	9.2	18.0	10.6	16.0	9.0	9.5	21.6	5.1	3.1	10.1	6.6	11.1	0.0	5.3	5.3	29.5	4.0	0.0	21.9	11.7	4.1	4.4	7.7	26.3	8.1	2.9	3.6	10.3	4.1	5.3	3.1	8.5	13.6	3.5	17.2	11.3	7.2	5.4	33.6	5.5	11.7	11.9	19.7	8.6	9.8	17.9	6.1	14.6	12.9	7.3	9.0	5.9	16.5	4.5
FDXR	"ADR, ADXR"	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 343.1"	"Group enriched"	"Detected in many"	7	"Granulosa cells: 329.3;Theca cells: 794.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 89.5;Hep G2: 173.5"					"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	3.9	343.1	6.9	2.4	8.4	2.2	3.8	7.8	8.1	7.8	8.6	9.7	4.6	6.7	5.1	26.0	12.9	4.1	6.0	6.6	6.7	6.5	14.9	5.3	2.9	7.6	7.9	20.5	12.9	5.9	4.1	3.0	7.5	6.7	3.2	0.5	7.1	4.4	7.7	16.4	5.6	2.3	7.4	33.9	7.6	45.6	7.0	4.7	6.0	1.7	2.5	6.2	10.5	7.5	12.5	65.6	9.6	10.8	6.8	9.1	89.5	14.8	15.9	8.6	17.1	18.3	10.8	29.6	2.6	6.2	4.8	24.9	6.9	18.4	2.5	27.9	15.2	22.6	10.6	173.5	19.0	5.0	75.1	29.2	20.3	9.1	3.1	7.0	43.9	10.9	36.1	4.8	13.4	53.4	19.7	10.6	5.5	11.8	14.5	10.6	16.4	16.2	7.1	21.0	5.2	12.1	10.0	21.7	11.2	10.9	47.4	4.7	20.5	5.9	51.9	9.4	7.4	12.7	2.3	6.5	16.1	7.7	20.6	1.7	6.0	5.0	5.6	4.5	5.0	4.8	5.1	6.8	7.3	2.4	4.4	5.4	2.0	10.3	3.4	1.4	15.4	5.2	6.9	8.4	7.8	8.1	6.6	6.7	7.6	7.9	7.5	7.4	7.0	7.5	4.0	3.2	3.9	7.5	8.2	9.7	17.8	42.6	17.1	4.9	6.6	8.4	3.8	5.7	23.3	9.2	4.2	53.2	2.8	18.6	5.9	11.1	6.5	28.2	4.3	4.6	7.1	4.0	1.4	7.9	18.9	12.9	13.7	3.5	5.7	329.3	12.5	13.9	23.1	3.3	2.2	13.1	36.7	6.2	2.7	14.9	5.9	4.6	5.4	1.0	3.9	11.4	8.2	3.0	1.3	9.0	16.9	4.5	7.1	5.2	24.9	21.7	73.6	5.1	0.0	6.2	18.3	6.3	6.1	33.7	18.2	46.1	8.6	794.1	20.3	17.4
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			2.1	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.2	1.2	0.0	0.0	18.8	18396.9	5.3	0.1	0.0	0.0	0.7	18.8	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	9.9	47.4	3.7	0.0	0.1	0.4	0.0	0.1	0.6	0.7	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	373	"liver: 17944.9"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			2.0	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	1.3	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.4	0.0	0.0	48.0	17944.9	0.5	0.1	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.1	6.8	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 148.3;esophagus: 139.7;skin 1: 271.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA		2500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.6	1.6	118.0	1.5	140.6	1.4	5.5	115.6	104.0	23.7	37.4	12.2	19.5	1.5	2.8	139.7	2.2	7.9	4.8	100.8	107.6	39.3	40.7	7.4	0.4	144.7	129.2	0.5	76.4	0.2	16.1	9.3	109.8	13.8	5.2	0.2	20.2	15.0	1.3	271.5	14.7	0.4	108.9	4.0	7.8	17.6	148.3	1.7	1.5	0.9	11.1	23.1	60.9	81.2	0.0	3.8	19.5	5.6	0.0	0.3	22.1	2.4	0.3	0.8	0.4	48.2	1.0	0.0	17.8	0.7	0.7	34.9	5.5	0.3	0.3	0.2	19.3	14.2	3.9	80.6	0.1	0.0	0.6	0.0	10.9	0.2	0.1	0.1	0.1	2.3	16.7	0.1	0.0	23.9	0.8	0.5	36.1	19.5	0.1	1.2	1.0	0.3	2.8	64.1	5.7	1.6	1.9	4.0	0.0	22.2	20.4	2.5	1.0	0.0	2.1	0.5	1.6	0.1	0.0	0.0	0.2	1.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.0	140.6	115.6	104.0	100.8	107.6	144.7	129.2	109.8	108.9	148.3	81.2	2.2	0.0	32.5	410.4	1.1	103.8	4.1	29.8	23.9	0.0	4.8	1.5	3.1	91.5	37.6	14.7	0.0	0.5	1.6	36.1	0.0	5.0	7.9	3.0	1.7	3.4	4.2	0.0	0.5	0.7	12.0	3.2	3.6	4.0	0.0	0.1	16.1	30.4	0.6	0.0	1.3	20.7	4.1	1.2	6.5	1.3	0.6	0.6	12.4	14.0	0.6	0.1	0.0	34.2	2.2	0.4	18.0	0.4	0.0	4.2	21.2	9.9	9.8	0.6	0.0	0.7	2.9	0.4	25.9	55.0	88.7	0.8	0.7	0.1	17.0	12.8
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16556.3"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 10221.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"Hep G2: 735.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	1.7	34.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.0	0.4	0.0	0.4	0.2	0.6	0.7	25.0	1.2	0.0	0.0	8.8	16556.3	50.2	0.1	0.0	0.0	1.4	15.8	0.0	0.4	6.3	0.0	0.4	0.0	0.0	0.4	0.3	0.4	0.5	0.6	0.0	0.0	9.1	8.7	3.0	0.1	0.3	0.4	0.0	0.0	0.5	0.6	0.1	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.5	0.4	735.3	0.2	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.3	6.4	0.0	0.0	0.6	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.1	1.7	0.0	3.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	19.2	214.4	0.0	31.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	633.4	2.5	0.0	0.0	0.0	0.0	0.1	0.0	21.9	4.3	0.0	0.1	9.2	0.0	157.7	0.0	48.5	0.2	0.5	0.0	0.1	11.4	1.1	202.4	10221.7	0.2	0.0	0.0	0.0	0.0	289.5	0.0	0.5	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	161.8	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.4	17.3	0.2	0.0	0.0
FGL1	"HFREP-1, HPS"	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 4163.9"	"Cell type enriched"	"Detected in many"	27	"Hepatocytes: 8261.7"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"A549: 55.4;Hep G2: 131.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		57000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.9	0.4	1.2	0.0	1.4	0.0	1.0	1.0	1.8	0.4	0.9	0.2	0.0	0.7	0.7	0.2	0.2	0.1	0.3	1.3	1.7	0.5	4163.9	1.2	0.0	1.3	1.6	0.3	660.1	0.0	0.2	6.3	1.3	3.8	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.2	1.1	3.8	0.6	4.3	1.5	0.0	0.3	0.0	0.0	0.1	0.1	1.2	0.0	55.4	0.0	6.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	131.9	0.0	1.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	1.3	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	1.0	1.8	1.3	1.7	1.3	1.6	1.3	1.1	1.5	1.2	0.0	0.0	1.9	12.4	24.6	0.0	0.2	0.0	0.0	0.0	1.3	0.9	2.1	301.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.3	42.9	5.4	1.0	7.6	0.0	176.4	0.1	71.2	0.4	0.1	0.0	7.8	0.0	0.0	173.8	8261.7	20.4	0.0	0.3	0.0	0.0	231.6	0.0	32.7	0.6	0.2	0.0	14.0	1.6	0.0	0.0	2.5	0.0	74.1	0.0	0.4	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	0.0	1.0	12.8	0.1	0.3	0.2
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24130659-24132849	"Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 171.1;skeletal muscle: 224.1"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 281.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.0;HMC-1: 1.2;RH-30: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019842	Uncertain					NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	1.0	7.3	0.7	0.2	0.8	1.7	1.2	1.1	1.1	0.9	0.6	1.3	0.9	0.8	0.5	1.3	0.8	0.2	171.1	0.6	0.7	1.8	27.0	1.4	0.5	0.8	0.7	1.4	15.5	0.1	1.5	0.1	0.8	3.3	0.3	0.8	7.4	0.4	224.1	1.6	2.3	0.0	0.6	10.2	1.3	2.2	0.7	0.4	2.0	1.7	0.2	0.7	0.9	1.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.1	0.2	2.0	0.2	0.0	1.2	0.2	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.2	0.2	0.2	0.6	0.0	0.0	0.3	0.3	2.0	0.0	0.1	0.3	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	1.1	0.6	0.7	0.8	0.7	0.8	0.6	0.7	1.0	2.7	0.0	0.0	0.0	0.6	0.1	0.3	0.4	0.0	1.8	1.3	0.9	281.6	1.5	0.2	0.0	0.0	0.2	1.1	1.9	0.0	1.0	2.2	0.5	0.3	5.0	1.2	0.0	0.3	3.0	0.2	12.2	1.1	0.9	0.0	0.6	1.1	37.4	0.2	0.0	0.2	1.1	0.0	0.8	0.3	3.9	0.0	0.4	0.0	0.0	0.9	0.9	2.1	0.0	0.4	0.8	0.3	0.7	0.2	0.3	3.8	0.6	0.3	0.7	0.0	56.8	7.5	1.5	0.3	0.7	0.6	0.7	0.8	12.3	0.9	0.2
FKBP3	"FKBP-25, FKBP25"	ENSG00000100442	"FKBP prolyl isomerase 3"	Q00688	14	45115599-45135319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 424.4;tongue: 372.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 377.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol		NA	NA		1300000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	40.9	46.8	100.3	35.8	102.3	38.4	50.0	110.1	122.1	38.1	91.8	49.4	44.7	31.4	64.8	54.7	31.4	29.8	109.5	101.9	100.6	66.5	69.7	27.6	53.7	100.7	99.3	35.3	32.8	55.5	56.6	46.9	100.1	57.7	49.1	82.3	37.1	37.9	424.4	38.3	47.8	39.2	99.8	39.9	38.0	52.9	101.4	59.6	40.1	372.0	57.7	43.3	38.6	105.8	161.0	175.3	249.0	132.4	109.0	117.8	98.3	96.2	110.3	149.3	163.5	154.8	134.1	85.1	98.9	110.0	84.1	130.0	188.4	124.8	211.7	123.7	111.0	69.8	138.8	202.6	107.1	122.2	72.8	112.0	127.5	87.2	80.1	136.8	198.0	131.9	102.9	62.1	179.9	196.9	197.5	163.0	126.7	178.3	164.5	187.0	183.7	102.9	242.2	183.7	151.2	59.2	154.8	94.5	156.0	186.4	222.6	89.9	128.7	113.0	195.6	59.9	75.1	104.0	198.8	132.5	68.3	83.0	108.1	23.4	22.4	22.1	18.7	27.3	22.8	29.7	25.0	25.7	33.3	21.8	23.4	26.7	3.6	24.2	29.4	43.0	30.8	20.2	100.3	102.3	110.1	122.1	101.9	100.6	100.7	99.3	100.1	99.8	101.4	105.8	48.3	41.7	46.6	25.8	45.3	47.8	94.4	205.5	45.5	79.3	39.9	46.7	202.5	48.6	101.4	93.8	10.4	320.9	51.2	56.4	252.4	131.1	212.7	55.0	83.3	58.5	56.1	50.9	49.7	73.0	135.4	70.0	36.7	68.1	53.7	75.6	38.2	91.1	131.1	40.4	44.5	71.2	124.1	39.9	43.0	377.4	80.8	53.7	69.4	17.8	110.7	80.7	50.4	21.1	34.3	88.4	53.7	97.8	58.0	76.4	91.8	220.1	73.5	67.4	105.2	71.3	118.5	154.0	111.2	65.0	47.9	165.0	48.8	84.1	96.1	77.6
FMO5		ENSG00000131781	"Flavin containing dimethylaniline monoxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 683.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	3.1	5.7	2.0	5.1	2.9	2.0	46.1	3.9	2.8	7.8	0.5	41.3	71.3	2.8	6.9	1.2	3.6	15.8	3.1	2.1	2.4	51.5	683.3	27.1	4.0	4.2	2.9	4.1	48.1	68.3	6.7	2.4	4.8	9.7	46.6	0.9	32.7	4.0	0.8	11.6	73.9	3.5	3.2	4.0	120.1	5.2	3.1	1.1	2.0	1.4	2.5	3.9	1.5	5.6	0.1	1.1	0.6	0.1	2.8	0.8	0.9	0.7	0.5	0.3	0.8	0.7	2.4	0.4	0.8	0.8	0.2	0.4	0.0	0.0	0.0	1.4	0.2	1.6	0.1	41.7	0.9	1.4	9.0	1.3	0.2	0.4	0.0	0.4	0.6	0.2	0.1	0.1	1.5	1.4	0.2	0.7	2.8	5.3	0.8	0.4	0.5	0.4	3.4	0.6	0.5	0.3	0.9	2.8	1.3	1.3	2.1	10.4	1.1	0.0	0.3	0.9	0.0	0.3	0.0	0.3	1.1	0.5	0.3	7.0	12.9	4.1	2.0	5.9	0.3	4.7	0.5	0.6	5.4	8.5	0.3	1.3	1.3	1.2	1.8	2.5	1.6	3.9	2.0	2.9	3.9	2.8	2.1	2.4	4.2	2.9	4.8	3.2	3.1	5.6	2.8	9.6	64.2	11.1	6.4	1.7	3.9	0.9	1.8	2.0	17.5	6.7	1.9	133.0	10.4	14.7	0.0	1.5	1.7	60.8	7.9	7.5	7.7	2.5	1.8	2.7	6.7	4.8	8.2	5.9	1.1	2.9	24.5	6.1	5.7	9.8	5.0	265.4	4.0	3.3	6.4	34.4	4.1	10.0	2.3	4.5	2.8	4.6	28.4	10.3	5.3	0.2	4.1	10.1	17.5	7.0	29.0	1.5	0.4	5.6	108.8	69.2	18.1	1.3	0.0	2.2	1.0	5.9	0.9	1.3	1.6	1.4	2.6	6.6	20.7	6.4
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735615-82751196	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 79.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 90.1;Proximal tubular cells: 167.2;Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 34.3;Hep G2: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		180000		"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	14.4	47.3	47.4	2.9	64.3	12.0	8.4	64.4	56.6	10.4	36.8	15.5	22.4	9.4	7.0	4.6	12.5	6.9	47.5	46.5	54.3	49.6	48.1	7.8	2.4	63.3	56.8	22.3	18.1	21.9	22.4	5.3	62.7	12.5	9.5	13.8	28.5	12.1	23.5	5.3	14.5	6.6	49.4	4.6	17.4	5.2	55.6	1.0	10.2	10.9	2.3	8.8	7.9	79.8	1.3	16.1	4.4	23.2	6.9	5.7	2.9	2.9	2.2	5.4	2.7	21.0	3.3	0.2	3.9	2.6	4.5	0.6	34.3	2.5	2.0	1.0	2.4	12.5	12.9	66.2	18.8	0.3	10.1	4.9	9.0	2.1	0.0	5.7	10.6	1.0	22.4	0.6	1.1	1.8	0.2	0.2	2.9	7.6	13.0	2.1	0.3	0.1	11.5	4.5	7.0	22.7	5.3	1.2	15.8	3.8	15.4	4.5	2.5	0.4	1.6	5.6	4.3	1.2	0.3	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	64.3	64.4	56.6	46.5	54.3	63.3	56.8	62.7	49.4	55.6	79.8	3.9	3.2	2.0	8.8	1.9	1.5	3.7	1.5	14.8	41.9	4.5	3.7	5.8	4.3	2.5	31.3	47.9	11.7	2.6	5.7	90.1	3.2	0.2	11.6	3.0	5.2	5.4	49.2	10.2	1.2	2.6	8.6	47.9	25.9	1.3	6.9	4.2	5.4	8.2	32.0	13.0	10.4	6.1	1.0	3.4	0.4	5.3	5.7	12.4	5.6	1.2	36.2	1.0	6.0	17.1	1.7	7.3	3.0	9.1	3.9	28.2	167.2	2.5	72.9	0.0	6.1	9.8	0.8	4.1	12.8	1.8	8.3	3.1	18.6	9.5	3.5
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22580998-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 36.2;pancreas: 26.6;stomach 1: 31.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"midbrain: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"midbrain: 3.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	14.2	0.0	7.3	3.7	2.1	0.0	0.1	4.3	4.0	0.0	0.0	0.0	0.2	36.2	13.7	0.0	0.0	2.5	0.0	26.6	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	31.1	0.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	19.3	0.0	0.0	1.2	0.0	0.0	28.8	0.0	0.0	0.0	0.0	10.3	0.0	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	22.7	24.7	0.0	0.0	0.0	0.8	0.0	42.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.0	96.1	78.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.1	0.3	0.3	47.1	12.5	0.0	0.0	0.0	0.0	21.7	0.0	25.6	0.1	30.8	2.6	0.1	28.1	0.0	0.0	37.0	0.0	0.3	37.8	27.1	4.5	0.0	0.7	63.7	0.0	0.0	0.0	87.2	6.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.4	6.8	0.0	0.2	1.0	1.0	0.0	10.0	0.0	0.0	0.0	0.2	4.1	0.2	0.0	0.0	0.0	1.0	0.0	28.7	0.1
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312098-1314758	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 107.2;urinary bladder: 53.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.4;Basal respiratory cells: 24.9;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 67.2;Suprabasal keratinocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 39.0;HaCaT: 44.7;Hep G2: 93.8;OE19: 117.1;RT4: 38.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059700			Supported	Nucleoplasm		Yes	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.3	0.0	6.9	0.2	5.2	0.0	1.4	7.1	7.1	6.7	3.8	0.8	10.4	0.9	0.3	11.3	3.9	5.4	0.0	4.7	5.1	9.8	6.4	4.0	0.0	5.6	6.0	0.0	6.5	0.1	2.5	1.1	6.0	8.9	0.4	0.1	30.4	1.1	0.2	25.7	0.6	0.0	5.3	0.0	107.2	0.2	7.5	0.6	3.6	0.6	8.0	53.5	16.9	4.7	16.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.1	0.1	39.0	22.6	0.0	0.7	0.0	0.1	44.7	0.0	1.7	0.0	0.0	1.1	0.0	8.2	93.8	0.0	0.0	2.4	0.0	16.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	117.1	0.8	0.0	0.0	0.0	0.4	38.2	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.2	7.1	7.1	4.7	5.1	5.6	6.0	6.0	5.3	7.5	4.7	0.3	16.0	10.6	0.0	0.0	60.4	3.2	24.9	6.8	0.0	5.3	5.1	0.8	0.0	16.8	40.5	0.0	0.0	0.0	0.0	1.9	3.0	0.0	5.2	3.0	0.4	0.0	0.0	1.2	13.4	0.0	1.4	67.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	2.9	0.0	0.0	0.7	1.8	15.9	0.0	0.0	0.0	0.0	0.5	11.8	0.0	0.0	0.2	0.6	0.0	6.2	5.0	0.0	0.0	0.0	1.6	0.0	0.0	22.2	45.5	0.0	0.3	0.0	0.0	3.9
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 939.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.4	1.7	5.4	0.2	6.8	0.0	0.4	3.6	8.4	1.3	3.0	1.3	1.3	1.2	0.4	0.3	0.9	0.1	1.6	4.9	4.7	155.7	939.8	0.2	0.2	4.6	3.9	3.0	4.0	0.0	3.4	0.0	5.6	4.2	0.0	0.0	0.2	0.6	0.4	0.3	1.7	0.0	3.5	0.5	0.5	13.9	4.4	0.0	0.9	0.0	0.0	1.3	1.0	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.4	6.8	3.6	8.4	4.9	4.7	4.6	3.9	5.6	3.5	4.4	5.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830408-5839722	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.4;kidney: 36.1;salivary gland: 45.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"Hep G2: 10.5;RPMI-8226: 4.0"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		51000	"Cluster 10: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.1	0.0	0.1	2.6	0.1	0.4	1.7	0.2	0.1	17.3	0.4	17.3	28.6	0.3	0.0	79.4	0.6	9.3	0.0	0.1	0.1	36.1	12.4	0.2	0.1	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	11.6	2.0	45.7	2.5	0.0	0.1	27.0	0.4	0.1	0.1	4.8	0.2	0.1	0.0	0.0	0.0	6.7	0.0	26.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.2	10.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	4.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.5	0.0	0.7	0.0	0.4	3.5	0.0	0.4	3.7	1.9	0.3	18.6	15.7	1.8	0.0	0.2	0.3	35.6	3.9	6.8	0.3	0.6	0.7	0.3	4.9	0.0	0.1	0.4	0.1	0.3	0.0	0.7	0.0	0.2	0.7	5.1	0.1	0.0	0.1	39.4	8.2	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.5	0.1	2.7	21.5	0.0	0.0	0.2	101.4	45.3	6.4	11.5	0.0	0.3	0.7	1.0	0.6	3.6	0.1	0.0	0.5	0.1	29.0	1.7
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 615.1;skeletal muscle: 1234.9;tongue: 466.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 718.3;Proximal tubular cells: 417.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 176.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					NA	NA		420000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	14.0	26.6	69.4	4.5	74.5	8.8	15.6	68.6	79.1	16.5	53.4	10.9	3.2	10.0	141.9	23.0	14.7	9.9	98.1	67.3	67.1	72.0	615.1	8.1	7.7	71.8	68.3	22.8	229.8	37.8	37.4	4.9	70.4	36.5	2.2	15.0	42.6	17.5	1234.9	32.8	6.4	4.6	68.8	10.7	31.8	55.0	76.1	24.8	22.2	466.4	4.3	12.9	15.3	94.5	21.6	24.1	25.2	56.9	30.9	37.3	34.3	25.2	41.2	31.8	28.7	54.8	15.1	11.3	17.2	30.0	3.8	9.1	39.8	15.5	8.5	81.5	46.2	34.9	20.3	176.7	18.2	0.7	11.5	41.8	5.5	33.8	0.1	44.0	6.9	43.0	50.6	26.6	52.6	22.1	103.9	12.0	28.6	10.7	75.4	103.1	22.3	81.4	38.1	19.5	8.4	58.5	1.9	14.3	32.0	16.1	65.3	48.1	12.2	34.6	35.6	1.9	11.6	119.0	24.8	19.5	32.2	46.1	40.7	3.7	2.5	15.3	18.8	3.4	27.3	22.0	26.3	23.8	11.2	32.3	40.6	30.8	1.5	18.2	6.1	47.3	15.8	14.9	69.4	74.5	68.6	79.1	67.3	67.1	71.8	68.3	70.4	68.8	76.1	94.5	9.2	0.0	7.2	5.5	18.0	58.9	42.1	57.8	116.7	41.0	60.3	99.9	99.3	127.2	12.9	16.5	56.3	35.7	15.4	0.8	92.0	39.9	5.2	6.5	7.4	9.2	7.2	35.8	7.4	33.6	41.2	30.9	10.2	4.0	4.5	43.3	18.9	718.3	81.7	18.5	10.1	1.5	6.1	29.5	13.3	16.0	83.9	13.9	32.0	3.7	4.7	57.3	10.3	4.0	36.7	13.5	0.1	139.5	12.5	24.1	0.1	417.4	6.1	61.7	32.9	77.8	47.1	4.3	22.6	42.1	42.9	12.0	19.7	31.1	3.3	23.2
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 88.6;ovary: 95.4;pancreas: 53.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8;testis cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.2	0.2	0.0	0.0	2.3	4.0	88.6	0.0	0.0	0.0	36.6	0.2	0.0	0.0	0.0	95.4	53.5	0.0	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.1	35.2	32.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.7	20.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.2	1.3	0.0	0.0	1.5	20.5	0.0	0.0	0.1	3.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	16.1	0.0	0.1	6.1	0.0	0.0	0.1	33.7	0.2	12.0	61.2	0.0	0.0	158.4	57.8	12.1	0.6	0.0	0.1	0.8	0.0	2.8	0.0	37.0	41.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	41.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.3	2.4	2.2	0.0	0.0	0.8	0.1	80.1	0.9	0.0
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761007	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favorable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.8	15.6	15.4	5.6	17.5	9.5	8.3	18.0	20.4	6.7	14.9	9.8	5.8	5.5	8.3	10.3	8.7	5.5	33.3	16.3	16.9	21.6	22.2	5.3	7.6	17.4	16.5	11.3	5.3	18.3	5.2	8.6	17.1	5.5	9.6	17.0	7.9	6.4	23.0	9.4	6.4	8.0	17.7	6.5	8.2	8.0	17.2	12.2	7.5	40.3	9.7	6.9	6.1	20.4	14.9	11.6	16.1	15.7	22.9	21.7	13.9	19.3	24.9	33.3	25.8	19.5	23.8	20.2	5.0	20.1	20.3	13.7	34.5	36.6	35.3	11.4	21.1	9.4	15.2	40.7	22.4	19.1	9.0	22.8	23.1	32.0	11.2	19.2	25.1	28.0	36.8	17.1	26.0	16.7	24.1	20.8	16.6	12.4	21.1	20.4	15.5	16.1	30.2	12.3	16.5	18.5	15.8	21.1	23.1	15.4	17.9	13.7	14.1	16.8	9.1	11.7	13.4	20.3	28.2	16.8	23.7	16.9	12.5	0.9	11.6	2.0	4.5	16.9	7.3	11.4	6.1	6.5	20.9	9.9	7.8	7.3	1.1	8.7	12.1	8.1	7.0	10.8	15.4	17.5	18.0	20.4	16.3	16.9	17.4	16.5	17.1	17.7	17.2	20.4	4.3	9.6	4.8	11.4	6.7	0.0	6.0	0.0	5.7	9.8	6.3	7.1	64.8	1.5	3.7	11.0	8.4	23.4	2.9	3.2	27.4	11.2	8.0	6.7	7.3	4.4	2.4	15.6	28.4	7.4	16.6	8.8	6.6	7.1	1.3	12.3	2.5	17.2	17.1	10.1	16.4	4.2	0.0	7.3	0.0	10.6	5.3	7.6	0.0	15.9	10.8	333.3	1.0	14.1	27.5	6.9	4.9	4.5	5.6	3.1	6.3	22.7	1.5	17.1	6.6	6.5	5.9	14.3	14.0	10.6	0.0	13.4	3.6	12.5	7.1	4.5
GCFC2	"C2orf3, DNABF, GCF, TCF9"	ENSG00000005436	"GC-rich sequence DNA-binding factor 2"	P16383	2	75652000-75710985	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077882	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA077882: AB_2686864"	"unprognostic (1.98e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (5.67e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (6.07e-2)"	10.7	10.5	13.8	4.2	16.3	7.4	12.1	14.4	17.3	19.2	9.7	9.7	3.7	11.1	11.4	9.6	13.7	4.7	11.3	12.2	14.4	19.0	28.5	7.8	8.8	13.7	14.5	14.3	14.1	7.5	11.2	6.9	13.9	14.0	3.8	11.7	7.8	5.5	29.1	15.8	8.1	6.3	15.1	12.3	9.4	12.0	14.4	7.6	12.1	9.1	6.5	9.0	10.4	17.3	14.4	13.9	9.8	11.6	5.3	6.7	12.7	9.5	7.7	9.7	9.2	16.7	10.3	14.2	13.4	6.5	11.9	5.5	11.9	6.5	13.0	20.9	25.5	10.9	13.6	44.9	8.3	18.8	10.2	7.2	8.2	4.8	14.5	11.0	11.6	17.6	16.5	8.2	9.3	11.3	19.6	31.8	15.5	10.5	15.3	22.8	20.1	34.6	16.3	15.7	18.0	22.6	12.8	14.5	16.2	6.9	10.8	10.6	12.6	9.3	12.2	13.4	19.3	9.5	17.7	10.8	9.2	11.7	20.7	0.6	8.1	3.8	10.4	5.7	11.9	18.2	9.7	12.1	9.4	12.6	14.3	13.2	0.4	5.4	9.6	13.3	11.5	8.9	13.8	16.3	14.4	17.3	12.2	14.4	13.7	14.5	13.9	15.1	14.4	17.3	11.6	16.0	11.2	49.6	15.7	27.8	20.5	14.0	21.6	11.2	14.4	13.5	22.4	17.2	20.2	12.9	0.0	36.7	14.8	7.3	21.5	16.0	31.5	11.4	18.0	15.0	16.2	12.0	60.8	19.0	23.5	21.9	8.2	8.7	13.9	15.6	13.2	24.9	12.5	16.8	51.7	7.5	8.2	13.9	12.0	75.4	16.8	8.8	14.2	20.6	7.1	10.6	16.5	75.9	75.9	13.8	7.8	9.8	11.3	18.0	6.2	19.3	15.1	9.1	13.1	20.2	13.5	15.5	22.7	16.5	24.7	23.7	13.3	17.4	10.6	16.8
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496839-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	19	"liver: 136.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 96.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA045855, HPA052227"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB034098: AB_2247323, HPA045855: , HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.8	7.1	0.8	0.2	1.3	0.9	0.6	4.7	1.6	0.5	1.4	0.1	0.7	0.5	0.6	1.5	0.2	2.3	0.4	1.0	1.3	0.5	136.4	0.2	0.6	1.7	1.2	5.8	1.8	0.2	0.4	0.2	1.6	0.5	0.3	0.9	0.4	0.2	0.3	0.8	0.2	0.3	0.3	1.6	6.5	2.7	1.1	0.2	0.1	0.1	0.3	0.3	0.4	1.4	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	13.4	0.7	20.7	0.8	0.0	0.4	0.3	1.0	0.5	0.1	2.2	6.4	0.1	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.2	4.2	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.4	0.3	0.0	0.1	0.0	0.2	0.8	1.3	4.7	1.6	1.0	1.3	1.7	1.2	1.6	0.3	1.1	1.4	0.3	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	7.9	0.1	0.6	0.6	0.0	0.0	2.0	10.4	0.0	0.2	18.3	0.1	0.0	0.1	0.7	96.5	0.1	0.0	1.6	0.0	0.0	2.1	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	13.7	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 45.8;Late spermatids: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340"	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	6.1	4.3	6.1	4.5	6.3	10.3	7.9	10.2	7.9	5.9	4.6	6.0	6.7	5.4	7.2	5.7	5.9	4.2	7.7	5.7	3.9	6.1	5.6	4.8	8.8	3.6	2.6	5.9	4.7	3.7	4.6	5.6	3.6	4.8	6.1	4.7	4.3	4.5	12.1	6.3	4.7	7.7	1.1	5.2	5.1	8.3	3.4	9.1	5.5	7.9	7.8	6.2	5.5	6.2	23.6	34.5	33.3	23.7	11.3	12.6	17.0	11.5	9.0	30.3	30.0	30.7	27.9	36.0	23.4	9.8	11.0	17.5	45.6	18.7	31.5	17.6	26.7	21.5	18.1	76.8	23.9	32.6	12.8	7.3	17.6	18.8	27.5	8.7	26.6	31.4	25.2	25.6	17.3	48.9	36.3	31.2	23.6	29.7	38.3	32.8	36.4	22.6	17.5	15.6	32.2	6.2	24.5	17.7	12.4	18.4	41.5	14.0	11.2	12.7	20.0	13.3	18.6	26.8	44.2	54.1	6.6	34.0	19.6	10.8	12.0	9.9	13.5	13.1	9.8	15.3	12.3	13.5	16.2	15.8	13.5	14.4	3.1	11.9	11.5	16.1	11.8	9.2	6.1	6.3	10.2	7.9	5.7	3.9	3.6	2.6	3.6	1.1	3.4	6.2	11.6	6.4	3.7	4.9	10.3	8.5	8.1	20.9	8.0	5.9	7.3	12.1	6.0	5.7	11.4	5.5	10.4	12.9	7.0	2.2	11.7	10.8	45.8	11.2	11.3	10.6	3.6	17.2	7.4	6.4	18.9	12.5	2.6	7.5	5.7	11.7	9.7	6.6	11.4	5.0	6.2	7.1	14.2	10.6	7.3	41.1	9.0	6.3	7.2	4.7	9.4	8.1	9.2	4.0	7.4	6.9	2.5	9.8	9.4	8.0	3.1	14.7	15.5	6.9	6.6	8.3	8.1	25.9	15.4	11.3	8.0	3.8	9.1	11.6	9.3	4.8
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	209	"intestine: 259.5"	"Cell type enriched"	"Detected in single"	4	"Intestinal goblet cells: 1.9"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 6.6;BEWO: 5.9;Hep G2: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	NA	NA	33900	540000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA021612: AB_1849506, HPA064596: "										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	259.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.7	0.0	0.0	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.5	5.9	0.3	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	9.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.0;kidney: 41.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	3.9	23.8	0.5	1.7	0.4	0.3	3.0	0.4	0.5	1.8	0.5	15.6	38.0	2.1	0.9	2.1	3.1	5.5	1.5	0.5	0.4	41.4	18.4	2.7	0.8	0.4	0.4	2.4	18.1	2.3	0.9	3.5	0.4	1.7	14.9	0.1	4.2	0.9	1.1	4.7	38.0	2.8	0.4	27.9	6.0	1.0	0.5	0.4	1.0	1.6	0.8	2.0	1.9	0.4	0.0	0.0	0.0	0.1	2.4	6.1	0.0	1.0	0.0	0.5	1.1	5.1	3.3	1.5	0.1	0.5	0.0	6.0	0.0	0.0	3.2	0.2	0.0	0.8	0.0	23.0	1.2	0.0	0.0	1.0	0.1	3.5	0.1	0.0	23.5	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.4	33.6	0.0	1.3	2.0	2.0	12.9	2.4	0.9	4.0	0.4	5.2	1.5	3.2	27.1	2.5	9.2	2.1	6.7	0.0	43.7	33.2	11.8	2.5	13.3	0.9	21.6	3.0	0.4	14.7	33.0	3.1	2.9	8.6	7.2	0.0	5.9	22.9	43.3	13.2	0.0	15.2	34.4	0.0	0.8	1.9	1.2	1.2	2.1	0.0	14.0	1.0	0.0	0.0	4.5	8.9	16.5	39.3	0.0	0.0	0.8	122.1	267.7	11.7	0.5	0.0	1.3	1.3	0.6	2.5	7.9	21.7	1.6	1.3	32.4	63.8	6.0
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731462	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.7;kidney: 107.7;liver: 79.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.2;Macrophages: 133.4;Proximal enterocytes: 144.2;Proximal tubular cells: 161.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"neutrophil: 178.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 178.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.4;Hep G2: 46.4"	"Low region specificity"	"Detected in all"							HPA060687	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"			"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	8.8	9.8	3.1	51.5	2.8	6.6	4.8	3.7	17.2	4.8	8.4	13.0	86.6	3.6	12.3	9.6	7.7	23.8	4.8	2.3	4.1	107.7	79.2	19.7	10.6	7.2	4.2	2.6	4.5	14.0	5.4	8.2	6.8	3.6	10.9	10.3	11.2	2.2	2.6	6.3	90.7	4.4	3.6	10.1	6.2	2.9	14.5	5.4	6.6	3.1	14.5	30.2	2.7	8.0	4.5	3.5	4.5	7.7	2.7	10.4	1.8	10.6	37.4	7.6	8.6	5.8	4.1	12.6	1.7	4.1	6.9	0.3	8.5	3.5	10.1	8.2	9.6	7.5	6.6	46.4	17.2	14.2	15.4	6.3	4.9	24.2	22.3	1.9	6.0	9.6	4.0	17.3	2.1	6.2	11.0	14.6	7.5	4.9	4.0	15.0	7.1	13.1	5.7	14.8	4.8	6.1	9.4	9.4	21.5	4.5	10.6	10.1	2.3	5.5	2.3	0.3	4.9	9.1	10.7	12.5	9.5	9.1	5.6	5.0	22.8	7.9	1.7	7.2	1.3	3.1	3.1	2.2	14.2	5.6	1.8	1.9	178.4	4.8	9.1	4.2	11.5	6.2	3.1	2.8	3.7	17.2	2.3	4.1	7.2	4.2	6.8	3.6	14.5	8.0	2.0	16.0	27.4	19.6	15.8	6.9	12.3	12.6	4.6	3.2	9.4	3.9	4.3	12.8	22.5	7.3	16.7	1.2	5.6	54.7	35.2	21.9	61.5	15.1	2.7	3.8	12.1	6.3	41.5	11.1	1.1	12.4	20.9	1.7	14.5	6.9	3.6	38.1	34.8	5.0	37.2	14.7	0.0	26.6	139.2	29.9	1.2	133.4	14.2	10.3	42.6	29.1	3.1	28.6	19.6	10.6	39.9	2.2	12.4	17.0	144.2	161.1	47.7	17.7	0.0	9.2	7.0	15.3	1.7	14.7	16.9	0.8	15.7	3.7	11.0	26.8
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GMPPA		ENSG00000144591	"GDP-mannose pyrophosphorylase A"	Q96IJ6	2	219498884-219506989	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035512, HPA035513"	Approved		Approved	Nucleoplasm		NA	NA		51000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA035512: AB_2674660, HPA035513: AB_10671934"	"unprognostic (3.43e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.40e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.90e-10)"	"prognostic favorable (5.24e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-1)"	22.6	25.8	19.3	23.9	20.1	19.0	21.6	20.1	22.6	32.1	22.4	29.7	28.8	26.4	68.7	25.5	24.6	19.7	27.1	20.1	20.5	25.7	68.5	20.9	20.7	20.5	19.8	20.1	60.3	24.7	48.5	21.2	20.0	37.3	32.3	8.0	40.1	23.4	22.8	17.8	30.0	26.2	19.6	35.2	32.5	9.6	21.3	13.2	28.6	12.6	23.8	25.2	23.1	19.8	43.4	36.0	21.2	37.8	79.5	70.6	56.4	73.8	98.6	85.2	105.2	66.8	40.5	23.4	51.1	107.7	54.3	40.1	39.7	63.9	73.3	45.3	35.0	45.5	35.7	119.3	72.0	24.1	51.7	54.3	50.7	79.9	89.9	43.9	52.8	29.7	82.3	66.3	66.8	55.5	23.8	45.3	21.7	52.8	38.5	18.6	22.9	42.4	48.6	30.1	27.4	24.0	31.0	46.3	52.1	44.4	31.5	38.8	30.9	49.2	33.6	89.4	40.9	45.4	19.4	28.9	100.4	26.7	55.8	76.0	52.6	37.3	30.1	56.0	35.0	32.1	23.4	31.9	43.5	24.1	17.3	15.7	11.8	36.4	59.3	43.9	34.8	35.2	19.3	20.1	20.1	22.6	20.1	20.5	20.5	19.8	20.0	19.6	21.3	19.8	12.5	16.0	14.4	5.5	18.8	5.6	12.8	25.2	6.2	6.1	20.9	13.5	13.2	10.0	20.1	16.5	6.2	37.6	16.6	37.7	35.2	24.3	1.3	8.5	15.8	9.5	10.8	19.1	3.1	30.0	79.8	19.2	38.7	14.4	19.0	13.3	11.0	36.3	33.7	1.7	3.6	61.6	10.2	17.6	10.0	3.4	18.3	16.5	12.4	1.9	15.9	11.1	12.3	1.0	4.9	19.0	37.6	13.5	50.3	15.1	45.9	36.8	11.6	4.7	13.1	7.9	27.1	4.4	6.5	9.9	8.5	47.2	13.5	10.7	29.1	15.1
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Approved		Approved	Nucleoplasm,Nucleoli		No	No		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032"	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	45.0	92.1	24.5	19.7	25.7	19.3	44.3	25.8	30.2	44.7	28.2	44.2	30.9	38.2	29.9	38.7	44.9	32.0	39.6	24.8	25.7	70.1	56.0	38.8	26.9	26.2	25.6	51.2	49.0	67.7	48.1	22.7	26.8	41.7	25.5	18.8	41.8	26.3	40.6	35.2	45.8	21.2	26.0	55.9	50.7	21.9	26.1	28.4	58.4	19.8	27.3	43.1	40.3	26.2	27.1	34.2	29.0	26.7	50.9	74.7	40.0	32.1	59.2	47.3	55.7	38.8	24.6	34.7	22.5	49.8	25.5	43.6	42.4	69.2	69.5	19.0	25.5	24.3	25.0	159.1	46.8	53.7	51.4	72.2	54.9	23.6	47.7	61.1	69.7	52.3	12.5	33.3	46.6	51.8	50.1	57.1	34.3	39.5	37.3	33.5	24.2	22.6	69.1	52.7	22.0	36.2	16.9	45.8	52.6	39.5	38.6	41.1	36.2	23.0	15.8	32.0	20.6	59.4	63.1	21.8	16.6	38.9	20.2	24.3	34.2	15.0	19.7	27.5	21.6	13.7	21.5	23.7	35.9	15.9	19.3	20.2	56.0	14.9	27.9	15.8	31.5	26.5	24.5	25.7	25.8	30.2	24.8	25.7	26.2	25.6	26.8	26.0	26.1	26.2	25.2	25.6	18.7	10.7	23.2	11.0	44.5	49.9	27.3	19.6	24.8	32.9	12.5	38.6	35.7	53.3	4.2	67.2	22.6	35.6	101.8	43.6	18.3	29.6	16.6	26.3	10.3	20.6	7.8	33.0	48.5	18.8	17.9	20.0	31.7	29.7	16.8	24.8	50.0	18.5	8.0	19.8	30.5	46.6	14.6	10.5	28.9	32.5	21.4	9.4	32.1	43.3	25.7	7.5	11.7	33.7	32.1	25.2	21.2	19.0	50.2	123.1	43.2	19.7	26.3	16.0	24.5	19.8	10.3	20.7	10.7	49.3	24.6	51.3	28.4	30.5
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 296.5;pancreas: 600.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.9	0.9	2.3	1.3	2.5	3.8	7.1	2.8	2.4	0.8	2.0	0.7	0.2	0.8	2.2	0.6	1.3	0.5	4.7	2.2	2.2	0.9	296.5	2.0	1.0	1.1	1.0	1.9	600.1	0.2	8.4	0.4	1.1	20.3	0.3	2.2	9.8	1.2	1.8	0.9	1.6	0.5	0.9	2.9	50.8	0.7	1.9	1.8	1.9	0.4	1.2	0.8	0.7	2.1	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.3	2.5	2.8	2.4	2.2	2.2	1.1	1.0	1.1	0.9	1.9	2.1	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
GORASP2	"GOLPH6, GRASP55, GRS2"	ENSG00000115806	"Golgi reassembly stacking protein 2"	Q9H8Y8	2	170928464-170967130	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 380.7;Syncytiotrophoblasts: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035274, HPA035275, CAB075758"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		830000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.38e-8)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-1)"	32.1	43.1	32.6	32.0	34.6	33.7	40.5	35.8	36.7	62.6	34.1	43.5	38.3	43.2	60.4	46.8	34.3	37.2	57.6	32.5	35.9	33.6	45.6	34.3	39.9	34.2	34.5	37.3	67.1	47.3	40.0	55.5	34.8	40.7	43.6	37.0	68.4	52.6	39.7	38.6	36.7	46.1	34.6	31.1	42.0	32.0	34.4	41.8	50.8	38.1	44.2	53.3	24.0	37.0	66.1	51.7	72.2	54.9	137.5	103.2	83.0	101.5	113.9	89.6	113.8	132.8	84.2	97.0	59.7	143.2	61.0	75.9	82.3	96.0	102.2	57.8	81.2	107.5	41.2	198.8	138.4	90.2	62.9	79.2	102.9	90.0	148.3	95.7	98.9	64.5	92.4	72.4	80.3	103.2	85.5	87.0	74.3	109.9	49.3	68.4	64.5	115.0	112.9	91.8	59.3	54.3	58.4	91.6	95.9	59.0	60.8	73.6	93.5	82.8	56.2	79.5	55.7	81.1	56.2	112.4	86.6	58.3	95.6	48.3	38.3	27.0	53.0	40.6	81.7	44.8	59.1	63.4	48.3	40.7	58.0	48.5	9.6	64.5	46.8	63.9	57.0	62.8	32.6	34.6	35.8	36.7	32.5	35.9	34.2	34.5	34.8	34.6	34.4	37.0	28.7	41.7	36.6	15.0	46.7	37.2	39.6	83.4	38.1	30.6	33.0	22.5	40.9	27.1	64.2	20.2	31.3	114.4	49.3	39.2	56.7	69.1	196.6	16.2	34.4	32.1	31.3	35.1	20.1	78.1	112.1	48.4	48.4	32.7	20.3	25.7	38.9	45.0	46.4	42.1	23.0	63.9	48.8	22.7	29.7	380.7	58.7	23.9	48.0	22.5	46.3	39.3	35.0	27.2	31.7	69.7	41.9	49.7	171.9	62.1	31.7	43.7	23.1	34.8	59.2	27.5	40.3	39.6	39.6	47.1	36.1	229.7	43.4	44.9	48.2	67.7
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985594	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 574.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.1;Extravillous trophoblasts: 61.0;Fibroblasts: 404.2;Muller glia cells: 88.9;Syncytiotrophoblasts: 148.6"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 269.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.8"	"Group enriched"	"Detected in some"	5	"HAP1: 514.3;Hep G2: 1825.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006316			Supported	"Plasma membrane"		NA	NA		27000	"Cluster 32: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	99.9	22.8	0.5	3.5	1.0	0.0	61.8	0.5	0.3	11.8	0.2	6.5	1.6	9.2	41.1	6.7	13.9	13.7	24.5	0.3	4.0	87.0	5.1	122.9	2.5	1.9	3.1	15.5	21.2	4.1	47.0	574.9	3.0	8.3	4.1	6.2	13.7	9.2	4.5	18.0	5.6	7.3	1.7	3.7	13.6	2.8	2.0	8.0	22.4	28.6	10.9	14.6	9.3	1.0	0.0	0.0	21.8	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	154.0	0.0	0.0	0.1	0.1	0.0	0.0	514.3	0.4	0.0	0.0	22.6	0.0	0.9	1825.2	0.3	0.0	0.5	12.9	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.5	0.1	132.1	0.1	0.0	0.0	0.0	0.1	122.4	6.1	15.3	40.3	0.0	0.0	0.4	233.8	0.5	23.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	1.2	0.0	0.7	0.0	0.0	0.0	0.1	0.5	1.0	0.5	0.3	0.3	4.0	1.9	3.1	3.0	1.7	2.0	1.0	28.5	0.0	1.7	0.3	1.0	10.5	4.8	17.0	0.0	0.4	5.0	10.4	0.5	1.5	20.0	5.5	0.0	65.1	0.8	0.5	19.6	0.3	0.9	0.2	0.4	1.8	1.8	0.0	2.5	1.6	61.0	404.2	0.5	1.5	0.0	1.0	2.2	0.0	26.7	0.0	2.5	3.1	2.0	0.0	6.1	2.4	10.5	1.0	3.6	23.4	0.0	88.9	0.0	3.5	1.4	1.7	2.6	3.0	0.4	2.7	1.2	40.7	24.3	3.1	0.0	21.7	21.3	6.9	7.1	0.2	4.0	148.6	1.1	7.6	4.1	0.6
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 9.6;Distal enterocytes: 15.4;Endothelial cells: 11.3;Hepatocytes: 23.5;Kupffer cells: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.9;intermediate monocyte: 2.8;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	19	"dendritic cells: 5.8;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;Daudi: 12.1;fHDF/TERT166: 8.6;Hep G2: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	10.6	12.6	12.7	1.5	11.7	0.2	8.4	9.0	15.9	5.4	8.1	10.8	0.6	5.8	0.3	2.2	4.3	1.2	7.1	10.0	9.6	9.7	27.9	12.1	1.9	9.9	10.2	2.4	2.1	0.4	6.1	6.3	10.5	7.2	1.4	0.9	2.9	5.0	4.3	2.8	3.6	1.8	8.4	8.5	45.3	1.5	11.6	0.9	9.7	1.3	1.0	6.1	4.7	9.2	1.1	0.4	0.3	11.5	2.7	2.6	1.1	6.7	4.4	2.1	3.7	0.2	0.3	12.1	1.1	8.6	0.1	0.6	0.1	0.0	0.2	2.6	2.1	0.0	1.4	22.8	0.4	0.1	0.7	1.5	0.0	1.3	0.0	1.6	0.6	0.2	0.1	0.1	0.5	0.8	0.0	0.4	2.2	2.4	7.9	1.1	0.0	0.0	0.2	0.0	0.1	4.5	0.0	0.5	2.5	0.8	0.2	0.1	1.6	0.4	2.8	6.9	2.1	0.0	0.0	4.4	3.8	0.2	0.2	0.0	2.9	0.0	0.0	2.8	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.4	12.7	11.7	9.0	15.9	10.0	9.6	9.9	10.2	10.5	8.4	11.6	9.2	9.6	0.0	0.0	1.0	1.2	0.5	0.0	0.5	1.8	0.0	0.5	0.5	2.8	0.0	0.0	5.5	0.0	0.0	0.0	15.4	0.0	0.1	0.0	4.4	0.1	11.3	1.2	0.0	0.8	3.1	0.6	1.5	0.5	1.0	0.0	0.4	1.1	23.5	0.6	0.0	0.5	2.8	0.0	16.9	2.7	0.7	2.8	2.9	0.0	1.9	0.6	4.4	0.0	0.5	0.1	0.8	7.4	1.2	0.1	0.8	0.2	5.6	0.0	0.4	0.0	0.7	7.2	0.5	2.7	0.1	0.3	0.0	0.0	0.1	2.0	0.1
GPHA2	"A2, GPA2, MGC126572, ZSIG51"	ENSG00000149735	"Glycoprotein hormone subunit alpha 2"	Q96T91	11	64934471-64935893	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pancreas: 360.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.5;Exocrine glandular cells: 17.4;Pancreatic endocrine cells: 2.4;Spermatocytes: 7.7;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 15.8"	"Region enhanced"	"Detected in single"		"cerebellum: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067068			Approved	Vesicles	"Secreted to blood"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA067068: "	"unprognostic (1.13e-1)"	"unprognostic (8.31e-3)"		"unprognostic (1.51e-2)"		"unprognostic (9.22e-4)"		"unprognostic (7.88e-3)"		"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.70e-1)"	0.0	0.1	0.3	0.2	0.6	0.1	0.1	3.6	0.6	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.4	16.9	0.0	0.3	0.3	0.8	0.7	0.3	0.6	0.4	0.3	2.7	360.5	0.0	28.0	0.0	0.6	0.7	0.0	0.1	0.3	0.5	0.0	0.5	0.5	0.0	0.2	0.6	1.1	10.8	0.4	0.1	0.3	0.0	0.5	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	21.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	3.6	0.6	0.3	0.3	0.4	0.3	0.6	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	17.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	7.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
GPR119	"GPCR2, hGPCR2"	ENSG00000147262	"G protein-coupled receptor 119"	Q8TDV5	X	130384345-130385660	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"pancreas: 2.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"pancreatic cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"															"prognostic favorable (6.93e-4)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884362-46931289	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 267.4;skeletal muscle: 176.4;tongue: 184.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 159.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	56.8	10.4	51.6	4.0	49.9	3.8	17.0	49.1	56.9	5.2	38.4	7.7	1.7	3.7	31.4	77.8	7.6	9.8	7.9	51.3	45.7	23.5	103.7	2.1	4.3	69.8	45.9	2.3	267.4	8.3	13.0	3.1	63.9	24.2	4.9	6.9	48.8	10.9	176.4	37.8	3.9	3.1	60.2	2.3	58.6	15.0	54.9	7.7	7.6	184.5	13.4	2.7	7.7	64.5	42.6	19.0	23.8	90.6	32.7	7.0	43.1	28.9	10.9	30.7	19.2	65.3	17.6	29.9	24.7	20.7	15.6	33.6	43.3	42.8	20.4	14.0	21.1	10.5	10.8	159.9	22.4	75.6	9.5	15.2	37.0	30.0	46.3	20.3	15.1	56.1	8.7	23.3	10.3	75.8	15.1	62.9	25.3	52.2	54.2	0.3	26.3	71.1	12.4	21.0	73.7	37.7	14.9	76.4	39.0	9.4	19.6	67.6	11.3	21.1	40.9	14.2	23.4	110.2	36.9	87.1	32.6	48.3	11.7	0.4	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	51.6	49.9	49.1	56.9	51.3	45.7	69.8	45.9	63.9	60.2	54.9	64.5	1.3	6.4	3.4	54.9	4.8	15.9	4.9	6.8	64.3	14.5	6.7	8.4	14.9	8.6	9.1	18.4	22.9	9.2	0.3	10.2	11.7	7.0	9.6	12.2	7.2	2.3	13.1	5.2	16.7	30.2	44.8	7.5	37.2	37.5	3.8	14.9	5.0	123.9	3.8	6.7	18.8	13.4	6.1	3.2	7.3	22.9	4.7	2.3	8.8	1.0	1.1	42.5	1.0	13.6	26.0	25.6	5.2	15.4	7.9	12.4	2.0	38.6	5.4	5.9	0.0	5.2	3.6	2.5	17.3	53.1	16.3	83.3	1.4	2.6	6.3	4.2
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		81000000	"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	13.6	23.3	12.3	18.7	11.1	25.9	11.0	10.6	11.7	28.5	25.8	42.5	54.3	16.0	21.6	37.3	21.6	30.5	25.4	12.9	12.5	45.3	35.8	17.4	23.6	9.5	14.2	23.1	26.5	82.3	14.8	23.5	12.0	35.3	46.6	12.8	25.8	29.4	28.9	12.8	50.8	17.9	10.7	22.1	41.8	11.6	17.6	26.7	16.9	21.3	24.0	22.5	27.7	11.2	49.4	197.8	35.9	40.1	35.8	38.3	29.1	23.4	46.8	31.8	36.7	66.0	31.3	95.8	94.8	32.0	96.1	59.2	62.3	51.1	33.1	22.6	40.7	104.6	67.0	197.8	88.4	38.6	159.7	72.6	28.5	48.9	20.9	33.5	43.3	57.3	73.2	55.1	67.9	44.1	147.1	32.0	65.4	191.9	31.5	43.8	41.9	59.3	56.0	124.3	28.2	31.8	31.2	87.8	58.8	40.7	37.5	32.6	63.8	21.0	34.7	37.3	35.2	20.2	29.4	70.0	51.9	51.8	62.4	32.3	5.9	15.0	5.0	5.4	8.8	3.6	4.5	5.4	6.0	2.3	2.8	3.7	8.2	3.6	7.9	3.9	4.5	3.1	12.3	11.1	10.6	11.7	12.9	12.5	9.5	14.2	12.0	10.7	17.6	11.2	8.2	3.2	20.8	12.7	13.7	4.2	15.2	9.4	52.3	6.7	6.7	5.0	26.8	30.0	15.0	12.9	16.7	17.0	20.3	61.8	9.8	11.4	8.4	61.4	13.4	9.9	34.1	28.6	18.1	19.8	6.3	10.0	33.1	41.3	6.3	64.3	12.1	43.4	18.2	3.3	27.4	51.7	8.2	40.5	5.8	18.9	7.2	22.1	8.8	11.2	20.6	12.6	17.5	12.5	10.0	15.2	32.0	10.9	15.6	27.5	75.7	19.0	11.7	8.0	6.6	7.0	8.6	1.2	3.4	39.6	5.4	6.4	17.3	17.2	47.5	33.5
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
H2AC4	"H2A/m, H2AFM, HIST1H2AB"	ENSG00000278463	"H2A clustered histone 4"	P04908	6	26033092-26033618	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.5;brain: 2.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.2	0.0	0.5	0.0	0.4	1.5	0.0	2.0	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.1	0.7	1.9	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.6	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.9	0.5	0.2	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.4	0.7	0.7	1.2	0.0	1.0	0.4	0.2	0.5	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.1	1.4	0.1	0.1	0.6	0.9	0.0	0.2	1.2	0.1	0.0	0.0	1.0	0.1	0.4	0.0	1.5	0.4	0.6	0.5	0.7	0.1	0.2	0.2	0.5	0.0	0.0	0.2	0.0	0.5	0.4	2.0	0.5	0.6	0.6	0.8	1.2	0.7	0.3	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 295.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 23.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					NA	NA		580000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	8.7	5.4	1.8	5.9	2.1	4.1	12.9	2.1	2.5	16.0	3.3	13.2	23.1	10.5	14.5	6.0	10.6	6.1	7.0	1.8	2.3	41.8	295.8	5.7	6.1	2.0	2.5	14.0	26.3	2.9	4.5	8.5	2.3	10.1	11.6	0.3	3.8	11.3	2.4	5.0	40.8	4.7	2.1	5.4	9.6	1.8	2.1	4.0	5.8	3.2	4.5	15.8	9.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	4.6	14.0	0.1	0.0	0.1	0.6	0.0	0.0	4.7	0.0	0.8	0.0	1.4	5.6	0.0	49.4	0.4	1.9	0.1	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.6	0.2	0.0	9.9	1.1	0.3	0.0	0.0	0.1	0.0	0.6	1.0	0.0	1.3	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	7.9	17.4	19.2	0.0	10.5	0.0	3.5	0.0	0.0	23.2	3.9	0.0	0.1	5.5	0.7	2.9	7.7	0.0	5.6	1.8	2.1	2.1	2.5	1.8	2.3	2.0	2.5	2.3	2.1	2.1	2.3	2.5	0.0	1.1	3.6	3.5	4.0	6.3	2.3	14.8	0.1	2.9	7.6	0.6	14.3	1.6	1.8	0.0	1.1	2.9	18.3	17.6	7.4	0.0	0.6	8.1	1.9	6.7	12.0	3.4	13.3	0.5	18.0	1.5	0.3	30.4	1.2	4.6	209.8	21.3	0.0	2.2	14.9	0.0	13.5	4.9	0.2	12.5	8.7	5.4	8.4	8.4	3.6	1.0	5.5	1.0	4.8	28.7	10.5	0.5	2.1	236.8	162.7	0.5	0.3	13.1	37.7	13.8	0.4	0.7	6.0	4.8	1.2	1.2	2.2	25.5	2.7
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2054.8"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 3227.7"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"myeloid DC: 1.5;plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.6"	"Cell line enriched"	"Detected in some"	440	"Hep G2: 448.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	10000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	1.0	1.2	17.7	2.0	17.6	5.4	1.5	17.4	30.4	2.3	20.8	0.8	0.9	0.3	0.6	0.5	2.8	0.6	415.0	17.8	20.2	1.1	2054.8	3.2	4.0	48.0	24.9	3.2	88.0	0.4	5.8	2.3	25.8	2.7	0.0	4.2	1.2	1.3	1.2	1.1	0.5	1.0	21.5	1.1	1.1	0.7	18.7	0.1	0.4	0.2	4.4	1.6	0.2	21.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	448.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.7	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	17.7	17.6	17.4	30.4	17.8	20.2	48.0	24.9	25.8	21.5	18.7	21.0	0.8	0.0	0.0	0.0	5.7	0.5	1.5	0.0	0.0	0.0	26.2	8.0	1.7	30.0	0.6	0.0	0.0	0.9	0.6	0.1	0.0	0.4	0.0	1.9	1.0	13.7	0.0	89.7	0.2	99.0	1.2	0.4	10.7	1.8	75.7	0.7	45.3	3227.7	187.9	0.0	0.0	0.7	0.0	63.2	1.2	0.0	0.0	28.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.6	0.1	0.0	0.1	4.2	0.0	0.1	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	18.6	0.7	4.3	0.5	0.2	2.2
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 218.4"	"Cell type enhanced"	"Detected in all"		"Urothelial cells: 302.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	43.0	48.6	27.8	23.1	33.6	54.0	37.6	58.6	33.7	43.5	34.0	38.3	25.1	37.0	30.7	74.6	33.8	26.7	47.2	27.2	30.9	37.0	74.3	32.9	28.7	30.2	30.1	38.5	34.7	56.5	34.4	35.5	32.5	30.7	31.2	66.9	42.6	31.0	218.4	50.8	33.6	30.8	28.0	30.4	43.7	42.7	31.3	26.3	51.3	133.6	37.3	39.8	51.5	36.6	95.1	54.6	49.2	30.4	144.0	77.2	44.7	54.8	54.1	47.4	39.7	41.0	47.8	72.1	57.8	97.3	34.0	62.6	63.2	47.7	69.6	44.5	24.9	75.6	44.3	163.9	66.9	81.8	52.7	66.3	64.4	52.2	80.9	63.6	87.5	42.2	54.4	32.1	72.8	72.4	31.8	31.7	36.0	76.6	47.5	53.6	58.0	30.4	71.3	93.2	36.2	40.8	79.8	54.5	49.0	56.3	58.7	49.5	93.4	56.6	42.9	41.9	49.0	34.3	52.9	79.0	28.0	37.3	49.7	9.1	5.7	8.3	4.5	4.8	5.2	4.8	5.2	4.1	6.4	6.3	4.2	4.3	3.0	6.3	3.8	5.3	5.6	2.4	27.8	33.6	58.6	33.7	27.2	30.9	30.2	30.1	32.5	28.0	31.3	36.6	63.4	48.1	80.8	84.5	60.7	86.7	93.5	61.2	48.3	98.9	40.8	28.6	108.1	25.8	94.8	71.7	98.0	70.2	72.1	40.9	11.7	44.2	3.6	101.6	83.0	60.0	48.7	41.2	89.9	36.1	42.9	59.9	96.8	118.1	32.9	81.6	46.4	84.7	29.0	65.6	101.1	33.0	63.1	43.9	34.5	8.7	69.0	54.0	33.8	90.9	65.1	40.9	78.2	100.0	127.9	52.6	33.9	74.4	71.1	106.3	37.1	22.4	148.4	194.5	46.0	77.4	78.9	50.6	100.0	83.7	114.9	140.0	61.4	97.0	44.5	302.9
HEPACAM	"FLJ25530, GLIALCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919205-124936412	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 222.6;choroid plexus: 79.7"	"Group enriched"	"Detected in some"	9	"Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"Hep G2: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			15.6	0.3	172.8	0.2	203.3	0.0	2.5	170.4	162.1	0.2	79.7	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.2	163.2	156.1	0.1	16.2	0.0	0.2	222.6	182.8	0.0	0.0	0.0	0.8	0.0	183.6	0.2	0.2	1.8	0.2	0.5	0.1	0.0	0.2	0.1	205.7	0.0	0.1	0.2	182.0	0.0	0.0	0.3	0.6	0.0	0.1	212.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	172.8	203.3	170.4	162.1	163.2	156.1	222.6	182.8	183.6	205.7	182.0	212.2	0.1	0.0	0.0	184.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	15.5	0.0	72.9	163.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
HEPN1		ENSG00000221932	"Hepatocellular carcinoma, down-regulated 1"	Q6WQI6	11	124919244-124920677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adipose tissue: 11.4;brain: 37.3;liver: 20.9"	"Group enriched"	"Detected in some"	23	"Astrocytes: 94.3;Muller glia cells: 29.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 114.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	287	"Hep G2: 55.5"									"HPA043768, HPA063054"	Uncertain		Approved	"Golgi apparatus"		Yes	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA043768: AB_2678662, HPA063054: AB_2684932"																		11.4	0.2	6.1	0.1	23.1	0.0	8.3	0.3	9.4	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	5.0	6.1	0.2	20.9	0.1	0.1	37.3	10.3	0.1	0.2	0.0	2.4	0.0	13.5	0.8	0.0	2.2	0.4	0.0	0.2	0.3	0.7	0.0	5.1	0.1	0.5	0.5	19.0	0.0	0.2	0.0	0.0	0.2	0.5	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	23.1	0.3	9.4	5.0	6.1	37.3	10.3	13.5	5.1	19.0	17.9	0.2	0.0	0.0	94.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	3.1	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.5	0.6	0.0	0.0	1.9	0.0	29.1	0.0	49.3	114.6	0.0	0.0	1.2	0.0	0.1	0.0	2.2	0.0	1.9	0.0	0.1	0.1	1.8	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HEXIM2	FLJ32384	ENSG00000168517	"HEXIM P-TEFb complex subunit 2"	Q96MH2	17	45160700-45170040	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9;testis: 44.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 150.9;Late spermatids: 274.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023323, HPA028455"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear speckles"		"HPA023323: AB_1850651, HPA028455: AB_10602603"	"unprognostic (9.03e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.01e-2)"	"prognostic favorable (2.53e-4)"	"unprognostic (2.36e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.85e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-2)"	4.8	10.1	8.5	5.2	9.0	4.6	4.6	12.2	9.8	4.9	13.4	7.1	10.2	4.7	4.5	4.7	5.6	7.8	6.9	7.2	7.3	10.5	15.1	4.2	7.3	9.1	8.4	6.2	10.8	7.5	7.9	3.4	8.2	6.0	2.7	4.8	11.5	5.7	56.9	6.6	7.6	2.8	8.6	6.4	8.1	44.6	9.0	5.0	8.7	15.1	3.3	5.8	3.9	9.1	9.0	31.7	6.9	15.3	7.5	12.3	13.1	4.9	5.9	7.8	8.6	12.1	23.4	5.6	25.0	3.5	4.0	14.6	6.8	6.0	2.4	12.9	10.9	4.2	33.4	55.1	5.4	3.6	8.9	10.7	5.6	6.8	2.4	15.1	3.9	11.3	4.6	13.4	3.6	15.6	5.7	7.6	7.5	12.5	13.8	7.7	10.4	17.1	9.8	8.8	8.2	7.2	4.4	8.8	20.7	4.8	23.3	6.1	3.8	14.0	7.5	9.4	11.7	20.7	23.9	5.2	11.0	6.6	10.7	8.2	11.7	10.6	4.8	9.4	8.0	10.1	3.5	5.8	10.2	5.5	2.7	5.0	8.2	8.1	3.1	12.9	4.7	12.0	8.5	9.0	12.2	9.8	7.2	7.3	9.1	8.4	8.2	8.6	9.0	9.1	3.1	0.0	1.5	1.6	4.8	2.0	4.0	3.1	5.7	13.1	6.8	7.2	0.3	5.7	2.5	1.8	4.2	11.7	4.1	2.7	19.6	5.5	150.9	4.9	3.0	4.3	4.8	0.8	2.2	1.6	5.4	3.9	3.6	3.4	7.0	8.8	5.3	7.7	7.0	3.3	3.0	6.2	4.1	9.3	3.3	274.9	5.9	16.4	3.6	1.0	4.9	11.6	5.2	1.5	3.1	1.6	3.1	7.2	7.2	2.0	18.3	36.2	1.8	9.9	0.0	5.4	4.6	41.4	13.7	3.3	3.0	6.2	2.1	7.2	6.1	2.5
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441968-3449486	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"liver: 217.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 85.6;Hepatocytes: 72.0;Late spermatids: 165.9"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	9300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	1.5	0.0	2.3	0.0	0.1	2.2	2.6	0.5	0.7	0.2	0.0	0.2	0.2	0.0	0.3	0.0	0.1	1.3	0.6	0.6	217.1	0.1	0.0	0.9	0.6	0.1	0.1	0.0	0.7	0.0	0.9	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.1	3.8	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.3	2.2	2.6	1.3	0.6	0.9	0.6	0.9	0.5	0.8	0.6	0.1	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	85.6	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.4	0.0	4.4	2.2	72.0	0.0	3.3	3.9	0.0	0.0	3.2	0.0	165.9	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	0.3	0.0	0.0	1.2	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	21.5	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1
HLF	MGC33822	ENSG00000108924	"HLF transcription factor, PAR bZIP family member"	Q16534	17	55264960-55325187	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 122.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 53.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 163.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	15.1	21.5	9.8	1.9	23.1	0.4	15.4	0.0	53.3	14.4	0.0	18.0	1.4	14.4	11.0	26.3	12.2	7.8	24.1	17.6	0.0	12.7	122.4	13.4	2.2	0.0	0.6	50.0	2.9	4.0	9.9	1.0	0.0	13.2	3.4	43.2	24.1	12.4	7.7	16.7	4.3	12.3	0.0	8.2	6.1	4.1	3.9	3.4	34.3	9.9	7.7	12.3	7.8	17.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.5	0.0	0.0	0.0	0.4	0.2	0.0	27.3	0.7	0.0	0.1	163.0	0.1	0.9	0.2	0.1	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.6	1.1	0.0	0.1	0.0	2.4	0.0	0.4	0.4	13.0	0.1	11.1	0.6	0.0	7.2	0.2	0.0	0.2	0.0	0.1	0.8	0.2	0.6	0.5	5.1	4.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.8	23.1	0.0	53.3	17.6	0.0	0.0	0.6	0.0	0.0	3.9	17.2	13.8	3.2	42.8	22.2	0.4	22.3	4.4	1.4	56.9	120.7	5.9	16.4	38.6	12.8	6.3	7.3	10.4	0.1	0.5	0.0	11.7	1.9	1.3	0.1	6.2	19.7	3.0	0.8	77.5	0.9	0.0	17.6	0.0	0.6	0.0	0.5	6.1	156.8	0.1	92.5	36.6	0.6	0.0	3.5	4.0	4.7	28.3	0.7	10.6	74.0	0.1	60.7	0.0	24.6	6.9	0.4	0.0	39.1	1.5	1.3	2.8	23.3	1.0	15.0	13.1	4.5	7.4	0.4	5.0	33.7	27.6	1.2	3.8	0.5	0.4	0.4
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 299.3;Kupffer cells: 263.7;Proximal tubular cells: 268.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"classical monocyte: 110.9;intermediate monocyte: 89.8;myeloid DC: 68.3;non-classical monocyte: 52.2"	"Group enriched"	"Detected in many"	23	"dendritic cells: 68.3;monocytes: 110.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 227.2;HSkMC: 87.9;RT4: 117.1;SuSa: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		130000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	70.4	18.2	13.0	41.7	13.3	12.6	62.3	13.1	18.8	57.3	19.2	53.9	29.3	62.8	27.1	17.5	34.5	68.7	21.7	15.6	19.1	109.7	245.9	49.0	35.1	16.0	15.3	91.0	29.0	40.2	9.5	46.8	18.1	37.0	56.4	6.1	30.5	44.3	5.9	17.4	29.1	33.1	16.1	37.5	29.1	10.3	14.5	8.2	14.6	11.9	16.4	49.7	24.5	22.2	0.7	0.9	5.6	14.6	61.9	64.6	0.4	3.9	6.2	0.4	2.3	29.7	15.7	0.9	50.2	17.0	0.8	1.1	11.9	0.0	0.1	0.7	4.9	0.2	44.5	227.2	28.0	0.3	0.6	87.9	0.1	21.5	0.0	4.7	15.9	0.1	0.5	0.7	47.4	3.7	0.0	0.5	28.1	39.3	5.6	0.5	1.5	0.2	67.9	117.1	0.1	0.8	22.1	28.4	0.1	107.9	1.0	53.2	4.8	4.8	11.8	6.2	16.3	0.4	0.3	0.7	20.9	27.8	3.3	1.3	110.9	0.7	0.5	89.8	0.3	1.8	0.2	0.2	68.3	0.5	0.3	0.4	3.9	0.5	52.2	1.5	0.7	32.6	13.0	13.3	13.1	18.8	15.6	19.1	16.0	15.3	18.1	16.1	14.5	22.2	15.5	28.9	44.1	9.4	5.0	35.6	81.5	64.6	30.7	0.7	78.1	65.4	2.2	133.0	88.9	60.7	0.0	54.9	2.6	59.4	123.3	122.1	1.5	28.3	50.6	9.4	16.4	16.8	16.8	48.0	81.6	54.2	20.9	115.3	0.0	17.4	19.2	165.7	299.3	0.0	13.8	67.8	24.4	263.7	97.2	4.2	131.4	127.4	56.9	31.9	122.0	25.5	4.1	45.8	14.3	71.0	108.6	105.3	0.2	39.8	31.9	268.3	38.4	0.8	78.9	55.2	55.7	0.5	0.9	33.2	25.9	37.6	4.0	43.9	83.5	126.1
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm		NA	NA		1800000	"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666"	"unprognostic (2.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	162.9	119.0	101.6	210.8	104.5	235.2	144.2	107.5	114.6	183.8	98.8	185.3	129.2	180.1	178.1	244.6	164.3	75.4	118.4	93.7	124.1	193.6	144.3	175.2	232.9	111.8	103.1	208.2	141.4	130.5	137.5	158.5	106.9	141.0	194.7	181.7	138.8	118.1	136.3	179.9	152.3	164.2	103.8	174.7	143.1	175.8	108.6	308.3	176.0	93.0	304.8	153.3	189.2	108.1	657.6	432.9	934.3	469.8	248.2	221.2	717.8	489.3	235.7	382.8	358.5	885.1	337.4	1315.9	366.5	388.4	518.3	370.6	944.2	616.7	712.9	609.6	556.2	996.1	620.3	1727.6	264.8	1064.7	584.0	249.8	288.3	569.9	422.1	217.9	537.3	587.4	723.1	414.3	492.1	891.1	746.9	444.4	507.3	762.5	405.0	947.2	790.1	414.2	547.9	1227.6	545.1	484.7	729.6	228.1	316.4	700.8	325.6	652.5	582.2	476.3	540.4	338.0	719.0	387.6	759.5	1117.2	305.4	699.5	320.0	8.9	21.2	10.8	25.0	22.6	20.2	21.2	20.0	22.0	23.4	20.4	17.5	18.1	8.2	23.5	23.0	37.8	25.9	14.5	101.6	104.5	107.5	114.6	93.7	124.1	111.8	103.1	106.9	103.8	108.6	108.1	274.8	166.7	255.1	84.5	277.4	351.8	429.6	442.1	224.8	192.8	155.2	135.1	64.2	114.4	302.7	160.0	98.0	512.7	368.9	200.7	121.3	257.2	47.2	296.5	387.2	289.7	275.0	288.6	56.9	273.8	563.0	231.4	184.0	343.0	278.1	222.6	196.7	165.0	342.7	148.0	70.5	315.0	193.3	221.0	372.5	44.0	204.7	258.3	192.1	73.1	311.1	187.1	232.8	65.9	88.6	276.1	184.0	209.5	336.6	288.9	136.8	156.7	257.8	164.4	151.2	319.3	461.9	362.8	208.3	331.1	330.5	496.0	307.9	214.1	310.7	382.6
HP		ENSG00000257017	Haptoglobin	P00738	16	72054505-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"liver: 61113.6"	"Cell type enriched"	"Detected in many"	43	"Hepatocytes: 59512.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 29.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 49.3;eosinophil: 80.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.2;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"Hep G2: 232.2;HSkMC: 121.4"									"CAB003787, HPA047750, HPA066795"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	100000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB003787: , HPA047750: AB_2680146, HPA066795: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	673.1	11.4	1.3	26.9	1.7	231.5	34.2	1.4	2.9	71.9	3.6	3.6	1.5	3.5	2.9	5.3	74.6	1.3	146.7	1.4	1.4	19.8	61113.6	91.3	1.7	29.7	2.0	9.9	7.6	0.2	49.9	2.5	3.7	7.3	0.6	0.7	6.1	0.2	5.0	3.4	4.4	4.5	2.3	72.0	6.2	2.1	8.3	2.7	6.3	0.4	3.0	3.8	3.3	5.9	0.0	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	8.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.2	0.2	232.2	0.3	33.3	6.2	121.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	2.0	0.4	2.6	0.0	0.0	1.1	23.6	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.8	5.1	0.0	0.8	0.0	0.0	3.9	0.0	14.1	0.0	12.7	0.0	6.2	49.3	80.2	0.0	2.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	14.2	0.0	2.1	0.0	0.0	15.2	1.3	1.7	1.4	2.9	1.4	1.4	29.7	2.0	3.7	2.3	8.3	5.9	0.4	19.2	228.7	1.6	96.1	0.1	0.7	1.9	0.0	0.4	0.4	0.3	66.6	1085.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	56.7	0.0	1128.3	0.0	10.4	0.1	45.5	0.0	1.3	3.8	0.4	1038.7	59512.7	2.3	0.0	0.0	0.2	4.1	1381.4	0.0	0.5	10.2	7.8	1.8	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	1.5	7.5	0.2	0.0	2.6	1.8	0.0	0.0	0.1	0.3	0.1	90.3	0.0	0.3	0.1
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2530.4"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1373.6;Proximal tubular cells: 2144.0"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 7.8"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 7.8"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 516.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		26000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	2.3	5.3	0.6	0.7	0.4	0.9	4.6	3.2	0.6	2.0	119.0	1.2	0.1	4.1	0.7	0.7	6.4	1.1	3.5	7.8	0.5	531.0	2530.4	2.0	0.3	1.5	1.0	4.7	3.9	0.1	1.1	0.3	0.8	2.3	0.5	0.3	0.2	7.3	2.2	0.2	0.9	1.4	0.6	2.3	1.9	10.2	3.5	0.1	0.7	0.1	0.1	3.7	1.9	1.0	0.3	0.9	0.6	0.6	0.3	0.6	0.6	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.6	1.1	0.2	0.4	0.2	0.0	0.0	0.3	0.8	1.2	5.4	516.4	11.5	1.8	16.4	3.6	0.3	0.0	0.0	1.3	0.0	0.5	0.8	0.0	1.3	1.3	0.2	0.4	9.9	0.4	0.0	0.3	1.6	0.5	0.0	1.4	0.1	0.1	1.5	0.1	0.1	6.9	1.1	0.9	0.2	0.0	0.3	0.1	0.1	0.8	0.6	0.7	0.2	1.2	0.0	0.0	0.6	7.8	0.0	0.8	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	3.9	0.0	1.3	3.8	0.0	0.3	0.6	0.4	3.2	0.6	7.8	0.5	1.5	1.0	0.8	0.6	3.5	1.0	0.0	0.0	0.0	0.7	15.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	55.8	0.0	92.0	0.0	0.8	0.0	0.0	193.7	0.5	38.0	0.1	0.0	2.6	0.0	80.2	1.0	16.2	0.3	0.4	0.0	0.1	0.0	0.0	38.9	1373.6	0.3	0.0	1.0	0.0	0.0	37.8	0.3	121.0	2.5	10.8	0.0	0.0	0.4	0.0	0.0	1.5	0.7	0.2	0.0	5.3	0.0	0.0	0.0	2144.0	0.0	0.0	0.0	2.0	0.2	1.8	1.4	0.0	0.0	1.1	8.0	7.1	0.0	0.0
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066573	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 200.5;liver: 866.2;pancreas: 272.1"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 442.2;Proximal tubular cells: 201.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 31.5;Hep G2: 47.8;T-47d: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	1.8	0.9	5.6	0.2	8.8	0.0	11.6	7.0	7.2	1.6	4.2	1.1	1.4	4.0	3.9	0.3	7.4	4.0	5.1	5.7	6.5	200.5	866.2	11.8	0.4	7.5	8.1	1.3	272.1	24.2	14.8	0.5	7.5	20.1	0.3	0.3	15.6	4.7	22.1	0.9	1.1	0.2	6.5	2.6	58.2	1.3	7.6	0.2	19.9	5.4	0.1	0.6	0.4	11.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.5	0.0	0.1	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.3	0.1	0.0	0.0	3.2	0.2	0.1	0.0	0.2	0.5	22.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.8	7.0	7.2	5.7	6.5	7.5	8.1	7.5	6.5	7.6	11.7	0.5	9.6	32.4	8.8	3.0	0.1	5.1	0.0	0.0	7.2	12.0	8.9	3.4	51.5	1.3	33.1	0.0	0.1	0.0	0.1	52.8	7.5	8.9	4.9	1.0	1.1	2.4	10.7	2.3	26.5	0.3	1.9	18.3	12.5	2.5	0.1	8.6	442.2	1.1	0.0	1.7	2.4	0.0	9.7	0.3	26.0	0.0	1.8	0.0	2.8	0.6	1.6	0.0	0.0	41.6	14.4	0.0	0.4	0.0	7.5	0.0	201.0	0.0	0.6	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.8	1.8	0.1	0.1	0.5
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063148-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 811.9"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 503.0;Smooth muscle cells: 128.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 50.6"									HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	49000000000	55000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		5.5	0.5	14.1	0.2	15.3	0.1	2.0	13.9	16.7	1.2	11.3	1.2	0.6	0.3	0.4	0.3	1.3	0.7	137.2	13.7	14.3	4.0	811.9	1.5	0.7	14.4	14.3	2.0	0.6	0.0	0.3	0.0	13.6	1.6	0.1	0.8	0.3	0.3	1.7	0.6	1.1	0.1	12.8	0.3	1.7	1.9	15.2	0.2	1.1	0.2	0.1	0.4	1.9	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	2.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.0	0.6	0.6	0.0	14.1	15.3	13.9	16.7	13.7	14.3	14.4	14.3	13.6	12.8	15.2	13.1	0.0	0.0	7.5	2.3	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.0	22.4	12.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	5.3	0.2	0.2	0.0	2.6	0.0	0.0	0.0	1.1	10.8	503.0	0.0	0.0	0.2	0.0	2.0	12.8	0.0	2.8	9.9	0.0	0.0	0.0	0.0	4.9	0.0	0.0	1.2	0.0	0.0	5.3	0.0	0.0	0.0	13.0	0.2	0.1	0.0	6.1	128.8	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	908	"liver: 5440.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 6095.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016725, HPA065318, HPA068847"	Approved				"Secreted to blood"	NA	NA	425000000000	190000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016725: , HPA065318: , HPA068847: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	1.1	0.8	0.8	0.1	0.7	0.1	5.9	1.0	1.0	1.6	0.6	1.2	0.4	1.0	0.2	0.5	1.6	0.3	0.9	0.7	0.7	1.4	5440.6	1.2	0.3	0.7	0.7	1.6	5.5	0.1	1.2	0.3	0.7	2.4	0.6	1.7	1.1	0.6	0.3	1.6	1.1	0.3	0.6	3.8	0.9	1.1	0.8	0.1	0.9	0.0	0.1	1.1	1.2	0.7	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.3	0.0	0.8	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.2	21.3	0.0	3.0	0.0	0.8	0.6	0.1	0.0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.9	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	0.2	1.1	0.0	0.5	0.3	0.2	1.0	0.1	0.4	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.0	1.0	0.7	0.7	0.7	0.7	0.7	0.6	0.8	0.7	0.5	3.2	0.5	0.3	15.1	0.6	0.2	0.2	0.0	1.5	19.1	7.7	0.7	80.1	0.2	0.0	2.1	0.1	0.1	0.6	0.0	0.1	2.3	0.2	0.3	6.2	0.0	157.7	0.7	0.6	0.1	0.4	0.0	1.2	0.0	1.1	132.8	6095.8	0.2	0.0	0.8	0.7	0.0	155.3	0.2	2.9	0.3	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.7	0.2	0.0	1.0	2.1	0.0	0.4	0.5	0.6	0.5	0.0	0.3	0.0	11.3	0.2	0.5	0.3
HYAL1	"HYAL-1, LUCA1"	ENSG00000114378	"Hyaluronidase 1"	Q12794	3	50299890-50312381	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 201.6;lymphoid tissue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 100.9;SK-BR-3: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		590000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	11.4	21.5	5.0	2.8	4.5	0.3	9.2	6.4	6.3	10.8	18.3	6.8	3.4	8.2	0.8	5.5	7.3	13.2	68.2	4.5	4.0	49.4	201.6	30.7	1.8	5.4	4.8	3.0	9.4	19.9	3.3	2.4	5.6	4.6	2.9	3.1	7.3	2.9	15.0	21.1	6.0	5.9	3.5	95.1	19.4	1.7	5.8	0.8	8.3	19.0	1.2	4.8	12.3	4.7	2.9	1.8	0.4	0.9	0.6	0.7	0.5	0.1	0.3	0.1	0.4	11.4	3.1	0.0	0.8	0.6	0.6	6.6	0.2	0.4	0.0	0.1	0.0	0.3	8.6	100.9	4.4	0.7	0.7	3.9	13.8	0.1	0.4	0.8	2.9	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.6	7.1	0.6	0.0	0.2	0.3	5.9	0.4	0.2	2.1	0.2	28.0	0.3	2.4	2.0	0.3	1.9	0.6	0.6	0.6	0.3	0.2	0.3	0.4	0.4	0.6	0.3	1.3	0.4	1.5	0.3	0.1	0.8	0.4	0.3	0.4	0.2	0.5	0.6	0.4	3.1	0.3	0.3	0.5	0.4	0.1	5.0	4.5	6.4	6.3	4.5	4.0	5.4	4.8	5.6	3.5	5.8	4.7	18.1	19.2	18.5	1.6	0.3	2.9	0.4	3.3	0.0	1.0	0.3	0.1	20.8	30.0	2.0	11.0	4.2	0.1	0.0	2.5	23.5	16.5	8.2	0.2	0.9	25.8	1.8	2.7	3.1	14.4	0.1	3.3	19.4	0.2	0.0	0.6	33.2	137.1	0.1	0.0	3.1	1.4	0.0	4.4	0.9	7.7	2.1	0.9	0.0	7.5	0.0	0.4	0.0	1.5	1.6	12.1	0.3	1.2	0.0	0.2	0.4	58.2	0.9	0.5	6.6	1.2	4.3	0.4	1.1	0.9	3.1	0.7	0.9	7.4	0.9	1.7
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 536.3"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 768.1;RT4: 524.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	150.8	230.8	24.0	37.5	23.9	10.7	63.0	24.6	30.9	67.9	40.8	124.9	179.4	22.9	164.9	92.2	36.6	69.5	25.3	23.5	26.1	122.0	536.3	49.8	33.3	26.4	25.7	84.4	39.9	42.0	16.7	82.5	25.9	214.6	131.2	35.0	59.3	79.1	25.7	23.6	117.4	43.8	25.5	40.1	113.6	57.0	30.0	21.8	45.5	28.1	29.8	153.1	39.9	30.6	66.5	109.6	152.5	63.3	275.1	191.4	86.7	26.3	122.3	44.2	107.3	176.1	159.1	13.1	168.8	84.4	181.6	101.4	112.4	130.7	43.0	8.8	41.7	56.7	87.3	768.1	367.3	37.0	54.7	169.5	278.0	102.7	74.2	69.8	126.1	37.2	58.1	44.5	68.9	42.8	26.3	66.2	284.5	479.7	43.9	25.2	54.8	37.8	206.3	524.0	25.9	45.2	100.5	99.7	351.7	161.2	37.9	111.0	81.1	45.2	44.1	65.3	29.6	20.8	34.5	16.9	148.2	226.7	37.0	12.4	70.1	11.0	9.1	32.3	10.6	10.6	8.2	10.9	50.9	10.1	6.7	7.8	13.8	17.2	15.5	18.8	15.1	29.9	24.0	23.9	24.6	30.9	23.5	26.1	26.4	25.7	25.9	25.5	30.0	30.6	13.9	12.8	49.5	39.2	20.2	12.4	18.8	60.5	52.3	19.5	61.8	31.5	21.8	45.8	69.1	29.5	25.0	320.2	23.7	106.8	21.5	31.1	13.8	31.0	23.4	22.0	58.4	30.3	16.6	86.5	178.8	29.6	76.0	108.8	14.0	257.5	39.7	328.2	175.3	11.8	16.2	98.4	57.0	130.2	23.8	11.2	24.5	71.7	26.6	19.7	47.8	25.4	18.6	66.4	20.0	44.8	55.5	29.3	13.7	53.2	181.2	108.5	21.9	56.6	13.1	7.8	23.6	8.0	26.2	82.4	14.9	95.6	19.8	127.1	129.3	46.7
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 116.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.9;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	NA	NA	14700000000	26000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.3	0.2	0.5	0.3	0.9	0.4	0.4	1.4	0.8	0.5	0.9	0.6	0.3	0.2	0.1	0.1	0.7	1.6	0.2	0.3	0.1	1.0	116.7	0.8	0.0	0.7	0.4	0.7	2.5	0.0	0.7	0.0	0.8	0.5	0.1	0.2	0.8	0.1	0.5	0.9	0.6	0.0	0.4	0.3	11.0	1.9	0.4	0.9	0.9	0.0	0.0	0.4	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	1.7	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.4	0.8	0.3	0.1	0.7	0.4	0.8	0.4	0.4	1.8	0.1	0.0	0.0	1.6	0.1	0.1	0.2	0.2	0.0	0.5	0.9	0.6	1.6	14.3	0.2	0.0	6.2	0.0	0.0	0.6	0.0	2.7	1.1	0.4	0.0	0.2	0.0	0.0	0.5	0.6	0.0	0.4	8.2	0.1	0.0	0.2	2.9	85.2	0.0	0.0	0.6	14.6	0.0	1.3	0.3	1.7	0.0	0.0	1.8	0.0	0.0	0.3	1.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.2	0.1	0.4	0.4	0.0	0.3	0.0	0.2	0.1	0.7	0.1
IGSF1	"IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2"	ENSG00000147255	"Immunoglobulin superfamily member 1"	Q8N6C5	X	131273506-131578899	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 73.4;pituitary gland: 167.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Astrocytes: 3.9;Bipolar cells: 14.0;Breast glandular cells: 5.0;Horizontal cells: 3.3;Melanocytes: 3.6;Skeletal myocytes: 7.2"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 65.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 47.6;SH-SY5Y: 31.2"	"Region enhanced"	"Detected in all"		"hypothalamus: 144.0"	"Low region specificity"	"Detected in all"			"HPA012732, HPA035582"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		100000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA012732: AB_2732404, HPA035582: AB_2674687"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (4.25e-8)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.52e-3)"	"unprognostic (8.03e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.13e-2)"	1.9	12.5	9.7	0.8	10.0	0.1	2.8	9.7	9.7	3.3	4.8	0.9	0.4	1.2	2.4	1.6	2.5	1.2	12.1	7.5	73.4	0.7	1.5	0.3	0.4	10.0	21.6	1.1	2.6	0.8	167.8	0.7	24.0	4.0	0.4	6.4	2.4	5.7	2.0	1.4	0.6	3.1	7.4	0.3	1.0	12.2	32.4	0.6	4.5	5.1	0.9	0.4	0.9	8.4	0.4	0.6	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.1	1.8	0.0	0.0	6.0	0.4	0.0	3.0	47.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	4.1	2.8	0.0	0.0	0.0	0.1	0.1	0.2	3.4	31.2	0.0	0.2	0.0	4.1	0.6	0.0	0.0	0.5	0.8	0.0	4.1	1.2	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.0	9.7	9.7	7.5	73.4	10.0	21.6	24.0	7.4	32.4	8.4	0.2	3.2	0.6	3.9	0.2	0.0	0.5	0.0	1.2	14.0	5.0	1.7	2.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.3	1.5	0.0	0.1	0.0	0.7	0.7	0.3	0.0	3.3	0.4	0.0	0.0	0.0	0.8	1.1	0.0	0.2	3.6	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.3	0.0	0.8	0.0	0.7	0.0	7.2	0.3	0.1	0.4	0.0	0.4	0.3	0.1	0.0	0.0	0.3
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846568-53865794	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;kidney: 59.8;liver: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	0.9	2.0	20.2	2.3	21.4	0.5	5.7	22.7	28.9	18.1	16.6	6.8	5.8	5.1	0.7	1.7	3.3	2.4	2.7	19.4	20.2	59.8	33.3	3.8	2.5	18.7	19.9	1.5	7.8	1.1	4.2	0.9	19.0	2.4	6.9	4.8	4.9	0.6	1.3	2.2	5.9	0.8	18.9	1.2	3.6	2.5	23.2	0.3	2.9	0.2	0.7	0.8	1.3	23.6	1.5	3.1	4.5	3.4	0.1	0.0	7.1	3.1	0.1	0.1	0.0	20.2	1.4	4.6	1.0	1.0	1.7	0.8	12.2	0.0	0.0	1.6	3.5	6.0	6.1	59.5	0.0	5.6	3.2	0.0	0.0	0.0	0.0	3.8	0.0	1.6	4.9	2.1	0.1	4.2	0.9	2.3	12.1	46.2	2.6	1.7	1.9	5.3	1.4	5.3	6.4	3.7	10.1	2.4	1.9	3.3	9.2	2.0	2.5	3.0	3.3	2.6	3.9	4.7	5.6	2.9	2.7	3.3	1.7	1.3	0.2	0.0	0.2	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.9	0.1	20.2	21.4	22.7	28.9	19.4	20.2	18.7	19.9	19.0	18.9	23.2	23.6	0.2	0.0	4.1	48.3	0.2	0.3	2.0	0.0	0.0	0.1	8.2	4.4	4.1	17.2	1.3	0.0	0.0	1.4	0.3	4.3	9.8	4.8	1.0	0.5	1.0	0.2	29.2	0.0	0.5	1.6	1.0	0.6	4.6	1.7	2.5	0.4	0.4	13.1	0.1	0.0	2.5	8.7	2.0	0.0	1.1	0.7	1.2	1.2	0.0	1.9	0.0	4.4	0.0	37.7	4.3	1.8	3.0	0.4	0.0	4.4	2.9	78.0	0.0	0.1	0.0	0.3	0.5	0.4	1.0	0.0	0.1	0.4	0.9	0.0	10.2	0.6
IL5	"EDF, IL-5, TRF"	ENSG00000113525	"Interleukin 5"	P05113	5	132541445-132556838	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;testis: 5.1"	"Cell type enriched"	"Detected in some"	7	"Spermatocytes: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.8;TIME: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB010304	Approved				"Secreted to blood"	NA	NA	4130		"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB010304: AB_2296159"	"unprognostic (1.66e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.30e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-2)"		"unprognostic (7.98e-2)"	"unprognostic (2.03e-2)"		"unprognostic (3.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	0.1	0.0	0.8	0.1	0.3	0.0	0.0	1.7	1.2	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.2	1.5	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.0	0.2	5.1	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	1.7	1.2	1.5	0.3	0.3	0.1	0.8	0.8	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.7	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	19.5	1.2	0.0	0.1	0.0	1.6	0.0	0.0	0.0
INHBC		ENSG00000175189	"Inhibin subunit beta C"	P55103	12	57434784-57452062	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	172	"liver: 165.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Hepatocytes: 5.7;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.4;Karpas-707: 6.3;RH-30: 2.8;U-266/70: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050755			Approved	Cytosol	"Secreted to blood"	NA	NA		21000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol		"HPA050755: "	"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	165.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.2	0.0	6.4	0.0	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.0	1.6	0.0	6.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	2.8	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537787-132783480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 6.7"	"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 250.8"	"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	22.5	16.9	26.8	12.0	85.5	9.5	17.3	56.9	30.4	29.6	10.9	54.2	19.2	49.5	19.5	29.6	30.7	15.2	75.0	20.4	21.3	14.1	14.6	25.1	8.4	20.5	37.7	19.5	12.8	12.2	14.7	28.8	20.4	24.5	16.7	16.9	13.5	23.6	75.4	22.9	23.4	42.1	17.5	13.9	27.6	22.9	50.5	6.8	14.1	50.3	7.3	35.5	22.7	27.0	35.4	13.7	22.6	21.9	33.8	23.7	18.4	36.4	27.9	23.3	15.4	32.6	14.0	3.1	13.7	38.8	15.1	19.5	24.8	15.2	27.9	10.8	14.4	5.1	17.3	44.7	24.3	12.9	11.9	16.0	14.9	15.0	28.2	18.6	16.3	6.6	7.6	18.2	12.6	28.3	3.6	40.9	10.5	21.0	24.3	7.6	14.9	5.6	19.4	19.9	5.4	18.5	18.3	26.5	22.6	20.5	17.2	30.4	13.7	14.9	17.2	20.1	21.6	3.6	18.4	11.0	14.4	8.6	6.5	6.7	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.3	26.8	85.5	56.9	30.4	20.4	21.3	20.5	37.7	20.4	17.5	50.5	27.0	14.7	9.6	19.7	14.7	4.5	5.4	4.4	1.9	0.0	10.5	7.1	5.3	10.1	4.3	6.4	7.3	0.0	3.9	5.0	24.8	0.0	6.5	12.3	2.8	22.8	10.0	6.1	3.2	33.5	9.2	3.7	5.6	6.6	5.9	8.8	8.6	15.0	17.9	2.9	8.4	25.2	9.9	2.0	7.2	12.0	17.0	7.2	6.9	1.8	19.7	4.1	9.6	0.0	18.1	29.2	12.1	11.5	11.7	2.5	6.5	13.8	4.3	2.5	5.2	6.6	6.5	24.3	6.3	7.3	2.8	5.8	2.5	2.7	10.7	13.9	8.6
INSIG2		ENSG00000125629	"Insulin induced gene 2"	Q9Y5U4	2	118088452-118110997	"Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033861	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB033861: AB_2249149"	"unprognostic (3.84e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.75e-2)"	10.4	6.2	5.0	5.7	5.4	3.8	8.5	7.3	6.3	8.7	7.2	8.8	9.6	9.4	8.9	6.6	7.0	8.2	8.5	7.1	5.1	12.3	28.0	10.3	7.3	5.4	5.8	10.3	11.7	12.4	7.0	9.0	5.7	8.0	7.3	8.9	8.5	6.3	7.8	10.2	9.7	8.8	5.3	11.3	12.6	6.3	6.4	9.6	10.6	6.8	9.1	7.3	8.1	5.5	33.0	7.7	9.2	4.8	26.1	13.2	11.7	9.0	10.2	7.5	13.7	6.7	32.8	6.3	31.6	12.8	14.6	13.5	8.0	17.9	14.6	13.2	11.1	6.6	8.8	38.2	6.0	8.8	9.9	17.5	14.2	8.3	14.6	22.7	18.3	9.7	3.8	11.3	11.4	4.2	9.4	6.0	4.4	10.5	10.0	6.3	7.6	7.2	12.1	12.0	7.5	8.8	5.5	9.0	5.2	10.2	4.4	6.0	21.1	10.9	7.9	8.5	4.5	16.3	12.3	6.5	17.4	6.4	6.6	6.6	6.8	12.3	7.2	10.4	8.2	7.7	7.2	6.8	7.4	6.4	8.0	9.1	7.0	9.3	11.6	7.1	7.1	6.0	5.0	5.4	7.3	6.3	7.1	5.1	5.4	5.8	5.7	5.3	6.4	5.5	9.6	35.3	28.9	17.3	30.9	40.9	13.4	98.8	13.6	14.9	26.1	10.7	19.5	62.9	36.9	44.1	12.5	20.0	26.7	13.5	19.6	89.7	4.1	11.8	10.2	18.1	20.9	12.6	27.7	62.1	37.7	18.6	15.8	18.5	21.0	10.9	42.8	48.7	29.7	25.2	25.1	13.1	34.6	23.6	46.3	4.3	12.8	19.0	32.0	20.6	23.4	22.8	16.5	27.2	20.5	92.5	14.4	14.3	50.8	25.3	34.4	29.6	23.9	12.4	0.0	21.3	30.1	38.1	16.1	11.6	40.1	19.8	21.5	8.4	13.2	32.1
ISCA2	"HBLD1, ISA2"	ENSG00000165898	"Iron-sulfur cluster assembly 2"	Q86U28	14	74493756-74497106	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030492	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030492: AB_10603772"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.89e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.98e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.68e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (5.23e-2)"	15.1	33.9	20.3	9.7	20.6	15.5	16.9	22.4	23.9	13.7	27.4	16.9	14.2	11.0	46.4	15.4	19.5	7.6	34.3	19.5	21.2	30.6	22.0	12.9	17.0	21.2	21.1	18.1	18.1	12.9	23.4	12.8	21.3	18.5	17.5	19.1	17.8	12.1	38.3	13.3	16.0	8.4	21.1	20.0	18.1	20.6	22.6	18.5	26.0	29.2	17.4	13.7	13.4	21.5	43.4	30.7	28.4	18.1	25.5	37.2	35.9	19.7	26.3	30.2	36.3	36.3	39.3	21.8	25.3	16.6	38.2	30.7	27.8	25.9	40.7	30.7	20.2	13.7	13.1	39.6	38.3	17.7	30.2	31.2	29.0	18.2	20.6	28.0	30.8	44.4	18.2	25.5	32.7	51.0	42.9	34.5	21.0	60.2	28.3	29.8	31.9	21.8	42.6	34.1	19.1	19.6	20.8	24.4	31.8	30.5	60.2	20.9	16.9	17.1	39.5	25.3	17.7	43.3	60.3	40.2	28.0	20.6	25.4	130.8	109.1	159.0	91.8	108.0	93.5	172.3	127.6	111.6	111.0	165.4	148.5	122.1	87.5	101.5	106.6	218.1	157.4	161.3	20.3	20.6	22.4	23.9	19.5	21.2	21.2	21.1	21.3	21.1	22.6	21.5	25.2	19.2	20.4	7.2	36.2	15.4	27.2	74.9	13.6	22.1	36.2	38.2	113.3	22.8	42.7	33.1	12.5	70.8	28.8	45.5	146.8	62.0	41.0	38.3	17.6	27.2	29.3	73.2	4.4	55.0	70.1	28.8	24.5	18.1	12.6	31.8	28.9	42.4	81.5	28.6	5.5	36.3	63.1	33.2	18.3	19.3	33.5	30.4	8.8	2.8	49.0	69.8	41.2	3.0	7.2	59.5	50.8	18.0	25.0	40.2	51.4	133.5	78.6	31.6	13.1	15.1	25.1	107.2	63.7	25.4	13.2	25.4	30.7	43.1	42.3	27.6
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"intestine: 37.5"	"Group enriched"	"Detected in some"	32	"Distal enterocytes: 24.2;Enteroendocrine cells: 19.4;Intestinal goblet cells: 16.0;Paneth cells: 19.4;Proximal enterocytes: 32.7;Undifferentiated cells: 23.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 1.6;Hep G2: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	37.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.0	0.0	0.0	0.0	0.0	0.0	27.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.1	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.8	0.0
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703316-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	668	"liver: 2156.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 489.6"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	453	"Hep G2: 1103.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		32000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.1	0.2	0.3	0.1	1.1	0.1	3.0	1.6	3.2	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.6	1.0	0.8	2156.1	0.6	0.1	0.6	0.5	0.0	0.2	0.0	1.7	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.4	0.0	0.0	0.9	0.3	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	1103.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.4	0.0	0.1	0.7	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	1.6	3.2	0.6	1.0	0.6	0.5	0.6	0.9	0.9	0.7	0.1	0.0	2.2	0.7	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.4	117.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.1	0.0	0.0	0.6	0.0	2.7	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	8.2	489.6	0.1	0.0	1.4	0.0	0.0	9.4	0.0	2.1	0.0	0.0	0.0	18.7	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	97	"liver: 792.7"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1183.8"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 17.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		9100000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	5.0	0.7	0.5	0.9	0.7	0.0	2.1	0.5	0.8	5.3	0.4	1.1	0.3	3.5	1.7	1.3	3.4	1.2	0.7	0.5	0.4	0.7	792.7	3.0	2.5	0.4	0.4	2.8	0.3	0.1	0.3	1.7	0.5	1.1	1.0	0.1	0.4	2.4	0.6	1.3	1.2	1.2	0.4	8.1	1.2	3.5	0.4	0.2	1.2	0.4	1.7	1.4	2.3	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.5	0.8	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.1	0.0	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.5	0.1	1.4	0.8	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.1	0.1	3.5	0.0	90.9	0.0	0.0	0.1	2.1	0.0	0.0	0.0	12.3	66.4	1183.8	0.0	0.0	0.0	0.0	0.0	85.1	0.3	132.0	1.2	0.1	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	9.1	0.4	0.3	0.0	0.1	0.3	3.6	19.2	0.0	0.1
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;intestine: 18.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.6;OE19: 18.2"	"Low region specificity"	"Detected in all"							HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.2	7.3	21.4	0.7	26.7	0.4	0.2	13.8	36.5	1.3	10.9	10.7	17.6	0.3	0.1	0.3	0.5	0.2	2.6	28.7	12.4	0.2	1.7	0.5	0.1	10.9	12.0	0.3	1.9	2.0	0.4	0.3	11.6	0.8	2.7	0.3	1.4	0.3	4.4	0.4	18.1	0.3	11.3	0.2	10.9	10.4	12.1	0.0	0.2	0.0	0.0	0.6	0.9	20.4	7.1	1.9	0.3	7.9	0.0	2.5	14.3	4.3	3.4	2.8	2.9	16.3	0.3	0.0	3.5	0.4	6.3	0.8	3.4	0.3	0.2	6.6	4.3	9.9	4.7	33.6	12.6	3.4	0.5	0.2	0.2	2.7	0.8	1.6	0.2	1.3	12.9	1.9	1.0	4.7	0.3	6.5	0.9	18.2	5.6	1.7	1.4	0.6	0.3	0.4	0.7	1.5	3.2	0.0	0.3	0.0	0.9	5.0	0.3	6.9	7.1	7.7	11.8	1.0	10.8	0.0	12.6	13.2	2.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.4	26.7	13.8	36.5	28.7	12.4	10.9	12.0	11.6	11.3	12.1	20.4	0.1	0.0	0.0	3.3	0.5	0.1	0.3	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.1	0.0	0.0	0.6	0.1	51.4	0.0	0.1	45.4	0.3	2.4	0.5	0.0	0.8	23.7	0.7	0.5	0.3	34.1	0.3	0.0	1.0	0.4	0.3	0.2	0.0	0.8	12.0	0.0	0.0	0.0	166.4	2.5	0.4	0.0	1.9	0.0	7.9	0.0	1.5	2.9	0.8	16.1	1.5	0.1	0.1	35.8	0.1	0.1	0.2	6.6	0.3	0.5	14.4	4.9	0.0	0.0	0.1	0.4	0.1	18.7	0.2
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 355.5;Late spermatids: 228.7;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.0"	"Group enriched"	"Detected in many"	15	"B-cells: 1.1;dendritic cells: 4.0;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: AB_2683034"	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	42.6	9.6	49.0	9.5	52.7	1.5	31.2	42.3	47.5	40.9	61.8	49.2	12.1	62.2	13.0	64.6	31.7	15.2	88.2	45.1	44.9	31.6	101.9	13.6	7.6	51.6	44.9	22.1	28.3	9.4	27.9	25.8	48.3	42.5	14.9	11.0	29.9	31.8	66.4	51.8	23.6	37.4	47.6	6.9	25.9	15.4	48.4	9.4	30.8	39.9	11.8	70.1	52.3	48.9	5.9	12.2	4.0	72.0	57.8	21.9	19.9	37.1	25.8	3.1	3.7	30.2	2.5	46.2	8.9	46.0	7.0	12.3	15.7	30.4	5.3	22.7	8.3	0.1	17.0	96.0	8.1	11.2	0.0	12.6	41.6	3.2	35.6	13.2	31.2	1.6	2.4	56.4	23.1	14.4	4.5	46.9	5.3	8.9	9.0	1.7	7.9	8.6	24.5	36.1	1.8	0.0	3.6	10.9	50.9	33.3	7.1	8.7	46.1	8.4	3.2	10.8	17.1	9.8	61.9	0.2	5.6	21.1	15.8	0.0	0.1	0.0	0.1	0.1	0.0	0.8	1.3	0.4	0.4	1.1	2.4	0.8	0.0	0.1	0.0	4.0	1.7	0.5	49.0	52.7	42.3	47.5	45.1	44.9	51.6	44.9	48.3	47.6	48.4	48.9	18.3	12.8	34.2	355.5	4.9	23.1	102.1	11.4	37.0	22.2	16.8	18.0	94.1	24.3	8.1	18.4	41.7	89.2	15.7	8.3	7.9	11.6	102.3	14.2	15.4	21.9	18.0	9.1	12.1	7.9	6.8	21.8	7.7	13.1	1.3	38.5	23.6	70.0	13.3	0.0	29.0	12.8	4.1	6.9	6.5	228.7	32.3	3.3	23.2	60.9	1.2	6.5	0.0	322.7	191.4	9.6	7.5	20.7	10.7	50.5	17.6	13.6	7.0	20.2	26.3	129.9	24.0	28.4	25.6	36.2	25.7	66.2	4.7	6.9	26.0	63.6
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 100.7;kidney: 28.0;retina: 36.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 93.0;Muller glia cells: 75.7;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 93.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7;SK-MEL-30: 2.1;U-266/70: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	0.1	0.3	56.7	2.1	86.3	0.0	0.1	100.2	58.4	0.2	8.7	0.5	0.2	0.1	0.0	0.1	0.1	0.1	0.1	51.4	78.7	28.0	2.1	0.1	7.3	92.7	94.7	0.1	0.1	0.1	0.4	0.0	87.5	0.2	0.2	36.7	0.3	0.2	0.1	0.4	0.5	0.0	71.8	10.5	0.9	0.6	83.6	0.4	0.2	0.1	1.9	0.1	0.1	100.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	1.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	2.1	0.5	0.0	0.3	0.1	0.0	0.2	0.5	0.0	2.0	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	56.7	86.3	100.2	58.4	51.4	78.7	92.7	94.7	87.5	71.8	83.6	100.7	0.1	0.0	0.0	93.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	3.7	4.2	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	13.0	0.0	1.1	0.0	1.1	0.0	3.7	0.0	75.7	0.0	35.7	93.7	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	3.5	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KIZ	"C20orf19, HT013, NCRNA00153, PLK1S1"	ENSG00000088970	"Kizuna centrosomal protein"	Q2M2Z5	20	21125983-21246622	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 203.0;Late spermatids: 127.3;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 92.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.78e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (2.05e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.12e-1)"	17.6	9.8	22.7	7.2	30.2	10.7	15.4	27.7	29.2	32.5	20.2	72.2	15.1	27.0	11.2	8.0	19.8	12.6	17.5	21.8	25.1	14.4	11.3	9.8	10.6	30.7	27.9	35.5	24.3	14.6	23.3	8.9	31.6	19.3	13.2	20.2	13.6	23.8	29.4	14.9	17.8	17.1	25.2	13.6	16.3	45.4	28.2	16.6	26.9	14.6	11.1	36.5	22.9	36.9	7.5	5.9	7.9	7.5	27.3	37.3	10.9	10.6	17.9	8.8	10.4	6.4	6.1	14.0	8.9	12.5	9.3	6.2	8.0	22.4	12.2	7.9	9.2	11.3	11.2	92.8	13.8	13.9	9.2	28.2	45.8	8.6	28.2	20.8	8.3	23.3	18.6	18.8	7.6	6.4	14.7	18.0	10.8	13.5	5.9	9.2	22.5	13.7	9.7	13.0	10.7	20.9	21.4	11.4	22.4	17.9	7.3	27.1	7.8	9.2	8.0	7.2	7.7	18.9	13.7	10.5	4.5	15.5	8.4	4.6	5.0	12.5	10.4	5.6	12.2	11.7	10.9	10.5	3.1	11.4	11.5	12.6	16.5	8.4	4.2	7.3	14.3	5.0	22.7	30.2	27.7	29.2	21.8	25.1	30.7	27.9	31.6	25.2	28.2	36.9	11.0	0.0	10.0	41.1	22.6	0.0	9.2	0.0	9.6	35.4	7.6	10.7	16.6	12.8	5.0	18.4	37.5	7.8	16.6	4.4	7.9	5.0	203.0	24.6	16.0	8.7	11.4	11.6	76.4	7.1	7.6	19.4	6.1	9.8	8.8	18.9	7.5	5.2	4.0	50.5	99.0	9.1	0.0	6.0	0.0	127.3	38.8	6.1	0.0	27.2	7.6	28.1	16.5	198.5	166.8	3.5	5.6	31.6	25.9	4.0	21.7	5.9	10.2	35.1	13.1	20.8	11.4	78.3	37.4	7.7	0.0	4.2	17.8	12.9	9.7	10.9
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406930-39451533	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 19.6;liver: 17.7;pancreas: 6.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"ASC diff: 6.7;Hep G2: 25.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					NA	NA		320000	"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	19.6	0.1	0.2	0.2	0.4	0.3	3.5	0.9	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.2	0.2	17.7	1.6	0.0	0.3	0.0	0.0	6.0	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.3	2.8	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	25.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.4	0.9	0.6	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.6	3.2	19.6	0.0	0.7	0.5	1.1	1.4	0.0	1.6	0.7	1.1	1.2	0.0	1.2	0.0	0.0	0.4	0.5	1.6	0.0	1.1	8.5	4.4	1.5	0.4	17.4	0.0	0.5	4.3	1.5	0.5	2.6	2.2	0.0	0.2	0.4	51.4	0.2	1.7	0.6	12.1	2.0	1.0	0.6	3.2	1.5	0.4	1.8	0.0	0.1	0.4	0.0	0.5	0.2	0.9	4.8	0.7	0.0	1.2	2.1	1.1	0.4	2.3	0.0	1.2	0.5	39.5	0.9	2.0	0.9	1.4	0.8	0.5	1.1	1.1
KLHL14	KIAA1384	ENSG00000197705	"Kelch like family member 14"	Q9P2G3	18	32672673-32773023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 12.7;thyroid gland: 13.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.9;Inhibitory neurons: 9.8;Muller glia cells: 19.4;Plasma cells: 45.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	90	"memory B-cell: 10.5;naive B-cell: 7.3"	"Lineage enriched"	"Detected in single"	106	"B-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;Hep G2: 15.7;REH: 4.2;RPTEC TERT1: 8.4;SCLC-21H: 3.2;U-698: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"hippocampal formation: 14.9;olfactory bulb: 8.1"	HPA024777	Uncertain		Supported	"Actin filaments,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Actin filaments"	"HPA024777: AB_1852576"	"unprognostic (3.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-6)"	"unprognostic (2.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.43e-2)"	0.5	0.2	0.2	1.8	0.3	2.4	0.5	0.0	0.6	2.9	0.0	0.2	0.2	1.7	1.0	0.2	6.6	0.3	0.1	0.2	0.3	5.0	0.0	0.3	7.1	1.4	2.3	0.3	0.0	6.9	0.3	0.8	0.7	1.4	0.2	4.7	0.4	12.7	0.0	0.1	2.0	0.8	0.8	8.7	0.2	1.0	0.2	0.3	13.8	0.0	5.3	0.6	0.5	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	15.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.2	1.3	0.0	8.4	0.0	3.2	0.4	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.6	0.2	0.3	1.4	2.3	0.7	0.8	0.2	0.1	1.3	0.0	0.0	0.3	21.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.1	0.0	3.9	0.0	4.5	7.1	0.3	2.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.7	0.0	0.1	1.7	9.8	0.0	0.0	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	19.4	0.0	1.5	0.2	0.0	0.0	0.0	45.7	0.0	0.5	1.1	0.0	0.8	0.0	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.2	4.7	0.1	0.0
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 5.3;liver: 8.7;stomach 1: 3.2"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 3.7;Proximal tubular cells: 7.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.5;Hep G2: 22.1;SK-MEL-30: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.9;olfactory bulb: 1.0"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Midbody	"HPA044257: AB_2678880"	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	1.3	0.3	0.3	0.4	0.3	0.4	0.6	0.9	0.4	0.4	0.0	1.1	5.3	0.3	0.2	0.2	0.2	0.4	0.3	0.1	0.2	1.3	8.7	0.5	0.4	0.5	0.2	0.1	0.7	0.1	0.0	0.5	0.5	0.3	0.1	0.1	0.5	0.3	0.4	0.9	4.8	0.2	0.1	1.1	3.2	0.1	0.4	0.0	0.3	0.0	0.1	0.3	0.2	1.3	4.4	1.6	0.0	0.1	2.0	1.5	7.1	0.3	0.2	0.4	0.4	10.5	6.2	0.2	1.7	0.8	0.6	1.7	0.0	0.3	0.0	9.0	1.8	4.7	0.7	22.1	1.4	0.3	3.0	1.9	1.6	1.6	0.3	0.2	1.8	0.1	3.1	2.2	0.3	2.3	0.1	0.7	0.4	1.7	0.2	0.4	0.4	0.2	0.2	1.4	0.2	1.1	2.6	0.4	10.1	0.1	0.2	0.3	4.1	1.5	6.6	8.1	0.2	2.9	2.3	0.2	1.5	0.8	4.8	0.5	1.5	0.1	0.3	0.8	0.2	0.0	0.1	0.4	0.8	0.0	0.1	0.2	0.6	1.1	2.2	0.2	0.0	0.7	0.3	0.3	0.9	0.4	0.1	0.2	0.5	0.2	0.5	0.1	0.4	1.3	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.7	0.5	0.7	1.5	0.5	1.8	0.0	0.3	0.5	0.9	0.0	0.6	0.0	0.4	0.5	1.0	2.4	0.4	0.0	0.6	0.5	1.3	1.1	0.2	0.0	0.0	1.4	3.7	1.1	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	2.4	7.5	0.7	0.0	6.6	0.0	0.9	0.4	0.1	0.3	0.1	0.5	0.5	0.2	1.0	0.1
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.9;seminal vesicle: 3.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 391.5"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 17.7"					"Low region specificity"	"Detected in all"			HPA060584	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.3	0.0	2.3	0.0	0.1	2.3	2.7	0.0	2.3	3.0	11.9	0.0	1.4	0.0	0.0	0.0	1.3	2.3	2.3	0.0	0.0	0.0	0.0	2.3	2.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	1.9	0.0	0.0	3.3	0.6	0.0	3.7	0.0	2.3	0.1	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.3	2.3	2.7	2.3	2.3	2.3	2.3	2.3	2.3	2.3	2.3	1.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.2	0.0	0.6	391.5	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.3	96.9	24.4	0.3	0.4	2.8	0.0	0.1	1.8	0.0	0.0	0.0	0.0	1.0	0.8	0.0	14.7	0.0	0.0	0.2	5.5	0.1	0.0	0.9	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.9	0.4
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007298-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"fallopian tube: 116.2"	"Group enriched"	"Detected in some"	9	"Endometrial ciliated cells: 98.1;Respiratory ciliated cells: 329.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.2;Hep G2: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.5	0.2	0.1	0.1	0.1	0.6	0.6	0.2	4.4	0.2	0.1	0.0	0.7	0.1	0.6	116.2	0.8	0.0	0.1	0.1	0.1	0.1	6.9	0.1	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.2	0.1	3.4	0.1	0.2	0.3	0.1	0.0	0.0	0.2	1.4	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.2	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.2	0.5	0.0	6.4	7.2	0.0	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.1	0.1	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	98.1	0.8	0.7	20.9	0.0	0.1	0.2	0.0	1.1	0.0	2.1	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	12.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	329.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569844	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 171.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 161.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		5500000	"Cluster 10: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.4	0.1	0.5	0.3	0.5	0.2	1.5	0.8	0.9	0.4	0.0	0.6	1.8	0.2	0.9	0.6	1.0	0.8	0.5	0.6	0.3	6.0	171.0	0.3	0.7	0.8	0.7	0.8	2.5	0.0	1.5	0.4	1.0	0.1	0.8	0.1	0.2	0.9	0.0	0.6	0.8	0.1	0.6	0.8	0.5	0.1	0.4	2.1	1.2	0.3	0.2	1.6	0.3	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.1	0.8	0.0	0.0	8.5	0.0	0.0	6.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	24.4	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.1	5.5	0.8	0.0	0.1	0.0	1.1	0.3	0.0	2.6	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	18.4	0.0	0.1	0.0	0.1	0.2	0.5	0.0	1.6	0.1	0.0	1.3	0.1	1.8	0.0	0.3	0.9	0.1	0.0	0.4	1.3	0.2	1.5	0.2	0.0	0.9	1.1	0.5	0.5	0.8	0.9	0.6	0.3	0.8	0.7	1.0	0.6	0.4	1.2	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	11.5	0.7	3.7	0.0	0.0	0.9	1.2	5.9	7.8	0.0	0.4	0.5	1.2	0.0	2.7	6.1	3.7	0.1	2.9	0.5	2.7	0.0	0.2	4.2	161.7	0.1	0.0	4.3	0.0	0.0	3.8	0.8	0.1	0.3	0.3	1.8	16.9	0.6	0.0	3.1	0.0	12.9	0.2	0.0	0.0	0.0	0.2	0.3	15.7	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.3	0.6	0.0	1.1	1.2	0.0	0.1
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 701.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 2578.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2578.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	139.3	43.7	53.5	165.8	81.9	207.0	95.5	79.6	70.0	121.2	70.5	121.1	46.3	100.5	77.8	62.7	108.2	114.1	63.9	52.2	63.0	182.3	107.7	192.1	112.3	94.0	79.4	67.6	64.6	56.5	39.0	71.3	92.7	105.9	116.1	63.9	116.4	83.4	36.3	71.6	57.9	93.5	77.3	119.6	70.7	10.6	77.6	68.6	116.8	37.6	123.7	214.1	83.1	109.4	79.2	157.8	89.4	43.8	13.9	11.0	90.7	100.2	309.0	93.6	139.1	62.6	206.3	39.9	126.8	86.1	108.7	95.5	40.1	186.4	88.4	304.2	45.8	2.8	117.1	310.3	212.9	12.5	12.9	35.0	320.8	79.6	210.7	84.4	0.3	2.7	25.3	149.5	1.5	75.8	1.8	183.3	146.4	104.0	0.6	12.1	19.6	228.2	79.0	110.4	22.2	68.0	172.9	219.4	183.9	136.3	122.5	66.7	0.8	38.7	65.3	23.0	24.2	59.2	140.6	100.5	45.1	95.8	225.5	508.8	149.5	284.0	459.6	130.2	277.2	174.0	284.0	412.7	178.0	173.9	318.9	381.4	2578.1	274.5	81.9	220.1	350.3	584.9	53.5	81.9	79.6	70.0	52.2	63.0	94.0	79.4	92.7	77.3	77.6	109.4	297.5	44.8	70.0	7.5	176.7	157.4	336.2	365.4	68.3	2.2	180.5	157.6	48.8	148.7	222.2	163.7	0.0	56.4	505.5	305.4	485.2	245.8	2.3	112.2	151.9	76.3	17.5	18.3	1.1	72.9	471.9	156.7	39.8	108.1	214.9	1.1	94.2	52.9	227.8	0.0	1.6	153.1	175.0	156.9	701.0	11.3	56.2	422.0	156.5	7.5	391.8	232.7	433.5	11.6	59.5	123.3	236.1	68.4	186.3	239.8	23.3	104.3	150.3	5.4	52.6	89.6	176.1	0.2	5.4	37.1	132.1	37.1	278.7	16.6	88.9	368.6
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 305.6;tongue: 125.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 31.0;Early spermatids: 25.4;Hepatocytes: 17.5;Late spermatids: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA039630: AB_10795467"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	2.8	5.9	17.1	2.6	17.7	3.3	2.3	13.6	21.5	15.1	10.0	14.1	2.7	6.5	3.1	14.7	4.3	3.1	40.7	18.3	14.8	3.7	32.0	4.5	3.1	17.3	15.5	4.3	3.4	3.2	13.2	1.4	18.1	4.6	4.0	4.4	6.3	4.2	305.6	3.5	4.1	6.9	14.4	3.3	5.0	12.5	18.0	7.3	4.4	125.0	5.3	6.2	19.9	17.5	26.1	18.1	16.2	29.7	9.3	6.5	0.1	4.0	14.5	9.2	8.6	17.2	27.7	5.9	13.2	2.4	31.1	9.8	14.3	18.1	8.1	14.7	3.6	3.2	4.6	53.3	8.6	8.2	2.7	2.6	7.0	11.3	5.4	11.2	18.7	34.6	4.0	7.6	8.4	3.6	31.0	8.4	5.3	26.0	46.3	23.8	8.2	14.8	15.1	2.7	32.4	16.2	2.0	2.5	10.9	4.1	3.4	9.2	10.6	6.3	64.7	10.7	8.9	13.6	22.3	9.3	12.6	32.7	1.7	0.0	0.2	0.0	0.4	0.3	0.4	0.1	0.3	0.4	0.6	0.0	1.0	0.4	0.0	0.4	0.1	0.1	0.0	0.3	17.1	17.7	13.6	21.5	18.3	14.8	17.3	15.5	18.1	14.4	18.0	17.5	1.9	0.0	4.6	9.4	1.1	1.5	0.5	0.6	0.0	8.5	1.5	0.6	31.0	2.8	1.3	0.0	4.2	0.1	0.8	0.8	0.0	3.9	25.4	1.1	1.3	2.4	5.4	1.7	10.0	4.7	0.2	2.8	1.5	0.7	0.0	2.5	2.2	17.5	0.5	1.7	10.1	2.0	0.0	0.6	0.7	50.1	3.1	0.8	1.8	1.9	1.2	7.5	1.0	6.6	3.9	5.8	3.1	1.5	1.7	0.8	0.3	1.6	0.6	2.0	0.0	5.2	1.9	8.5	4.8	0.1	0.6	0.0	1.3	1.8	2.1	0.6
LRRC75B	"C22orf36, FAM211B, MGC131773"	ENSG00000178026	"Leucine rich repeat containing 75B"	Q2VPJ9	22	24585620-24593208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 34.3;Hepatocytes: 25.6;Muller glia cells: 39.9;Proximal enterocytes: 46.7;Proximal tubular cells: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 5.3;MCF7: 5.0;SH-SY5Y: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002540	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA002540: AB_1079263"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.69e-2)"	1.8	0.7	5.8	0.0	5.5	0.3	1.8	5.7	7.4	1.9	3.6	3.2	0.0	1.0	0.5	2.1	1.5	0.0	2.9	5.2	6.0	5.6	3.6	0.8	0.0	6.0	6.1	3.2	3.5	0.0	1.3	0.1	5.7	2.8	0.1	0.6	2.0	0.4	2.5	1.8	1.6	0.0	5.9	0.5	2.5	7.5	5.9	0.1	1.6	0.0	0.1	3.5	1.9	5.8	0.1	2.8	0.0	1.5	0.3	1.1	0.2	0.4	0.4	0.9	1.0	2.0	0.0	0.0	0.7	0.8	0.8	3.0	0.2	1.5	0.0	0.9	1.8	0.2	0.3	5.3	2.6	0.0	0.0	0.0	1.1	1.0	0.1	0.5	0.7	0.0	0.1	0.0	0.1	5.0	0.0	1.0	1.3	3.4	1.1	0.0	0.1	0.0	1.2	0.3	1.4	4.2	1.4	0.4	0.5	0.3	0.0	0.5	1.5	1.6	0.9	0.6	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.8	5.5	5.7	7.4	5.2	6.0	6.0	6.1	5.7	5.9	5.9	5.8	1.6	12.8	5.9	9.4	0.3	0.0	2.5	0.0	2.2	2.8	16.2	18.7	4.4	34.3	0.0	7.3	0.0	2.5	0.9	10.7	11.7	9.8	1.6	2.3	3.6	1.8	1.2	1.3	3.8	8.9	0.4	7.1	14.3	6.1	0.0	7.2	2.9	25.6	1.1	1.7	4.1	8.0	0.0	1.6	0.0	7.9	12.8	1.4	0.0	1.0	0.3	39.9	0.0	7.1	2.2	4.0	6.2	9.8	0.6	8.0	46.7	44.5	0.0	1.8	0.0	4.5	4.2	0.5	1.3	2.5	0.0	1.1	0.8	2.0	6.4	1.3
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 188.1;Late spermatids: 464.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 154.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 154.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Midbody	"HPA059840: AB_2684137"	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favorable (9.50e-4)"	37.8	31.1	26.7	16.4	27.2	24.2	30.0	28.7	31.4	30.4	31.6	32.0	13.8	27.6	35.2	18.7	34.4	16.2	50.8	27.1	28.3	51.8	95.8	18.8	24.2	28.1	27.7	34.0	27.3	33.5	21.2	13.6	28.7	29.1	20.4	26.5	16.2	26.8	42.3	19.2	18.0	22.6	27.3	16.9	27.9	37.6	27.7	25.1	22.8	34.1	21.9	34.8	23.0	28.5	33.2	29.7	30.3	25.9	74.1	64.0	9.6	27.9	39.3	14.8	21.7	42.8	39.2	22.6	92.2	31.5	21.6	21.6	14.1	25.5	25.6	41.6	19.8	10.1	8.3	112.1	56.6	35.9	20.4	45.0	24.5	40.0	98.6	41.4	58.5	37.3	23.2	39.6	59.0	43.5	39.1	26.3	34.3	46.5	17.2	47.8	18.4	30.8	56.3	15.1	29.8	27.7	16.6	26.3	45.1	18.5	27.5	19.5	16.0	21.4	15.8	35.1	19.6	35.1	51.2	38.5	59.7	35.6	20.1	154.9	16.7	59.3	19.7	21.8	28.2	29.5	29.8	24.2	14.3	24.8	24.3	24.1	63.8	22.1	25.9	17.9	33.0	24.5	26.7	27.2	28.7	31.4	27.1	28.3	28.1	27.7	28.7	27.3	27.7	28.5	32.5	19.2	18.9	9.1	29.9	21.0	57.6	26.8	25.6	28.9	41.2	39.4	55.1	27.1	17.2	23.9	14.6	29.1	24.6	9.6	76.3	41.3	188.1	24.2	12.9	35.8	30.0	8.4	10.6	44.2	10.6	30.8	21.9	15.9	15.8	20.5	15.0	53.9	16.5	15.2	14.1	15.0	28.5	16.4	14.5	464.6	28.9	16.2	17.8	4.7	45.7	48.0	22.6	9.5	11.2	30.2	14.6	38.0	15.8	41.6	19.2	125.4	25.4	34.0	13.1	25.8	26.3	112.5	27.5	18.2	20.9	14.9	22.9	16.3	24.5	56.7
MADCAM1	MACAM1	ENSG00000099866	"Mucosal vascular addressin cell adhesion molecule 1"	Q13477	19	489176-505343	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.7;lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.8;Endothelial cells: 7.6;Muller glia cells: 5.4;Rod photoreceptor cells: 5.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 7.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;Hep G2: 1.8;U-266/70: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB075699, HPA077998"	Enhanced					NA	NA		80000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB075699: , HPA077998: "	"unprognostic (2.30e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.17e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.42e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.07e-2)"	0.9	0.7	2.7	13.9	3.3	0.2	1.1	5.2	5.2	0.6	0.4	6.6	2.8	0.5	0.3	1.5	0.5	2.2	0.5	2.6	2.5	0.6	1.0	0.4	0.4	3.2	4.3	0.6	3.0	2.2	1.7	0.2	3.4	0.8	2.5	0.8	0.6	0.1	0.6	0.5	11.7	0.1	2.2	8.6	2.9	1.6	2.6	0.0	2.0	0.1	0.2	0.6	0.6	4.4	0.3	0.0	0.0	0.4	0.3	0.0	0.5	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.9	0.0	0.1	0.5	0.0	0.0	0.0	1.1	1.4	0.0	1.1	1.8	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.6	0.1	1.0	0.1	0.5	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	1.8	0.7	0.3	0.0	0.4	0.0	0.0	0.3	0.8	0.3	0.3	0.4	0.3	0.2	0.2	0.0	0.6	0.7	0.7	7.0	0.3	0.2	0.2	0.0	0.1	2.7	3.3	5.2	5.2	2.6	2.5	3.2	4.3	3.4	2.2	2.6	4.4	1.4	0.0	0.0	1.0	1.5	0.5	0.5	0.2	2.8	6.8	1.0	1.4	0.8	1.5	0.0	3.7	0.0	0.6	2.2	0.3	0.0	0.2	0.3	0.6	0.9	7.6	0.0	0.4	1.6	0.0	0.3	2.8	1.1	0.3	0.0	2.8	1.4	0.3	0.5	1.7	1.7	0.8	0.0	0.6	0.7	0.5	0.9	0.3	0.0	0.0	0.4	5.4	4.1	1.0	0.8	0.1	0.1	0.7	1.0	0.5	0.2	0.8	0.8	5.6	0.0	0.8	0.8	2.1	2.1	0.7	0.4	0.3	1.5	1.1	0.1	0.4
MAGED4	"KIAA1859, MAGE-E1, MAGE1, MGC3210"	ENSG00000154545	"MAGE family member D4"	Q96JG8	X	52184823-52192268	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.0;ASC TERT1: 2.7;Hep G2: 7.7"									HPA003554	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA003554: AB_1853497"					"unprognostic (7.71e-2)"					"unprognostic (8.21e-2)"				"unprognostic (4.07e-4)"	"unprognostic (6.15e-2)"			0.1	0.2	2.0	0.1	1.6	0.0	0.3	0.3	3.8	0.2	0.8	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.1	1.5	3.5	0.1	0.0	0.0	0.0	1.4	1.2	0.2	0.1	0.0	0.3	0.1	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.0	0.5	0.5	0.0	2.7	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	7.7	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	2.0	1.6	0.3	3.8	1.5	3.5	1.4	1.2	1.3	1.0	4.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 476.5"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	2.1	1.2	0.0	1.7	0.0	7.4	2.2	6.4	0.7	2.4	0.0	2.7	1.6	2.8	0.0	1.2	2.7	1.2	1.3	0.1	0.0	1.0	476.5	1.8	2.7	0.0	0.0	2.9	2.9	0.0	2.3	0.6	0.2	1.6	0.0	6.9	2.5	0.0	5.1	5.3	3.4	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.6	0.4	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289658	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 1346.5"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 5534.4"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					NA	NA		1900000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.5	0.5	0.4	0.1	0.8	0.0	0.4	0.1	0.5	0.2	0.9	0.2	0.2	0.1	57.5	0.1	1.2	0.0	0.2	0.2	0.2	0.9	1346.5	0.4	0.1	0.6	0.8	6.3	43.8	0.1	0.8	0.1	0.4	0.0	0.0	0.0	0.3	1.9	0.0	4.2	0.0	0.2	0.8	0.5	0.2	3.7	0.2	0.4	0.4	0.0	0.0	0.5	0.1	0.2	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.0	3.2	0.1	0.0	0.0	0.0	0.3	0.5	1.6	0.0	94.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	1.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.1	0.5	0.2	0.2	0.6	0.8	0.4	0.8	0.2	0.2	0.0	0.0	0.5	0.0	8.8	2.0	0.1	0.4	0.0	0.0	0.2	0.6	0.7	67.2	0.9	1.8	0.0	0.0	0.0	0.0	1.9	0.1	23.9	3.0	0.0	5.3	0.0	69.5	0.1	4.6	0.0	0.0	0.0	0.2	0.0	7.6	76.8	5534.4	0.1	0.0	0.0	0.0	0.0	100.4	0.6	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.1	0.0	0.6	10.2	0.0	0.0	0.0	0.2	2.7	0.3	0.0	2.7	0.0	6.0	1.0	0.0	0.0
MATN3	"EDM5, HOA"	ENSG00000132031	"Matrilin 3"	O15232	2	19992052-20012668	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.2;placenta: 11.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.5;Sertoli cells: 26.3"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 13.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"Hep G2: 143.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 1.7"	HPA051250			Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		440000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"		"HPA051250: AB_2681406"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.62e-5)"	"unprognostic (1.27e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.51e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.15e-2)"	2.2	0.6	5.1	0.5	3.2	0.0	2.7	3.4	5.7	2.5	2.5	0.6	0.4	2.1	0.9	0.5	1.9	2.1	0.4	3.4	3.9	1.9	0.0	13.2	0.3	5.2	6.0	0.7	0.4	0.4	0.3	11.3	5.2	1.6	0.5	0.3	0.6	4.6	0.3	0.8	0.4	1.7	4.7	0.3	1.8	0.9	7.6	0.1	1.3	0.6	0.3	0.8	1.2	3.6	6.4	4.9	16.1	0.1	4.5	9.7	1.0	2.0	1.1	6.5	8.2	4.7	2.7	0.0	0.8	1.7	6.2	1.1	0.4	12.7	9.2	0.0	0.4	0.0	1.1	143.4	1.1	0.0	0.0	21.3	0.7	7.1	1.7	4.5	8.7	0.0	0.0	0.0	13.8	2.5	0.0	0.0	5.0	0.2	2.4	0.0	0.0	0.0	19.5	4.5	0.1	2.1	10.6	1.8	6.5	27.1	19.2	0.1	4.9	9.5	11.4	0.4	1.2	0.1	0.0	0.0	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	3.2	3.4	5.7	3.4	3.9	5.2	6.0	5.2	4.7	7.6	3.6	1.6	38.5	2.2	0.0	0.0	0.3	0.3	2.6	0.0	0.0	5.4	1.3	0.3	0.0	2.3	1.8	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.8	2.8	0.0	0.0	0.1	0.2	1.9	1.9	0.0	0.5	0.0	4.4	0.0	0.0	0.1	0.0	0.2	0.0	4.1	0.0	0.3	0.4	1.5	0.1	3.6	4.7	0.0	0.0	0.0	0.5	0.2	1.1	0.0	4.5	0.0	0.3	0.0	0.8	1.6	0.0	26.3	0.8	6.8	0.0	1.3	0.0	0.1	0.1	0.1	6.3	0.0	0.2
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298564-36320637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 316.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 30.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	16.2	19.4	17.4	12.1	18.5	35.1	24.9	20.7	22.0	27.9	17.9	17.0	16.9	26.6	21.3	16.5	16.5	16.5	14.2	16.7	19.7	26.2	29.0	76.7	17.4	15.9	17.5	32.2	17.6	19.7	22.4	19.1	16.4	18.5	22.2	22.3	15.9	16.3	7.2	28.5	17.3	20.2	17.2	15.6	31.2	18.2	20.0	17.9	81.7	9.3	16.0	15.2	13.5	21.4	29.6	15.4	31.7	32.1	31.3	30.0	24.1	24.8	30.7	32.2	33.6	31.2	28.9	28.0	36.8	32.1	16.8	22.1	33.7	22.9	39.3	40.5	25.5	16.4	14.7	55.0	33.9	33.8	17.5	30.8	35.1	21.1	27.2	33.2	20.4	38.3	28.4	33.8	24.2	28.8	32.5	27.7	26.9	25.2	44.6	15.4	27.7	19.5	37.2	22.7	47.3	18.8	20.4	19.5	33.4	27.3	31.9	21.6	16.0	35.6	23.2	26.3	26.0	27.8	34.5	44.0	13.6	17.3	25.3	2.0	12.6	3.0	14.6	9.9	18.5	16.4	17.6	18.0	12.8	12.3	22.6	18.5	7.0	12.9	8.1	14.5	23.6	13.3	17.4	18.5	20.7	22.0	16.7	19.7	15.9	17.5	16.4	17.2	20.0	21.4	16.0	218.0	316.0	18.3	14.9	90.2	30.7	41.5	22.2	24.9	15.3	23.0	10.7	10.0	106.7	25.8	2.1	24.7	12.2	16.1	58.7	21.2	4.2	20.9	28.2	18.3	31.5	9.7	21.2	19.0	21.1	29.7	13.3	35.6	13.3	30.2	16.1	25.2	18.7	92.5	24.8	15.5	20.3	9.5	15.4	4.2	32.0	14.5	21.4	9.4	11.5	29.0	12.3	31.7	27.0	17.8	18.6	27.1	18.9	29.0	18.9	49.6	34.9	24.1	13.1	18.0	27.8	50.1	35.5	17.9	65.5	19.8	20.6	25.5	21.1	21.4
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2810	"liver: 280.9"	"Cell type enriched"	"Detected in some"	66	"Hepatocytes: 238.5"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1900000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	280.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	238.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0
MBOAT4	"FKSG89, GOAT, OACT4"	ENSG00000177669	"Membrane bound O-acyltransferase domain containing 4"	Q96T53	8	30131671-30144665	"Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 3.6;stomach 1: 3.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.6;Cholangiocytes: 12.8;Ductal cells: 3.1;Enteroendocrine cells: 3.5;Excitatory neurons: 2.4;Inhibitory neurons: 3.1;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.1;OE19: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044509			Supported	"Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA044509: AB_2678966"	"unprognostic (4.35e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-6)"	"unprognostic (9.87e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.66e-2)"	0.1	0.5	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	1.7	0.9	0.2	0.1	0.1	0.1	0.4	0.3	0.4	0.1	0.1	0.1	3.6	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.4	3.7	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.1	0.1	0.6	0.1	0.4	0.7	0.0	0.4	0.6	0.2	1.0	0.7	1.2	0.8	0.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	1.1	0.0	0.0	0.0	3.5	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.6	0.0	0.2	0.0	1.0	0.0	0.0	0.0	3.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MCEE	"GLOD2, MCE"	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 92.0;Proximal tubular cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	17.8	30.0	8.9	12.3	9.7	9.1	32.7	10.5	12.5	22.1	15.4	20.1	20.1	13.1	30.5	26.3	14.8	14.2	35.9	8.9	9.4	33.7	69.8	13.7	14.7	9.5	9.1	18.5	36.1	35.6	24.1	17.6	9.9	23.9	23.9	12.3	42.8	17.8	36.5	28.4	16.9	12.2	9.7	16.0	23.5	6.0	9.4	13.3	14.1	61.7	15.5	16.5	21.9	11.7	12.1	5.2	10.6	7.6	34.3	46.6	30.2	18.5	23.3	9.2	13.9	14.7	14.8	18.7	5.5	18.5	7.0	12.5	12.4	9.6	9.5	17.1	10.7	12.7	16.3	42.5	19.5	14.5	10.3	31.3	13.5	6.2	12.3	20.5	10.6	14.6	17.1	31.9	9.1	15.5	10.9	16.9	9.6	33.1	14.6	12.8	12.3	35.2	14.8	10.4	11.9	8.8	6.9	40.1	18.1	12.1	31.7	13.4	13.7	10.6	8.3	10.9	7.5	30.7	13.1	20.0	17.5	23.7	9.9	20.3	23.2	27.6	15.4	25.6	21.9	21.6	19.3	15.5	19.9	16.7	17.6	15.0	6.1	16.5	25.3	23.9	35.3	14.6	8.9	9.7	10.5	12.5	8.9	9.4	9.5	9.1	9.9	9.7	9.4	11.7	11.1	25.6	13.4	13.7	12.8	8.5	10.5	18.4	21.6	2.6	37.5	27.3	75.2	25.8	18.2	5.5	2.1	36.2	11.2	14.0	92.0	13.3	1.1	17.2	16.2	9.0	9.0	12.0	13.3	18.4	36.8	23.3	17.3	20.2	0.0	5.2	12.8	73.0	15.1	5.0	14.5	32.5	18.3	10.4	8.7	1.0	29.2	9.4	14.2	14.0	9.1	7.3	5.2	16.1	20.8	9.6	16.2	17.7	42.0	11.0	35.0	77.1	19.4	8.6	26.3	12.7	17.9	3.7	5.1	25.6	20.9	11.4	10.1	16.9	23.0	11.9
METTL22	"C16orf68, FLJ12433,MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 119.9;Late spermatids: 357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	"Nucleoplasm,Nucleoli rim"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli rim"	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: AB_2684150, HPA074173: AB_2686672"	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	4.4	5.8	9.0	5.7	10.2	7.7	4.5	16.4	13.2	6.7	9.5	5.9	4.9	5.9	6.1	5.3	5.4	4.4	9.3	8.8	9.1	5.1	6.6	4.7	6.1	12.7	10.7	6.4	6.1	3.1	5.1	5.0	13.3	7.2	4.0	10.4	4.7	5.2	20.2	8.4	4.1	4.7	9.1	4.7	5.1	13.7	12.6	4.0	5.2	5.9	5.0	5.5	5.8	12.9	4.3	8.7	9.7	9.3	3.6	9.1	8.4	7.2	3.8	8.4	9.5	8.5	9.8	6.7	6.3	6.4	3.1	7.9	6.1	11.5	5.5	9.8	8.4	6.9	17.3	24.6	10.8	7.2	5.1	9.2	8.2	9.2	10.1	5.1	6.8	9.2	9.4	6.6	6.5	15.2	7.4	17.0	5.2	1.9	8.5	11.1	7.3	13.9	4.1	4.5	11.9	7.9	6.3	7.3	4.7	5.2	8.0	5.9	5.4	10.0	8.7	8.2	3.3	8.9	5.3	10.4	3.6	9.3	4.7	1.6	2.5	2.0	0.9	1.9	0.9	0.9	0.9	1.0	2.3	0.8	1.1	0.5	9.7	1.6	2.2	1.3	1.2	1.0	9.0	10.2	16.4	13.2	8.8	9.1	12.7	10.7	13.3	9.1	12.6	12.9	5.1	9.6	5.6	8.5	7.6	3.3	6.9	7.5	8.6	13.8	5.8	6.1	18.3	4.3	6.0	0.0	4.2	12.8	2.7	4.9	11.7	9.3	119.9	3.5	6.5	7.2	7.2	18.5	13.4	9.8	9.8	7.4	9.2	3.5	8.2	11.3	5.7	7.4	29.5	1.7	14.3	7.0	2.0	31.8	9.6	357.8	10.8	27.5	1.8	12.2	17.6	4.9	11.3	12.5	13.3	8.4	6.8	13.9	7.7	11.0	8.3	8.9	3.4	11.8	0.0	9.0	8.5	39.6	15.7	7.5	2.7	13.3	6.6	7.8	6.5	8.1
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511342	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Oogenesis, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	12.1	18.5	12.1	11.3	13.0	5.8	16.0	12.6	13.1	12.9	12.5	11.9	7.6	13.2	18.1	11.7	18.8	9.8	16.7	12.5	12.9	14.1	11.7	12.9	19.0	14.1	13.1	15.0	11.5	19.0	13.0	15.2	13.7	17.3	12.9	8.6	14.2	16.7	16.8	16.5	10.6	16.3	13.1	13.9	11.2	19.8	13.4	17.8	16.8	18.6	21.2	14.4	12.4	13.7	39.6	57.7	55.0	22.2	40.5	33.4	27.5	35.9	26.0	41.7	48.5	22.0	46.4	40.8	22.6	22.3	54.2	41.6	66.4	35.2	65.7	39.1	39.8	25.9	31.9	88.1	16.6	34.8	28.2	25.0	30.3	26.0	30.2	18.6	54.8	20.8	32.0	23.5	55.9	29.1	31.0	28.6	46.4	66.1	70.7	30.7	42.6	36.5	38.8	26.6	33.4	36.6	38.7	50.6	37.5	42.7	39.8	22.8	36.6	15.0	24.8	27.6	24.9	24.9	32.5	29.0	18.2	27.7	32.0	6.5	8.9	8.9	8.0	11.5	12.4	14.3	10.0	9.4	10.9	10.8	10.3	9.3	0.9	15.7	9.6	13.0	15.5	8.4	12.1	13.0	12.6	13.1	12.5	12.9	14.1	13.1	13.7	13.1	13.4	13.7	12.5	12.8	20.1	15.7	16.2	14.9	23.3	21.2	21.1	23.4	15.1	16.5	30.6	12.8	13.6	12.9	14.6	31.1	16.2	5.4	3.9	14.5	188.2	11.7	11.4	14.7	10.8	20.4	15.0	10.0	15.7	15.3	7.1	10.0	8.8	20.4	9.7	9.5	16.6	21.9	13.7	8.7	14.2	10.0	9.9	24.3	17.1	10.8	16.0	10.3	17.9	14.9	15.5	19.1	21.7	10.8	6.5	19.9	14.9	18.8	5.5	9.1	15.3	21.0	32.9	16.4	17.5	42.4	20.3	12.4	12.4	25.3	13.2	13.2	13.4	19.0
MIA2	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI"	ENSG00000150527	"MIA SH3 domain ER export factor 2"	Q96PC5	14	39230231-39388513	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 125.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	12.1	26.6	5.6	16.8	6.9	23.6	22.1	5.8	7.9	29.7	58.0	30.8	80.4	15.7	40.2	26.9	22.2	30.3	16.6	9.4	6.5	78.4	138.9	15.5	16.2	5.6	4.7	9.6	43.6	40.5	15.5	11.2	6.4	21.1	34.6	12.8	52.5	19.2	54.5	9.9	78.4	12.3	4.1	14.5	45.3	21.0	5.1	14.3	46.7	20.7	19.8	16.2	17.2	7.1	23.0	25.1	10.4	18.5	20.6	23.2	14.5	13.3	13.9	9.3	9.6	19.7	125.4	27.5	40.1	15.0	18.9	34.1	12.7	15.0	11.0	21.4	10.6	17.2	11.5	106.1	48.2	23.2	30.7	14.4	83.7	9.2	69.2	59.0	15.3	31.8	16.6	68.3	14.0	22.1	14.9	18.9	12.0	87.2	20.8	15.2	18.3	34.9	42.7	24.7	8.7	5.1	31.0	32.5	20.4	13.1	31.2	24.8	24.3	14.1	9.2	10.4	8.8	38.7	35.7	27.2	7.9	14.5	12.0	40.9	16.3	25.9	15.4	18.0	14.0	11.7	11.6	14.4	17.8	13.1	14.2	13.2	34.5	14.6	21.0	12.3	11.8	11.8	5.6	6.9	5.8	7.9	9.4	6.5	5.6	4.7	6.4	4.1	5.1	7.1	26.7	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	33.1	19.9	0.0	5.7	0.0	44.1	0.0	5.6	35.9	0.8	7.9	42.9	0.5	78.7	30.7	7.1	0.0	0.0	0.1	42.7	5.0	4.6	0.0	93.5	0.0	10.3	0.0	3.8	7.6	0.0	0.1	1.8	0.0	0.0	0.0	0.6	0.0	12.7	0.0	0.0	23.8	0.0	1.0	0.0	0.0	41.3	0.0	0.0	8.1	0.0	6.6	61.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.0	13.6	20.0	0.2	0.0
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227060	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 18.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005662			Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.1	0.1	0.3	1.0	0.2	0.2	0.2	1.2	0.3	0.1	0.2	0.7	1.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	2.4	0.3	0.2	0.2	0.1	0.6	0.0	0.2	0.3	0.1	0.6	0.1	0.2	0.2	0.0	0.2	0.7	0.1	0.1	1.0	0.8	0.4	0.2	0.2	0.1	0.0	3.4	0.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.1	0.2	9.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	49.7	6.5	13.0	6.4	10.0	12.6	11.3	7.3	7.3	7.2	10.4	9.6	9.7	18.2	19.6	19.5	11.0	10.3	6.2	0.3	0.2	1.2	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.4	0.6	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.1	0.1	0.0	0.5	0.0	0.3	0.1	0.1	1.5	0.0	0.0	0.3	0.1	0.1	0.0	0.1
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	72.3	85.1	5.5	0.7	4.1	0.2	51.2	16.3	9.4	3.0	0.2	7.8	58.8	0.6	16.3	3.4	12.9	5.5	3.5	4.5	1.4	36.2	609.7	2.7	0.0	5.6	1.4	4.9	23.1	6.3	13.4	0.0	6.1	3.7	1.5	0.7	8.7	0.8	58.1	4.5	46.8	0.5	1.3	0.3	4.7	30.9	2.2	0.9	7.3	13.8	0.0	2.0	2.7	2.1	0.2	2.5	0.0	5.9	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.3	0.0	0.6	1.2	0.0	0.0	0.0	0.2	6.1	0.0	4.8	46.5	1.3	0.2	1.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.1	6.3	0.1	0.0	0.7	8.2	1.0	0.0	0.0	1.2	0.0	0.1	25.5	0.7	1.0	4.4	0.0	0.1	11.4	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	4.1	16.3	9.4	4.5	1.4	5.6	1.4	6.1	1.3	2.2	2.1	0.6	0.0	16.2	2.3	1.6	1.1	4.8	0.6	0.6	9.9	1.4	1.3	3.4	84.4	4.7	3.7	20.9	0.1	0.3	3.2	1.9	2.9	3.2	0.7	0.2	2.5	90.1	16.0	33.4	1.0	0.1	6.5	4.6	0.8	0.0	0.1	12.8	286.6	0.4	1.7	29.1	19.6	0.0	11.2	1.5	1.2	2.8	2.8	7.2	30.9	0.2	2.0	1.0	2.0	0.9	1.4	13.9	1.2	0.1	2.2	108.9	14.1	3.2	6.5	0.0	23.9	1.0	5.1	1.1	0.5	0.9	0.5	1.7	0.0	31.9	4.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717838-75732958	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 48.2;liver: 25.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 4.5;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028834	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.0	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.1	0.1	0.0	13.9	44.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.6	0.0	0.2	0.2	0.0	0.6	48.2	0.7	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.3	1.5	0.2	0.0	0.0	0.0	0.0	73.8	0.0	0.0	0.0	0.1	0.0	0.0	2.4	2.7	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.4	79.6	0.0	0.0	0.0	36.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.3	0.0	0.0	0.6	159.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.1
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201038	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 24.4;liver: 18.9"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 81.9;Paneth cells: 56.3;Proximal enterocytes: 88.9;Undifferentiated cells: 26.3"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 11.0;liver cancer: 11.1;stomach cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"CACO-2: 2.9;Hep G2: 10.7"									HPA011940	Approved		Approved	Centrosome		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.1	0.1	0.5	1.7	0.4	0.9	0.1	1.4	0.7	0.0	0.2	13.4	24.4	0.2	0.2	0.2	0.1	0.2	0.1	0.5	0.2	1.2	18.9	0.1	0.2	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.1	7.2	0.4	0.1	0.1	0.5	0.4	23.8	0.8	0.0	0.2	0.2	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.9	0.8	0.1	0.4	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.4	10.7	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.2	0.3	0.1	0.3	0.4	0.1	0.0	0.3	0.4	0.4	0.1	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.6	0.6	0.1	0.6	0.3	0.2	0.1	0.0	0.6	0.3	0.8	0.8	0.2	0.3	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.4	0.2	0.3	1.6	0.5	0.2	0.3	0.1	0.1	0.5	0.4	1.4	0.7	0.5	0.2	0.3	0.1	0.4	0.0	0.4	1.1	0.3	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	81.9	0.0	0.1	0.0	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.1	7.4	0.0	0.0	0.0	14.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.3	0.0	0.0	0.2	88.9	5.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.1	0.5	0.1	26.3	0.4
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130632-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	22.6	18.4	15.2	20.4	16.4	26.5	25.0	17.7	21.4	19.9	15.4	17.6	17.7	22.1	27.5	28.6	16.6	18.4	23.2	15.3	17.7	17.8	30.8	16.9	25.2	17.1	17.0	25.9	19.7	22.9	15.8	20.3	17.0	24.6	19.1	15.1	21.0	16.7	33.1	26.7	15.5	16.8	15.6	19.6	17.8	15.4	16.3	22.5	21.7	24.0	27.5	23.8	18.1	17.6	45.8	33.7	42.7	51.3	39.1	36.7	58.3	49.8	39.6	40.6	29.7	60.7	32.9	64.3	30.5	35.3	31.0	41.1	54.8	35.3	54.1	44.7	43.2	77.3	26.3	139.1	34.1	101.0	58.2	32.0	44.4	33.4	44.4	27.4	34.8	39.1	113.5	49.1	41.0	49.1	81.6	101.5	71.0	63.5	38.1	66.6	66.7	75.4	33.1	49.0	51.8	40.0	33.6	75.0	49.9	36.1	38.2	44.5	36.0	47.2	51.1	45.3	64.0	41.0	50.6	104.1	40.5	82.8	49.1	17.6	12.4	9.8	15.2	17.8	20.2	18.0	19.6	18.8	15.3	15.0	21.4	19.2	1.9	17.1	26.1	16.3	18.3	11.3	15.2	16.4	17.7	21.4	15.3	17.7	17.1	17.0	17.0	15.6	16.3	17.6	38.6	35.3	55.5	8.1	36.8	33.4	42.7	37.8	30.7	37.2	26.0	36.8	44.5	30.0	53.0	18.4	4.2	50.5	47.7	17.9	25.4	47.8	6.0	40.4	52.4	40.4	18.0	26.9	9.8	41.8	48.1	43.2	19.9	65.4	48.1	31.2	21.8	33.2	27.2	18.5	11.4	21.6	26.4	17.7	20.8	6.3	48.7	19.0	12.4	15.0	39.2	25.5	47.4	12.1	15.9	33.1	15.0	43.6	25.6	40.6	14.2	22.7	29.2	53.2	39.5	62.2	49.1	70.2	84.5	35.6	33.5	32.4	39.9	42.8	28.2	31.9
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"adipose tissue: 75.6;adrenal gland: 166.5;breast: 44.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 16.1;Granulosa cells: 43.7;Horizontal cells: 43.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.5;HSkMC: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011024, HPA011093"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA011024: AB_10599292, HPA011093: AB_10600889"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	75.6	166.5	0.1	1.8	0.1	0.0	44.2	0.0	0.5	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.0	0.6	2.0	0.1	0.0	0.3	2.4	1.0	0.1	0.2	0.0	2.0	0.7	0.0	0.1	1.7	0.1	0.0	0.2	1.0	2.0	0.0	0.2	1.3	3.5	0.1	0.0	0.0	0.6	0.5	0.0	0.1	0.7	0.2	0.0	1.4	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.7	0.2	0.4	0.2	0.8	0.2	0.5	0.0	1.9	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.4	0.0	0.1	0.0	0.0	0.7	0.0	0.1	1.3	0.0	0.0	0.0	43.7	0.0	1.7	0.1	43.7	0.6	0.0	0.0	0.0	0.0	6.6	0.6	0.1	0.0	0.0	0.0	0.3	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	1.6	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0
MRPL50	"FLJ20493, MRP-L50"	ENSG00000136897	"Mitochondrial ribosomal protein L50"	Q8N5N7	9	101387633-101398618	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 203.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022925	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	Cytosol	"HPA022925: AB_1854117"	"unprognostic (6.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.21e-10)"	"unprognostic (7.06e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	9.6	16.0	10.6	8.3	11.6	4.0	11.8	15.8	13.5	7.8	9.7	8.1	8.6	7.8	12.7	7.1	8.0	7.2	14.5	11.1	11.2	13.3	14.0	7.1	11.0	10.0	11.1	11.9	11.9	13.1	8.9	8.2	10.3	9.8	8.6	19.0	8.4	8.0	10.9	5.7	8.3	7.2	10.8	9.4	10.1	6.5	10.8	8.6	9.1	14.9	11.6	10.3	5.7	11.5	12.6	14.9	23.3	13.6	16.0	17.0	16.5	16.0	15.2	17.3	14.6	20.4	12.3	30.6	10.1	12.5	21.3	28.4	23.0	19.2	18.6	18.6	13.7	15.0	16.4	59.0	17.2	27.5	13.9	14.0	21.9	14.0	25.5	13.0	15.9	15.9	32.1	16.1	17.8	20.7	17.0	20.3	25.6	73.9	20.2	17.1	33.1	19.2	25.8	13.7	22.4	16.6	17.0	16.9	18.5	15.9	11.9	17.0	13.2	11.8	17.6	20.7	15.4	12.0	38.0	12.8	15.0	16.0	16.9	9.8	12.5	9.9	13.9	15.2	16.8	20.6	19.3	16.0	16.3	19.5	22.4	20.3	2.2	14.7	15.9	13.0	23.1	16.8	10.6	11.6	15.8	13.5	11.1	11.2	10.0	11.1	10.3	10.8	10.8	11.5	33.0	16.0	20.8	11.4	46.4	90.5	133.6	203.4	51.2	19.1	31.0	31.9	76.0	35.8	86.9	57.0	12.5	74.8	29.3	15.3	152.6	66.8	10.4	31.4	33.6	41.0	19.8	30.1	12.5	69.4	73.8	46.9	23.4	25.7	44.5	24.0	32.2	43.9	51.9	5.0	15.1	28.0	162.8	25.9	50.6	7.4	34.2	28.3	30.2	5.6	32.1	21.9	27.8	8.0	17.2	66.8	32.7	40.6	39.4	112.8	26.4	186.5	67.4	18.2	46.0	37.6	52.4	44.7	39.3	41.6	99.3	76.5	43.2	63.1	34.3	130.4
MRPL52		ENSG00000172590	"Mitochondrial ribosomal protein L52"	Q86TS9	14	22829879-22835037	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 549.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012319	Approved		Supported	Nucleoplasm,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA012319: AB_1854118"	"unprognostic (8.98e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.52e-2)"	"unprognostic (8.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.41e-1)"	76.5	105.6	106.9	53.7	109.6	51.9	72.4	113.6	130.8	66.5	109.4	88.3	70.0	72.8	30.8	141.6	61.0	20.6	193.7	107.7	110.4	130.8	154.2	73.5	41.7	113.4	109.8	59.9	108.7	70.6	70.1	32.9	113.6	83.5	33.9	15.2	79.6	35.6	155.2	96.6	77.7	25.6	111.5	96.3	113.4	67.7	112.0	62.0	83.2	55.4	41.3	85.0	78.2	112.9	237.5	181.4	97.4	121.4	59.3	69.1	236.8	161.2	115.0	140.8	133.4	224.1	321.9	178.8	172.5	111.3	143.4	210.8	79.8	223.4	105.6	190.8	132.6	133.6	65.6	518.5	180.3	211.9	183.6	104.8	150.4	182.7	154.5	111.2	226.6	222.7	139.4	172.8	104.6	329.2	172.5	320.0	180.1	292.5	397.5	210.2	121.5	210.4	149.9	138.7	96.8	125.1	124.5	120.6	178.3	68.9	116.0	198.9	176.5	146.4	172.0	185.1	249.2	169.4	219.1	228.0	133.3	143.3	239.6	101.5	111.2	60.2	74.5	128.9	69.5	140.9	82.2	68.2	159.1	111.6	75.9	74.2	19.1	74.5	96.4	131.3	100.7	98.5	106.9	109.6	113.6	130.8	107.7	110.4	113.4	109.8	113.6	111.5	112.0	112.9	105.5	73.7	85.4	5.2	132.5	121.2	88.0	169.2	98.4	23.2	131.2	145.2	103.4	167.3	118.0	136.1	18.8	177.3	82.5	220.9	277.8	245.2	72.4	106.5	89.8	104.4	138.0	112.5	5.7	314.5	287.7	65.8	165.1	116.3	123.0	70.5	106.4	291.0	236.2	20.2	6.2	268.0	107.8	140.2	125.1	58.3	55.9	120.1	124.5	6.5	221.5	80.4	107.1	5.5	9.1	396.9	215.6	49.2	156.4	111.8	313.7	549.8	99.9	33.7	65.7	70.7	147.7	135.4	105.3	190.8	149.2	126.0	85.0	80.3	233.8	98.8
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	10	"liver: 927.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 362.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.6;NB-4: 17.3;U-266/70: 21.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	29.3	28.0	8.1	1.0	8.3	6.3	8.2	8.8	14.0	12.6	8.1	5.1	50.6	8.9	11.3	7.3	10.5	7.4	4.9	8.1	8.4	96.9	927.9	5.9	3.6	8.4	8.4	12.5	16.4	9.4	29.3	5.8	8.3	12.9	2.1	5.3	8.1	5.1	3.6	14.8	31.1	2.1	8.1	13.9	8.8	34.9	8.2	2.2	36.4	2.9	1.7	6.0	6.9	8.3	0.2	0.4	1.2	2.0	3.7	7.6	3.7	1.1	1.4	0.6	0.8	3.9	1.2	0.3	2.6	1.3	0.5	0.8	0.6	1.5	0.6	1.3	0.7	0.6	2.6	84.6	5.8	0.0	1.6	10.2	2.6	0.7	2.1	14.1	1.4	3.5	0.7	9.9	1.9	0.6	0.5	17.3	0.2	1.1	1.0	0.4	0.5	2.2	4.2	0.6	0.2	2.8	0.0	1.6	0.4	2.5	1.5	5.7	0.9	1.9	0.6	0.1	0.2	21.8	2.9	0.5	2.2	3.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	8.3	8.8	14.0	8.1	8.4	8.4	8.4	8.3	8.1	8.2	8.3	3.1	6.4	3.9	10.1	3.5	2.9	4.6	5.8	6.8	8.2	6.1	10.2	2.2	45.8	5.4	27.6	8.4	4.8	1.0	5.1	62.6	6.9	7.6	2.3	3.5	3.4	8.3	29.7	1.1	3.9	19.7	5.2	9.2	3.2	1.3	36.9	10.0	362.8	1.4	1.7	2.0	8.9	6.1	10.7	1.4	2.6	3.1	1.2	3.6	2.8	0.1	8.9	0.0	3.0	2.9	2.1	7.2	1.9	1.6	1.3	57.0	61.9	6.7	6.9	0.0	2.3	10.9	21.8	9.2	2.6	4.7	5.1	2.1	22.8	13.7	3.4
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99564081-99623997	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 275.2;liver: 266.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 244.2;Proximal enterocytes: 605.4"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.8;Hep G2: 12.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		640000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.3	0.1	0.9	0.2	0.9	0.0	0.2	0.8	0.9	0.1	0.3	1.3	243.2	0.1	1.0	0.1	0.6	1.3	0.9	0.8	1.5	12.9	266.6	0.3	0.3	1.1	1.6	2.0	0.0	0.0	0.5	0.0	1.3	0.5	0.3	5.6	0.1	0.2	0.4	0.1	275.2	0.5	1.2	0.0	0.8	9.6	1.2	0.2	0.1	0.3	0.1	0.9	0.0	1.9	0.0	0.2	10.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.2	0.1	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.5	0.1	0.2	0.1	0.1	1.0	0.0	0.0	0.7	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.8	0.9	0.8	1.5	1.1	1.6	1.3	1.2	1.2	1.9	0.1	0.0	0.0	4.6	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.8	4.3	0.1	1.8	0.0	0.2	0.2	0.2	0.0	0.0	44.2	1.0	0.1	0.1	0.0	2.7	1.6	0.0	0.0	0.8	1.5	0.2	0.0	30.1	3.6	244.2	0.1	0.0	0.7	16.7	2.0	3.5	0.0	12.0	0.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.2	12.5	0.4	0.1	0.0	605.4	23.5	1.0	0.0	6.6	0.5	0.5	32.1	5.7	0.0	0.0	0.0	0.4	12.0	21.0	0.0
MUSTN1	Mustang	ENSG00000272573	"Musculoskeletal, embryonic nuclear protein 1"	Q8IVN3	3	52833114-52835019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1689.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.3;Skeletal myocytes: 1.0;Smooth muscle cells: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.7;Hep G2: 8.0;HSkMC: 4.8;RH-30: 4.4"															NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.79e-2)"	"unprognostic (3.73e-2)"			"unprognostic (4.11e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.88e-2)"	86.1	10.1	107.0	9.3	118.7	6.5	46.4	106.9	177.9	89.1	105.7	27.2	8.4	44.6	49.0	44.9	52.1	42.5	142.5	104.2	105.8	17.5	12.5	31.0	5.4	107.2	107.4	37.6	6.6	1.6	12.1	4.5	110.3	43.8	21.2	0.8	26.3	59.3	1689.2	28.7	26.7	30.6	99.9	10.9	22.1	4.3	118.5	5.7	31.1	305.6	3.9	54.5	65.7	105.1	0.0	0.0	4.7	0.0	0.5	2.1	1.9	0.0	0.5	0.2	0.5	0.0	0.5	0.0	0.0	1.4	0.2	0.4	0.6	1.3	0.4	0.1	0.5	0.0	1.4	8.0	0.3	1.0	0.4	4.8	1.0	0.6	0.7	0.9	1.2	0.9	0.0	0.0	0.3	0.1	0.4	1.6	0.1	0.6	1.0	0.3	4.4	0.0	0.9	0.0	0.2	0.3	0.3	0.4	0.4	2.0	0.1	2.6	0.0	0.6	0.2	1.0	0.2	0.0	0.0	0.3	0.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	107.0	118.7	106.9	177.9	104.2	105.8	107.2	107.4	110.3	99.9	118.5	105.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYBPHL		ENSG00000221986	"Myosin binding protein H like"	A2RUH7	1	109292365-109307011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"heart muscle: 105.8"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 156.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;RH-30: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077633			Approved	Vesicles		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA077633: "	"unprognostic (6.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (5.89e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.10e-1)"	"unprognostic (7.05e-9)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.64e-1)"	0.0	0.1	0.6	0.0	1.2	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.3	0.0	105.8	2.2	0.5	0.0	0.0	1.2	0.0	0.6	0.6	0.0	0.0	0.0	3.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.0	0.5	0.5	0.6	0.0	0.0	0.6	0.0	0.1	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.4	2.8	2.2	0.5	0.6	0.6	0.6	0.3	0.6	2.4	0.0	0.0	5.1	0.3	0.0	0.0	0.1	0.7	0.0	1.8	0.1	0.1	156.7	0.0	1.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	3.1	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	2.2	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.8	11.1	0.0	25.0	1.6	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.4
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 222.5;skeletal muscle: 321.5;tongue: 255.9"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 198.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 4.6;Hep G2: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		Yes	No		830000		"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles	"Golgi apparatus, Cytokinetic bridge"	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	0.4	0.2	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.2	0.0	0.6	1.1	0.3	0.0	6.0	0.9	0.4	222.5	0.1	0.1	31.4	0.2	0.3	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.1	4.5	0.7	1.2	7.1	0.0	321.5	2.2	5.2	0.2	0.0	0.0	0.2	9.0	0.0	1.7	0.3	255.9	0.1	0.1	0.4	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.3	0.0	1.9	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	18.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.1	1.0	0.2	0.5	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.6	0.2	0.1	0.6	0.0	0.1	0.6	198.3	0.0	0.0	3.7	0.0	0.0	0.1	3.6	1.9	0.1	16.2	0.4	0.0	1.6	1.2	0.0	0.4	0.4	0.0	6.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.7	10.3	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.5	2.4	0.0	0.0	0.2	13.0	33.2	0.0	2.5	6.6	10.0	1.3	0.0	0.2	0.0	0.6	0.0	0.3	2.3	2.2	0.3
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		7800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	6.3	7.0	20.3	5.7	21.6	6.2	5.5	17.9	29.6	5.5	17.6	8.8	6.5	6.6	2.6	6.4	4.8	3.4	5.4	23.6	18.3	8.2	9.0	5.7	6.4	19.2	18.0	3.6	6.2	4.8	5.4	4.1	18.5	5.7	3.0	0.6	5.4	3.3	6.1	6.7	9.8	3.4	17.8	11.8	9.4	3.3	19.6	3.5	5.7	2.4	2.8	6.4	5.1	20.9	2.5	9.7	1.6	10.4	4.0	5.0	10.8	7.1	12.7	9.3	11.2	8.0	19.9	1.0	8.8	9.6	15.8	7.3	4.4	7.8	2.6	11.8	13.3	3.6	5.7	53.1	12.7	8.8	14.6	7.7	8.1	6.0	2.7	11.0	14.6	8.8	11.5	14.1	5.5	11.3	4.0	23.6	5.0	6.3	10.2	10.4	3.7	19.3	5.8	3.9	4.0	5.6	5.6	14.2	15.1	1.4	9.7	10.5	11.0	9.9	7.2	24.0	5.3	6.9	6.3	2.3	4.6	13.1	8.3	3.9	39.3	10.4	17.9	35.0	14.2	17.3	17.1	15.4	50.5	14.2	14.0	13.2	1.2	10.6	23.6	12.9	16.3	20.1	20.3	21.6	17.9	29.6	23.6	18.3	19.2	18.0	18.5	17.8	19.6	20.9	8.1	0.0	2.7	7.8	15.0	2.9	4.7	4.5	7.4	14.7	5.2	5.1	3.1	8.6	4.7	5.5	31.3	13.3	10.2	21.8	1.9	11.3	0.4	3.0	3.7	8.4	1.2	9.1	44.5	8.5	14.9	4.6	28.1	4.1	1.3	8.9	9.7	7.7	27.2	16.8	21.5	13.6	2.0	24.9	8.6	1.0	8.1	20.6	3.6	2.8	24.0	4.5	18.6	4.0	6.9	9.5	18.4	6.4	13.2	4.1	28.9	9.0	3.2	13.8	0.0	4.3	4.8	4.4	8.4	8.8	2.4	9.4	12.1	5.8	12.4	3.2
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640723-73642422	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 732.4"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 2565.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"Hep G2: 10.7"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.1	0.3	1.1	0.1	0.5	0.1	0.2	0.1	0.7	0.2	0.0	1.1	4.6	0.1	0.0	0.0	1.2	0.6	0.1	0.8	0.8	732.4	82.7	0.2	0.0	0.6	0.3	1.3	0.2	0.0	0.6	0.0	0.1	0.2	0.1	1.8	0.1	0.1	0.0	0.0	7.2	0.1	0.4	1.1	0.6	0.5	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.1	0.7	0.8	0.8	0.6	0.3	0.1	0.4	1.0	0.8	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	36.8	0.0	0.0	0.0	0.3	187.9	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.9	51.1	0.0	0.0	0.0	1.1	0.0	1.0	0.4	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	61.3	2565.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.6	0.1
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1885.3;salivary gland: 2081.6;skeletal muscle: 1828.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"myeloid DC: 204.4"	"Lineage enriched"	"Detected in all"	11	"dendritic cells: 204.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 57.0;HMC-1: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	192.0	400.6	1613.1	27.4	1885.3	2.8	321.6	1623.2	1666.4	395.4	1189.8	198.3	72.1	229.7	260.3	229.5	305.0	130.7	327.2	1551.7	1590.0	150.1	544.4	115.5	48.6	1690.6	1686.1	476.1	93.7	278.5	88.5	45.3	1581.9	171.3	111.0	134.1	2081.6	208.0	1828.7	220.3	125.4	127.7	1584.5	152.0	130.9	33.3	1752.7	40.1	99.9	1591.4	100.4	158.0	265.8	1597.9	10.9	2.3	6.8	12.6	1.1	0.0	1.0	0.2	4.5	3.9	2.2	15.1	20.0	0.6	4.0	0.3	6.2	17.6	30.3	6.3	5.4	0.1	10.9	14.3	2.2	57.0	1.3	1.3	39.0	11.8	13.1	0.9	1.9	6.3	0.0	12.6	29.0	1.2	0.6	9.4	5.0	4.0	17.9	35.2	0.8	14.6	0.7	3.7	7.6	27.4	0.1	19.4	3.0	3.3	14.4	17.3	26.6	8.2	0.0	1.2	20.8	0.4	0.4	6.1	4.8	0.3	1.8	0.3	4.7	0.0	6.5	0.7	8.3	1.5	11.4	6.4	12.6	11.9	204.4	4.4	18.7	14.0	1.4	3.0	0.1	7.0	9.4	15.3	1613.1	1885.3	1623.2	1666.4	1551.7	1590.0	1690.6	1686.1	1581.9	1584.5	1752.7	1597.9	98.0	0.0	11.9	379.0	6.7	28.7	83.7	86.4	12.0	6.3	240.7	201.2	180.2	151.5	110.9	40.5	10.4	11.5	9.1	81.4	485.2	104.9	6.3	33.3	11.0	53.9	33.5	8.4	1.1	21.7	0.7	62.3	18.8	40.2	48.8	79.0	164.2	214.9	20.7	3.3	3.9	77.4	57.0	30.8	137.6	14.4	348.6	30.4	321.9	47.8	8.7	548.0	1.0	42.7	71.0	16.3	37.9	166.3	1.2	68.5	18.5	41.3	70.8	15.5	598.2	167.7	162.8	1.7	5.5	21.6	30.4	21.6	11.9	66.8	118.9	155.9
NDUFA10	CI-42k	ENSG00000130414	"NADH:ubiquinone oxidoreductase subunit A10"	O95299	2	239892450-240025743	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 332.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059529, HPA067045, CAB070846"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756"	"unprognostic (2.12e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.02e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (2.09e-7)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.95e-1)"	55.4	91.1	36.3	29.6	40.2	50.3	50.3	39.8	51.2	41.0	38.9	83.2	81.6	37.8	28.3	74.6	43.6	31.2	184.8	41.7	36.0	94.2	103.6	35.4	32.3	41.9	39.4	45.4	58.5	99.3	38.5	37.9	41.3	33.1	84.3	31.2	55.9	33.1	206.4	72.4	64.3	39.8	34.0	37.7	71.7	35.3	37.7	45.3	38.8	332.0	49.7	47.3	49.2	39.4	74.4	65.5	46.3	81.5	54.8	95.4	75.5	49.0	70.9	71.3	77.8	72.8	82.8	51.0	31.8	64.2	60.8	96.2	109.8	103.1	92.6	59.7	90.9	72.9	65.6	174.6	72.4	96.9	58.6	95.5	80.3	68.5	85.0	66.6	96.6	74.6	102.0	34.8	81.8	124.8	95.6	110.5	56.3	114.4	81.0	93.2	114.4	81.2	108.7	152.1	70.5	54.6	55.3	131.8	108.9	33.3	121.2	97.4	69.9	52.7	60.7	70.7	75.8	77.3	24.6	79.2	60.3	80.9	72.8	30.2	106.3	47.1	72.9	115.8	93.8	95.4	70.7	77.5	147.9	77.0	68.2	69.4	26.7	97.6	103.3	49.7	92.7	104.6	36.3	40.2	39.8	51.2	41.7	36.0	41.9	39.4	41.3	34.0	37.7	39.4	66.8	76.9	74.1	31.6	63.5	104.9	96.5	193.5	60.3	80.8	88.4	89.5	354.8	87.2	114.0	77.3	62.6	216.4	58.1	137.3	311.0	112.5	47.5	66.8	83.2	67.4	92.9	57.6	83.1	78.5	124.0	71.7	62.2	76.6	65.9	103.7	66.4	139.1	125.2	50.5	68.5	152.3	103.7	90.5	82.0	85.3	50.1	65.2	112.1	27.2	107.8	72.2	53.5	37.7	71.4	77.7	125.5	49.2	56.7	62.1	182.7	303.0	77.7	110.4	65.7	74.6	77.3	84.2	73.4	107.2	118.9	218.1	63.0	185.3	234.2	110.0
NDUFA6	"B14, CI-B14, LYRM6, NADHB14"	ENSG00000184983	"NADH:ubiquinone oxidoreductase subunit A6"	P56556	22	42085526-42090884	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1536.8;Distal tubular cells: 954.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 181.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (3.48e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (7.00e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.84e-2)"	9.8	30.9	14.3	19.2	13.1	25.9	28.0	13.9	18.9	9.6	19.1	37.6	12.5	15.7	21.3	38.5	8.8	10.9	124.2	13.4	15.0	37.3	51.4	15.4	20.6	14.9	13.7	9.3	31.2	109.2	17.8	25.2	16.1	17.8	57.6	19.8	28.2	18.8	115.1	12.4	38.1	14.2	12.9	18.0	30.7	22.2	15.0	3.7	20.3	101.5	11.9	24.0	9.3	13.1	48.1	1.9	4.5	44.2	94.6	78.9	6.3	0.3	0.3	0.8	1.0	54.1	99.2	0.7	1.4	67.4	2.3	47.9	1.2	1.2	4.5	0.4	0.7	1.0	10.2	181.7	0.9	55.3	73.1	28.1	27.7	57.0	102.2	1.6	33.9	2.0	73.9	94.1	1.6	90.8	35.6	3.7	34.5	134.6	138.7	60.2	48.6	0.3	1.3	6.0	1.0	31.8	96.4	56.5	143.4	6.0	113.2	0.6	0.0	2.3	110.2	41.9	72.6	41.5	64.0	4.5	35.8	95.8	98.9	127.4	109.8	123.4	78.2	114.0	84.8	111.8	106.0	72.9	156.5	85.3	88.4	88.2	37.7	98.6	99.4	99.3	109.0	213.5	14.3	13.1	13.9	18.9	13.4	15.0	14.9	13.7	16.1	12.9	15.0	13.1	103.3	60.9	94.1	15.7	103.8	185.7	228.5	445.8	76.8	58.7	105.7	132.8	1536.8	164.5	189.2	180.3	45.9	422.1	105.6	349.0	954.8	267.3	181.3	104.0	99.6	123.3	170.8	140.8	9.7	253.9	443.7	152.2	114.7	106.6	105.2	70.1	94.2	598.6	357.9	35.3	13.4	293.3	386.6	114.6	255.4	52.0	100.9	145.8	288.1	5.6	198.0	129.4	117.4	5.0	9.3	260.5	361.8	110.6	166.7	202.6	517.5	597.8	131.4	99.7	105.2	98.9	329.1	142.5	163.8	159.9	186.0	764.1	123.8	117.7	301.9	230.4
NDUFAB1	"ACP, ACP1, FASN2A, SDAP"	ENSG00000004779	"NADH:ubiquinone oxidoreductase subunit AB1"	O14561	16	23581014-23596316	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 588.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054364, HPA076020"	Approved		Supported	Nucleoplasm,Mitochondria		No	No		100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA054364: AB_2682463, HPA076020: "	"unprognostic (3.33e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (1.94e-7)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.16e-1)"	89.7	127.1	104.3	49.6	106.8	60.4	81.0	114.8	157.6	64.0	117.4	123.0	102.9	68.8	50.1	98.8	66.5	32.0	588.8	107.1	113.5	132.9	165.8	61.9	52.2	110.4	105.6	54.3	84.5	110.4	94.2	47.5	112.0	63.5	89.0	91.9	75.7	58.6	425.0	71.9	90.1	51.1	107.5	72.1	109.6	61.7	108.2	60.2	66.0	432.0	59.2	79.8	70.7	106.9	172.8	125.6	151.8	136.8	107.5	116.0	212.9	129.4	96.8	129.2	105.7	110.1	135.8	284.0	206.6	94.7	158.2	138.6	271.2	155.4	102.6	161.8	312.6	151.8	203.0	507.0	112.2	284.8	121.0	108.0	212.6	95.2	102.2	120.0	167.0	249.5	326.6	139.6	142.7	262.1	221.6	431.9	394.7	254.5	288.5	299.5	171.0	389.3	120.2	140.6	209.8	163.1	144.6	260.8	258.2	167.2	211.2	235.0	131.1	116.5	122.4	113.4	180.5	175.2	283.2	321.9	130.2	228.7	134.9	77.1	179.9	80.0	127.0	222.8	142.3	171.7	150.7	143.4	239.4	151.6	139.0	145.8	37.9	117.8	175.8	268.1	177.6	204.7	104.3	106.8	114.8	157.6	107.1	113.5	110.4	105.6	112.0	107.5	108.2	106.9	136.2	99.3	99.7	9.8	96.1	122.1	142.9	416.9	79.6	91.1	131.7	191.5	1366.5	105.8	200.3	112.2	45.9	290.9	101.3	210.9	708.3	187.3	129.5	185.5	113.2	129.4	202.4	125.1	13.1	210.2	312.2	153.3	119.3	110.8	84.9	124.4	93.9	300.6	263.2	52.2	14.3	253.5	321.4	109.0	89.1	39.6	96.9	114.3	156.5	5.6	179.6	165.0	109.2	7.5	13.2	227.1	174.8	121.5	166.9	180.3	316.8	611.4	261.6	127.6	92.1	134.0	261.9	142.9	118.8	181.5	142.2	224.5	94.5	256.6	360.0	190.7
NECAB3	"APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51"	ENSG00000125967	"N-terminal EF-hand calcium binding protein 3"	Q96P71	20	33657087-33674463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044785, HPA070595, HPA071786"	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186"	"unprognostic (8.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (6.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-1)"	10.2	55.9	20.1	2.2	21.2	1.5	10.4	18.9	33.9	11.8	20.4	14.4	13.6	9.1	6.9	8.9	10.9	4.5	45.7	21.7	21.2	13.3	13.3	11.1	2.3	23.3	19.1	41.2	19.1	17.5	10.3	3.9	24.4	27.2	4.4	6.5	13.6	7.8	60.3	6.9	10.6	3.7	16.6	6.5	30.5	10.6	23.2	1.9	19.2	31.7	1.7	14.6	10.0	22.3	8.2	7.1	5.1	10.5	4.0	7.8	24.6	11.2	4.2	7.1	6.2	33.2	5.3	9.1	26.2	6.6	16.7	9.7	5.3	3.3	2.6	3.2	7.7	8.7	30.7	39.3	10.5	2.1	8.0	9.7	4.8	6.6	2.1	7.6	4.8	4.8	12.6	4.8	9.3	12.5	3.3	8.6	2.2	8.7	17.5	9.7	13.3	15.9	6.6	6.1	32.4	9.0	26.1	28.7	12.0	5.6	36.6	10.4	4.0	8.6	12.4	11.3	12.7	17.7	7.8	17.1	16.9	4.0	3.8	0.0	1.3	1.8	0.3	1.3	0.9	0.2	0.6	0.3	1.2	0.9	0.4	0.1	0.0	1.2	3.5	0.0	1.6	0.6	20.1	21.2	18.9	33.9	21.7	21.2	23.3	19.1	24.4	16.6	23.2	22.3	5.4	16.0	45.5	14.7	4.1	3.1	6.5	2.7	8.6	19.4	20.5	11.6	29.9	10.0	5.9	5.5	8.4	20.6	3.8	22.5	33.2	3.7	93.1	5.7	7.2	2.4	19.9	4.0	13.0	7.5	26.1	12.5	26.5	5.4	3.8	14.0	2.2	9.1	8.9	8.4	14.5	16.2	4.1	6.0	6.2	54.0	26.4	5.5	12.4	1.0	3.6	18.2	2.1	6.0	4.5	4.4	15.1	23.7	11.7	14.2	45.9	12.2	3.8	20.8	6.6	9.2	12.1	20.5	20.6	9.3	3.1	20.7	5.4	23.9	20.0	10.0
NEDD8	Nedd-8	ENSG00000129559	"NEDD8 ubiquitin like modifier"	Q15843	14	24216857-24232367	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	169.0	224.3	156.9	71.5	162.3	91.0	156.7	158.6	219.1	152.4	152.5	172.9	55.9	147.6	132.6	202.1	131.3	51.0	299.8	163.1	168.6	195.8	175.7	147.7	81.2	163.7	158.7	138.1	110.9	289.1	143.9	84.3	162.4	133.7	88.7	74.6	139.3	85.5	294.3	182.2	128.8	97.7	157.5	164.6	146.8	77.9	162.1	125.7	132.8	197.1	113.1	152.0	157.5	162.0	166.9	292.7	223.8	159.9	255.2	223.2	165.6	218.7	237.4	259.5	237.5	204.6	196.1	142.1	126.9	317.1	212.3	169.2	230.8	349.5	365.6	201.9	139.7	150.2	272.9	710.7	220.8	251.8	151.6	237.0	231.8	217.2	172.0	239.1	317.3	162.3	139.3	161.5	409.4	380.3	203.4	241.1	166.1	303.7	335.8	141.3	176.9	146.1	302.7	322.1	96.7	221.7	188.3	192.6	168.4	229.5	117.6	199.2	230.3	145.4	144.9	184.9	198.5	187.9	322.7	210.6	102.6	146.2	139.6	461.6	277.3	459.9	214.7	302.8	235.5	311.9	246.0	241.0	276.3	273.4	229.8	233.1	299.8	233.7	310.5	369.7	327.3	526.6	156.9	162.3	158.6	219.1	163.1	168.6	163.7	158.7	162.4	157.5	162.1	162.0	276.4	144.2	156.8	0.0	182.1	277.9	227.5	644.7	166.8	101.0	263.4	301.5	464.7	215.9	301.5	310.8	47.9	525.7	237.0	267.8	594.8	344.9	72.6	201.8	189.4	259.5	212.4	220.7	0.0	406.9	625.0	246.0	108.1	195.4	218.6	228.7	222.0	431.5	576.3	106.0	0.0	286.4	362.2	288.7	345.5	77.3	272.1	255.4	268.6	0.0	394.0	275.0	346.1	0.0	0.0	449.8	311.5	275.7	161.3	254.4	340.2	845.8	279.7	95.9	210.4	178.7	318.4	150.0	196.9	252.1	386.6	419.5	216.0	289.8	291.8	275.5
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241809065-241817413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 75.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 74.6;Enteroendocrine cells: 34.4;Hepatocytes: 124.4;Intestinal goblet cells: 38.5;Oligodendrocyte precursor cells: 50.3;Paneth cells: 58.0;Proximal enterocytes: 76.0;Undifferentiated cells: 38.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"Hep G2: 57.7;HMC-1: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037394	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.9	0.2	2.3	0.1	2.5	3.5	0.2	2.2	4.4	0.5	0.6	15.5	10.7	0.2	0.0	0.0	0.7	0.4	0.3	2.1	2.5	1.8	75.8	0.4	0.0	5.0	2.8	0.3	0.1	0.0	1.1	0.0	2.7	0.4	2.2	0.1	0.8	0.0	9.0	0.1	9.2	0.0	2.6	0.3	0.1	0.7	2.7	0.0	0.3	0.8	0.0	0.1	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	57.7	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.5	2.2	4.4	2.1	2.5	5.0	2.8	2.7	2.6	2.7	2.9	0.2	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.6	1.5	0.7	1.8	0.0	0.0	1.1	74.6	3.9	0.0	0.1	0.0	0.1	0.3	34.4	0.0	0.4	0.0	0.0	0.2	0.5	0.0	1.3	0.1	1.1	124.4	1.5	0.0	0.4	38.5	2.0	4.2	0.7	0.2	0.6	4.0	0.0	0.0	0.0	26.2	0.0	50.3	0.1	0.0	58.0	0.7	0.4	0.0	76.0	23.6	0.2	1.3	0.0	3.6	0.4	0.5	0.5	0.0	0.0	0.0	1.3	0.0	38.4	0.1
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469689-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	32.2	26.4	25.6	23.3	28.4	64.4	40.3	30.5	37.7	30.5	25.0	30.1	23.4	34.7	32.5	26.2	32.0	17.6	23.7	25.9	26.6	31.3	32.9	24.2	35.3	27.1	27.0	39.6	25.7	33.3	20.8	29.2	27.7	24.8	29.0	25.2	24.6	26.6	53.4	35.2	26.8	31.4	27.7	28.6	27.0	28.6	26.9	37.5	28.4	39.2	36.8	32.3	27.7	31.7	37.6	73.1	54.5	51.5	52.0	37.3	72.1	48.6	50.7	101.3	81.4	72.1	66.8	92.6	35.0	44.7	71.1	63.7	109.0	60.1	118.7	61.8	57.3	83.2	44.1	229.3	70.5	110.4	56.9	46.5	75.0	79.9	94.4	39.6	52.2	69.5	93.6	64.1	50.4	88.8	82.3	86.0	69.5	84.8	97.1	67.1	65.6	47.9	65.7	70.4	55.6	62.8	57.6	68.3	83.8	55.0	42.2	70.4	39.8	47.8	57.3	45.1	71.3	79.4	148.7	133.3	20.6	56.1	52.2	67.0	62.3	58.5	88.0	71.8	93.5	129.0	94.6	89.9	74.8	107.7	121.3	95.5	19.1	109.5	71.7	79.1	116.1	93.3	25.6	28.4	30.5	37.7	25.9	26.6	27.1	27.0	27.7	27.7	26.9	31.7	33.8	35.3	29.2	2.9	52.1	70.6	63.8	78.2	72.8	23.2	25.5	31.2	20.2	21.5	46.8	27.6	16.7	59.3	45.3	19.9	33.2	38.6	7.2	24.3	25.9	36.5	24.6	35.1	7.5	36.0	43.3	34.4	16.3	27.5	45.0	23.2	25.4	21.4	29.8	25.2	6.8	22.7	28.5	19.2	39.0	6.9	35.1	21.1	32.0	9.4	34.3	26.8	46.4	4.0	11.0	31.1	22.8	28.2	30.4	42.9	25.8	35.5	36.6	28.6	19.7	51.5	36.0	68.7	64.2	39.6	67.6	57.2	47.6	20.5	27.2	49.5
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452697-25585531	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.4;Granulosa cells: 29.6;Inhibitory neurons: 32.6;Oligodendrocyte precursor cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 37.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000686	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Microtubules, Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	4.0	8.6	4.9	2.0	5.9	0.6	4.0	10.4	6.1	10.1	8.8	9.8	3.2	7.2	7.2	5.8	5.2	3.3	4.0	4.4	6.9	15.1	8.1	4.1	2.2	7.9	7.1	18.9	5.4	8.2	9.9	1.5	7.0	8.8	2.1	4.7	4.4	3.7	4.5	2.4	3.9	3.5	5.5	4.9	6.3	7.7	6.5	15.7	10.2	1.2	2.2	3.6	8.5	6.8	1.0	10.8	23.0	15.1	2.6	7.5	7.1	3.6	3.1	3.1	4.4	2.8	7.5	0.6	5.0	5.6	7.6	0.8	3.4	0.7	2.6	0.5	4.7	1.6	5.0	37.5	5.4	0.6	0.1	9.2	0.7	3.6	0.0	8.8	6.8	17.8	1.9	0.3	3.8	9.6	21.7	0.7	6.5	0.1	1.1	0.5	17.9	0.8	1.5	1.3	22.7	16.0	8.2	3.0	9.1	18.3	4.9	6.4	0.3	0.1	8.6	0.1	0.2	2.3	4.4	0.1	0.2	0.6	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.9	10.4	6.1	4.4	6.9	7.9	7.1	7.0	5.5	6.5	6.8	1.2	0.0	14.6	42.4	0.8	2.0	4.9	2.5	5.7	3.0	2.8	3.3	6.5	12.8	4.8	7.3	25.0	2.8	0.6	0.4	0.0	5.6	0.6	4.2	7.3	2.3	6.1	0.0	7.4	1.2	1.3	8.7	4.6	3.4	0.0	29.6	8.9	8.4	2.3	8.4	32.6	2.3	8.2	0.3	2.0	2.7	13.1	0.8	0.0	12.2	0.0	3.2	2.1	47.3	19.4	2.8	1.5	12.4	0.9	4.5	0.7	8.8	13.7	1.9	6.6	10.8	4.7	2.5	5.0	4.3	0.9	1.5	1.1	21.0	2.5	1.9
NIPSNAP1		ENSG00000184117	"Nipsnap homolog 1"	Q9BPW8	22	29554808-29581327	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 291.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.7;Proximal tubular cells: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059227	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA059227: AB_2683951"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (8.82e-6)"	"unprognostic (2.81e-2)"	"unprognostic (8.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.72e-1)"	10.7	43.9	35.4	17.5	37.8	15.5	31.5	31.8	38.5	21.5	33.4	37.4	67.0	19.4	24.9	25.8	26.8	19.8	21.8	37.6	41.7	117.8	291.8	17.8	23.3	37.1	36.5	32.3	24.4	68.0	36.5	17.3	39.3	23.9	38.5	46.2	26.0	27.2	4.4	20.6	49.2	17.8	30.7	19.1	29.3	11.9	36.7	36.7	32.9	5.4	28.3	20.1	18.3	31.7	69.1	81.1	165.3	206.9	29.2	59.4	30.7	39.5	70.7	53.2	68.7	55.5	90.6	48.8	76.8	56.9	56.0	68.2	87.7	100.7	65.1	98.8	90.5	16.8	37.0	173.5	44.1	36.5	23.0	59.5	50.8	44.1	55.0	129.0	73.4	105.3	31.8	78.9	49.2	156.4	59.3	50.1	140.0	106.2	67.5	115.9	51.7	142.6	128.3	59.1	203.9	179.5	46.1	83.2	92.1	79.5	137.1	57.7	34.7	23.2	79.6	28.6	31.9	106.4	56.5	45.6	62.1	57.3	39.4	10.8	9.4	15.9	34.2	17.4	41.2	29.0	34.4	36.2	21.6	27.3	32.6	39.5	13.8	39.5	10.7	11.0	44.9	22.1	35.4	37.8	31.8	38.5	37.6	41.7	37.1	36.5	39.3	30.7	36.7	31.7	7.4	25.6	15.7	6.8	16.3	4.8	12.6	15.8	18.8	22.6	25.5	18.5	22.9	28.6	18.6	42.3	10.4	44.4	9.2	14.4	68.4	45.8	2.1	6.2	13.7	10.1	41.9	24.6	16.9	18.5	14.6	14.2	25.5	12.0	26.0	33.5	11.7	116.7	14.4	10.1	19.9	31.5	26.4	8.7	4.3	6.1	11.1	8.1	5.4	3.7	21.3	38.7	28.8	6.6	10.3	17.8	20.2	14.3	7.3	6.8	35.2	134.7	9.8	24.4	13.1	7.2	12.3	1.4	8.3	20.5	8.1	14.8	20.5	48.1	47.4	8.8
NKD1		ENSG00000140807	"NKD inhibitor of WNT signaling pathway 1"	Q969G9	16	50548396-50649249	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 45.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 27.4;Smooth muscle cells: 13.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 12.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;CACO-2: 13.6;Hep G2: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041352, HPA049413"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli fibrillar center"		"HPA041352: AB_2677428, HPA049413: AB_2680753"	"unprognostic (1.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.02e-3)"	"unprognostic (5.59e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.88e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.44e-2)"	1.7	0.7	7.3	0.7	7.9	0.1	1.0	7.1	4.6	2.5	2.1	4.8	1.1	6.0	4.2	3.2	4.7	2.8	0.5	4.0	5.5	1.6	0.6	6.8	0.4	9.3	12.8	2.9	1.2	0.2	0.4	1.9	7.2	3.5	1.4	0.7	0.5	2.7	0.3	2.0	2.0	5.7	7.0	1.5	2.1	1.1	14.6	0.7	0.3	0.2	0.5	2.2	1.2	7.7	0.0	0.1	6.3	0.5	2.4	0.0	0.2	0.0	0.0	0.0	0.0	13.6	0.3	0.0	0.2	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.7	0.7	0.0	36.5	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.1	1.4	0.5	0.6	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.9	7.1	4.6	4.0	5.5	9.3	12.8	7.2	7.0	14.6	7.7	0.3	0.0	0.0	4.2	0.2	1.5	1.2	0.2	0.0	2.1	0.3	0.8	0.8	0.0	0.5	0.0	6.2	2.5	0.7	0.2	0.0	0.4	7.4	0.5	2.0	0.9	1.8	0.4	0.4	0.4	0.4	3.8	1.5	0.7	0.0	3.7	0.4	1.7	0.4	0.0	1.0	0.5	0.0	0.0	3.0	2.2	1.8	0.8	8.8	45.9	0.2	6.7	0.0	57.3	27.4	0.3	0.0	3.4	0.5	0.9	0.2	0.1	0.1	0.8	13.1	0.4	13.4	1.1	7.1	0.6	1.1	2.3	2.4	0.0	0.5	1.4
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833721-14896157	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 76.3;Hep G2: 126.5;LHCN-M2: 65.8;RPMI-8226: 90.4;SiHa: 144.9"									"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (3.15e-4)"	24.1	27.6	4.4	10.3	4.4	0.0	23.6	4.4	16.0	22.0	4.4	32.3	0.7	25.6	0.0	24.9	20.4	0.4	92.3	4.5	9.6	32.0	28.3	26.9	2.7	4.8	4.3	21.3	133.9	0.0	29.2	6.8	4.5	21.6	8.2	4.2	31.1	4.5	101.7	28.1	26.1	8.2	4.3	19.9	36.4	31.0	4.5	0.0	21.5	1.4	0.2	28.8	22.2	5.1	1.2	56.8	51.4	76.3	0.0	4.6	42.2	3.4	9.1	11.5	11.0	0.8	2.8	4.3	2.8	8.8	1.0	0.7	8.8	0.7	11.3	6.2	0.0	3.7	57.8	126.5	48.7	5.8	2.7	0.6	0.5	6.2	6.3	1.2	9.0	0.0	29.7	2.6	65.8	0.0	1.6	0.0	0.0	0.0	0.0	1.9	4.3	90.4	0.0	2.6	1.1	45.8	144.9	0.0	0.1	1.7	63.1	0.6	2.1	1.9	0.1	2.6	58.1	0.3	2.1	4.7	2.3	2.3	1.3	3.7	0.2	0.2	0.0	0.4	0.3	0.0	0.1	0.3	0.1	0.5	0.2	0.3	0.6	1.9	2.0	1.6	0.3	0.6	4.4	4.4	4.4	16.0	4.5	9.6	4.8	4.3	4.5	4.3	4.5	5.1	5.6	3.2	10.5	9.1	5.3	6.4	1.4	10.6	3.4	8.7	7.8	5.8	58.4	7.2	8.6	11.0	6.2	6.8	4.2	14.4	0.0	15.6	32.9	3.3	3.1	7.3	7.7	5.5	12.7	29.4	12.4	7.9	11.7	4.2	23.6	13.0	7.9	7.6	6.3	35.3	16.2	11.7	2.0	12.7	2.8	12.0	2.8	10.3	5.4	7.5	11.2	5.4	16.5	13.6	32.1	27.4	10.8	6.4	16.2	2.1	16.1	7.9	7.4	8.5	6.6	5.7	7.5	16.1	13.1	6.7	5.8	9.6	4.2	9.5	13.0	1.6
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"placenta: 135.7"	"Cell type enriched"	"Detected in some"	45	"Extravillous trophoblasts: 1002.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 48.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 428.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		1900000		"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.0	0.1	1.6	0.0	1.9	0.0	0.2	0.6	1.8	0.2	0.1	0.0	1.1	2.1	0.3	0.3	0.4	0.2	0.3	1.0	1.0	1.2	10.0	2.2	0.0	1.7	2.7	0.1	0.4	0.9	0.2	135.7	1.3	0.3	0.0	0.0	0.6	0.1	8.2	2.2	0.3	0.1	0.9	0.2	2.1	2.8	1.3	0.0	0.0	0.5	0.0	1.4	0.2	0.8	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	10.0	0.4	0.0	1.8	0.3	0.2	0.4	2.4	0.0	0.0	0.1	1.1	2.2	2.8	428.6	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.2	11.2	0.0	0.0	0.6	0.0	0.2	0.1	67.9	0.4	0.0	0.2	0.1	0.0	0.2	15.7	1.6	4.2	1.7	6.2	2.3	0.1	4.9	0.0	0.5	6.3	0.0	0.2	0.1	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.6	1.8	1.0	1.0	1.7	2.7	1.3	0.9	1.3	0.8	0.0	0.0	3.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.6	1.3	1.2	0.0	0.0	0.0	0.0	10.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.6	0.0	1002.5	1.2	1.5	0.3	0.0	0.1	0.0	3.6	18.4	0.0	1.1	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	12.7	0.0	0.0	22.0	0.1	0.0	0.3	0.0
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 54.2;liver: 48.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 12.3;Hepatocytes: 44.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.8;Hep G2: 17.9;SCLC-21H: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB070127, CAB070128"	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.6	0.1	0.4	0.0	0.7	0.0	0.4	0.9	1.1	0.6	0.3	1.6	54.2	0.4	0.0	0.4	0.5	5.8	0.1	0.7	0.2	0.9	48.1	0.2	0.0	0.3	0.4	0.6	0.6	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.1	0.1	0.1	0.3	50.5	0.1	0.3	0.0	1.5	1.1	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.9	1.1	0.7	0.2	0.3	0.4	0.4	0.3	0.3	0.6	0.2	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.8	0.8	5.7	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.3	12.3	0.3	0.1	0.2	1.8	2.7	0.3	0.5	0.0	0.2	0.0	0.5	0.0	0.0	1.4	44.7	0.0	0.0	0.1	0.3	0.0	1.0	0.3	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.2	3.4	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3	0.1	0.3	0.7	0.2	0.1
NPIPB3	"KIAA0220, NPIPL3"	ENSG00000169246	"Nuclear pore complex interacting protein family member B3"	Q92617	16	21402237-21448567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 2.8;Gastric mucus-secreting cells: 2.0;Skeletal myocytes: 3.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 161.9"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-5)"	"unprognostic (1.50e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.00e-4)"	53.3	47.1	141.3	37.2	137.3	149.4	47.7	127.7	184.3	71.8	111.9	72.4	28.5	38.3	51.8	44.4	58.6	28.5	60.8	118.8	134.1	71.1	65.1	66.3	77.0	133.3	147.3	49.6	47.2	13.1	70.5	21.9	127.9	74.9	34.9	51.7	43.5	22.6	87.9	140.9	76.7	28.1	90.1	99.7	51.3	46.6	134.8	53.6	75.6	24.1	34.8	48.0	52.5	122.8	37.9	37.2	24.5	40.1	30.0	18.1	73.5	25.7	9.6	13.3	14.1	57.5	44.0	56.4	24.1	38.9	17.7	47.0	13.6	41.4	12.5	30.8	20.6	26.6	58.7	161.9	25.6	48.8	46.0	8.8	16.8	35.3	44.3	20.4	19.4	52.5	49.7	77.3	20.4	69.7	51.8	114.0	41.0	22.5	42.5	75.7	25.4	35.0	28.8	23.2	27.8	21.1	15.7	32.5	25.9	47.2	35.7	20.7	29.5	62.9	36.4	6.4	40.4	37.8	30.8	49.2	25.0	38.3	34.9	3.5	2.3	1.5	2.6	1.4	1.2	2.2	1.5	1.6	1.2	2.4	2.0	1.3	2.1	2.0	1.1	4.8	0.9	0.1	141.3	137.3	127.7	184.3	118.8	134.1	133.3	147.3	127.9	90.1	134.8	122.8	0.1	0.0	0.0	1.6	0.5	2.8	0.4	0.2	0.6	0.0	0.1	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	1.7	0.0	0.0	1.0	2.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.2	1.8	1.9	0.0	0.0	1.0	1.5	1.3	0.0	0.0	0.0	0.7	0.8	0.0	0.0	1.7	0.0	0.0	3.1	0.8	0.0	0.0	1.3	1.7	0.0	0.8	0.2	0.0	0.2
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0;parathyroid gland: 39.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.6	18.4	11.0	0.1	16.9	1.2	2.1	7.4	40.0	4.9	2.2	1.1	2.2	5.0	0.9	1.0	3.2	1.9	2.3	12.4	9.2	6.6	1.6	1.8	0.6	7.5	7.6	1.5	11.0	39.2	18.5	0.5	10.0	6.6	1.0	5.7	2.7	1.4	0.3	2.2	1.2	3.6	2.3	12.5	1.9	5.1	7.1	2.9	25.3	0.3	0.4	2.0	2.3	13.5	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	11.0	16.9	7.4	40.0	12.4	9.2	7.5	7.6	10.0	2.3	7.1	13.5	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913975	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.9;liver: 142.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 97.2;Distal tubular cells: 52.8;Exocrine glandular cells: 42.4;Gastric mucus-secreting cells: 90.2;Hepatocytes: 173.4;Proximal enterocytes: 49.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 52.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"Hep G2: 78.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.7"	"Not detected"	"Not detected"			HPA003983			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Vesicles	"HPA003983: "	"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.0	21.4	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	76.9	0.0	0.0	0.0	0.0	10.1	12.9	0.0	0.0	33.8	142.4	2.4	0.0	0.0	0.0	0.0	30.6	1.6	0.3	0.0	0.1	0.0	0.4	0.2	0.0	0.0	2.7	0.0	26.5	0.0	0.0	11.5	26.4	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	78.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	15.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	8.4	97.2	0.7	12.9	0.0	0.0	0.0	0.9	52.8	31.3	0.4	0.1	0.0	0.2	24.4	8.0	0.0	42.4	0.0	0.3	90.2	0.0	0.0	3.0	2.5	173.4	0.1	28.6	0.0	7.6	16.2	3.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.3	0.0	0.2	0.0	49.8	0.1	0.0	0.4	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.3	0.1	11.0	0.2
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.2;liver: 47.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	12.3	28.2	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.4	0.0	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.2	0.0	0.1	0.0	0.0	31.2	0.6	0.1	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
NUBPL	"C14orf127, FLJ12660, huInd1, IND1"	ENSG00000151413	"Nucleotide binding protein like"	Q8TB37	14	31489956-31861224	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 68.2;Inhibitory neurons: 74.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029203	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA029203: AB_10602810"	"unprognostic (1.49e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.21e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.64e-8)"	"unprognostic (2.82e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.56e-2)"	9.7	6.4	4.2	3.9	4.6	1.8	8.9	4.5	4.8	4.9	4.2	7.6	4.9	5.8	7.6	4.6	6.4	5.3	17.0	4.0	5.0	12.2	12.3	4.1	5.7	4.9	4.7	6.8	5.5	7.9	3.8	5.5	4.5	6.3	7.8	5.2	11.9	6.1	11.9	4.7	5.8	5.4	4.3	6.6	4.7	3.5	5.0	5.5	8.0	17.4	5.4	4.2	3.2	5.8	13.6	8.5	6.4	3.3	8.9	16.4	11.5	7.3	8.2	8.9	10.2	5.9	15.3	9.8	9.2	9.1	7.5	11.7	8.6	15.5	15.3	7.1	11.1	3.5	6.3	30.4	8.8	10.4	3.0	10.7	17.0	6.0	12.8	7.3	5.0	7.0	6.4	4.9	9.8	7.4	7.7	7.1	5.4	10.8	13.1	8.6	13.4	5.3	10.2	10.0	6.0	6.2	12.2	10.8	14.5	7.2	21.1	5.4	4.9	8.6	5.9	5.6	6.8	8.1	9.7	9.3	5.5	7.3	7.9	0.0	1.1	0.4	2.1	1.2	1.7	2.6	2.7	2.3	4.4	1.7	3.0	2.4	0.4	2.5	0.7	2.2	1.8	0.9	4.2	4.6	4.5	4.8	4.0	5.0	4.9	4.7	4.5	4.3	5.0	5.8	6.9	12.8	9.8	68.2	10.1	9.6	8.6	5.4	9.1	15.3	10.2	7.1	36.9	15.7	10.6	9.2	20.9	11.2	7.5	6.3	7.9	6.8	24.1	12.6	10.8	6.3	7.2	6.7	48.2	5.7	10.2	12.0	7.1	5.4	14.5	16.4	4.6	15.3	4.9	10.1	74.8	12.0	2.0	4.1	16.1	7.4	6.5	6.1	12.4	54.4	2.8	16.2	5.2	87.9	99.6	5.2	5.8	11.7	8.0	4.4	5.1	19.1	18.7	28.4	13.1	11.8	9.8	15.7	5.2	7.3	11.6	5.7	6.4	23.1	18.2	5.9
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120211032-120230334	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 396.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.9;Fibroblasts: 135.9;Hepatocytes: 218.8;Muller glia cells: 279.4;Theca cells: 149.0;Urothelial cells: 192.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.3;intermediate monocyte: 1.6;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 2.4;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 115.5;Hep G2: 190.1;NB-4: 139.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA		69000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	66.0	91.5	47.7	18.0	56.8	10.8	42.6	35.8	57.1	66.7	40.5	61.9	47.7	54.2	16.0	22.8	54.6	34.5	55.1	48.1	36.5	51.4	396.6	19.2	5.8	39.0	37.8	61.0	74.1	6.7	27.4	8.1	37.1	33.5	36.5	30.7	53.9	13.7	13.2	12.0	57.3	29.1	35.9	54.4	33.5	3.7	45.0	4.6	25.9	12.2	3.7	42.6	40.4	44.6	24.9	7.5	30.9	14.4	47.8	53.4	1.7	47.7	53.8	20.5	30.0	7.5	37.3	0.0	115.5	35.6	33.7	25.7	8.9	13.2	8.2	18.7	21.1	21.1	4.7	190.1	42.4	46.7	7.9	66.8	7.9	19.8	54.8	39.9	59.7	12.7	14.0	22.7	5.0	9.4	0.3	139.9	11.6	7.3	40.8	11.8	0.9	23.7	31.8	13.4	1.5	10.0	14.0	15.2	40.2	8.6	4.8	74.7	32.7	39.3	14.7	40.8	4.6	0.8	0.7	0.4	30.3	76.2	14.1	0.0	3.3	0.0	0.1	1.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.1	0.0	0.3	0.5	0.1	0.8	47.7	56.8	35.8	57.1	48.1	36.5	39.0	37.8	37.1	35.9	45.0	44.6	19.4	0.0	0.6	102.2	3.7	9.4	33.6	7.3	12.5	3.2	6.0	7.0	5.5	34.3	3.5	71.7	2.1	2.1	1.1	135.9	27.4	14.8	0.2	4.7	70.9	40.0	22.8	12.8	0.6	28.7	5.5	135.9	11.7	12.2	1.3	2.6	12.5	218.8	6.0	0.0	2.3	56.5	4.1	11.5	20.9	1.1	16.8	11.0	16.0	23.4	10.2	279.4	0.0	5.5	11.0	28.2	56.5	4.5	14.5	31.3	111.1	79.3	0.4	10.6	52.6	8.6	40.8	0.7	6.9	11.3	10.2	6.2	3.1	149.0	45.8	192.5
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"salivary gland: 371.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.2;Breast glandular cells: 10.3;Ductal cells: 6.5;Exocrine glandular cells: 8.2;Gastric mucus-secreting cells: 6.6;Glandular and luminal cells: 10.5;Theca cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 31.7;OE19: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.8	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.3	0.1	3.6	1.0	0.1	0.6	0.2	0.1	0.5	0.0	0.0	0.8	1.2	0.0	2.4	0.3	1.2	0.7	0.0	0.5	3.6	0.5	0.3	0.0	1.8	0.8	0.0	371.5	1.4	0.0	0.0	0.7	7.3	0.0	0.0	9.8	0.0	0.2	0.0	4.1	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.2	0.0	0.1	3.2	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.3	0.4	0.0	1.5	1.3	1.8	0.0	0.4	0.0	0.0	0.0	6.5	0.0	2.3	0.9	0.1	0.0	0.0	0.0	8.2	0.0	0.0	6.6	10.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	4.2	0.5	0.4
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	193	"liver: 42973.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 58657.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 193.9"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 193.9"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 1182.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	61000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	13.4	10.3	0.1	12.7	0.3	223.1	6.6	0.0	0.4	2.7	0.2	1.5	0.1	2.7	0.3	1.9	1.9	1.0	3.4	0.2	0.2	4.9	42973.6	24.4	0.7	0.4	0.2	1.6	8.1	0.0	1.4	1.3	0.1	57.6	0.0	1.1	1.4	0.0	2.0	1.7	2.3	0.3	0.2	51.3	19.2	2.7	0.1	1.2	2.8	0.3	0.1	1.6	2.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	3.4	0.6	1182.7	0.1	5.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.2	1.0	0.1	0.0	0.7	7.1	0.0	0.0	0.4	0.0	0.0	5.7	5.5	0.0	0.0	0.4	102.0	1.2	0.0	0.5	0.0	0.0	1.2	0.6	3.5	0.0	4.3	0.1	0.0	4.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.9	0.0	1.0	0.0	0.0	1.8	0.1	0.3	0.0	0.4	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.2	0.0	3.2	18.1	0.0	81.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1166.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	1.3	0.2	34.4	0.0	890.4	0.0	4.9	0.3	0.2	0.0	2.5	0.0	0.0	930.9	58657.7	0.1	0.0	0.0	0.0	0.0	1260.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	327	"liver: 8873.2"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 10792.5"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	40	"neutrophil: 12.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	232	"Hep G2: 831.1"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	41000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	4.0	4.0	0.2	3.2	0.4	27.1	3.0	0.0	0.2	1.3	0.2	0.3	0.2	2.1	0.1	0.4	0.4	0.6	0.8	0.1	0.1	1.7	8873.2	5.8	1.1	0.2	0.3	0.3	2.1	0.0	0.2	0.2	0.1	23.6	0.1	3.6	0.3	0.0	0.4	0.4	0.4	0.1	0.2	7.3	21.9	1.4	0.1	0.5	0.3	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	831.1	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.1	1.1	0.4	2.5	0.0	0.3	1.9	0.1	0.0	0.3	0.1	0.0	2.6	2.0	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.1	0.1	0.2	0.3	0.1	0.2	0.1	0.2	0.0	0.0	10.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	263.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.6	1.1	0.1	7.0	0.0	141.7	0.0	6.0	0.0	0.0	15.8	1.3	0.0	0.0	162.8	10792.5	0.0	0.0	0.0	0.0	0.0	236.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83931311-83966332	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 147.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.2;Hepatocytes: 78.4;Late spermatids: 261.1;Proximal enterocytes: 99.0"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.2;monocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"A549: 66.8;Hep G2: 103.7;T-47d: 73.3;WM-115: 62.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA019239			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA019239: AB_1854779"	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	8.5	26.5	7.0	4.8	8.3	0.8	7.1	7.6	7.0	4.0	4.3	7.4	31.3	3.3	1.2	12.3	4.5	8.4	10.1	5.2	7.3	14.1	147.4	9.3	1.3	10.1	9.0	4.3	8.5	3.0	3.7	1.6	10.2	5.6	2.5	2.0	5.2	2.2	22.4	3.3	18.7	1.6	5.5	10.5	13.9	15.2	9.3	0.8	13.2	9.6	1.2	12.8	5.7	9.3	4.7	66.8	0.8	2.9	4.1	5.9	5.0	7.7	7.5	7.0	2.5	16.9	24.0	0.1	18.0	6.7	31.5	12.6	3.2	4.9	2.6	1.1	0.8	1.2	15.5	103.7	15.0	2.3	25.7	3.6	3.9	18.1	4.1	3.9	7.2	4.8	6.5	6.5	9.1	31.9	0.9	0.9	0.6	16.5	15.8	2.3	6.7	3.3	4.8	5.9	0.4	1.5	16.0	5.1	32.6	1.7	73.3	2.7	23.1	10.6	16.0	15.7	5.3	2.7	1.2	0.2	35.6	3.6	62.8	0.1	2.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.2	0.0	12.6	0.0	0.0	1.0	7.0	8.3	7.6	7.0	5.2	7.3	10.1	9.0	10.2	5.5	9.3	9.3	2.2	16.0	3.9	0.0	0.6	1.5	8.1	15.7	5.2	0.8	7.9	4.3	9.0	8.6	18.5	1.8	0.0	1.4	0.5	41.8	5.9	11.3	56.2	6.1	1.0	5.4	4.2	0.0	0.1	6.6	0.4	5.4	26.0	5.3	1.3	2.7	6.1	78.4	10.5	0.0	0.1	12.9	12.2	9.4	3.0	261.1	4.1	7.3	7.2	0.0	3.0	8.6	0.0	0.0	0.2	13.2	23.5	12.0	1.3	11.8	99.0	11.7	5.0	0.6	13.1	4.7	5.1	2.3	1.3	6.0	1.7	1.4	0.6	4.6	10.5	5.9
OXA1L	"MGC133129, OXA1"	ENSG00000155463	"OXA1L mitochondrial inner membrane protein"	Q15070	14	22766522-22773042	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003531	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA003531: AB_1079539"	"unprognostic (4.04e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.15e-3)"	77.7	90.7	27.6	40.8	28.5	71.9	67.6	31.4	28.8	59.4	47.1	72.9	66.3	55.0	48.1	76.6	55.8	49.6	147.2	27.5	29.6	70.8	108.6	54.8	70.0	31.3	29.1	71.2	98.0	105.3	27.5	38.0	31.1	45.0	57.7	41.9	64.2	44.8	234.9	69.3	58.9	46.1	29.1	62.3	83.9	25.0	31.6	63.6	54.9	272.5	75.5	61.3	60.4	31.1	89.3	121.3	48.8	82.1	146.7	217.4	94.4	64.0	138.1	94.3	107.9	91.1	96.4	167.0	86.4	75.0	73.0	121.0	103.0	126.3	90.0	67.6	65.4	79.1	73.2	329.7	165.5	150.9	88.4	211.0	137.6	75.4	114.9	114.7	273.3	93.8	62.2	124.0	103.4	130.0	91.8	51.3	53.2	118.5	150.0	92.9	87.2	128.3	117.9	103.4	35.1	67.0	94.6	205.7	129.7	58.4	89.2	122.7	86.2	52.7	62.2	98.5	75.4	94.0	84.7	78.1	41.6	83.6	60.0	11.9	68.1	18.5	29.5	71.6	36.0	51.0	42.5	37.4	95.1	54.4	47.4	35.6	15.1	41.7	58.5	26.9	55.8	53.7	27.6	28.5	31.4	28.8	27.5	29.6	31.3	29.1	31.1	29.1	31.6	31.1	30.6	48.1	44.0	7.8	83.7	69.5	61.1	89.0	92.8	31.0	52.1	46.5	118.0	72.9	62.1	29.5	10.4	72.8	32.5	48.9	74.3	85.2	10.2	20.4	40.3	58.6	40.7	64.3	6.8	161.3	113.0	47.6	66.8	23.1	80.4	56.5	64.2	102.9	143.4	18.5	7.5	75.3	38.7	148.1	76.8	13.3	57.2	85.6	51.6	3.7	133.4	22.9	74.2	4.5	8.0	86.3	69.7	36.9	84.2	45.6	101.4	116.0	42.6	38.3	39.5	39.4	43.0	31.8	28.4	112.9	67.3	57.2	57.9	70.6	112.1	74.9
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836889-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 496.6;liver: 1408.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 250.2;Hepatocytes: 807.7;Proximal tubular cells: 344.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA		40000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.2	6.4	2.1	0.0	1.9	0.0	0.2	1.8	3.4	0.1	1.1	0.3	0.1	0.1	0.5	0.0	0.1	79.4	0.0	2.2	2.3	496.6	1408.4	0.0	0.1	2.8	2.3	0.1	9.2	0.8	3.0	0.0	2.3	1.5	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.6	0.3	0.4	3.3	2.5	0.7	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	238.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.2	1.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.9	1.8	3.4	2.2	2.3	2.8	2.3	2.3	2.6	2.5	2.8	0.0	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.5	250.2	0.0	5.5	0.0	0.0	0.0	0.0	21.5	2.4	66.8	0.0	0.1	1.1	1.8	21.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	807.7	0.0	3.3	2.3	0.0	0.0	22.2	0.0	15.7	0.6	1.8	0.0	0.0	0.0	0.6	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.4	0.0	344.4	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.1
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180295	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.4;Excitatory neurons: 13.3;Hepatocytes: 10.7;Inhibitory neurons: 15.8;Muller glia cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 10.3;HDLM-2: 16.7;Hep G2: 19.6;MCF7: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.0	0.8	4.4	0.5	4.4	1.6	1.0	8.4	40.1	1.7	0.0	0.3	0.0	1.2	0.5	5.2	2.2	0.4	0.7	8.0	13.1	3.0	9.6	2.1	0.0	51.0	8.8	3.4	1.4	0.3	7.9	0.1	48.4	3.9	0.0	1.6	5.0	1.4	0.7	1.1	0.2	0.0	7.9	1.9	0.4	1.7	14.1	0.0	7.3	0.1	0.1	1.4	1.9	16.4	0.9	2.1	0.4	2.3	0.0	0.2	4.9	2.6	2.5	0.5	0.4	0.5	8.0	0.0	10.3	0.3	1.4	0.5	1.3	1.0	0.1	16.7	1.4	0.4	3.5	19.6	0.7	0.1	1.2	0.2	1.0	0.7	0.0	1.1	0.6	0.0	1.4	0.0	0.2	10.8	0.0	1.0	3.9	0.0	4.2	1.0	0.0	4.0	0.0	1.6	9.8	0.9	1.6	0.2	6.5	0.5	0.7	0.8	4.5	0.5	4.1	6.7	4.9	1.8	0.1	0.6	0.3	0.0	7.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	4.4	4.4	8.4	40.1	8.0	13.1	51.0	8.8	48.4	7.9	14.1	16.4	0.0	0.0	1.1	7.2	0.3	0.5	3.1	0.6	0.0	11.4	2.5	2.4	0.8	1.5	2.6	0.0	0.0	0.0	1.5	0.0	5.9	2.3	0.3	5.9	1.5	0.7	0.0	0.4	13.3	2.8	0.2	0.8	0.0	7.0	0.0	2.1	0.0	10.7	0.1	0.0	15.8	0.0	0.0	0.9	1.5	0.2	0.0	1.1	0.0	1.9	1.8	29.7	0.0	6.6	1.2	1.8	0.0	1.2	0.5	6.0	0.0	3.0	3.0	3.6	0.0	0.1	0.9	0.0	1.8	0.3	0.3	0.0	0.2	0.1	0.0	4.5
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 42.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.2	8.0	25.1	2.4	24.8	1.3	2.8	32.4	38.5	2.1	19.3	7.7	1.1	2.6	2.1	2.0	2.7	1.9	4.2	28.1	22.3	8.8	6.5	3.1	3.1	25.3	22.8	3.9	27.9	6.6	30.2	0.7	26.8	3.6	1.0	2.7	2.7	2.7	8.7	1.8	4.1	1.6	21.9	4.8	5.9	42.9	25.8	3.4	2.4	5.3	2.2	3.7	1.7	25.4	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	25.1	24.8	32.4	38.5	28.1	22.3	25.3	22.8	26.8	21.9	25.8	25.4	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087477-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		No	No		1600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996"	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	278.3	276.3	145.5	199.8	155.0	390.0	240.4	168.5	203.5	209.3	159.1	259.9	172.8	253.9	142.6	278.4	193.8	134.9	223.2	142.1	155.6	218.1	304.3	233.6	227.1	163.7	146.9	186.0	249.9	174.6	140.2	194.8	159.2	143.9	125.8	90.5	185.0	139.5	782.3	216.6	203.1	172.4	163.8	241.3	214.5	95.2	150.4	301.0	170.8	308.3	209.6	233.8	206.0	190.9	384.9	387.5	327.1	257.5	345.1	262.4	525.9	280.5	257.2	272.0	227.0	453.0	250.6	522.9	140.9	320.7	293.7	334.7	388.4	408.6	276.5	376.2	299.9	419.2	219.5	701.3	388.0	350.8	385.8	230.3	261.6	224.5	310.5	203.4	350.7	138.9	437.2	375.6	346.2	475.7	454.7	524.7	331.5	361.1	253.2	362.9	358.0	527.1	375.5	389.6	309.7	249.1	230.3	465.8	342.1	229.8	277.6	314.2	325.1	253.5	317.6	217.6	359.4	495.7	551.2	531.7	268.6	480.4	319.5	42.6	89.7	141.5	80.3	92.5	73.8	41.1	62.1	69.3	82.9	36.4	62.8	71.2	138.2	95.4	80.5	58.9	81.7	100.5	145.5	155.0	168.5	203.5	142.1	155.6	163.7	146.9	159.2	163.8	150.4	190.9	241.0	153.8	132.7	27.4	312.7	484.0	296.0	192.1	196.9	64.9	270.8	212.6	0.6	208.8	134.5	196.8	22.9	372.4	208.7	401.7	272.0	196.0	34.4	187.6	220.8	242.8	178.6	485.3	19.1	199.2	470.1	196.9	227.9	284.8	114.2	129.6	227.0	392.7	385.7	58.9	18.0	239.8	138.4	509.2	795.9	34.4	186.1	382.4	300.6	30.0	422.9	122.3	347.1	14.1	49.1	211.7	311.7	186.5	357.1	278.5	338.4	481.0	128.6	56.1	170.9	222.9	241.9	131.0	65.5	267.0	545.8	703.4	291.2	148.4	232.9	366.6
PCGF2	"MEL-18, RNF110, ZNF144"	ENSG00000277258	"Polycomb group ring finger 2"	P35227	17	38733898-38749817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047732, HPA063531"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047732: AB_2680138, HPA063531: AB_2685031"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.10e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	33.6	38.3	3.3	4.6	3.2	0.0	33.0	7.7	5.5	44.7	4.3	24.4	3.7	40.6	2.4	21.4	35.9	6.1	37.3	3.2	5.2	56.5	12.9	33.4	2.1	2.6	3.0	40.5	22.9	2.9	55.6	6.8	2.9	37.5	1.6	7.2	22.6	2.7	9.3	21.6	22.7	2.1	1.2	28.3	25.3	13.3	4.1	0.2	41.7	0.9	0.8	27.3	30.8	3.1	16.9	38.2	9.2	34.5	7.2	2.3	11.7	13.1	6.2	6.2	7.4	21.1	17.6	1.3	14.3	4.2	16.3	26.2	3.4	6.1	2.5	10.4	20.1	7.9	20.7	52.4	2.3	1.2	9.4	2.5	2.8	9.0	6.1	9.6	7.5	7.9	14.9	21.2	3.9	37.8	1.5	0.2	11.7	7.4	15.3	12.6	14.7	3.3	3.2	22.5	16.4	26.8	12.6	9.0	20.8	9.0	35.4	1.6	22.0	24.8	27.1	24.8	23.2	12.5	4.1	4.3	13.3	2.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.2	7.7	5.5	3.2	5.2	2.6	3.0	2.9	1.2	4.1	3.1	49.6	3.2	16.0	2.0	1.1	14.1	11.2	19.7	23.9	59.9	20.6	17.0	2.1	15.7	10.1	20.2	10.4	13.3	0.8	23.7	52.8	24.9	15.1	8.0	22.1	46.4	13.2	0.0	6.5	13.7	26.7	21.9	12.8	12.8	1.3	14.0	51.0	2.9	4.8	35.3	7.0	12.5	22.4	2.9	5.5	5.0	37.0	2.9	14.2	6.5	3.2	26.4	2.1	9.5	2.4	18.9	10.3	29.3	3.8	15.4	22.3	59.6	5.0	16.5	0.0	16.8	16.7	6.1	15.7	9.6	16.9	22.2	0.9	13.3	13.2	11.1
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900958-81911432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.7;testis: 261.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 763.2;Late spermatids: 2829.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 218.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		84000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favorable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	29.7	16.8	40.0	9.5	40.1	12.1	25.2	44.4	45.8	14.9	30.4	25.5	63.9	18.0	13.5	26.3	23.9	9.9	47.7	41.2	37.7	44.0	165.7	21.3	12.0	47.0	43.0	20.9	25.3	20.2	14.4	12.0	47.3	24.2	16.7	8.6	22.3	12.1	33.5	16.3	43.0	9.6	41.3	12.8	35.4	261.7	41.0	13.5	16.2	29.3	11.9	21.2	15.1	44.0	42.6	23.9	18.8	53.1	91.8	48.0	27.9	29.9	63.2	40.7	48.0	94.0	43.0	14.8	16.0	31.1	75.3	34.5	28.6	55.1	23.5	4.5	24.3	32.1	33.3	218.2	97.8	32.5	26.0	39.8	31.4	36.8	28.4	14.5	38.6	44.0	60.6	29.6	30.8	35.7	39.3	40.1	15.1	147.2	25.9	25.4	20.2	52.4	49.2	78.8	23.9	21.9	22.4	121.7	29.0	36.5	33.9	75.3	26.1	30.0	19.7	22.9	25.0	19.3	9.1	15.3	31.2	42.8	29.9	1.5	2.4	0.9	4.6	2.6	3.0	4.2	5.5	4.7	4.5	5.6	4.5	4.6	0.7	3.3	2.1	4.4	3.6	3.1	40.0	40.1	44.4	45.8	41.2	37.7	47.0	43.0	47.3	41.3	41.0	44.0	11.5	0.0	17.3	15.0	11.1	5.4	8.1	11.7	6.8	12.5	25.1	11.0	17.0	62.9	9.6	25.8	0.0	73.1	21.0	41.6	119.3	19.5	763.2	29.0	7.5	8.7	13.9	47.8	5.3	18.3	39.7	7.7	36.2	15.8	9.5	39.6	21.8	166.0	24.1	16.8	4.6	29.1	20.3	11.8	3.3	2829.0	27.7	8.1	33.8	0.0	14.7	26.7	22.6	3.5	12.2	17.8	18.8	25.9	13.4	11.4	144.4	130.3	29.4	10.6	26.3	6.2	11.5	253.1	18.1	16.5	5.7	50.8	13.6	34.4	48.7	7.7
PDE11A		ENSG00000128655	"Phosphodiesterase 11A"	Q9HCR9	2	177623244-178072777	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 6.3;parathyroid gland: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0;Hepatocytes: 11.1;Late spermatids: 46.4;Oligodendrocytes: 14.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;fHDF/TERT166: 2.4;HAP1: 1.4;Hep G2: 2.8"									HPA034560	Approved				"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA034560: AB_10602140"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-4)"	"unprognostic (1.64e-3)"	2.3	0.3	0.8	0.1	2.0	0.2	1.7	1.9	1.2	0.6	0.6	0.5	0.8	1.2	0.4	0.0	0.3	0.4	0.3	0.6	2.1	0.5	6.3	0.0	0.0	2.5	2.1	0.4	1.1	9.8	0.9	0.0	2.7	5.2	0.4	1.4	1.4	0.8	4.4	0.1	0.5	1.1	3.7	0.1	0.4	2.8	1.9	0.1	1.3	1.3	0.0	0.0	0.1	3.2	0.0	0.4	0.2	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.2	1.6	0.0	0.6	2.4	0.3	0.1	1.4	0.0	0.0	0.0	0.9	1.1	0.1	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.2	0.4	0.1	0.6	0.0	0.3	0.2	0.0	0.2	0.0	0.5	0.0	0.3	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.8	2.0	1.9	1.2	0.6	2.1	2.5	2.1	2.7	3.7	1.9	3.2	0.1	0.0	0.0	2.3	0.2	0.6	1.4	0.1	0.0	1.7	4.2	0.8	0.0	1.5	0.1	0.0	0.0	0.1	0.3	0.8	0.0	0.8	37.0	0.3	0.2	0.6	6.7	2.7	1.6	6.7	0.0	0.6	0.0	0.2	0.0	0.0	1.4	11.1	0.1	0.0	8.2	0.9	6.1	1.2	2.1	46.4	1.5	0.3	0.0	0.0	0.0	4.7	0.0	6.0	14.9	2.3	0.0	0.7	0.0	5.4	0.6	1.3	0.1	1.0	0.0	2.0	0.6	6.8	6.9	0.0	1.3	0.3	0.3	0.3	1.3	1.0
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283164-287215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 2509.7"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 294.9"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 7.9;Hep G2: 6.7;Karpas-707: 2.9;MCF7: 4.6;SH-SY5Y: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	2.8	0.6	64.4	0.4	70.1	0.6	0.8	80.5	96.0	0.6	61.2	2.7	23.9	0.3	0.9	0.9	0.7	0.1	4.4	64.2	66.7	0.6	0.6	0.7	0.2	76.6	67.1	1.5	2509.7	0.0	7.6	2.5	73.2	1.0	0.3	2.4	1.0	0.1	0.6	0.4	7.1	0.0	69.9	0.3	191.7	1.0	68.7	0.0	0.4	0.0	0.5	0.5	0.6	88.5	0.0	1.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	3.9	0.1	0.5	0.0	7.9	0.0	0.3	6.7	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.3	2.9	0.1	4.6	0.1	0.4	0.2	1.6	0.0	0.1	0.0	0.9	0.0	0.0	1.6	3.7	0.0	0.1	0.0	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.4	70.1	80.5	96.0	64.2	66.7	76.6	67.1	73.2	69.9	68.7	88.5	0.0	0.0	0.5	1.6	1.9	0.5	0.0	0.0	0.0	4.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.1	0.3	0.1	0.0	0.0	12.4	294.9	1.3	5.5	65.7	0.1	0.0	0.1	0.0	0.0	0.4	0.0	14.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	1.6	0.6	0.0	2.0	22.2	25.5	1.4	0.4	0.2	0.0	3.9	1.1	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	1.4	0.0
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118136124-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2083.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 3705.6;Hepatocytes: 2242.4;Proximal enterocytes: 2177.7;Proximal tubular cells: 4542.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA008819, CAB009906, CAB013493, HPA063904"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		51000000	"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708"	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	217.9	1754.1	941.2	84.0	966.0	121.8	235.5	987.9	1049.0	258.0	958.4	208.9	601.4	186.6	383.7	219.5	218.4	154.8	463.8	932.6	951.5	1046.1	2083.1	176.4	122.7	959.0	965.9	335.9	357.5	1162.7	292.3	128.8	982.6	261.6	191.2	336.1	344.5	233.2	580.3	190.3	510.6	167.6	1006.6	121.2	201.7	152.2	1025.0	138.1	739.7	546.8	160.2	200.8	179.0	1081.7	289.2	241.6	340.0	348.8	493.5	250.2	500.0	214.5	262.3	347.7	177.1	151.6	96.4	439.6	221.3	336.2	139.9	194.4	495.0	202.8	257.7	115.1	454.2	220.0	274.7	1021.7	289.2	403.6	94.5	240.8	334.7	203.9	140.0	396.1	162.7	240.9	375.8	169.2	356.4	346.3	226.8	813.7	319.7	243.1	273.9	446.1	235.6	829.7	428.7	277.2	397.5	306.9	439.9	306.2	446.0	200.4	443.6	293.0	168.9	253.7	147.0	254.0	237.3	161.6	315.1	234.1	301.1	303.2	280.9	5.0	67.5	20.0	155.2	76.4	247.0	271.7	258.9	193.1	205.1	210.0	244.6	201.2	8.0	138.1	68.6	231.6	259.7	258.4	941.2	966.0	987.9	1049.0	932.6	951.5	959.0	965.9	982.6	1006.6	1025.0	1081.7	193.7	403.8	433.3	101.5	230.9	318.1	449.3	367.6	288.5	539.4	538.4	590.7	697.3	713.4	243.2	783.5	95.9	999.6	144.6	207.1	3705.6	507.9	44.3	499.3	319.0	186.5	320.6	218.1	93.7	244.6	862.3	347.9	169.2	369.8	371.8	419.7	213.8	2242.4	591.6	721.8	99.6	378.8	335.7	201.4	239.0	84.4	543.1	195.3	743.5	53.4	296.8	1792.2	101.0	39.2	199.8	184.2	313.3	731.6	279.3	517.4	2177.7	4542.6	291.6	411.6	368.1	337.5	347.8	330.6	145.7	367.7	325.2	615.5	216.7	921.6	631.3	399.5
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 172.1;brain: 348.9;placenta: 467.0"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 2015.8;Syncytiotrophoblasts: 2856.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 773.3;HAP1: 1015.3;Hep G2: 805.0;SCLC-21H: 488.6"	"Region enhanced"	"Detected in all"		"hypothalamus: 110.7"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	3.2	172.1	101.2	2.6	111.9	0.9	24.6	43.7	46.4	7.5	0.0	5.5	0.8	5.6	1.9	2.3	10.0	3.2	1.6	43.5	331.8	7.3	2.4	15.4	5.1	55.2	122.0	65.1	11.4	2.1	88.3	467.0	136.0	2.7	2.0	23.0	9.1	2.6	2.2	0.6	1.5	3.9	32.2	2.0	2.8	41.1	348.9	13.2	11.4	3.3	3.2	3.6	1.6	23.0	22.8	111.6	773.3	329.0	16.0	28.5	45.0	60.7	35.3	42.8	57.3	187.6	37.0	2.5	2.2	70.2	87.5	6.9	1015.3	43.1	58.9	2.9	107.0	0.1	121.8	805.0	12.0	129.6	0.2	63.9	13.9	105.7	73.0	37.1	25.8	0.0	0.5	243.7	84.5	5.8	0.5	0.1	355.4	19.1	70.5	48.5	247.6	67.4	194.3	83.2	488.6	28.2	0.4	16.9	59.9	192.8	105.8	0.3	0.0	33.7	2.0	4.2	46.9	65.2	46.4	97.1	76.3	0.1	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	101.2	111.9	43.7	46.4	43.5	331.8	55.2	122.0	136.0	32.2	348.9	23.0	4.0	153.8	82.4	11.4	37.1	0.8	9.1	2.5	0.6	87.5	49.4	74.3	42.8	5.7	69.8	16.5	8.4	2015.8	3.3	0.9	64.6	18.1	4.5	9.7	3.0	8.4	60.4	0.0	15.8	5.3	205.1	45.3	2.0	15.4	2.5	24.2	4.2	4.7	175.8	37.0	21.9	0.6	8.2	0.0	0.6	18.9	9.0	1.7	14.2	4.7	0.0	109.0	0.0	10.1	12.8	5.2	0.0	4.1	1.5	9.6	0.0	22.0	8.9	29.7	6.6	173.1	23.0	52.9	51.5	2.5	0.9	2856.1	2.6	68.9	0.7	0.6
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810077-56840728	"Predicted intracellular proteins, Transcription factors"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 76.9;brain: 218.4;choroid plexus: 177.0;ovary: 260.1;placenta: 135.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 345.8;Granulosa cells: 224.1;Horizontal cells: 148.0;Syncytiotrophoblasts: 477.1;Theca cells: 395.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 103.6;Hep G2: 218.1;RH-30: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026070	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.68e-3)"	2.4	76.9	76.5	1.5	56.5	0.1	10.9	4.4	41.2	8.7	177.0	5.1	0.6	22.8	5.8	2.2	12.9	1.9	3.5	28.7	218.4	3.4	4.5	1.8	0.5	51.9	105.8	260.1	2.5	9.9	28.8	135.1	95.6	3.0	1.7	17.9	5.4	4.9	0.7	1.5	1.4	9.2	27.4	0.8	2.1	33.6	130.4	1.0	5.7	1.8	6.2	3.5	3.3	42.8	0.0	0.0	4.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	218.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.6	0.0	71.7	0.1	0.1	0.1	0.2	6.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.5	56.5	4.4	41.2	28.7	218.4	51.9	105.8	95.6	27.4	130.4	42.8	4.1	0.0	4.6	0.0	0.2	4.8	1.9	0.0	4.0	31.0	10.9	17.8	17.2	1.5	1.8	1.8	8.4	345.8	1.6	0.0	1.9	0.9	32.0	1.3	35.0	3.5	0.0	0.0	0.0	0.0	45.4	56.9	0.0	1.6	0.0	224.1	4.6	4.3	34.3	148.0	0.0	0.0	0.0	0.6	1.7	19.4	58.7	1.2	14.2	0.0	0.0	17.0	0.0	0.0	0.0	0.3	0.0	109.9	0.0	2.0	0.0	1.1	2.2	13.7	13.1	29.5	17.0	53.0	36.2	2.0	2.6	477.1	0.2	395.9	0.0	0.7
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.9	28.9	22.2	2.2	24.3	3.1	13.9	23.5	25.7	10.8	19.7	11.3	6.7	11.4	8.5	17.2	10.0	4.2	16.1	20.6	21.6	18.1	22.0	8.8	4.3	25.4	22.6	12.8	19.8	10.4	18.5	3.8	22.1	16.1	4.4	4.6	14.3	6.9	18.6	14.0	9.6	4.1	23.4	10.2	12.7	22.0	23.3	3.7	13.1	10.2	3.4	12.9	11.3	25.3	18.6	16.9	13.2	7.4	7.9	9.7	11.5	9.6	10.9	14.2	11.3	27.2	13.9	10.8	27.1	11.9	8.7	12.1	11.6	16.3	8.1	16.8	21.9	8.5	17.2	55.3	16.4	14.2	4.2	9.0	9.3	10.8	16.0	10.4	13.9	12.5	9.9	7.4	14.7	26.2	9.1	6.0	9.6	8.0	31.3	7.8	13.8	18.9	17.8	6.3	18.2	15.3	13.0	8.2	29.2	7.1	8.3	3.5	14.8	6.7	5.9	17.2	10.8	19.0	7.6	8.6	17.6	10.9	6.1	1.6	5.8	1.7	3.8	8.7	4.4	5.9	3.3	5.1	9.4	4.9	3.8	3.0	0.6	3.6	7.6	7.8	2.1	4.2	22.2	24.3	23.5	25.7	20.6	21.6	25.4	22.6	22.1	23.4	23.3	25.3	12.8	3.2	4.4	3.3	9.5	8.8	13.7	15.4	15.9	16.8	16.4	15.4	1.1	11.5	8.9	14.7	0.0	26.7	6.7	8.3	35.2	26.8	51.7	8.5	9.0	11.2	13.2	9.2	5.1	30.3	25.2	11.5	12.8	10.3	0.0	22.8	7.5	10.5	22.9	13.5	5.6	10.3	12.2	11.2	7.2	194.7	10.5	9.6	23.2	2.8	18.7	45.2	8.2	8.0	6.7	21.0	7.7	13.5	14.9	14.6	17.5	27.8	8.6	14.8	0.0	15.5	10.9	28.9	22.8	22.4	6.1	27.5	6.9	30.2	14.6	14.1
PFDN4	"C-1, C1, PFD4"	ENSG00000101132	"Prefoldin subunit 4"	Q9NQP4	20	54208087-54228052	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024055	Approved					NA	NA		220000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA024055: AB_1855236"	"unprognostic (2.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (9.40e-4)"	"prognostic unfavorable (7.66e-5)"	"unprognostic (7.87e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.44e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.47e-10)"	"unprognostic (9.43e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.57e-2)"	5.5	6.2	12.6	4.8	12.9	5.3	6.0	12.5	19.0	5.8	10.7	3.7	2.0	8.0	5.8	5.3	4.7	5.8	14.2	13.1	14.4	6.4	4.0	3.9	6.8	13.3	13.9	7.9	3.7	5.8	2.6	6.6	13.8	5.4	4.2	3.4	4.1	5.2	8.8	4.4	2.7	6.3	12.7	3.2	2.3	7.6	13.2	4.8	6.9	8.2	4.9	5.8	2.7	13.1	9.9	3.4	11.6	3.8	8.1	19.4	11.5	9.2	7.1	21.8	9.6	12.6	9.9	7.2	30.1	10.4	12.6	8.4	13.3	11.9	36.7	7.2	10.0	6.1	13.1	42.6	10.5	12.5	6.8	10.3	16.8	9.4	17.3	11.3	13.8	8.9	11.6	8.2	20.0	38.8	12.8	29.5	14.1	6.2	16.5	9.9	4.1	13.2	18.7	12.7	13.6	14.4	11.2	30.3	31.9	10.5	9.4	25.4	6.9	15.5	18.8	21.8	20.8	5.1	8.1	11.0	15.4	11.0	13.7	3.6	5.4	2.6	4.4	5.8	6.2	6.0	5.9	5.3	7.8	5.2	6.1	5.7	0.8	7.6	5.5	8.6	12.5	5.0	12.6	12.9	12.5	19.0	13.1	14.4	13.3	13.9	13.8	12.7	13.2	13.1	46.7	28.9	32.9	6.2	47.3	91.1	86.4	190.5	59.7	16.5	67.6	82.2	73.6	52.9	68.7	40.5	0.0	124.4	53.2	45.5	107.6	147.5	196.9	67.6	53.5	65.3	71.2	77.2	14.7	137.9	147.1	66.6	19.9	82.1	43.1	52.1	84.6	71.6	95.3	13.5	14.6	56.7	85.5	104.3	104.8	35.7	78.9	46.8	62.2	8.4	172.5	41.7	52.5	12.1	11.9	145.8	68.5	68.1	35.1	69.0	42.7	135.4	66.6	15.7	105.2	55.5	64.6	181.4	92.8	57.3	88.5	93.4	53.6	48.5	66.5	76.7
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 59821.1"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	19.4	7.0	0.0	0.3	0.1	0.2	6.6	1.2	0.5	6.7	0.0	26.4	1327.3	2.8	0.9	85.5	9.2	2.3	6.2	0.1	0.0	4.9	11.0	378.8	0.3	0.0	0.0	3.9	136.3	0.0	7.4	2.8	0.0	83.9	0.3	0.1	4.6	437.7	2.5	3.4	3.2	0.0	0.0	7.7	59821.1	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
PHETA1	"FAM109A, FLJ32356, IPIP27A, SES1"	ENSG00000198324	"PH domain containing endocytic trafficking adaptor 1"	Q8N4B1	12	111360651-111369121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 32.6;Granulosa cells: 9.6;Hofbauer cells: 10.6;Pancreatic endocrine cells: 33.8;Theca cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;dendritic cells: 3.1;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 43.5;OE19: 34.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (2.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	7.3	17.1	6.3	3.6	5.5	1.6	6.8	4.9	5.8	11.2	4.5	14.9	28.6	9.8	2.2	12.6	7.8	5.2	19.3	5.0	6.5	9.8	19.5	10.9	2.2	7.1	6.2	14.0	29.0	2.9	5.1	2.5	5.9	9.4	5.4	1.1	9.5	3.6	10.2	20.0	27.9	3.5	5.4	23.2	22.7	10.9	7.0	1.2	6.5	4.6	2.0	7.1	8.6	5.4	8.5	7.4	6.2	9.5	8.5	7.4	16.5	5.4	4.7	4.2	2.2	11.7	5.7	0.2	11.5	8.2	5.9	4.6	3.3	3.5	1.8	3.4	7.6	5.7	2.7	43.5	5.0	1.1	7.4	6.1	8.8	6.3	2.0	8.3	6.3	2.8	13.4	0.6	5.2	8.0	1.4	6.8	9.7	34.3	17.6	5.6	4.2	2.5	4.3	4.7	1.4	18.6	8.4	12.8	3.7	5.2	8.7	2.1	7.6	6.2	12.4	7.2	4.2	5.5	5.0	1.0	6.2	3.8	7.1	0.0	1.2	0.2	0.3	1.9	0.4	0.2	0.1	0.1	3.1	1.0	0.0	0.4	0.0	0.3	1.9	0.3	0.0	0.9	6.3	5.5	4.9	5.8	5.0	6.5	7.1	6.2	5.9	5.4	7.0	5.4	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.3	3.2	0.0	0.0	0.0	3.7	0.0	1.3	1.4	0.0	3.9	6.8	0.0	2.8	5.2	1.3	0.0	0.0	0.0	32.6	5.5	1.8	0.0	4.0	0.0	9.6	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.3	0.0	0.0	7.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.2	0.2	8.9	0.0	0.0
PHKB		ENSG00000102893	"Phosphorylase kinase regulatory subunit beta"	Q93100	16	47461123-47701523	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073380			Approved	"Golgi apparatus"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA073380: AB_2686598"	"unprognostic (2.87e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.98e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (3.89e-9)"	"unprognostic (3.56e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.53e-2)"	29.7	42.4	15.8	21.9	16.2	28.2	36.1	18.3	19.5	33.8	34.1	39.0	37.8	26.8	32.8	34.5	25.6	30.6	32.7	14.3	21.3	47.2	30.1	30.0	26.2	15.8	16.0	24.2	26.6	56.7	21.6	37.1	18.6	36.2	41.5	18.9	46.1	32.2	159.0	18.9	38.0	32.1	13.8	29.0	40.4	30.6	18.9	31.0	54.1	80.7	29.0	26.5	21.2	16.6	36.7	53.3	60.3	39.1	41.2	38.8	74.9	42.8	41.2	30.1	15.0	29.4	62.2	44.5	63.5	62.7	23.7	50.6	57.0	66.9	42.3	13.8	29.8	42.1	45.4	98.3	37.0	46.2	47.7	35.1	33.4	20.3	38.2	65.4	59.8	53.5	58.8	27.4	43.7	26.3	45.2	44.1	25.5	61.1	39.8	75.7	73.3	74.3	59.2	31.1	31.5	35.8	70.9	92.4	12.0	66.1	36.0	37.7	66.5	54.4	25.4	28.0	22.9	31.1	24.6	57.2	34.5	30.2	22.7	11.1	21.0	18.4	11.8	18.9	15.3	30.6	12.2	9.7	20.6	34.7	11.8	11.7	10.4	18.5	23.7	13.9	15.8	12.6	15.8	16.2	18.3	19.5	14.3	21.3	15.8	16.0	18.6	13.8	18.9	16.6	49.3	19.2	38.0	66.9	46.8	8.9	17.5	28.8	18.8	34.9	28.7	23.4	61.2	32.9	39.9	42.3	100.1	48.5	29.3	43.1	23.5	19.6	64.7	33.5	31.1	42.9	30.5	40.1	109.8	15.6	26.3	28.8	47.9	38.3	18.3	52.6	39.3	30.9	28.4	23.5	149.0	37.8	20.3	58.7	17.0	89.8	25.4	45.1	8.8	104.0	72.2	25.8	32.0	133.2	118.4	27.2	26.4	35.7	28.1	30.2	48.9	35.9	26.7	71.8	26.3	33.3	30.6	53.9	19.5	47.2	7.2	33.8	24.7	74.9	38.6	26.7
PHYHIPL	"Em:AC025038.1, KIAA1796"	ENSG00000165443	"Phytanoyl-CoA 2-hydroxylase interacting protein like"	Q96FC7	10	59176643-59247774	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 18.4;brain: 45.5;retina: 30.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 210.6;Early spermatids: 208.4;Horizontal cells: 144.7;Inhibitory neurons: 170.2;Late spermatids: 241.4;Muller glia cells: 246.1;Oligodendrocyte precursor cells: 264.9;Oligodendrocytes: 357.1"	"Group enriched"	"Detected in many"	5	"glioma: 21.1;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.3;Hep G2: 34.3;SCLC-21H: 6.1;SH-SY5Y: 19.4;SK-BR-3: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038746	Uncertain		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA038746: AB_10673293"	"unprognostic (6.34e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.67e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.60e-7)"	"unprognostic (1.29e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	0.3	18.4	22.5	0.4	30.1	0.0	0.4	31.6	36.9	1.6	0.3	2.1	8.5	0.7	1.8	0.3	1.1	0.1	0.3	21.2	36.1	11.0	1.1	0.2	0.0	41.3	32.1	0.8	5.4	0.0	6.7	1.8	32.8	2.8	0.3	30.5	0.7	2.6	0.6	0.3	8.9	0.1	42.4	0.1	0.6	6.5	26.2	0.0	0.2	0.0	0.0	0.1	1.2	45.5	0.0	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	19.4	0.0	8.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	30.1	31.6	36.9	21.2	36.1	41.3	32.1	32.8	42.4	26.2	45.5	3.1	0.0	0.0	210.6	0.0	0.0	14.0	0.0	0.0	135.2	0.2	1.0	0.5	2.8	0.0	3.7	12.5	1.0	0.0	0.1	13.7	0.6	208.4	24.1	8.0	1.6	0.0	2.7	97.3	6.5	0.3	1.2	0.0	71.9	0.0	0.8	0.7	1.8	0.5	144.7	170.2	3.0	0.0	0.0	0.0	241.4	13.1	1.3	1.8	11.2	0.0	246.1	0.0	264.9	357.1	1.7	6.3	0.4	0.0	4.0	24.0	80.3	0.0	53.9	0.0	3.0	2.4	137.1	27.2	0.1	0.0	49.0	0.6	0.3	9.6	2.8
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946356-196969060	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 205.1;Intestinal goblet cells: 61.3;Paneth cells: 129.7;Proximal enterocytes: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA058599, HPA059920"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA058599: AB_2683771, HPA059920: AB_2684162"	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.7	1.6	8.2	2.0	8.5	1.0	5.4	8.6	9.6	4.3	4.4	39.1	1.6	3.4	0.7	4.2	3.4	2.0	6.9	8.1	9.2	2.1	2.6	3.7	1.1	7.6	8.6	0.8	2.7	3.0	4.1	1.0	10.0	6.1	16.7	3.1	4.7	2.6	7.4	4.7	11.7	2.7	5.3	1.9	4.6	1.6	8.6	1.2	1.9	3.2	0.5	10.4	4.6	7.7	1.8	1.2	0.7	2.8	7.7	3.7	0.7	2.6	7.3	2.0	1.6	1.7	1.5	0.3	5.1	5.9	1.3	3.0	0.1	0.4	0.5	0.5	0.3	0.8	0.6	6.5	3.6	0.0	2.9	3.7	5.6	0.3	0.9	2.2	2.4	4.7	0.2	2.2	1.9	3.2	0.3	1.5	0.1	2.2	0.9	0.4	0.1	0.6	3.0	3.3	1.1	1.2	3.7	0.3	1.5	0.3	7.2	2.6	6.0	1.6	0.4	4.7	0.9	1.0	0.1	0.1	0.4	1.1	0.6	0.0	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	8.2	8.5	8.6	9.6	8.1	9.2	7.6	8.6	10.0	5.3	8.6	7.7	8.9	0.0	1.1	20.5	1.7	7.8	9.1	3.8	6.8	7.1	22.6	33.9	8.0	1.5	2.8	9.2	2.1	0.0	2.8	205.1	5.9	2.3	2.1	5.1	3.0	5.5	13.8	3.0	31.3	3.6	0.0	5.0	1.5	6.5	5.7	0.3	12.1	10.3	1.8	15.2	21.9	61.3	10.2	4.4	3.4	5.0	4.1	2.2	8.8	5.6	4.1	4.6	2.1	12.5	2.7	3.2	129.7	6.4	1.9	7.4	50.0	5.4	2.7	7.0	0.0	7.7	6.5	1.2	0.2	11.5	5.1	0.1	1.7	0.0	44.4	14.7
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057216	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"kidney: 146.0;liver: 506.6"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 225.4;Proximal tubular cells: 163.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 73.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 36.7;Hep G2: 120.2;NTERA-2: 68.4;RH-30: 90.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		380000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.4	0.6	14.3	0.6	17.5	0.3	0.3	17.5	15.6	0.7	11.4	3.6	13.6	1.6	24.4	1.8	8.8	3.4	0.4	13.8	15.3	146.0	506.6	1.2	0.9	15.1	16.3	0.9	0.7	1.7	0.8	4.2	14.7	2.0	1.1	4.4	0.5	3.4	0.3	0.7	4.3	2.0	13.0	1.0	0.9	0.3	16.3	0.4	0.2	0.1	0.5	1.3	0.5	14.2	0.0	0.0	36.7	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.8	0.0	0.1	0.2	0.6	0.0	0.1	0.5	0.5	0.5	0.2	120.2	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	1.1	0.0	0.2	0.0	0.7	68.4	2.4	0.0	0.3	90.7	2.2	0.0	0.1	11.2	3.8	0.3	0.2	0.5	5.9	0.2	4.4	0.0	0.1	0.2	0.1	4.3	0.9	11.4	0.4	0.0	0.6	3.6	1.0	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.4	1.8	0.2	0.1	0.8	1.4	0.3	0.1	0.1	0.4	0.3	14.3	17.5	17.5	15.6	13.8	15.3	15.1	16.3	14.7	13.0	16.3	14.2	0.4	0.0	0.6	12.4	1.4	0.3	0.3	0.2	0.0	2.9	0.2	0.3	0.5	5.7	0.1	0.0	4.2	0.2	0.7	0.2	9.8	0.0	1.5	0.2	0.3	0.8	1.2	5.3	0.2	0.2	7.7	0.7	1.5	0.2	5.7	1.3	5.3	225.4	1.2	0.0	0.5	0.0	0.0	6.0	2.1	2.1	0.3	2.2	0.0	1.0	2.2	29.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.3	1.9	163.7	0.0	1.4	0.0	0.7	0.4	0.1	1.0	0.0	0.1	0.4	1.2	0.1	0.1	0.1
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322115-120327779	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1519	"pancreas: 117705.6"	"Cell type enriched"	"Detected in many"	17	"Exocrine glandular cells: 20351.4"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	10.0	6.5	0.2	1.7	0.1	2.9	5.8	0.2	0.6	5.8	0.0	2.3	15.8	2.3	0.0	3.3	1.8	0.9	21.5	0.2	0.2	2.7	7.2	32.1	4.0	0.1	0.1	77.5	117705.6	0.0	4.4	6.0	0.2	4.4	0.3	0.7	21.3	0.0	1.9	3.4	7.7	0.1	0.1	3.0	8.7	4.3	0.1	0.3	1.5	0.0	0.0	1.3	1.9	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	1.9	0.2	0.2	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.6	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	12.8	91.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.8	1.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.2	1.9	24.3	10.6	0.4	0.1	1.1	1.2	0.0	0.1	20351.4	0.0	0.3	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.1	1.2	0.0	0.0	0.0	41.0	3.1	1.5	0.0	1.0	43.9	0.0	2.1	0.0	0.0	1142.1	1.7	3.4	0.1	0.2	4.1	7.6	1.0	0.0	0.0	0.0	3.4	0.5	0.2	0.0	0.1	0.0	0.3	12.5	1.2	0.1
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 74.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 45.5;Hep G2: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		6600	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	9.3	8.9	11.7	5.7	52.3	4.8	7.6	0.0	74.3	8.2	0.0	18.1	7.2	9.3	3.5	5.4	9.6	8.5	11.7	17.4	0.0	13.2	4.3	5.0	1.8	0.0	0.1	3.7	14.7	44.3	4.3	19.6	0.0	13.4	4.1	7.1	29.0	18.8	14.4	2.6	5.7	8.1	0.0	3.6	8.0	3.0	9.8	6.8	3.8	11.0	0.9	15.9	6.7	23.8	0.2	1.2	4.8	0.3	8.7	16.1	6.3	20.2	13.1	5.2	3.1	45.5	5.0	2.2	8.2	3.9	0.3	0.0	3.7	0.0	3.8	0.0	4.4	1.0	3.5	68.7	2.2	1.1	0.7	1.1	0.8	7.1	0.0	6.5	10.6	13.0	7.1	26.0	0.1	6.2	1.0	3.3	15.0	10.6	6.6	14.7	0.0	12.1	4.0	16.8	16.9	7.2	0.1	4.1	0.9	17.1	19.9	6.6	1.9	16.8	7.5	1.3	12.7	19.4	24.5	33.9	8.6	12.6	29.5	0.3	1.3	1.2	1.4	0.3	2.0	0.1	0.4	0.5	0.1	0.2	0.2	0.4	0.8	1.1	0.1	0.3	0.1	0.2	11.7	52.3	0.0	74.3	17.4	0.0	0.0	0.1	0.0	0.0	9.8	23.8	74.8	0.0	3.4	563.5	1.1	1.9	20.8	2.3	8.0	7.6	8.1	23.2	26.9	7.2	2.6	16.5	0.0	2.4	16.8	1.3	33.2	1.2	9.9	42.1	5.1	54.6	0.0	6.5	2569.1	13.4	2.8	25.8	3.6	83.6	1.3	0.2	26.4	2.8	0.8	1.7	1774.0	2.1	0.0	8.2	1.2	4.3	3.4	9.1	7.2	211.7	12.2	18.2	15.5	783.1	34.8	1.8	0.5	3.8	6.1	20.2	0.1	9.4	9.9	4.1	0.0	7.4	13.3	4.7	5.6	2.5	1.7	1.8	15.4	1.1	1.2	18.9
PLEKHB1	"KPL1, PHR1, PHRET1"	ENSG00000021300	"Pleckstrin homology domain containing B1"	Q9UF11	11	73646178-73662819	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 1531.3;choroid plexus: 728.4;retina: 758.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 344.0;Early spermatids: 145.6;Late spermatids: 184.4;Muller glia cells: 496.6;Rod photoreceptor cells: 460.4"	"Cancer enhanced"	"Detected in all"		"glioma: 59.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 83.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 83.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 77.2;OE19: 53.3;U-266/84: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (1.20e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (3.59e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.44e-2)"	2.7	6.7	1011.3	7.7	1362.5	1.3	10.4	1275.8	1156.9	6.9	728.4	52.9	11.6	3.0	15.0	4.7	24.3	10.3	14.7	914.2	1059.3	12.3	2.1	15.2	8.9	1472.5	1259.8	3.0	22.9	88.1	135.2	0.9	1433.2	13.2	9.0	758.1	59.0	8.6	9.4	5.2	19.8	3.0	1263.6	4.2	20.5	20.2	1172.4	5.6	28.8	11.9	7.6	8.2	5.5	1531.3	0.7	2.0	4.8	3.8	2.0	0.6	0.2	0.2	0.1	0.3	0.3	8.5	16.2	0.1	20.0	0.5	0.6	0.4	2.6	0.4	0.4	11.0	12.5	0.0	1.0	77.2	1.2	0.0	0.2	0.7	0.0	0.3	0.0	4.1	0.1	19.4	0.3	10.5	0.3	6.3	5.3	0.3	3.1	53.3	1.0	3.8	0.1	2.6	0.7	1.4	11.8	2.8	0.0	0.3	1.7	3.5	5.6	1.0	0.0	0.0	2.2	0.1	1.6	17.5	30.4	11.3	2.8	0.0	0.8	0.2	0.5	1.1	17.1	0.0	41.5	18.3	41.4	30.6	0.5	7.9	83.7	47.3	0.9	4.3	0.1	0.9	26.9	27.4	1011.3	1362.5	1275.8	1156.9	914.2	1059.3	1472.5	1259.8	1433.2	1263.6	1172.4	1531.3	0.7	6.4	13.5	25.5	5.3	0.4	1.1	1.7	0.6	53.6	19.1	11.8	8.1	25.8	4.5	7.3	344.0	0.5	1.9	0.8	11.7	30.6	145.6	27.4	0.5	3.9	62.8	0.0	1.1	0.8	0.1	2.0	13.7	3.7	11.4	10.4	1.8	0.2	2.7	20.2	0.6	11.2	22.4	0.3	0.3	184.4	2.5	0.9	10.6	7.5	1.6	496.6	6.2	15.6	96.4	2.9	3.9	0.7	1.0	4.0	0.9	13.9	42.8	460.4	0.0	2.5	1.8	2.6	1.7	0.3	0.1	0.1	9.7	0.1	6.5	1.6
PLLP	"PMLP, TM4SF11"	ENSG00000102934	Plasmolipin	Q9Y342	16	57248547-57284672	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 844.1;choroid plexus: 1086.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 161.5;Glandular and luminal cells: 134.3;Oligodendrocyte precursor cells: 140.2;Oligodendrocytes: 193.4;Pancreatic endocrine cells: 119.0;Proximal enterocytes: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"naive CD4 T-cell: 14.5;naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	8	"T-cells: 14.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 27.8;Hep G2: 81.1;OE19: 79.6;RPTEC TERT1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041862	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA041862: AB_2677712"	"unprognostic (7.96e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (2.06e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.32e-2)"	14.5	2.8	549.6	2.3	673.5	2.3	12.1	352.7	646.8	24.6	1086.0	10.5	33.5	6.3	2.4	34.3	22.6	27.4	8.4	489.4	603.1	41.0	9.8	50.7	2.4	769.3	601.6	3.0	52.5	14.8	4.4	2.6	775.8	12.8	12.6	2.0	41.9	27.9	3.8	99.5	33.4	2.4	689.1	19.6	79.8	6.2	844.1	1.1	12.8	6.3	4.9	9.6	26.1	779.6	1.6	5.7	7.1	1.4	0.0	0.1	3.6	1.1	0.3	0.4	0.3	15.9	6.8	0.5	27.8	0.0	1.8	5.2	3.3	5.0	0.1	1.6	2.7	7.3	3.0	81.1	1.0	0.7	1.8	0.2	1.2	0.1	0.6	3.6	8.0	1.7	1.3	1.9	0.1	2.0	0.9	1.8	5.9	79.6	2.3	0.9	1.3	1.4	33.5	17.1	1.6	2.8	1.9	2.2	3.3	2.2	11.7	2.2	6.0	1.2	1.6	1.0	1.3	1.4	1.7	0.9	1.6	0.5	4.7	1.7	1.0	0.7	0.8	0.5	0.6	0.7	2.2	0.6	0.2	1.2	14.5	5.7	1.8	0.6	0.5	0.5	0.6	2.2	549.6	673.5	352.7	646.8	489.4	603.1	769.3	601.6	775.8	689.1	844.1	779.6	18.4	64.1	26.5	0.3	1.4	13.9	15.9	61.4	22.8	2.7	23.8	23.6	3.2	161.5	26.4	90.1	2.1	2.2	1.8	26.6	15.6	61.3	0.9	66.9	12.4	20.5	1.2	5.3	0.5	70.2	1.3	5.1	76.0	134.3	3.8	13.4	11.0	4.2	0.7	5.0	0.7	23.7	93.6	0.8	2.2	1.5	4.7	2.1	3.6	25.3	1.3	0.5	0.0	140.2	193.4	119.0	66.8	22.2	1.3	5.8	149.9	28.6	4.0	7.7	0.0	3.6	4.0	1.6	3.3	54.2	42.8	1.1	2.4	1.2	36.1	13.3
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359872-95396375	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 616.7"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 509.6"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	380000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	1.4	3.8	2.1	0.5	2.0	0.0	31.2	1.7	1.9	5.3	1.4	2.0	7.9	0.9	3.6	0.5	1.3	4.4	1.0	1.8	2.1	2.7	616.7	14.2	0.1	2.3	2.2	12.4	14.3	0.2	24.9	0.8	2.9	0.9	2.8	0.1	26.3	3.9	0.3	7.4	3.1	0.2	2.1	0.3	2.3	9.0	2.1	1.6	7.1	0.3	5.9	1.4	0.9	1.9	3.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.1	17.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	1.7	1.9	1.8	2.1	2.3	2.2	2.9	2.1	2.1	1.9	2.5	6.4	45.9	24.5	0.6	0.9	0.9	9.3	1.8	0.0	5.4	4.3	0.5	31.5	23.9	3.7	0.0	1.7	0.3	3.2	1.9	0.3	14.5	0.0	0.4	1.9	0.0	8.0	0.1	2.0	2.2	5.2	0.5	0.0	0.0	0.4	10.0	509.6	0.2	0.0	0.2	1.8	12.2	8.1	0.3	4.8	8.1	0.2	14.2	4.7	0.0	3.2	0.0	17.6	0.1	1.2	1.2	3.0	0.0	2.1	6.0	6.7	6.5	0.1	0.0	0.8	2.1	21.4	16.9	0.3	1.3	1.4	0.8	6.6	2.3	0.4
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347368-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 1135.4;liver: 675.2"	"Cell type enriched"	"Detected in some"	9	"Proximal enterocytes: 17736.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 348.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 34.2;Hep G2: 128.3"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		210000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.6	0.5	0.7	4.2	0.7	0.5	0.3	0.4	0.7	0.2	6.5	74.6	1053.8	0.8	0.1	0.4	0.7	2.6	0.3	0.6	0.4	145.4	675.2	0.2	1.5	1.2	0.7	0.4	0.1	0.1	0.8	0.1	1.1	0.3	35.7	0.0	1.7	0.3	0.2	1.3	1135.4	1.7	0.4	0.8	2.7	12.2	0.6	0.3	0.2	0.3	0.1	0.3	0.2	0.8	0.2	0.5	0.1	1.2	0.1	0.0	14.6	0.0	0.0	0.0	0.0	34.2	0.6	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.5	128.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	3.5	0.4	5.0	0.0	0.2	0.9	2.9	0.0	0.0	0.9	4.6	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.4	1.3	0.0	1.4	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.4	0.7	0.6	0.4	1.2	0.7	1.1	0.4	0.6	0.8	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	9.2	0.0	0.2	0.0	773.7	33.2	0.1	1.9	0.6	0.0	0.6	18.4	13.5	0.1	0.2	0.2	0.2	1.5	0.1	8.9	0.0	12.5	1021.3	0.2	0.0	0.0	676.2	0.0	20.9	0.0	7.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1815.7	1.5	0.0	0.1	17736.9	412.0	0.1	0.0	0.0	0.0	0.1	140.2	38.2	0.0	0.0	0.3	3.5	0.0	607.1	0.1
PRCD	RP36	ENSG00000214140	"Photoreceptor disc component"	Q00LT1	17	76527586-76553578	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 48.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 134.3;Cone photoreceptor cells: 152.2;Muller glia cells: 100.4;Rod photoreceptor cells: 551.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;Hep G2: 2.1;HSkMC: 1.1;SH-SY5Y: 2.4"					"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.31e-4)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.19e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-2)"	1.0	0.6	0.2	0.4	0.1	0.0	1.1	2.8	0.7	1.5	1.5	0.5	0.4	0.9	0.0	0.3	1.0	0.2	1.5	0.1	0.3	0.6	0.2	0.7	0.7	1.3	0.6	0.6	0.3	0.2	0.2	0.5	1.4	0.9	0.1	48.0	0.5	0.3	0.4	0.5	0.5	0.1	0.2	1.1	0.3	0.4	0.4	0.0	0.7	0.0	0.2	1.3	1.3	0.3	0.0	0.0	0.0	0.0	0.7	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.8	0.7	0.1	0.3	1.3	0.6	1.4	0.2	0.4	0.3	8.5	0.0	0.0	0.7	13.5	0.5	0.2	0.6	0.0	134.3	0.1	0.5	5.4	0.0	0.7	0.0	152.2	0.1	1.3	0.0	0.0	0.2	4.3	0.3	0.4	7.8	0.0	0.0	2.1	0.0	0.0	5.3	0.0	0.0	0.0	0.2	1.1	0.0	0.1	37.0	4.9	0.0	0.0	0.0	1.1	11.0	6.2	0.5	7.2	2.8	0.1	100.4	0.0	0.5	26.0	0.2	0.0	1.9	1.8	0.2	0.0	0.2	0.3	551.3	6.6	10.5	3.4	3.3	0.9	0.1	0.3	0.3	1.2	1.1	0.0	0.1
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 598.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 432.9"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.7"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 156.1"					"Low region specificity"	"Detected in all"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	NA	NA		5200000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.2	0.0	0.6	0.1	1.1	1.1	0.1	0.6	1.0	0.4	0.0	1.0	0.8	0.1	0.1	0.1	0.2	0.6	0.1	0.6	1.0	14.8	598.5	0.2	0.6	1.6	0.8	0.2	0.3	0.0	0.3	0.1	1.5	0.2	0.6	0.2	0.2	0.1	0.2	0.6	0.8	0.0	0.4	0.4	2.6	0.1	0.8	0.6	0.2	0.0	0.3	0.4	0.2	1.1	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.1	0.0	0.9	0.1	0.4	9.5	0.0	0.3	0.0	0.0	0.2	0.1	7.8	156.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.6	0.4	2.3	0.7	0.0	0.1	0.0	0.0	0.9	0.4	0.0	1.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	59.7	0.0	0.3	0.6	1.1	0.6	1.0	0.6	1.0	1.6	0.8	1.5	0.4	0.8	1.1	0.0	0.0	0.0	0.3	4.1	0.8	0.4	11.2	0.0	0.0	0.1	0.0	0.4	47.1	1.2	0.0	0.0	0.0	24.0	3.9	5.9	0.5	0.1	3.4	0.1	0.6	10.3	18.7	0.1	0.2	0.0	0.7	2.0	0.2	0.0	0.0	12.1	432.9	3.7	0.0	0.5	9.3	0.0	9.3	4.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.1	0.0	0.0	0.0	3.8	84.8	3.4	0.0	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.1	1.1	0.0	1.8	0.3
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"kidney: 140.1;liver: 173.6"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 157.6;Proximal tubular cells: 559.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 28.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"Hep G2: 33.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.1	173.6	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	1.5	0.0	12.9	0.0	0.0	0.0	0.0	27.4	0.0	2.8	0.3	0.0	0.3	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	157.6	0.1	0.0	0.1	0.0	0.0	4.7	0.0	0.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	559.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0
PRORP	"KIAA0391, MRPP3"	ENSG00000100890	"Protein only RNase P catalytic subunit"	O15091	14	35121846-35277622	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	11.3	17.0	11.0	17.0	12.2	12.2	13.9	12.4	16.1	13.6	16.6	19.9	15.3	8.4	16.7	19.2	11.8	10.4	13.7	11.4	12.1	25.0	24.9	12.5	21.2	13.2	12.5	7.0	10.6	19.3	9.7	11.0	12.8	10.6	20.8	6.2	13.1	9.6	15.1	17.3	14.5	11.9	11.6	13.6	13.6	12.1	13.1	31.1	15.6	17.1	22.5	15.4	11.9	14.4	47.5	34.9	23.6	33.1	25.1	21.0	22.7	31.1	25.3	35.9	26.1	35.8	26.3	53.0	39.0	27.2	9.9	33.9	43.8	47.3	36.5	39.2	12.9	22.6	24.9	77.9	25.2	27.2	23.0	28.3	37.7	33.9	31.6	30.2	50.0	41.3	38.4	13.6	42.5	54.9	46.0	33.3	26.8	30.4	33.4	42.9	40.4	28.1	52.6	44.6	24.0	25.0	40.0	43.3	26.8	29.0	55.4	23.9	44.5	30.7	25.7	22.1	25.8	15.5	40.4	53.9	14.5	32.0	32.5	30.9	10.3	7.2	30.3	9.6	43.9	20.1	47.3	32.8	13.8	14.4	41.6	30.1	14.4	24.7	8.2	20.4	56.1	24.3	11.0	12.2	12.4	16.1	11.4	12.1	13.2	12.5	12.8	11.6	13.1	14.4	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158648-113172386	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 109.2"	"Group enriched"	"Detected in some"	52	"Hepatocytes: 63.5;Proximal tubular cells: 20.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;Hep G2: 3.6"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	650000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.3	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	14.4	109.2	0.1	0.3	0.0	0.0	0.1	0.7	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.5	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.3	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.4	1.1	0.4	1.6	3.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	0.5	0.3	0.4	0.8	1.4	0.1	0.6	0.1	0.1	0.0	0.5	1.3	0.0	0.0	0.1	0.6	0.7	0.0	0.4	0.3	0.3	0.0	0.3	0.1	0.7	0.4	0.3	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.5	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	20.5	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRPSAP1	PAP39	ENSG00000161542	"Phosphoribosyl pyrophosphate synthetase associated protein 1"	Q14558	17	76309478-76384521	"Predicted intracellular proteins"	"Nucleotide biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062396			Approved	Cytosol		NA	NA		24000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA062396: AB_2684750"	"unprognostic (1.12e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (3.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.51e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.37e-2)"	26.4	26.2	24.2	13.7	24.3	22.2	27.6	25.1	29.3	29.1	24.0	22.7	16.6	22.6	28.0	34.9	21.8	18.9	21.5	22.4	26.6	26.4	69.9	27.5	18.5	29.2	26.2	21.1	25.1	43.9	21.9	20.9	29.9	20.7	25.5	29.4	65.8	19.0	16.6	24.7	19.4	23.1	23.5	15.9	23.2	35.6	27.3	18.1	49.3	13.9	26.0	19.0	27.2	26.3	38.6	46.4	54.7	26.9	36.3	32.2	21.5	33.9	46.9	55.7	45.9	33.8	32.4	44.2	18.2	50.9	44.4	22.3	49.8	40.5	55.3	17.4	44.7	32.6	36.0	149.2	45.0	28.0	24.8	35.3	32.4	40.1	34.9	54.1	110.4	44.2	40.1	40.3	37.2	41.2	50.9	25.8	13.8	65.7	41.2	41.0	70.9	32.8	42.7	43.8	31.1	51.0	37.4	37.4	77.8	60.9	61.3	32.5	42.3	63.9	46.8	38.2	42.4	27.0	18.2	31.2	28.4	25.5	27.7	18.3	16.4	22.1	16.4	14.5	17.3	17.2	16.4	15.7	14.2	13.6	13.8	13.4	5.3	19.1	14.1	14.1	24.6	13.4	24.2	24.3	25.1	29.3	22.4	26.6	29.2	26.2	29.9	23.5	27.3	26.3	37.7	0.0	14.2	25.5	18.2	13.0	33.3	42.6	16.5	33.9	34.7	40.6	17.3	38.6	25.0	14.7	35.5	49.4	23.5	21.2	49.0	60.6	32.3	26.2	25.8	43.6	15.7	13.2	29.5	29.6	65.0	21.3	23.9	40.9	20.3	70.3	20.7	38.5	29.9	60.6	52.9	26.0	44.7	18.9	21.3	27.5	29.2	21.9	32.0	15.9	64.2	129.4	18.6	24.6	27.7	38.8	18.7	46.3	16.8	25.1	26.3	27.9	32.5	40.4	59.2	25.7	30.8	118.0	97.7	24.8	14.6	30.6	24.2	19.2	34.3	22.3
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome 20S subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 156.3;Late spermatids: 474.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003049	Approved		Supported	Nucleoplasm		NA	NA		18000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	118.4	141.3	88.3	117.3	92.4	155.5	131.1	88.9	140.7	81.3	86.6	128.6	115.1	82.4	98.7	126.0	84.0	69.7	169.1	92.2	97.6	98.0	172.8	123.6	137.6	92.6	90.5	71.3	91.9	82.8	83.2	120.7	96.0	74.7	130.0	63.9	87.8	81.1	350.1	107.5	114.8	94.4	92.8	114.4	95.9	247.9	94.7	290.1	82.3	203.9	139.7	132.6	85.7	92.4	502.2	367.2	257.6	264.9	209.8	214.5	523.1	252.2	300.3	368.2	329.0	338.8	341.7	322.9	492.1	244.4	220.4	337.5	306.6	280.0	434.5	337.9	170.1	257.6	233.6	1011.6	235.8	542.0	225.8	166.7	229.4	256.6	324.7	178.2	312.2	548.1	284.2	220.4	298.7	522.9	838.2	458.2	249.3	391.0	407.0	1249.4	261.3	256.9	312.8	634.9	275.1	230.8	285.5	402.2	274.7	211.9	473.8	351.4	267.1	235.8	231.8	245.7	283.6	234.0	576.3	605.9	192.4	335.7	272.0	232.1	364.6	242.2	241.0	344.8	243.0	212.8	230.9	248.9	373.6	171.5	182.5	217.5	131.9	300.6	343.7	385.3	317.0	711.5	88.3	92.4	88.9	140.7	92.2	97.6	92.6	90.5	96.0	92.8	94.7	92.4	20.8	44.8	40.7	20.2	37.7	33.3	14.9	37.2	69.4	13.7	16.5	15.0	1.4	22.8	45.7	14.7	25.0	32.2	24.8	22.4	21.5	34.2	156.3	21.2	14.9	30.5	18.0	56.8	32.7	36.7	26.0	28.4	46.4	28.2	54.5	10.1	29.6	20.0	22.6	25.2	31.2	18.3	22.4	36.7	89.5	474.9	22.7	62.2	24.9	22.5	34.1	8.6	34.0	20.6	29.4	32.8	19.5	17.3	114.6	15.9	43.1	25.4	59.5	19.4	13.1	17.8	31.3	35.1	20.0	89.8	33.1	41.3	53.7	9.2	22.2	17.1
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1146.8"	"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		6200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	84.0	116.0	129.1	58.7	134.2	32.0	81.0	141.4	134.3	71.3	141.1	80.8	61.1	71.0	129.5	102.3	93.3	61.0	136.8	136.4	141.1	98.5	119.1	64.7	49.0	137.9	138.4	61.6	80.9	143.5	80.1	90.1	145.2	76.8	88.7	59.7	73.5	78.6	332.4	76.0	53.0	103.4	141.3	50.3	81.0	57.8	136.5	79.5	72.3	274.1	68.6	92.1	68.4	146.5	181.0	398.9	250.6	245.5	360.4	318.9	261.8	252.0	307.3	446.1	376.1	329.2	282.2	228.0	228.1	352.1	298.4	239.7	428.4	320.2	401.9	139.9	311.4	146.9	260.3	1146.8	287.3	170.2	162.1	354.2	292.0	331.8	264.1	289.7	475.5	190.5	218.6	121.5	376.0	557.2	97.6	218.4	285.7	341.6	631.4	133.8	197.7	150.7	349.9	256.6	336.0	251.0	179.9	354.8	245.4	322.2	175.0	217.7	254.1	212.4	210.1	197.3	247.8	99.7	218.4	158.8	164.9	140.8	274.6	97.8	127.6	58.0	89.4	125.6	103.5	103.8	101.1	85.1	137.6	99.7	135.0	102.5	48.1	67.4	92.7	172.4	91.3	147.8	129.1	134.2	141.4	134.3	136.4	141.1	137.9	138.4	145.2	141.3	136.5	146.5	94.2	76.9	69.2	16.0	47.3	140.2	174.1	461.5	100.7	61.0	130.4	135.5	157.6	112.9	240.4	95.6	29.2	400.1	40.2	75.0	275.9	277.7	93.0	149.0	109.5	150.0	154.6	82.5	17.6	231.3	435.2	139.9	73.9	88.0	31.0	162.6	89.6	171.6	221.6	70.7	18.0	109.2	329.6	57.5	80.9	106.4	118.7	64.0	115.6	15.9	138.2	170.8	25.7	11.6	29.4	285.7	88.0	122.2	78.2	185.1	81.2	437.8	268.9	71.8	98.6	87.1	355.1	174.4	81.6	144.7	157.1	430.2	43.4	215.7	148.9	215.3
PSME2	PA28beta	ENSG00000100911	"Proteasome activator subunit 2"	Q9UL46	14	24143362-24147570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1063.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062661			Approved	Nucleoplasm		NA	NA		5900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA062661: AB_2684825"	"prognostic favorable (1.27e-4)"	"unprognostic (7.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.90e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.47e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.07e-3)"	81.3	204.5	25.7	86.6	26.0	42.8	79.7	25.5	40.1	93.7	28.8	104.6	165.9	68.6	48.6	112.5	75.0	30.6	105.3	25.7	28.2	142.0	228.1	107.9	89.6	30.7	26.5	71.7	102.1	27.7	123.7	30.7	27.5	94.1	79.2	18.1	84.0	33.8	63.7	72.6	152.9	44.0	28.1	204.6	101.6	56.9	28.7	52.1	92.2	26.6	80.2	74.0	80.6	27.8	95.2	93.2	59.5	140.6	42.8	59.9	85.6	47.7	108.4	145.7	182.4	72.7	183.9	111.0	30.7	59.8	166.5	79.1	32.1	92.0	87.6	198.6	28.9	75.2	45.8	277.1	135.9	103.4	100.1	61.2	26.3	115.1	44.1	65.6	79.3	78.2	37.2	165.2	61.5	188.6	204.2	140.0	19.8	142.3	112.1	189.2	93.2	119.2	108.9	209.4	36.8	47.7	101.6	168.8	70.3	31.0	89.0	110.7	63.4	80.7	75.1	38.2	102.5	143.7	215.1	140.7	52.9	110.0	99.7	110.3	605.5	217.5	421.1	1217.1	431.5	432.6	412.2	415.9	504.7	357.2	305.7	373.8	192.3	543.4	801.7	375.6	447.3	1562.7	25.7	26.0	25.5	40.1	25.7	28.2	30.7	26.5	27.5	28.1	28.7	27.8	185.3	51.3	113.7	5.2	198.5	154.9	174.3	754.8	126.3	39.7	104.5	120.8	69.5	140.2	287.7	117.7	22.9	296.6	223.6	316.1	299.3	370.5	12.6	113.0	147.3	159.7	98.0	74.2	1.7	567.1	296.6	128.6	132.5	109.9	141.5	83.4	69.7	236.6	332.1	28.6	2.2	288.5	319.4	143.7	224.9	15.5	74.0	237.8	136.9	2.8	763.7	69.8	326.5	2.5	1.3	303.1	324.5	77.8	389.3	282.8	1063.1	373.6	293.7	19.2	46.0	62.0	453.3	54.6	24.8	144.5	139.8	228.2	228.6	229.0	338.5	224.4
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47856673-48111197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 479.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	0.5	0.1	0.6	0.0	0.6	0.0	0.3	0.0	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.3	0.5	0.2	0.5	0.8	0.5	0.4	0.3	0.5	0.0	0.2	1.0	0.2	0.2	0.0	0.9	0.3	0.0	0.5	0.1	0.8	0.5	1.0	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.2	0.3	0.0	0.8	0.1	0.0	0.3	0.3	0.4	0.0	0.0	9.4	0.0	1.3	3.9	12.4	1.2	2.8	0.0	0.4	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	21.8	0.5	0.0	0.0	6.2	5.4	0.0	0.1	4.4	1.8	2.5	0.0	0.0	9.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.5	0.1	0.0	0.0	20.1	0.0	0.0	9.9	2.3	1.9	0.0	0.2	0.0	0.0	0.0	3.3	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.5	0.8	0.5	0.2	1.0	0.0	0.5	0.3	0.4	0.5	0.0	1.1	6.5	0.0	0.1	0.0	1.0	0.0	1.0	0.4	0.3	0.2	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	90.6	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	479.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	89.9	0.0	0.6	0.0	2.5	2.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase 4A1"	Q93096	6	63521746-63583436	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.7"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3071.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 533.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	39.4	140.5	24.1	37.4	29.5	227.4	31.5	30.9	35.9	41.5	28.3	107.9	55.1	43.8	15.3	53.5	34.6	58.9	31.7	24.7	37.5	50.5	493.7	54.8	24.4	32.5	28.0	54.7	69.5	16.1	41.1	72.5	32.1	44.2	110.1	22.5	68.2	21.0	300.0	66.0	50.8	56.6	34.9	19.4	55.2	62.5	27.9	26.2	39.2	113.0	24.6	51.6	33.6	44.8	71.5	122.9	106.2	128.3	85.8	77.2	239.1	113.9	97.6	58.4	79.2	103.5	45.4	65.1	50.6	88.7	95.7	41.8	97.0	197.9	94.3	61.0	51.6	43.8	320.2	533.9	175.7	118.6	57.7	91.3	383.6	124.7	320.5	63.5	80.3	65.0	106.1	148.7	151.5	140.9	52.4	69.1	50.6	91.0	53.7	70.9	53.4	60.5	132.4	120.6	44.7	62.5	278.5	71.8	140.1	156.9	59.8	122.0	77.5	132.9	130.6	89.5	122.3	90.7	94.9	121.7	60.9	72.5	154.1	45.4	20.4	15.1	12.8	21.3	20.1	12.9	14.5	14.3	17.2	10.7	12.8	12.9	48.4	16.3	16.6	9.1	18.8	15.4	24.1	29.5	30.9	35.9	24.7	37.5	32.5	28.0	32.1	34.9	27.9	44.8	33.3	22.4	90.3	4.6	105.4	681.3	268.7	94.1	261.8	22.3	98.4	55.4	78.5	207.3	83.0	75.4	16.7	248.7	99.8	336.5	80.3	186.9	716.1	189.8	68.8	47.0	129.6	30.9	11.7	193.9	215.1	90.8	178.4	279.5	63.0	41.2	41.4	528.8	98.6	11.8	9.9	253.4	63.1	71.6	236.5	3071.4	28.6	99.7	170.7	5.6	47.4	22.0	15.5	9.5	20.4	151.8	196.9	24.0	110.6	166.4	181.3	112.1	61.2	24.6	6.6	44.4	110.2	47.2	26.3	181.8	641.0	459.6	123.4	79.1	214.6	164.1
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070696-65130331	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 911.4;Syncytiotrophoblasts: 703.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		3000000	"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: AB_2683051"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	142.5	142.9	84.2	90.6	86.8	232.4	119.1	85.2	105.2	122.6	103.7	128.1	133.6	109.7	179.9	155.0	103.5	100.1	127.3	89.0	91.9	194.1	194.9	141.9	70.5	86.0	88.4	94.4	133.9	113.1	117.2	148.3	91.3	96.6	126.8	89.4	131.8	93.8	100.3	101.3	127.6	117.4	87.7	88.6	135.9	86.2	90.4	59.0	129.6	80.4	91.1	119.2	120.5	91.3	211.3	150.7	186.2	110.5	445.5	261.2	287.5	299.9	212.3	134.8	142.8	270.1	137.5	85.8	167.9	311.2	221.4	130.6	173.7	277.6	214.1	96.3	100.6	108.3	119.2	403.8	281.9	115.4	93.7	232.0	279.6	176.9	158.5	213.3	271.2	67.7	157.2	96.6	271.1	190.6	67.3	138.6	148.6	329.1	134.6	68.3	177.3	137.3	266.1	236.0	133.9	118.5	139.2	230.6	282.4	218.7	143.3	106.9	253.4	172.5	214.6	183.2	171.8	147.6	95.3	205.6	230.2	173.9	170.4	96.8	84.6	78.7	41.9	86.3	46.7	42.6	45.4	45.8	76.0	29.3	43.2	45.1	102.1	56.4	80.9	63.1	59.0	54.3	84.2	86.8	85.2	105.2	89.0	91.9	86.0	88.4	91.3	87.7	90.4	91.3	84.8	83.3	89.1	51.2	64.6	297.2	322.0	384.6	74.0	48.5	117.1	71.8	120.7	87.2	218.6	125.0	6.2	309.5	70.3	182.0	328.7	216.5	350.3	102.8	110.9	133.0	133.4	45.0	50.7	219.5	366.9	171.6	105.0	162.8	50.7	67.1	102.4	183.7	375.3	58.9	53.4	200.4	262.4	122.9	221.6	911.4	145.7	153.3	197.5	83.4	110.5	144.7	41.2	50.3	71.7	234.0	148.2	212.9	107.1	323.2	168.4	441.7	162.4	45.6	72.3	103.8	210.9	193.8	106.7	90.7	293.8	703.8	70.5	76.5	168.4	477.9
RAB42	MGC45806	ENSG00000188060	"RAB42, member RAS oncogene family"	Q8N4Z0	1	28592200-28595449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 24.5"	"Cell type enriched"	"Detected in many"	7	"Hofbauer cells: 91.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.0;Hep G2: 14.3;HSkMC: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050290			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum"		"HPA050290: AB_2681075"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.00e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.07e-3)"	3.0	0.7	0.9	1.7	1.1	0.8	2.2	1.5	2.9	2.2	1.5	2.1	1.4	1.7	0.6	0.7	1.0	1.7	0.9	0.9	0.8	0.9	1.2	2.8	6.6	1.9	1.3	0.4	0.5	2.7	0.3	4.5	1.6	0.7	2.3	0.9	2.6	0.6	0.3	0.6	1.6	1.5	1.1	3.5	1.3	1.4	2.3	24.5	0.6	0.6	3.6	1.9	1.1	3.9	0.1	0.7	0.9	0.0	4.1	10.0	0.0	0.4	3.8	4.1	5.3	2.0	1.5	0.2	2.0	4.3	0.4	0.2	4.1	0.0	2.7	0.1	0.0	0.3	6.8	14.3	1.7	1.1	0.0	8.8	0.1	2.2	0.0	0.4	1.2	0.1	0.1	0.1	0.9	0.0	0.1	2.2	4.8	0.0	0.0	6.5	0.0	1.7	1.8	0.0	0.3	1.5	3.7	0.1	0.0	0.6	0.2	1.8	0.4	0.0	1.2	3.9	0.0	0.3	2.1	0.2	0.1	3.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.9	1.1	1.5	2.9	0.9	0.8	1.9	1.3	1.6	1.1	2.3	3.9	0.5	0.0	0.0	0.0	0.7	0.1	0.2	0.7	0.0	0.5	1.2	1.0	0.4	1.5	1.0	0.0	0.0	0.6	0.1	0.2	0.0	8.5	5.3	3.4	3.9	0.3	0.0	0.4	0.1	0.0	0.8	3.4	0.0	3.2	0.0	0.5	2.5	0.0	91.3	0.0	0.1	0.1	0.0	3.5	1.7	12.2	1.5	11.7	0.0	1.0	1.1	1.0	0.0	0.0	0.1	2.9	1.2	0.0	1.2	0.2	0.3	0.5	0.4	0.9	0.0	4.5	0.9	2.5	1.8	0.4	0.4	0.4	0.3	0.2	0.1	0.1
RAB5IF	"C20orf24, PNAS-11, RCAF1, RIP5"	ENSG00000101084	"RAB5 interacting factor"	Q9BUV8	20	36605779-36612557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 216.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 215.9;Exocrine glandular cells: 348.7;Hofbauer cells: 242.6;Pancreatic endocrine cells: 442.2;Proximal tubular cells: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057387	Uncertain		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA057387: AB_2683425"	"unprognostic (2.14e-1)"	"unprognostic (4.75e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.56e-6)"	"unprognostic (4.47e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.37e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.98e-2)"	45.2	49.0	33.0	46.4	33.4	69.0	33.4	36.0	40.4	45.4	35.8	71.6	49.3	29.1	40.9	152.2	27.3	38.6	53.0	32.8	34.9	53.1	115.7	41.9	38.6	35.0	33.7	22.6	42.8	55.2	20.8	33.4	34.4	29.8	59.9	28.6	56.3	27.6	216.9	39.8	43.2	34.7	35.4	57.0	48.5	37.5	36.1	41.6	27.8	78.2	56.4	50.3	58.1	37.0	224.8	164.4	59.9	75.2	127.2	74.8	142.5	135.8	79.4	132.7	119.5	455.9	279.5	96.6	327.4	122.2	244.8	163.2	123.3	219.3	130.5	73.5	119.1	230.0	233.3	516.7	149.1	247.4	109.3	92.6	225.0	187.7	110.1	70.4	124.5	104.0	158.9	226.4	125.2	156.9	148.6	318.2	98.5	227.1	344.6	114.8	137.2	245.9	119.3	163.5	99.3	76.0	195.3	513.2	187.6	89.3	111.5	206.5	135.1	192.6	132.5	195.3	211.7	138.8	236.0	162.2	204.4	281.3	104.7	22.0	76.9	97.3	17.7	38.9	17.8	35.7	21.2	27.4	47.9	33.6	26.1	19.4	120.6	18.4	46.4	32.8	39.8	28.1	33.0	33.4	36.0	40.4	32.8	34.9	35.0	33.7	34.4	35.4	36.1	37.0	47.5	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	87.1	64.5	0.0	0.0	0.0	42.3	0.0	83.1	111.1	0.0	76.3	215.9	0.0	43.0	34.8	24.4	0.0	0.0	0.0	348.7	126.8	14.5	0.0	61.6	0.0	24.3	0.0	0.0	242.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	93.0	0.0	0.0	0.0	0.0	442.2	0.0	0.0	11.9	0.0	0.0	147.8	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	135.6	27.0	29.9	0.0	0.0
RABGGTA	PTAR3	ENSG00000100949	"Rab geranylgeranyltransferase subunit alpha"	Q92696	14	24265538-24271611	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 59.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043488	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA043488: AB_10794887"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.01e-1)"	11.3	14.7	6.9	7.7	7.0	10.0	11.3	7.6	9.4	14.7	6.1	12.2	11.0	9.3	10.0	59.2	12.1	9.2	16.3	7.5	8.5	13.7	14.8	13.9	9.8	8.3	7.7	10.6	17.7	16.9	15.2	7.8	8.2	12.2	8.5	3.1	20.1	8.3	19.1	19.9	13.1	6.9	7.4	17.1	16.3	11.8	7.9	9.0	11.9	12.5	12.4	10.0	19.4	8.1	10.6	13.0	6.8	10.6	8.9	17.4	31.9	15.2	12.8	21.4	19.4	12.2	17.4	13.1	11.8	16.3	9.5	20.4	7.0	33.2	9.2	20.8	14.4	8.6	11.0	45.9	17.9	18.8	36.3	19.9	35.9	11.4	13.5	11.6	19.7	16.4	9.0	16.1	16.3	41.0	12.5	10.1	2.3	14.0	19.2	9.3	6.2	14.5	20.5	15.6	16.9	9.7	10.5	29.9	12.8	9.4	12.5	13.7	14.5	11.2	7.8	6.1	10.5	17.2	13.9	8.7	9.5	11.5	17.6	11.9	25.7	17.1	16.0	46.8	13.3	16.3	15.3	12.4	32.0	10.4	12.8	10.0	7.3	16.9	33.1	5.4	18.1	18.4	6.9	7.0	7.6	9.4	7.5	8.5	8.3	7.7	8.2	7.4	7.9	8.1	9.3	9.6	11.6	4.6	18.0	17.7	19.6	61.6	35.9	7.7	13.8	14.0	12.4	15.7	28.1	5.5	6.2	38.0	14.4	25.0	15.6	23.4	3.3	9.7	5.8	9.3	13.1	7.8	5.1	27.1	31.1	10.1	23.4	11.9	36.2	8.3	9.7	7.1	26.5	11.8	4.3	14.5	26.4	17.9	10.4	7.7	9.0	18.3	16.0	3.7	18.8	9.0	12.3	4.0	3.7	39.3	23.7	7.2	20.3	15.4	27.7	20.4	15.5	5.3	6.6	5.8	12.0	3.3	34.2	36.9	12.4	57.3	16.8	10.3	18.0	20.9
RALGAPA1	"DKFZp667F074, GARNL1, GRIPE, KIAA0884, RalGAPalpha1, Tulip1"	ENSG00000174373	"Ral GTPase activating protein catalytic subunit alpha 1"	Q6GYQ0	14	35538352-35809304	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 394.0;Inhibitory neurons: 233.9;Oligodendrocyte precursor cells: 239.3;Oligodendrocytes: 412.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000851	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	Mitochondria	"HPA000851: AB_1078945"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.46e-1)"	13.5	18.5	24.0	9.0	28.1	7.1	16.0	36.0	29.0	21.6	18.3	17.6	7.7	16.5	13.8	15.8	17.9	9.4	12.8	24.2	26.3	14.4	13.0	14.1	9.6	26.6	25.5	23.9	16.3	25.5	23.4	7.4	26.2	17.5	14.5	39.4	13.0	10.5	18.4	20.1	14.7	12.6	25.9	12.0	15.8	10.6	26.4	9.7	16.3	10.9	9.0	15.9	18.3	33.6	7.4	8.7	11.0	9.6	16.4	11.4	7.0	5.2	5.4	6.7	6.0	5.2	6.4	7.2	7.2	7.1	8.8	12.0	13.4	10.2	6.2	16.1	5.1	6.7	11.0	26.3	8.4	11.4	10.4	8.6	18.3	5.8	14.1	11.0	9.5	14.2	6.7	17.9	5.9	11.8	8.5	5.4	5.0	18.2	12.9	6.9	6.7	4.6	13.8	11.9	10.2	16.7	11.0	18.9	9.6	10.6	18.0	5.3	8.7	6.5	5.0	7.6	6.5	14.6	14.4	9.3	3.0	7.3	7.2	0.0	0.2	0.0	0.7	0.3	0.9	0.5	0.7	0.9	0.3	0.3	0.4	0.7	0.0	0.7	0.3	0.4	0.8	0.1	24.0	28.1	36.0	29.0	24.2	26.3	26.6	25.5	26.2	25.9	26.4	33.6	40.2	16.0	30.9	162.6	63.9	38.1	28.3	13.9	62.0	86.1	27.7	21.5	19.4	15.7	25.2	23.9	394.0	10.9	105.8	31.0	0.0	12.8	19.5	47.0	38.5	31.4	31.1	14.9	215.3	15.8	5.5	34.6	54.0	50.8	53.4	41.6	18.5	14.8	9.2	52.2	233.9	23.3	16.2	10.0	39.9	8.7	34.2	35.4	19.6	173.3	16.8	30.5	16.5	239.3	412.8	15.9	25.9	29.0	86.3	36.0	26.6	10.4	25.2	119.1	39.5	59.0	37.8	47.0	38.0	55.9	46.2	15.2	80.7	24.0	28.7	27.1
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 11920.3"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 12711.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 1117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	210000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	730.7	32.4	30.2	6.2	34.4	1.1	394.2	12.4	48.1	5.8	12.4	11.2	4.8	2.3	0.9	1.1	2.1	7.5	16.7	32.2	113.0	142.8	11920.3	24.5	0.6	21.5	19.3	4.1	82.4	0.1	519.9	12.4	21.3	8.6	6.7	3.0	13.7	4.6	6.2	16.4	19.2	0.8	14.9	5.5	11.9	4.7	46.2	1.5	7.9	5.3	0.1	19.0	8.8	18.0	0.0	14.7	0.0	0.0	2.9	0.0	0.1	0.3	0.1	2.5	0.4	264.9	0.5	1.5	2.7	0.3	0.2	0.8	0.0	0.0	0.3	0.2	0.2	2.2	1.1	1117.2	0.2	9.2	0.2	18.7	0.5	0.7	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.1	7.3	1.3	2.4	121.7	0.4	7.0	0.0	0.0	0.6	0.9	0.2	9.6	0.0	0.0	0.6	0.5	0.8	0.4	0.0	7.8	0.2	0.3	0.9	0.3	3.7	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	34.4	12.4	48.1	32.2	113.0	21.5	19.3	21.3	14.9	46.2	18.0	9.1	0.0	4.2	0.3	17.2	0.8	0.5	0.0	0.0	0.0	2.1	6.7	0.7	999.4	0.6	23.9	6.2	0.3	0.2	21.9	97.8	7.8	2.8	1.6	3.1	10.8	62.5	152.4	5.8	0.2	22.6	10.5	0.0	22.1	0.0	0.0	158.1	12711.6	17.8	0.0	7.2	40.7	0.0	210.4	3.0	2.4	3.1	7.8	1.8	1.0	0.0	0.8	0.0	1.0	1.1	29.2	28.0	5.7	0.3	2.1	0.8	785.3	0.7	0.5	0.0	7.3	3.8	3.1	13.9	0.0	0.9	1.4	12.3	0.0	1.7	1.4
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.8	13.9	5.6	4.1	6.6	0.9	7.1	5.2	7.8	15.7	5.3	8.1	6.6	14.5	2.4	3.0	10.9	11.5	13.5	4.6	4.7	30.8	6.8	10.6	2.8	6.1	6.1	10.2	9.2	8.6	3.2	37.1	6.3	7.7	4.8	24.3	2.1	9.9	144.2	3.6	5.6	12.1	4.9	14.9	20.8	15.1	7.6	1.9	3.3	19.6	1.2	7.4	7.5	7.8	0.2	12.0	17.8	0.0	8.3	7.3	0.0	5.3	4.8	4.3	6.4	0.6	0.2	0.0	21.9	28.0	2.0	0.3	5.3	1.6	5.0	0.0	4.8	1.1	8.8	67.3	9.0	1.4	0.4	10.6	3.0	2.6	2.7	16.5	20.6	3.8	10.2	0.0	19.1	0.4	5.2	0.0	7.7	0.2	7.9	4.5	24.9	6.4	14.1	0.7	4.9	19.0	6.3	6.9	6.9	11.1	1.4	2.4	18.5	8.2	21.1	0.2	5.9	0.0	0.0	0.0	4.1	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	5.6	6.6	5.2	7.8	4.6	4.7	6.1	6.1	6.3	4.9	7.6	7.8	13.7	16.0	8.7	3.6	1.0	1.8	1.0	0.5	0.6	3.4	3.7	2.5	29.5	1.5	2.3	1.8	135.5	66.1	0.2	0.7	1.9	3.8	75.2	11.0	14.7	13.6	8.3	3.8	74.3	16.0	3.4	8.6	34.1	4.5	0.0	59.0	17.9	9.6	11.3	334.8	23.1	7.7	4.1	21.5	1.4	35.3	8.1	14.1	1.8	57.1	0.4	16.0	0.0	14.1	155.5	16.4	2.5	4.9	0.1	1.2	1.5	36.4	10.2	25.1	6.6	16.7	11.8	2.8	1.4	0.6	1.4	302.4	0.8	15.2	4.3	0.4
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684560-20701216	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 478.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 67.3;Gastric mucus-secreting cells: 47.4;Hepatocytes: 55.8;Intestinal goblet cells: 110.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 92.6;ASC TERT1: 107.2;Hep G2: 136.9;HSkMC: 63.1;OE19: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		61000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	106.4	7.8	5.5	8.9	5.7	1.2	96.6	5.4	8.3	95.6	8.5	56.5	22.0	59.2	37.0	20.1	77.3	55.6	44.1	5.5	8.1	40.3	478.8	40.3	12.2	6.9	6.6	111.7	41.0	14.7	12.5	5.7	6.9	76.7	65.2	4.7	74.8	45.8	14.1	47.4	41.9	25.9	6.7	11.8	84.7	10.6	5.3	5.8	26.5	31.5	10.6	65.3	75.9	7.8	2.7	12.1	2.6	0.1	92.6	107.2	0.5	10.5	23.8	1.4	4.5	3.4	4.1	0.1	2.9	24.6	6.2	2.5	1.4	2.6	1.7	17.2	1.8	0.3	2.9	136.9	10.2	1.3	0.6	63.1	5.8	1.6	10.3	34.6	12.6	4.2	0.1	12.2	6.9	1.5	1.0	0.2	0.5	92.3	10.3	0.6	2.1	3.6	2.9	2.4	0.1	0.5	5.0	2.3	2.6	4.2	3.4	0.2	13.3	3.0	1.7	4.1	0.3	2.6	3.5	0.4	4.7	1.3	2.7	0.2	24.1	0.1	0.8	1.2	1.0	5.3	1.5	0.6	13.8	4.9	0.3	0.6	0.6	0.6	0.1	3.3	3.3	8.4	5.5	5.7	5.4	8.3	5.5	8.1	6.9	6.6	6.9	6.7	5.3	7.8	1.8	38.5	19.1	2.0	3.4	2.8	1.7	2.5	11.4	0.0	9.9	2.5	0.2	28.6	4.7	3.7	0.0	0.2	0.3	30.4	0.0	34.4	0.2	0.1	0.8	4.0	67.3	8.4	0.1	22.2	0.4	39.2	47.4	0.8	1.3	0.3	5.0	55.8	1.6	0.0	0.2	110.0	2.0	6.2	4.0	0.3	12.5	3.6	3.6	1.9	2.7	1.3	1.0	0.0	0.9	12.8	33.2	4.1	5.9	1.7	41.7	10.2	11.6	0.3	0.0	2.6	8.1	0.2	0.1	10.2	4.1	0.4	0.8	0.1	39.6	1.5
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160660	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Excitatory neurons: 8.8;Gastric mucus-secreting cells: 7.7;Inhibitory neurons: 8.2;Microglial cells: 10.3;Oligodendrocyte precursor cells: 9.5;Plasma cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"CAB009063: AB_2127706, HPA048745: AB_2680509"	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.3	18.5	4.9	9.1	4.8	9.5	14.3	4.2	6.6	16.7	3.6	15.0	7.1	18.2	6.9	16.2	14.8	6.9	19.6	4.6	4.1	17.5	15.8	14.9	10.4	5.3	4.4	17.8	23.9	10.4	18.7	6.9	4.5	16.6	6.6	4.1	16.9	7.1	41.5	19.3	15.9	9.6	4.5	26.1	17.9	16.4	4.8	11.7	16.5	17.9	9.6	15.1	14.0	4.4	6.1	10.8	10.5	14.8	6.1	6.3	23.2	9.9	15.1	18.2	15.6	10.2	13.5	10.9	6.9	11.8	10.2	7.6	5.4	11.8	9.7	13.2	4.2	11.0	9.5	32.5	12.8	17.5	18.8	12.3	10.4	7.2	12.9	9.6	12.0	7.9	5.9	12.9	7.7	17.3	17.6	8.6	5.3	9.9	12.7	10.1	9.8	6.8	8.9	20.8	9.9	12.7	8.6	25.6	12.5	9.2	7.4	13.3	11.1	12.6	10.2	8.8	8.9	21.4	21.2	11.5	4.4	6.1	13.6	0.0	0.8	0.8	0.6	1.7	1.8	0.4	0.9	0.6	0.5	0.4	0.6	0.4	1.7	1.7	1.0	1.8	1.1	0.4	4.9	4.8	4.2	6.6	4.6	4.1	5.3	4.4	4.5	4.5	4.8	4.4	0.9	0.0	4.6	16.0	5.2	0.6	0.3	0.0	4.6	0.6	1.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	1.0	0.8	0.0	0.3	0.1	1.0	1.3	1.3	0.0	3.8	8.8	0.0	0.5	1.3	7.7	0.9	0.0	1.1	0.4	0.8	0.4	0.0	8.2	0.3	2.0	0.6	1.5	0.4	0.3	2.7	0.0	10.3	0.5	0.3	3.1	9.5	7.3	0.2	0.2	0.0	8.7	0.2	0.5	0.2	0.8	0.8	0.0	1.4	1.2	1.6	0.8	5.7	0.9	0.5	4.3	0.8	0.1	0.3
RPS6KA3	"CLS, HU-3, MRX19, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 236.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	21.1	18.8	6.9	33.7	10.2	16.2	14.8	12.7	12.8	16.1	8.5	32.8	24.1	17.5	8.5	18.7	15.1	26.9	21.1	8.7	9.4	19.5	45.0	32.3	31.3	8.4	10.0	10.6	17.2	59.4	5.9	19.5	8.5	19.9	31.8	15.7	13.2	18.0	51.8	15.0	27.6	27.8	8.7	29.2	21.1	5.5	10.6	32.9	21.2	40.3	32.6	34.2	8.5	8.0	44.9	77.0	28.4	14.8	27.1	47.3	8.6	38.0	57.4	27.8	37.7	87.7	56.2	29.3	12.8	40.0	40.5	30.9	32.8	32.2	51.1	24.8	26.1	34.6	46.2	236.8	27.7	67.8	34.2	30.3	25.1	43.5	54.4	24.3	101.9	30.4	23.1	81.0	29.4	21.2	44.2	20.7	20.6	57.8	45.9	23.3	60.0	33.8	23.9	36.9	13.1	12.8	51.1	15.3	54.4	35.3	0.1	20.0	57.3	30.1	20.8	96.3	21.7	64.3	42.1	32.1	56.9	33.1	72.6	11.9	3.8	7.9	4.7	5.3	8.3	2.4	5.4	5.2	5.6	3.2	3.7	4.5	5.8	6.6	6.0	6.7	2.9	2.2	6.9	10.2	12.7	12.8	8.7	9.4	8.4	10.0	8.5	8.7	10.6	8.0	60.6	44.8	67.5	31.6	34.8	54.4	37.0	21.2	10.2	37.8	20.4	10.8	22.9	34.3	41.1	16.5	22.9	4.0	70.0	63.5	3.9	26.3	0.4	10.8	24.0	61.1	25.0	19.1	142.2	30.5	6.7	31.6	24.5	26.1	44.3	8.3	34.6	65.4	22.6	13.5	108.4	59.1	28.5	40.8	104.3	1.5	13.1	62.6	37.4	126.5	53.7	27.5	46.4	116.6	27.0	37.4	57.9	21.1	25.5	56.6	33.5	25.1	23.3	9.7	19.7	41.5	21.3	6.4	8.7	13.8	55.5	3.6	66.0	14.2	61.1	63.8
RTKN	B5	ENSG00000114993	Rhotekin	Q9BST9	2	74425835-74442422	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 149.6;liver: 124.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NK-cell: 2.3;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.6;NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 96.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030259	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA030259: AB_10601484"	"unprognostic (4.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.43e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-3)"	9.8	8.3	69.5	5.0	104.1	0.6	11.3	85.4	84.6	13.5	51.9	20.3	31.8	8.7	3.5	20.8	12.7	14.2	17.3	72.0	84.3	54.4	124.7	10.3	3.1	100.4	95.5	7.7	30.8	20.7	14.7	11.8	95.7	19.1	12.6	1.9	26.0	9.5	12.8	32.0	25.3	6.3	73.4	5.2	15.3	3.3	93.5	6.3	19.5	7.5	5.3	8.3	16.6	149.6	50.4	15.5	19.5	56.3	11.8	13.7	82.1	7.6	9.9	11.0	8.0	76.3	26.8	0.3	21.2	7.4	13.6	67.2	7.3	48.6	5.3	9.9	31.3	12.0	2.8	96.7	7.2	0.0	0.1	8.4	37.7	9.5	30.0	20.2	5.5	0.7	6.2	0.3	16.5	35.8	1.9	10.1	20.9	70.9	30.3	11.1	60.6	7.6	52.4	0.3	19.0	18.8	20.7	79.3	45.2	17.5	44.6	4.4	0.6	20.5	14.0	9.3	10.6	4.8	3.7	1.8	19.6	0.1	19.5	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.1	0.2	0.6	1.0	0.0	0.1	0.0	2.3	0.0	6.6	0.0	0.4	69.5	104.1	85.4	84.6	72.0	84.3	100.4	95.5	95.7	73.4	93.5	149.6	4.3	9.6	11.8	4.9	2.0	20.0	22.1	37.2	19.4	0.1	14.4	12.2	3.1	28.6	18.3	11.0	2.1	46.7	4.5	21.7	21.5	43.0	0.7	12.6	6.1	8.8	30.7	1.3	0.5	20.1	8.3	8.9	15.8	26.0	1.3	4.9	5.3	40.1	10.1	0.0	0.9	20.1	18.3	2.2	3.8	1.5	12.8	1.1	28.4	3.7	0.7	6.9	5.2	34.7	48.2	30.5	31.0	8.6	1.4	35.4	44.7	54.7	5.8	0.4	6.6	36.9	3.9	1.1	5.6	12.9	21.6	33.4	2.5	3.1	30.5	15.6
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231355-18236802	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"liver: 1943.5"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 2132.8;Respiratory ciliated cells: 706.8"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 28.8"	"Not detected"	"Not detected"							"CAB026061, HPA060139"	Supported				"Secreted to blood"	NA	NA	65000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026061: , HPA060139: AB_2684210"	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	7.4	0.5	0.3	0.4	0.3	0.0	6.7	0.3	0.6	15.6	0.3	0.2	0.0	0.0	0.2	0.5	0.5	1.0	0.1	0.3	0.3	0.4	1943.5	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.8	0.0	0.3	1.2	0.0	0.1	11.4	0.1	3.4	0.5	0.1	0.1	0.3	1.2	0.1	1.3	0.4	0.9	0.0	0.0	0.2	0.1	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.1	28.8	0.3	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	184.7	0.0	0.0	2.1	1.4	0.0	18.6	172.6	0.0	0.0	0.0	0.0	3.5	0.0	4.0	0.6	0.4	0.0	1.6	0.0	21.5	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	27.5	2132.8	0.1	0.0	0.0	0.0	71.2	38.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	706.8	0.0	0.0	0.0	23.6	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.5
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508690-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 96.0;Inhibitory neurons: 276.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.6;Hep G2: 65.6;K-562: 44.7;RH-30: 29.0;WM-115: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067811	Uncertain		Supported	Vesicles		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	0.6	1.8	2.8	1.3	5.6	0.1	4.1	1.0	2.6	1.4	0.1	6.0	3.0	4.2	0.8	8.9	0.9	2.2	1.2	2.7	4.0	7.4	7.5	3.4	0.3	8.7	4.1	0.4	1.3	5.7	3.8	12.2	9.1	1.4	8.1	8.9	2.3	2.4	0.2	1.9	4.4	3.1	0.0	1.4	4.5	7.6	7.2	0.1	2.1	0.1	0.7	1.5	1.9	0.8	11.2	1.4	1.4	2.0	0.0	0.0	0.1	3.6	1.3	0.3	0.2	16.6	0.1	0.6	3.6	0.0	0.6	0.1	0.3	2.5	0.4	0.0	2.0	0.8	1.5	65.6	0.2	0.0	1.3	0.0	0.1	0.3	0.1	0.0	6.8	0.0	44.7	0.6	4.8	0.1	0.0	0.0	0.1	8.4	2.8	0.0	29.0	6.5	0.1	2.3	0.5	0.1	0.9	0.2	2.8	0.3	0.0	0.0	4.9	0.5	1.5	0.5	1.3	0.1	1.1	0.0	0.1	0.1	20.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	5.6	1.0	2.6	2.7	4.0	8.7	4.1	9.1	0.0	7.2	0.8	1.7	3.2	5.9	1.3	1.0	1.8	5.6	0.5	2.2	96.0	2.9	23.5	2.6	0.0	0.0	18.4	2.1	0.2	0.0	5.4	9.8	2.2	0.5	1.1	10.7	11.1	16.9	0.0	15.7	0.2	0.3	6.9	19.4	1.8	0.0	7.0	6.1	28.1	0.8	0.0	276.9	11.6	0.0	1.0	1.4	1.3	0.3	0.7	0.0	45.0	0.0	9.2	0.0	5.5	0.9	0.6	3.4	3.4	0.1	3.0	5.2	19.7	0.0	4.0	0.0	3.1	2.0	0.5	0.2	36.4	1.6	0.3	0.5	3.6	25.7	4.2
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 47.9;liver: 114.4;pancreas: 43.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8"	"Lineage enriched"	"Detected in single"	16	"T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		230000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	1.1	2.2	3.6	2.5	3.5	0.9	0.8	1.9	3.9	2.6	0.7	1.1	1.8	2.0	47.9	0.6	1.9	1.3	2.4	3.3	3.5	12.0	114.4	2.6	4.1	4.4	3.1	3.0	43.2	2.1	4.1	0.9	3.4	2.3	0.4	0.6	5.3	1.8	0.6	0.4	1.3	0.9	2.9	1.3	3.0	0.7	4.2	4.3	1.6	0.3	2.4	1.1	1.0	3.1	0.0	0.1	1.4	17.4	0.1	0.5	2.3	0.1	0.7	0.9	1.1	0.3	0.2	0.0	2.4	0.3	2.2	0.1	0.0	0.3	0.7	0.0	0.3	2.5	0.0	31.1	1.9	0.1	0.3	4.2	0.0	2.0	0.1	0.4	0.2	13.1	0.1	0.4	11.1	3.2	22.5	2.4	2.8	1.7	0.2	1.6	18.5	39.1	0.0	0.1	1.7	14.7	0.0	0.4	3.9	0.8	2.4	0.2	0.1	3.3	3.0	0.3	0.0	0.3	0.0	1.3	2.1	1.4	0.1	0.3	0.1	0.1	0.3	0.0	0.8	0.0	3.3	0.8	0.0	0.3	6.7	1.2	0.5	0.1	0.0	0.3	8.8	1.4	3.6	3.5	1.9	3.9	3.3	3.5	4.4	3.1	3.4	2.9	4.2	3.1	0.1	0.0	1.9	6.8	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.8	0.8	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.8	1.2	5.7	1.5	1.1	0.1	2.3	0.0	0.3	1.3	0.8	2.9	120.6	0.1	0.0	0.7	0.0	0.0	1.6	0.6	0.8	4.7	0.2	0.0	1.9	0.0	4.2	1.0	0.5	0.3	0.1	0.0	3.0	0.7	0.3	0.0	21.3	0.0	0.3	0.0	1.6	3.5	0.1	0.8	0.0	0.1	0.0	4.2	1.6	0.0	0.2
SCFD1	"C14orf163, KIAA0917, RA410, SLY1, STXBP1L2"	ENSG00000092108	"Sec1 family domain containing 1"	Q8WVM8	14	30622291-30737694	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003579	Approved					NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003579: AB_1079872"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.32e-2)"	23.2	29.3	11.8	22.3	12.4	9.9	29.2	12.3	12.6	34.0	13.0	27.6	22.2	21.8	40.8	29.7	21.7	19.6	29.6	11.9	12.4	32.5	35.1	22.5	26.2	11.8	12.1	23.6	46.4	41.8	29.3	27.8	11.8	27.7	29.8	14.9	52.3	24.0	24.6	19.5	23.8	22.9	11.5	19.0	28.0	26.6	11.6	25.6	44.3	29.3	29.1	30.0	20.8	12.0	71.7	26.0	37.8	22.9	64.1	67.0	53.4	57.0	68.4	69.5	83.5	42.2	58.9	36.9	24.2	79.7	38.8	44.5	41.3	46.5	80.0	53.2	22.2	30.7	28.6	149.5	77.9	50.2	32.4	49.1	39.1	48.9	78.1	58.5	45.5	26.5	42.6	68.0	74.7	66.8	30.7	27.8	40.7	83.9	45.1	30.2	42.1	42.2	70.7	45.6	35.9	33.0	58.7	54.4	53.6	42.9	70.5	35.3	48.1	41.9	44.0	43.0	45.3	45.3	40.8	49.4	26.9	36.7	52.9	26.8	17.2	20.2	14.0	23.2	17.8	20.1	16.2	17.3	23.7	14.7	15.2	14.1	3.0	23.1	27.8	16.9	24.4	16.1	11.8	12.4	12.3	12.6	11.9	12.4	11.8	12.1	11.8	11.5	11.6	12.0	33.0	51.3	31.3	67.9	47.7	25.0	55.2	55.1	18.2	35.0	26.9	27.1	35.3	18.6	50.8	25.8	43.8	61.9	51.3	31.8	64.6	49.2	29.3	34.9	51.6	32.3	47.2	24.2	123.0	50.6	61.0	47.9	20.9	34.2	53.7	32.1	24.3	20.6	44.9	30.3	112.8	44.9	36.7	27.7	33.4	16.6	38.5	35.5	37.4	90.9	66.9	31.1	62.8	112.6	106.6	41.2	23.5	40.3	70.9	42.3	28.8	40.9	52.1	39.9	13.1	53.7	49.0	71.8	53.5	20.5	24.4	83.0	41.4	47.8	30.0	43.5
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SDR39U1	"C14orf124, HCDI"	ENSG00000100445	"Short chain dehydrogenase/reductase family 39U member 1"	Q9NRG7	14	24439766-24442905	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044294, HPA075356"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA044294: AB_10961400, HPA075356: "	"unprognostic (2.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.87e-3)"	"prognostic favorable (2.34e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.32e-2)"	41.5	73.9	55.4	14.8	56.9	28.9	44.6	59.7	65.1	40.4	53.4	43.3	16.9	33.5	17.7	35.1	35.8	11.6	83.7	54.0	55.7	60.2	57.9	35.1	22.6	56.7	57.9	47.2	50.1	22.7	58.1	14.4	56.6	47.2	9.3	37.9	38.0	23.1	96.7	40.1	42.1	11.6	57.4	57.7	47.5	34.7	58.5	27.8	38.7	72.5	14.1	41.1	33.4	57.3	20.1	35.4	25.5	30.0	34.8	26.5	24.4	11.5	16.3	26.4	30.2	27.4	26.0	28.4	30.0	13.4	19.6	37.1	22.8	29.2	11.5	38.2	39.5	25.3	26.1	74.1	16.9	23.7	23.4	29.7	34.6	19.0	27.2	26.9	28.5	65.5	23.1	24.5	26.3	36.2	40.2	39.2	24.1	31.3	32.6	50.9	13.2	20.9	47.5	27.1	43.8	36.8	30.3	55.4	28.3	15.1	38.1	34.9	14.2	8.0	25.5	23.7	15.3	38.3	26.9	35.7	21.1	30.6	21.2	39.1	38.3	23.8	40.3	23.7	39.2	49.7	30.7	32.3	43.7	49.7	43.2	45.2	11.4	58.4	20.3	60.7	40.2	33.0	55.4	56.9	59.7	65.1	54.0	55.7	56.7	57.9	56.6	57.4	58.5	57.3	34.9	28.9	21.7	10.1	35.0	26.5	40.8	40.1	21.6	37.2	44.2	47.2	0.2	45.8	36.5	40.5	12.5	48.4	41.6	19.7	121.3	29.1	16.9	16.9	15.9	27.3	27.6	35.3	12.2	19.9	24.3	24.8	13.3	17.8	36.1	28.4	21.0	38.6	30.2	28.6	12.6	25.8	38.7	19.3	19.6	26.3	32.9	21.6	42.7	12.2	22.9	63.4	37.0	11.1	17.0	15.7	17.7	31.6	34.4	24.9	21.3	71.7	26.8	47.4	0.0	25.5	24.0	67.1	22.6	21.0	27.3	56.1	28.6	27.0	22.5	29.8
SEC23A		ENSG00000100934	"Sec23 homolog A, COPII coat complex component"	Q15436	14	39031919-39109646	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		83000	"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	45.9	32.0	11.4	31.8	14.2	13.1	20.9	18.3	16.8	36.2	31.4	40.0	57.7	42.7	19.9	34.1	21.5	32.1	46.9	13.3	18.9	23.1	80.8	20.2	21.0	13.8	14.0	33.9	12.0	8.1	10.5	27.1	15.3	34.0	34.2	38.5	10.5	52.6	54.2	12.8	52.6	90.5	7.6	20.5	16.8	23.5	12.7	18.9	17.9	58.5	22.0	40.7	17.9	15.4	52.1	90.8	76.9	74.7	161.3	173.0	25.9	195.1	176.4	135.2	166.8	93.2	44.2	12.6	46.9	279.6	54.9	41.2	99.6	86.3	208.6	39.6	36.9	21.8	67.7	347.3	122.4	35.9	31.3	134.0	48.8	91.6	73.7	114.6	130.8	26.9	15.6	30.1	125.8	47.5	32.9	16.9	18.4	81.7	91.3	44.0	111.8	19.1	84.7	75.6	8.5	20.5	132.8	43.0	51.8	68.6	51.5	12.4	138.4	75.0	57.8	110.8	52.0	27.0	36.6	56.0	50.3	31.4	70.2	70.5	34.3	38.6	26.6	29.3	38.4	23.6	33.1	34.9	31.1	21.1	34.9	28.0	29.5	42.1	27.3	26.7	38.1	31.4	11.4	14.2	18.3	16.8	13.3	18.9	13.8	14.0	15.3	7.6	12.7	15.4	35.4	16.0	26.9	34.9	30.5	25.9	33.5	15.5	15.4	39.7	11.8	10.3	54.6	15.7	18.8	31.3	68.8	16.0	36.0	87.0	7.9	9.8	13.4	11.3	42.8	41.1	24.5	6.1	48.3	5.6	43.7	55.0	26.5	18.8	27.9	56.9	118.9	133.6	25.6	30.3	51.1	31.6	12.2	36.4	32.3	18.6	74.9	24.3	24.9	48.7	25.6	19.4	32.0	34.2	44.3	17.8	34.1	71.5	38.5	37.5	88.6	32.8	10.1	58.7	39.5	27.6	51.4	18.0	15.5	15.7	24.0	24.8	32.3	31.0	30.2	56.5
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 2087.6;liver: 6268.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Hep G2: 567.4;HSkMC: 451.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	1800000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	719.1	424.3	164.8	179.9	345.6	40.1	617.5	386.0	290.0	460.0	145.5	644.0	620.0	335.8	459.7	240.7	376.5	670.5	237.2	156.3	231.3	853.7	6268.1	512.0	552.4	519.4	316.4	701.2	229.0	246.0	108.3	973.0	490.3	214.2	714.2	59.2	170.8	374.1	156.4	171.8	2087.6	233.2	310.3	948.8	257.0	87.8	284.7	170.4	147.0	265.6	177.4	414.3	213.1	524.3	0.7	1.7	7.7	1.0	43.6	12.2	7.3	4.1	10.9	0.0	0.0	12.5	65.3	2.0	36.3	1.5	1.4	1.7	0.2	0.1	0.0	2.4	52.7	3.1	0.2	567.4	25.9	3.2	0.4	451.1	0.7	0.0	0.1	1.9	0.1	1.5	6.4	12.9	23.5	1.3	1.1	6.4	30.6	17.0	0.9	1.3	2.0	100.8	12.5	8.0	2.2	2.7	2.7	16.7	1.6	54.6	125.4	0.7	0.7	3.2	1.7	5.2	1.0	8.4	1.5	2.0	1.7	5.9	1.5	0.1	0.1	0.5	0.5	0.1	0.6	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.5	0.6	0.2	0.9	0.3	0.3	164.8	345.6	386.0	290.0	156.3	231.3	519.4	316.4	490.3	310.3	284.7	524.3	312.7	448.7	529.3	0.0	15.2	0.0	0.0	0.0	0.0	0.0	312.0	271.1	0.0	0.0	102.1	125.0	0.0	223.4	9.4	0.0	197.6	73.4	0.0	83.8	231.0	75.8	0.0	0.0	0.0	52.8	17.5	358.7	0.0	116.1	26.5	458.1	0.0	0.0	858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	373.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	4.9	0.0	0.0	1044.7	52.5	0.0	0.0	0.0	133.1	0.0	0.0	0.0	0.0	112.9	10.0	361.8	0.0	0.0
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 84.6;liver: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	2.4	12.7	13.1	5.9	10.9	0.4	3.6	18.9	12.3	6.9	12.8	53.6	53.4	3.5	32.1	3.6	5.9	9.0	3.0	10.0	11.6	19.1	102.4	5.8	2.5	11.2	14.4	18.9	31.3	7.3	9.9	3.9	11.5	20.2	84.6	7.3	8.5	3.0	2.6	18.3	41.2	4.6	9.6	3.1	20.9	3.7	17.0	0.8	15.3	0.8	0.9	4.0	5.0	9.9	0.2	31.7	8.0	3.4	5.0	1.6	6.8	1.2	3.4	1.7	1.7	30.5	5.2	0.5	4.2	1.5	0.6	2.1	8.0	1.4	1.4	0.7	4.9	1.7	3.0	113.8	12.5	1.2	1.0	8.3	1.8	1.6	0.9	22.2	4.4	3.5	3.3	0.4	2.5	2.0	0.5	1.2	1.3	69.1	1.8	3.1	0.7	1.5	7.4	1.0	2.5	12.5	1.1	2.1	3.2	8.7	8.7	1.5	3.0	1.0	3.7	0.8	0.3	1.1	0.6	0.5	0.9	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	10.9	18.9	12.3	10.0	11.6	11.2	14.4	11.5	9.6	17.0	9.9	0.3	3.2	1.1	3.9	1.2	0.0	0.6	0.7	0.6	3.5	2.5	2.0	1.2	20.0	0.2	0.0	0.0	8.8	0.0	66.4	0.0	2.7	0.2	1.6	0.7	0.6	8.5	0.8	3.0	2.6	1.9	2.0	27.0	0.3	0.0	3.4	2.2	60.5	0.9	11.8	14.1	34.6	2.0	3.3	0.0	0.2	2.1	0.2	1.8	0.0	0.0	0.9	0.0	3.5	5.5	2.4	38.5	1.2	0.2	3.0	47.6	6.4	2.4	1.6	0.0	0.1	0.4	1.1	1.9	0.5	0.1	2.9	0.2	12.7	45.9	0.9
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34022.4"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.1	9.7	7.3	225.0	7.1	157.1	100.6	9.1	21.3	105.7	11.1	151.0	278.6	42.3	5.3	10.1	22.4	352.3	12.5	7.3	11.1	621.2	34022.4	570.7	37.0	20.9	14.4	5.4	201.0	5.2	9.1	26.6	15.8	12.6	178.8	2.6	33.6	140.5	3.7	8.2	760.9	75.7	12.2	313.6	282.5	3.0	16.2	15.0	23.0	11.9	25.2	55.8	9.1	16.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.3	7.1	9.1	21.3	7.3	11.1	20.9	14.4	15.8	12.2	16.2	16.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280460-94293268	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"liver: 346.9"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 259.1"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.4	0.4	0.4	0.6	0.7	3.3	0.6	3.2	1.4	0.6	0.4	0.7	0.7	0.7	0.5	0.4	0.3	0.5	0.6	0.4	0.4	0.5	346.9	0.4	0.8	1.5	0.5	0.9	0.5	0.2	0.2	0.5	0.8	0.4	0.7	3.1	0.4	0.4	0.5	1.7	0.7	0.6	0.4	0.7	0.7	0.6	0.7	1.3	0.7	0.4	0.4	0.2	0.1	2.5	0.6	0.2	1.8	0.7	0.7	0.6	0.4	0.5	0.5	0.9	0.8	2.7	0.6	2.1	0.3	0.4	0.2	0.4	2.2	0.5	1.3	0.8	1.4	2.0	0.8	21.2	0.4	1.6	1.1	0.6	0.5	0.3	0.7	1.1	1.0	1.1	0.5	1.3	1.0	0.3	1.4	0.8	0.8	0.2	0.6	0.9	1.2	0.9	0.5	0.7	0.9	0.8	0.4	0.4	0.2	1.0	0.9	0.9	0.6	0.7	0.4	0.7	0.6	1.1	0.5	0.9	0.9	1.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	3.2	1.4	0.4	0.4	1.5	0.5	0.8	0.4	0.7	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	2.8	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	6.6	8.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	3.3	259.1	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452800	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"liver: 490.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 278.7"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		230000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favorable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.1	5.3	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	490.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.9	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.3	0.0	0.0	4.3	1.8	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	278.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.2
SERPINA12	"OL-64, Vaspin"	ENSG00000165953	"Serpin family A member 12"	Q8IW75	14	94487274-94517844	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 396.4"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 20.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 1.8;melanoma: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		6500000		"Cluster 61: Skin - Cornification"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 28: Keratinocytes - Keratinization"				"unprognostic (1.82e-3)"				"unprognostic (6.44e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-2)"		"unprognostic (5.98e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.64e-3)"				"unprognostic (6.67e-2)"			0.3	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	396.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612384-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 9176.5;pancreas: 4910.2"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 20.9;Exocrine glandular cells: 33.0;Fibroblasts: 68.6;Late spermatids: 12.2;Pancreatic endocrine cells: 18.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 449.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	NA	NA	697000000000	94000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favorable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	91.8	58.0	100.4	43.4	116.5	2.1	371.0	117.7	293.8	368.8	110.3	79.5	11.7	44.9	11.5	42.5	116.6	146.0	311.7	103.6	320.0	215.5	9176.5	169.9	5.0	196.3	183.1	181.5	4910.2	1.0	271.2	14.6	138.3	580.5	13.3	131.5	1505.8	54.9	177.8	55.7	91.6	83.1	141.4	31.7	290.5	66.9	176.3	2.6	72.6	38.9	6.4	207.4	70.4	173.0	0.2	0.5	0.0	0.3	0.2	0.8	0.3	0.1	0.1	0.0	0.0	1.2	4.9	0.6	4.5	0.0	3.3	0.9	0.0	4.4	0.0	2.7	0.0	1.0	0.2	449.9	56.9	1.9	0.7	52.0	63.9	0.0	2.5	5.4	0.0	0.0	0.3	0.2	0.0	17.1	0.5	0.5	0.8	1.6	0.0	0.6	2.2	0.2	3.8	0.2	0.1	0.0	1.8	2.5	65.6	0.4	2.4	0.0	0.6	0.0	8.5	0.1	19.4	1.1	2.0	2.1	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.4	116.5	117.7	293.8	103.6	320.0	196.3	183.1	138.3	141.4	176.3	173.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.5	1.8	0.0	5.6	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	20.9	3.7	0.2	0.1	0.3	0.0	0.0	0.0	33.0	0.0	68.6	9.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	18.7	0.0	0.4	0.3	0.5	0.0	0.1	1.5	0.0	0.0	1.7	0.8	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561442-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 550.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 94.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 28.4"					"Not detected"	"Not detected"			"HPA003607, HPA068939"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA	14500000000	14000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA003607: AB_1079914, HPA068939: "	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.4	41.0	0.0	1.5	53.4	0.0	0.0	0.0	7.3	550.0	0.0	0.0	0.0	0.0	0.0	116.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	245.9	0.0	3.7	0.0	0.0	0.0	0.0	11.7	30.0	0.0	3.3	0.3	0.3	0.0	2.7	0.0	93.8	0.0	0.0	5.1	4.5	0.0	0.2	5.3	478.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593118	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Fertilization, Lipid transport, Transport"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 484.5;liver: 785.6;testis: 432.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 400.4;Endometrial ciliated cells: 175.2;Glandular and luminal cells: 345.3;Hepatocytes: 198.2;Late spermatids: 277.8;Peritubular cells: 144.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078846	Enhanced				"Secreted to blood"	NA	NA		2100000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA078846: "	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	5.1	484.5	1.8	3.3	2.4	0.0	19.6	2.2	1.7	29.6	3.0	5.3	5.5	31.8	1.2	0.8	26.3	160.5	19.0	1.6	7.2	151.4	785.6	1.0	3.6	3.5	3.8	30.1	173.9	0.2	3.2	0.1	5.3	6.8	1.9	14.0	9.4	153.3	46.4	3.3	3.6	2.1	1.7	112.2	12.1	432.4	2.8	0.9	4.1	152.6	4.7	2.3	4.0	3.7	0.8	0.1	2.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	12.0	12.2	0.0	8.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	261.3	0.3	0.4	0.0	1.7	0.3	0.1	0.0	2.3	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.1	0.5	0.2	3.9	0.1	0.4	17.4	0.2	0.1	7.9	0.9	0.1	0.0	0.5	0.0	0.6	0.4	1.5	0.2	0.1	0.2	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	2.2	1.7	1.6	7.2	3.5	3.8	5.3	1.7	2.8	3.7	0.9	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.2	18.9	14.1	0.8	400.4	0.1	33.1	2.1	0.0	0.1	0.0	64.6	103.2	78.7	175.2	19.7	40.3	0.0	2.7	0.0	122.2	0.0	18.2	0.5	345.3	0.0	78.2	2.5	198.2	0.0	8.4	0.0	0.0	0.0	3.2	0.7	277.8	57.2	1.9	0.0	0.0	0.6	5.4	0.0	0.0	0.2	18.3	0.0	144.4	0.0	0.1	0.0	7.5	0.0	1.4	6.6	11.6	1.5	11.1	2.9	0.0	0.6	0.3	1.8	58.7	0.0	0.1
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032435-106038727	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	612	"liver: 282.2"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 182.8"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	475	"Hep G2: 69.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	NA	NA	39800000000	25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	282.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	182.8	0.0	0.0	0.0	0.7	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1341	"liver: 5056.6"	"Cell type enriched"	"Detected in some"	49	"Hepatocytes: 2707.9"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"Hep G2: 84.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		120000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.3	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.2	3.7	5056.6	0.3	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.7	0.1	0.0	0.3	0.1	0.2	0.0	0.2	1.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	84.2	0.0	1.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.2	1.8	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.3	0.1	3.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	37.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	1.6	0.0	34.7	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.1	42.1	2707.9	0.2	0.0	0.1	0.0	0.0	55.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	3.7	0.0	0.0	0.2
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 1253.1"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 283.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 208.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		50000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.3	0.2	0.1	0.0	0.8	0.2	0.4	1.7	0.8	1.0	87.7	0.0	0.0	2.0	0.0	0.1	0.9	0.4	1.1	1.7	0.0	0.3	1253.1	2.5	0.0	0.0	0.0	1.8	0.5	10.1	0.8	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.0	0.0	0.8	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	208.2	0.1	0.8	0.5	0.1	0.0	1.6	0.0	0.0	20.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	2.4	16.5	0.0	0.7	0.0	0.0	3.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.2	7.2	0.2	13.9	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.5	0.1	0.0	0.1	0.8	1.7	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	11.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	1.6	0.0	0.1	2.3	0.0	0.0	1.3	0.0	3.9	283.7	0.1	0.0	0.9	0.0	0.0	6.3	0.0	0.0	1.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	3.4	0.0	0.0
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755265	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 1578.5"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1007.7"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 44.7"	"Lineage enriched"	"Detected in many"	23	"dendritic cells: 44.7"	"Cell line enriched"	"Detected in some"	24	"Hep G2: 145.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	NA	NA	11900	61000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	11.6	2.0	1.4	4.3	1.5	0.4	18.3	1.2	2.2	7.1	11.1	4.2	0.7	8.7	101.4	3.0	19.6	0.7	2.5	2.0	1.4	74.1	1578.5	12.9	3.0	1.6	1.6	7.7	9.2	0.1	1.9	0.8	1.7	21.4	0.5	0.5	6.1	32.6	4.3	5.5	11.6	1.8	1.3	7.1	3.7	12.5	1.8	2.6	7.9	0.4	3.5	7.3	5.8	2.2	1.8	6.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.9	0.0	0.3	0.9	0.0	3.3	0.0	0.0	0.0	0.1	0.9	145.9	1.1	0.8	0.1	1.6	1.2	0.0	0.7	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.7	0.1	0.3	0.3	0.1	0.9	1.3	0.0	0.3	0.0	0.2	0.6	0.0	1.1	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.9	1.4	0.0	0.8	0.0	0.5	0.0	0.0	10.7	0.5	0.0	0.0	0.0	1.2	0.0	44.7	0.0	1.2	1.4	1.5	1.2	2.2	2.0	1.4	1.6	1.6	1.7	1.3	1.8	2.2	1.6	3.2	19.6	0.3	5.3	1.5	4.9	10.3	8.0	0.2	20.5	8.8	0.7	27.1	7.0	1.8	6.2	0.2	32.1	0.7	9.8	0.0	0.6	0.1	2.7	3.4	4.2	23.6	1.6	4.9	0.3	2.7	0.0	0.3	1.3	0.3	14.6	1007.7	7.7	0.0	1.9	2.1	12.2	32.2	20.1	0.8	33.8	8.2	1.8	1.0	10.9	0.1	0.0	1.0	0.7	3.8	2.7	26.7	3.2	2.8	2.2	87.5	4.4	0.4	0.0	1.3	1.2	0.4	0.5	1.3	1.6	0.3	2.6	0.0	3.3	1.8
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 407.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.3	2.4	12.5	0.7	22.8	0.2	1.9	16.5	16.1	2.0	4.9	0.8	0.3	1.8	1.0	0.9	2.4	1.9	1.0	10.1	16.2	407.6	21.7	1.4	0.6	18.3	19.5	4.5	9.0	0.2	2.6	43.2	19.0	6.3	0.5	1.1	4.9	0.8	1.0	2.2	0.4	1.9	12.5	0.6	4.7	8.7	19.9	1.1	1.4	0.3	0.7	1.8	1.4	37.4	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	12.5	22.8	16.5	16.1	10.1	16.2	18.3	19.5	19.0	12.5	19.9	37.4	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930691	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"liver: 79.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 30.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038270	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	30.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 782.3;choroid plexus: 202.7"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 4607.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	0.6	4.6	546.9	0.6	731.2	0.4	3.8	388.1	782.3	1.2	202.7	0.2	0.5	1.0	0.3	0.2	0.3	0.2	0.9	631.1	432.5	0.2	34.9	0.6	1.9	450.6	533.6	0.1	9.5	0.1	2.6	1.1	384.2	0.3	0.1	60.1	4.6	0.1	0.3	1.3	0.2	0.3	409.7	0.5	2.1	1.7	498.7	0.2	0.3	0.5	1.6	0.3	0.6	453.4	0.0	0.1	0.5	0.0	0.2	2.1	0.0	0.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	1.1	0.0	0.1	0.5	0.0	0.3	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.1	0.1	0.1	546.9	731.2	388.1	782.3	631.1	432.5	450.6	533.6	384.2	409.7	498.7	453.4	0.4	3.2	4.8	4607.2	0.4	2.9	0.0	0.0	0.0	109.9	8.1	2.4	3.1	0.0	0.0	0.0	148.0	25.6	0.3	0.1	0.0	0.1	96.6	1.8	11.7	1.6	0.0	0.0	83.7	3.4	1.0	3.1	1.1	1.5	0.0	0.7	0.0	6.7	3.3	6.7	81.5	0.0	0.0	0.0	3.0	97.9	0.0	0.6	1.8	194.9	31.6	10.1	0.0	634.9	12.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.8	161.2	0.0	0.3	1.8	0.5	1.3	0.0	1.1	269.4	0.2	0.0	0.0	0.1
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 427.9"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 254.5;Proximal tubular cells: 91.8"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	47.6	427.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.5	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	254.5	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	91.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 183.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.3;Late spermatids: 76.9;Proximal enterocytes: 50.9;Proximal tubular cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"Hep G2: 158.9;SK-BR-3: 116.6"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	17.8	14.8	5.3	3.0	5.0	9.5	16.8	5.6	6.2	6.5	6.4	26.1	21.4	3.8	2.7	38.8	9.2	5.5	10.4	4.6	5.2	72.9	183.3	4.3	2.5	6.6	5.2	4.8	35.8	17.3	6.3	1.8	5.1	17.2	6.8	0.6	26.0	6.1	5.8	17.3	20.1	0.9	5.8	4.8	24.0	35.0	5.4	3.9	9.6	1.9	2.9	9.1	11.5	6.6	45.3	81.8	7.6	38.1	2.9	2.3	15.3	19.2	6.1	23.2	17.4	49.5	18.4	20.2	14.3	4.5	11.2	28.3	10.8	19.3	4.2	14.9	66.2	16.7	49.0	158.9	3.3	37.5	19.5	1.6	10.0	16.5	3.2	4.5	13.6	27.9	28.0	24.3	8.2	85.4	54.3	40.0	7.8	18.8	63.9	41.0	16.3	63.6	21.1	39.6	49.8	34.0	18.1	116.6	4.0	2.0	50.3	20.4	6.1	17.9	58.6	26.5	34.4	15.3	8.3	12.0	7.8	39.0	15.9	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.2	5.3	5.0	5.6	6.2	4.6	5.2	6.6	5.2	5.1	5.8	5.4	6.6	1.4	0.0	2.2	1.6	1.3	0.0	4.5	0.0	2.2	4.9	14.6	7.5	3.8	17.2	3.1	14.7	0.0	16.4	2.3	10.2	25.4	16.9	30.5	22.3	3.8	1.5	4.9	8.2	1.2	22.9	6.9	2.3	18.8	16.4	0.0	5.1	3.6	42.3	8.0	0.0	1.7	15.3	0.0	2.4	0.0	76.9	2.1	2.0	0.0	0.0	0.8	1.9	3.1	0.5	1.2	9.9	19.3	1.9	4.3	4.7	50.9	84.6	7.3	4.2	0.0	1.3	1.6	27.9	3.1	15.9	0.0	4.2	1.5	5.3	27.2	7.9
SLC25A47	C14orf68	ENSG00000140107	"Solute carrier family 25 member 47"	Q6Q0C1	14	100323339-100330421	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	355	"liver: 534.7"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 270.2"	"Cancer enriched"	"Detected in single"	273	"liver cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (2.54e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	534.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.9	270.2	0.0	0.0	0.0	0.6	0.0	6.7	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.1
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.8	7.0	2.5	1.5	2.5	1.4	2.7	5.4	3.3	2.9	0.1	2.2	5.2	2.1	0.2	1.6	2.1	1.2	1.2	2.9	2.0	5.8	16.8	2.0	1.5	3.9	2.5	2.5	3.3	0.1	3.3	0.3	3.2	3.0	0.1	0.6	3.2	0.1	1.4	2.5	4.5	0.0	1.0	2.4	3.1	1.2	2.0	0.1	3.2	0.3	0.1	1.8	1.9	2.6	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.5	2.5	5.4	3.3	2.9	2.0	3.9	2.5	3.2	1.0	2.0	2.6	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281718-7288257	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8;skeletal muscle: 223.6"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Hep G2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	16.9	5.2	1.4	0.2	1.7	1.1	11.2	0.9	1.5	9.2	0.9	53.1	0.8	9.3	1.2	5.9	11.3	0.7	98.8	1.3	1.1	2.6	3.7	2.1	0.2	1.0	1.5	3.2	0.8	3.4	4.4	0.6	1.2	9.9	1.1	0.4	6.3	3.3	223.6	4.1	9.7	4.3	1.0	0.3	11.7	3.3	1.3	0.1	4.5	63.2	0.0	27.0	5.6	1.1	0.0	0.0	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.9	1.5	1.3	1.1	1.0	1.5	1.2	1.0	1.3	1.1	1.7	0.0	0.0	1.0	0.0	1.8	0.9	0.3	2.2	0.1	1.5	1.3	135.2	0.0	0.2	0.0	0.0	0.3	0.0	1.0	7.9	0.1	16.6	0.2	0.1	3.7	0.0	10.7	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.3	1.8	2.8	0.1	0.0	0.0	0.8	0.0	0.3	0.3	4.8	0.0	0.1	7.2	1.0	0.0	6.0	0.0	0.0	0.0	0.1	1.2	8.6	0.0	0.8	0.8	0.3	0.4	0.4	32.9	7.0	19.8	1.7	2.2	0.5	1.1	1.0	0.1	0.5	1.0	0.7
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96313444-96383711	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 117.2;Proximal enterocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 103.8;Hep G2: 132.3"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	14.7	8.8	13.5	14.4	20.6	11.4	16.4	17.8	20.6	16.5	12.3	49.1	65.1	14.9	12.1	13.7	14.6	20.6	12.2	14.3	16.0	32.1	56.4	19.2	12.4	25.5	19.7	17.3	31.4	16.4	7.2	25.5	22.1	14.2	46.4	4.3	13.0	11.0	3.9	9.4	65.8	13.9	16.6	10.0	43.1	7.2	20.1	7.5	29.5	6.9	11.7	17.2	13.1	27.8	33.2	27.6	15.8	30.2	20.3	37.3	27.9	14.7	30.2	21.6	17.5	60.4	103.8	0.6	24.5	13.5	49.9	47.6	22.2	21.8	18.7	16.4	16.8	11.3	9.8	132.3	32.5	0.1	0.0	32.2	27.6	16.3	48.7	51.0	46.7	0.0	22.3	0.4	23.7	27.2	0.3	0.1	13.2	67.5	28.5	0.1	0.0	0.0	54.4	21.3	5.5	35.9	11.9	24.8	68.5	53.3	16.4	24.7	41.3	14.5	16.2	21.2	13.8	0.0	0.9	0.1	30.2	0.1	20.4	1.2	0.9	0.6	1.3	1.1	1.6	0.7	2.1	2.9	1.2	0.9	0.7	1.4	0.1	1.8	2.1	0.2	3.9	0.5	13.5	20.6	17.8	20.6	14.3	16.0	25.5	19.7	22.1	16.6	20.1	27.8	14.5	9.6	11.0	12.1	4.3	5.2	8.9	2.1	1.8	1.1	15.1	13.1	7.2	27.1	4.6	12.9	2.1	28.1	12.9	61.7	11.7	8.1	0.2	21.0	14.0	12.6	9.6	1.3	0.8	24.5	45.1	9.5	20.4	31.6	4.5	20.0	13.2	43.2	20.5	1.7	1.1	42.0	4.1	23.0	9.7	0.6	10.8	17.7	17.8	20.6	8.9	10.2	7.2	11.1	117.2	25.4	43.5	6.0	6.3	15.5	67.0	23.6	6.7	3.6	13.1	6.8	11.2	1.4	4.4	8.6	5.4	26.5	14.6	7.0	34.9	17.9
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 331.6;retina: 172.9"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 88.3;Cone photoreceptor cells: 187.7;Hepatocytes: 114.6;Muller glia cells: 80.1;Rod photoreceptor cells: 124.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 49.8;SCLC-21H: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	1.4	0.1	30.8	0.1	33.8	1.0	1.4	38.7	42.1	0.5	27.4	0.2	1.3	0.3	0.4	1.1	0.6	0.4	5.6	29.8	30.8	5.1	331.6	0.2	0.5	35.8	40.5	6.3	37.2	7.9	4.6	1.2	34.9	0.5	0.1	172.9	1.8	0.1	35.8	0.8	0.6	0.2	32.4	0.2	1.9	1.9	36.4	0.0	1.3	35.8	0.3	0.1	0.4	35.0	0.0	0.0	1.2	7.0	0.1	0.0	1.7	0.0	0.0	1.3	0.6	4.1	0.0	0.1	1.1	0.0	0.3	0.0	1.9	0.0	0.9	0.1	0.6	0.0	1.0	49.8	0.1	0.5	0.0	0.1	0.0	0.1	0.0	5.6	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.5	0.5	0.0	0.2	0.2	15.4	1.3	0.7	0.2	0.0	2.1	2.0	0.3	0.0	0.2	1.2	0.0	1.0	0.3	0.0	0.1	0.2	0.3	0.1	2.9	0.2	0.3	0.2	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.4	0.0	0.2	0.1	0.1	30.8	33.8	38.7	42.1	29.8	30.8	35.8	40.5	34.9	32.4	36.4	35.0	0.3	0.0	0.0	17.6	0.4	0.0	0.1	0.0	0.6	88.3	3.2	1.7	3.3	17.2	0.0	0.0	187.7	0.2	0.0	0.0	0.0	1.8	0.3	0.4	0.0	3.9	3.5	2.7	0.2	2.2	0.1	0.2	0.0	0.5	0.0	0.1	2.2	114.6	0.1	8.4	0.6	0.2	0.0	2.6	0.0	0.0	2.1	0.1	0.0	7.5	0.6	80.1	0.0	4.5	3.7	0.6	0.0	0.4	0.0	0.0	0.0	4.2	0.0	124.0	0.0	0.6	0.3	2.9	3.3	0.9	0.0	1.4	0.2	0.0	0.2	0.0
SLC39A4	"AEZ, AWMS2, ZIP4"	ENSG00000147804	"Solute carrier family 39 member 4"	Q6P5W5	8	144409742-144416844	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 88.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 406.4;Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CAPAN-2: 36.4;Hep G2: 97.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.59e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.04e-4)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.87e-1)"	0.1	0.2	0.1	1.4	0.2	0.5	0.3	0.0	0.7	0.7	0.0	33.1	88.1	0.4	0.1	0.2	0.9	0.5	0.0	0.2	0.0	18.4	1.3	3.1	0.1	0.0	0.0	3.3	1.4	0.0	0.2	1.0	0.0	1.3	0.5	0.0	1.2	0.3	0.0	0.5	74.9	0.1	0.0	0.7	2.9	1.3	0.0	0.0	3.9	0.0	0.0	0.6	0.6	0.0	2.3	0.2	0.0	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	2.1	36.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	6.4	0.8	1.6	0.6	97.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	2.2	0.0	1.7	0.0	0.4	0.1	0.5	0.1	0.4	0.0	1.1	0.0	0.4	0.9	1.9	0.2	0.4	0.1	0.4	1.7	0.1	0.0	0.1	0.2	0.0	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	19.2	24.8	0.3	21.3	18.7	36.6	46.9	38.7	0.2	45.0	50.3	7.4	20.0	24.1	42.3	0.0	17.0	15.4	112.8	50.9	40.0	1.4	41.8	12.9	10.9	42.6	26.3	1.0	42.9	69.7	16.8	29.6	51.9	37.4	8.5	8.9	27.4	32.1	3.3	0.2	95.0	30.5	18.2	21.0	2.0	8.1	23.5	21.4	0.0	25.9	11.3	23.7	0.0	0.1	75.6	135.0	6.4	31.9	60.8	406.4	230.3	26.9	1.0	6.6	7.5	11.1	2.9	33.1	46.4	30.0	11.2	15.4	23.2	98.2	46.3
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 127.3;kidney: 100.3;liver: 103.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.2;Hepatocytes: 43.3;Proximal tubular cells: 52.9;Skeletal myocytes: 67.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 12.2;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.6;granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"A549: 21.3;AN3-CA: 16.7;Hep G2: 41.5;U-266/70: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced					NA	NA		18000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	1.9	127.3	2.1	0.8	2.6	2.7	1.3	3.5	15.8	29.4	9.3	2.0	1.3	16.2	2.5	1.9	7.4	3.8	5.4	15.7	1.6	100.3	103.9	7.0	1.6	3.0	2.5	7.7	0.3	1.4	16.5	0.4	3.1	6.3	1.0	1.2	2.6	12.3	34.1	25.0	1.3	7.7	2.5	3.7	1.2	14.5	4.3	1.5	6.2	37.7	1.3	1.0	10.6	3.3	0.1	21.3	0.6	16.7	0.5	0.1	0.1	0.6	0.5	2.5	2.3	0.0	0.6	0.2	3.9	3.1	8.3	0.1	7.4	0.6	0.6	0.1	9.8	0.2	10.6	41.5	0.2	0.2	0.5	0.4	3.7	1.9	0.3	2.8	5.9	0.0	0.0	0.0	0.0	3.0	0.1	0.4	2.2	0.3	0.8	0.2	0.2	0.2	0.0	1.3	3.9	3.4	7.0	0.1	1.9	5.6	7.1	1.9	0.0	0.1	0.8	0.3	2.0	31.0	13.1	0.1	0.8	0.1	3.6	0.3	1.4	12.2	0.3	0.9	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.0	0.1	6.6	0.0	0.5	2.1	2.6	3.5	15.8	15.7	1.6	3.0	2.5	3.1	2.5	4.3	3.3	0.5	6.4	3.7	0.7	1.3	4.7	2.3	0.4	6.2	0.9	0.1	0.8	4.1	4.3	0.1	1.8	0.0	0.0	1.7	0.0	3.9	0.1	15.5	3.0	1.3	1.2	0.0	0.0	3.5	0.0	0.0	4.4	0.0	9.2	5.7	189.2	0.0	43.3	1.5	0.0	14.4	0.0	0.0	2.9	1.2	4.8	3.7	2.5	1.8	3.7	0.4	1.4	0.0	2.5	0.3	0.0	0.0	1.5	3.9	2.3	0.0	52.9	0.8	0.9	6.6	67.8	3.3	0.6	1.1	1.1	6.7	0.0	1.7	0.3	0.0	1.5
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 43.9"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 677.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 8.3;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.1	0.1	8.5	0.0	24.2	0.0	0.6	22.0	22.6	0.0	5.0	0.3	3.3	0.0	0.0	0.0	0.1	0.2	0.1	8.6	17.0	3.0	0.8	0.1	0.0	27.2	21.5	0.1	0.3	0.0	0.3	0.0	27.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	8.1	0.0	14.5	0.2	0.1	0.4	20.7	0.0	0.1	0.2	0.0	0.1	0.1	43.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	24.2	22.0	22.6	8.6	17.0	27.2	21.5	27.3	14.5	20.7	43.9	0.0	0.0	0.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	2.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	677.9	0.0	2.4	0.0	0.1	0.0	35.2	7.2	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.2	0.6	0.0
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 43.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 22.4;Proximal enterocytes: 84.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.8	43.3	0.1	1.2	0.2	0.1	2.5	0.0	0.0	0.0	3.8	7.8	3.0	0.0	0.2	0.2	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.1	1.1	42.0	0.0	0.0	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	22.4	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	2.8	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.5	6.3	0.5	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.5	4.5	0.0	0.7	4.4	0.1	0.0	0.2	2.9	0.0	1.3	0.0	11.0	0.3	0.3	0.0	1.9	0.1	0.0	0.0	7.5	2.9	0.1	1.7	0.4	0.0	0.0	84.0	4.1	0.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	3.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816201-10940714	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 153.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.0	0.0	50.5	0.0	78.7	0.0	1.1	57.3	32.6	0.7	9.6	0.0	0.0	0.5	0.1	8.2	0.5	0.0	0.0	22.6	96.6	0.0	0.1	0.0	0.0	60.0	128.4	0.0	0.1	0.5	0.3	0.4	61.9	0.7	0.0	11.0	1.0	0.0	0.2	5.7	0.0	0.1	41.8	0.4	0.0	1.4	153.3	0.0	0.0	0.0	0.1	0.4	1.8	21.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.0	2.2	0.0	0.0	0.2	0.3	0.0	16.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.9	4.5	3.9	0.1	0.0	0.1	5.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	78.7	57.3	32.6	22.6	96.6	60.0	128.4	61.9	41.8	153.3	21.1	0.0	0.0	0.0	85.2	0.0	1.3	0.7	0.3	4.0	8.4	0.9	0.9	1.4	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	13.7	0.0	7.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.0	0.0	0.8	0.9	3.4	0.2	0.0	6.5	0.0	26.4	0.0	23.1	0.8	0.2	0.0	6.8	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.6	0.1	0.6	1.8	10.6	3.7	1.0	0.1	0.0	0.0	1.7
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436606-116461458	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.0;salivary gland: 20.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 115.7;Basal respiratory cells: 94.9;Club cells: 225.6;Pancreatic endocrine cells: 170.4;Respiratory ciliated cells: 58.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 3.4;OE19: 1.2"									HPA003193	Uncertain		Approved	Vesicles		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.1	2.2	0.0	0.1	7.7	0.3	0.1	7.0	0.0	1.4	0.9	0.2	0.0	2.3	0.2	0.8	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	1.0	0.7	0.0	20.6	1.3	0.0	3.2	0.6	0.1	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	1.1	1.6	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	22.4	115.7	0.0	0.1	0.1	0.3	94.9	0.0	0.0	17.6	11.6	0.2	0.0	225.6	0.0	0.0	0.0	0.1	18.1	0.0	17.6	0.1	0.2	0.0	0.5	2.4	0.0	0.0	32.0	0.0	1.0	10.7	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.1	0.0	0.0	0.1	0.0	0.5	16.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	10.2	0.0	0.0	10.5	0.2	0.0	58.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.4	0.0	0.4	0.0	8.9	23.4
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 232.0"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Group enriched"	"Detected in some"	11	"midbrain: 232.0;pons: 86.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	7	"midbrain: 38.9;pons: 29.1"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.5	10.3	0.0	0.0	2.8	1.7	0.0	0.9	0.1	0.2	0.2	0.0	28.8	0.1	14.8	232.0	0.1	1.4	0.2	0.0	18.4	86.1	0.1	0.1	0.1	0.7	0.2	0.1	0.5	40.3	0.0	0.0	0.1	0.9	0.3	0.2	0.0	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	10.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.2	14.8	232.0	86.1	0.0	0.2	0.2	1.1	16.0	5.0	0.3	0.0	0.1	0.4	0.1	17.1	1.2	0.1	0.0	1.0	0.0	1.9	1.8	0.0	125.4	1.5	0.2	0.0	0.0	2.8	0.2	0.6	3.2	0.0	0.0	0.9	0.0	8.6	1.3	0.0	0.5	2.5	0.2	2.2	0.3	9.5	0.0	0.6	2.3	0.0	1.0	1.2	2.2	0.3	5.9	0.0	0.0	0.1	0.5	2.1	0.5	0.5	0.4	0.0	0.4	0.1	0.3	100.9	0.4	0.7	0.8	0.0	1.3	0.5	0.5	0.9	4.8	0.3	106.4	0.5	0.2	4.1	0.3
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 56.6"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 243.3;Proximal enterocytes: 144.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 81.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066060	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.2	56.6	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	10.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.7	1.4	243.3	0.1	0.0	0.0	3.1	0.0	5.2	0.0	0.2	0.0	0.1	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	144.8	17.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	2.0	1.5	0.0
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.0;breast: 14.2;skin 1: 32.2"	"Group enriched"	"Detected in some"	22	"Breast glandular cells: 367.0;Breast myoepithelial cells: 324.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.8"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.3	0.9	6.7	0.2	14.1	0.5	14.2	21.2	8.5	0.7	0.2	3.3	0.9	0.7	0.5	1.0	1.2	0.0	0.8	11.9	23.5	1.3	7.4	0.8	0.6	37.8	14.8	0.7	1.7	0.3	1.6	0.2	28.3	1.5	0.3	0.6	4.7	0.1	1.0	32.2	1.7	0.1	38.2	1.1	0.8	8.1	14.2	0.1	0.6	0.0	0.0	0.9	0.8	55.0	0.9	0.0	0.3	1.4	1.0	1.6	2.4	0.3	0.0	0.3	0.7	0.0	0.2	0.0	0.7	0.1	0.5	0.5	0.0	0.0	0.0	0.6	2.1	0.5	0.4	59.6	0.8	0.1	1.7	0.0	1.3	0.4	0.8	0.7	1.6	0.6	0.1	0.2	0.2	0.2	0.2	0.5	0.0	0.0	2.2	0.4	0.6	0.4	0.1	0.9	0.2	0.8	0.4	0.0	2.2	1.0	0.1	2.6	0.9	0.2	0.8	0.8	0.8	3.8	4.7	0.2	0.1	1.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.1	21.2	8.5	11.9	23.5	37.8	14.8	28.3	38.2	14.2	55.0	3.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	367.0	324.9	0.0	0.0	0.0	1.8	0.0	0.1	10.1	0.0	5.9	0.5	0.0	3.8	0.4	6.3	0.0	0.0	0.0	0.8	0.1	2.9	0.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	2.3	0.9	0.0	0.0
SNTB1	"59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43"	ENSG00000172164	"Syntrophin beta 1"	Q13884	8	120535745-120813273	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.2;Hepatocytes: 66.8;Microglial cells: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.9;OE19: 78.5;U-266/70: 77.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA024659	Uncertain				"Intracellular and membrane"	NA	NA		25000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA024659: AB_1857713"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	7.9	66.4	7.5	5.5	6.5	18.9	8.0	5.8	5.9	5.6	42.9	6.2	5.7	4.4	2.7	8.4	6.0	4.3	4.9	6.1	11.8	12.6	89.3	15.4	7.3	7.2	11.4	2.5	45.0	1.4	2.6	8.6	7.8	4.8	6.4	4.8	34.8	3.4	28.2	9.8	6.3	3.1	6.0	11.9	24.1	9.8	9.1	3.4	61.4	32.4	3.5	3.9	3.6	6.5	0.1	1.8	0.7	0.0	11.3	22.9	0.1	6.0	36.7	1.8	2.7	12.0	1.6	0.0	10.7	6.8	0.0	0.1	2.0	0.0	1.3	5.6	6.5	0.0	0.3	84.9	1.2	16.9	0.0	11.4	0.0	10.1	0.0	14.9	0.4	10.4	0.0	32.3	5.9	3.3	0.0	13.7	2.1	78.5	8.7	0.0	43.8	0.1	34.4	2.0	0.1	0.4	2.4	12.5	30.2	0.7	1.5	30.5	0.0	23.7	1.4	0.0	2.0	77.2	33.0	34.8	18.4	49.0	26.7	1.8	0.8	2.7	2.2	0.4	0.5	0.5	0.4	1.1	0.6	0.2	1.1	1.1	0.1	1.6	0.3	0.0	0.0	0.6	7.5	6.5	5.8	5.9	6.1	11.8	7.2	11.4	7.8	6.0	9.1	6.5	1.9	12.8	27.2	70.2	4.7	0.4	0.7	0.9	1.8	2.4	8.5	6.0	2.0	2.8	9.0	5.5	2.1	0.8	8.4	1.3	9.8	1.5	9.3	2.4	5.8	4.2	0.0	14.1	2.4	10.9	2.2	9.8	11.2	6.2	1.3	8.8	13.2	66.8	11.3	0.0	3.1	3.9	16.2	29.9	4.3	4.2	4.7	18.1	1.8	45.9	12.1	16.0	18.6	2.5	12.2	4.3	1.9	13.2	2.8	1.1	0.1	3.3	13.8	0.7	13.1	3.9	14.3	1.1	0.2	10.1	1.0	0.3	12.0	11.0	4.1	0.6
SNX5		ENSG00000089006	"Sorting nexin 5"	Q9Y5X3	20	17941597-17968980	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 271.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 639.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020679, HPA051187, HPA076450"	Approved		Supported	Vesicles,Cytosol		NA	NA		8200	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020679: , HPA051187: AB_2681379, HPA076450: "	"unprognostic (6.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (2.30e-10)"	"unprognostic (1.67e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.99e-1)"	42.4	51.4	12.5	43.7	15.2	57.5	37.6	14.9	12.4	35.7	14.5	37.6	47.1	28.3	49.4	35.2	33.5	24.9	28.5	11.0	13.5	59.3	33.7	36.1	59.1	15.5	13.6	51.4	32.0	24.8	21.7	28.9	16.8	23.6	40.1	14.2	34.3	17.2	70.8	28.7	40.2	24.4	17.2	57.5	33.1	15.5	14.0	21.2	70.2	21.8	51.2	34.7	32.5	21.2	103.0	108.6	45.3	49.6	29.6	49.8	270.7	84.1	43.3	49.9	55.9	104.8	140.2	169.6	48.6	49.9	69.7	112.2	63.8	124.6	67.2	44.1	57.8	150.1	49.5	639.4	48.0	106.6	173.9	49.2	54.2	54.6	98.3	37.1	72.8	111.3	72.8	109.6	58.6	79.6	94.2	92.6	48.4	87.0	55.3	110.0	115.2	126.1	61.2	116.4	45.0	26.4	76.0	113.7	102.1	34.0	62.4	67.8	57.3	77.8	98.7	49.2	101.5	77.8	129.2	137.2	38.5	37.6	69.6	69.6	58.7	83.6	54.8	81.7	50.0	80.6	49.6	54.6	71.9	75.2	29.7	42.7	4.8	39.0	92.3	37.2	67.3	54.9	12.5	15.2	14.9	12.4	11.0	13.5	15.5	13.6	16.8	17.2	14.0	21.2	35.6	64.1	113.1	21.5	93.0	31.7	45.7	49.0	48.3	19.1	48.9	44.2	38.5	38.6	59.8	49.7	27.1	101.0	54.9	59.6	160.4	47.8	43.6	51.1	42.3	48.7	31.7	98.4	18.8	44.8	137.7	57.7	52.0	66.9	130.8	47.9	139.9	41.4	151.9	16.8	19.9	54.4	34.6	174.6	47.2	16.0	60.9	88.2	26.6	31.9	68.4	66.3	55.6	24.6	20.3	37.2	58.3	51.6	96.7	49.2	100.0	271.5	52.0	19.8	19.7	50.7	39.6	19.1	44.6	83.5	32.4	78.5	53.0	66.5	100.1	57.4
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103486-53124535	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 19.5"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 14.3"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.5;Hep G2: 22.6;U-266/70: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.3	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.8	0.0	0.2	11.6	0.4	0.2	0.1	0.6	0.4	0.1	0.0	0.0	0.4	2.9	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.4	0.1	0.0	0.3	19.5	0.0	0.0	2.1	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	9.5	0.1	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.0	0.0	1.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.2	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.7	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.5	0.0	0.0	0.0	14.3	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0
SOX12	SOX22	ENSG00000177732	"SRY-box transcription factor 12"	O15370	20	325552-330224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 52.3;Cone photoreceptor cells: 41.7;Horizontal cells: 32.0;Rod photoreceptor cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055052, HPA061627"			Enhanced	Nucleoplasm		No	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA055052: AB_2682685, HPA061627: AB_2684571"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-3)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.12e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.20e-2)"	4.0	8.2	10.1	2.4	9.1	3.0	3.8	12.3	11.4	9.7	6.7	10.6	1.8	9.9	5.1	4.8	8.5	2.1	6.7	9.2	7.5	10.4	4.8	3.9	2.6	10.2	8.1	11.7	6.5	3.7	6.8	2.3	9.2	8.1	1.2	8.5	4.1	6.1	1.1	4.4	5.3	3.7	7.1	6.1	5.4	8.9	8.3	4.0	9.8	1.3	1.7	7.2	6.4	10.6	7.9	27.1	26.0	17.7	12.3	9.0	7.8	10.6	9.2	9.5	9.4	5.5	8.0	17.5	8.0	12.3	19.9	9.2	18.9	3.5	5.4	8.8	13.3	11.3	10.9	55.3	15.8	15.7	2.9	12.4	10.9	8.0	3.2	15.4	12.6	11.8	26.9	9.0	6.2	19.2	5.4	38.4	42.3	4.4	35.3	27.7	6.6	14.2	13.5	1.0	31.7	36.9	7.1	30.9	41.0	10.6	29.4	21.7	14.3	36.5	36.0	1.0	9.5	25.5	28.8	18.1	6.8	15.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	10.1	9.1	12.3	11.4	9.2	7.5	10.2	8.1	9.2	7.1	8.3	10.6	3.8	0.0	3.2	15.3	2.6	3.4	2.5	2.7	15.4	52.3	8.5	6.2	11.3	5.7	0.8	7.3	41.7	1.4	1.6	2.3	15.6	1.3	0.9	12.1	16.2	8.6	9.1	5.5	6.5	0.4	0.4	5.3	0.5	6.6	0.0	22.8	8.9	8.7	2.3	32.0	9.2	4.5	2.0	1.3	4.5	2.0	10.2	1.7	5.4	6.5	0.8	9.9	1.0	10.6	10.1	0.4	0.8	12.4	0.8	3.3	1.1	5.1	1.2	39.1	0.0	3.2	7.6	1.3	6.9	3.9	1.1	0.7	2.9	18.4	3.9	0.5
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box transcription factor 9"	P48436	17	72121020-72126416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.7;salivary gland: 80.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.2	54.7	4.4	50.4	0.1	28.0	42.3	58.5	7.4	46.8	17.1	19.7	2.9	0.9	13.7	7.5	13.0	15.8	50.6	49.3	12.7	3.5	3.1	1.1	73.7	72.2	0.3	38.4	0.1	10.3	0.3	48.8	24.8	17.8	15.0	80.1	10.9	2.7	23.3	15.1	1.2	56.9	0.2	40.5	30.7	51.4	0.5	20.2	1.2	4.4	1.9	6.4	49.0	31.1	19.2	38.9	78.1	3.9	1.1	0.1	4.8	4.2	8.2	4.4	27.0	40.8	0.0	2.9	1.1	43.8	31.3	0.0	18.6	7.5	0.0	2.5	0.0	4.2	97.0	0.3	0.0	0.1	0.7	1.6	9.5	9.0	47.0	0.0	0.0	0.0	0.1	11.7	0.4	0.0	0.1	1.5	74.3	29.1	0.0	31.4	0.4	35.2	2.0	1.9	1.9	4.0	4.7	0.1	21.0	16.7	0.2	0.0	15.8	42.0	8.5	66.5	0.0	0.0	0.1	11.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.4	42.3	58.5	50.6	49.3	73.7	72.2	48.8	56.9	51.4	49.0	1.1	12.8	5.6	160.0	1.9	55.4	88.2	28.9	166.8	3.0	141.0	108.2	13.6	190.1	21.1	36.8	0.0	0.3	2.8	52.1	7.9	55.3	5.1	18.4	0.9	3.2	59.7	0.0	3.1	46.7	0.0	26.0	144.8	21.7	4.5	1.9	0.0	3.4	0.2	0.0	1.5	99.0	24.4	0.0	3.4	14.5	4.4	2.3	12.4	9.4	1.0	141.3	0.0	4.5	11.1	40.8	39.1	0.4	2.8	81.1	17.7	61.0	36.4	6.8	6.6	59.9	14.5	10.2	3.1	273.5	17.8	0.1	2.8	0.1	103.8	77.2
SP5		ENSG00000204335	"Sp5 transcription factor"	Q6BEB4	2	170715337-170718078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 8.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.8;Cardiomyocytes: 3.1;Distal tubular cells: 3.9;Endometrial stromal cells: 7.1;Fibroblasts: 4.4;Intestinal goblet cells: 4.3;Spermatogonia: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 122.1"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Low region specificity"	"Detected in some"			HPA074123			Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli	Nucleoplasm	"HPA074123: AB_2686664"	"unprognostic (1.16e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.77e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-8)"	"unprognostic (8.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.17e-1)"	2.5	1.2	0.5	0.2	0.5	0.0	1.4	2.2	0.3	8.8	0.5	1.5	1.0	3.7	0.4	1.2	1.2	0.2	0.2	0.2	1.4	0.2	2.1	0.5	0.2	0.3	1.4	0.4	0.4	0.3	0.1	0.2	0.2	1.7	0.2	0.0	1.5	0.2	0.2	4.6	1.4	0.1	0.0	0.0	3.1	0.8	1.8	0.1	0.1	0.0	0.8	1.5	2.2	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	27.7	0.1	0.0	0.5	0.0	0.5	1.5	0.3	0.0	0.0	3.5	0.3	0.4	0.1	122.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.0	2.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	4.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	2.2	0.3	0.2	1.4	0.3	1.4	0.2	0.0	1.8	0.2	0.2	0.0	0.0	0.3	0.0	0.8	0.1	0.0	2.8	0.0	0.2	0.3	3.1	0.0	0.0	1.8	0.0	1.5	0.1	0.3	3.9	0.0	0.2	2.3	7.1	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.3	0.0	0.0	0.0	2.5	0.2	0.0	0.4	4.3	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.7	0.2	0.1	0.3	0.2	0.0	1.6	0.0
SPATA21	"spergen-2, spergen2"	ENSG00000187144	"Spermatogenesis associated 21"	Q7Z572	1	16387117-16437424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"testis: 7.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 40.4;Late spermatids: 44.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.7"	"Cell line enriched"	"Detected in single"	7	"Hep G2: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA032080			Approved	Vesicles,Cytosol		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Vesicles, Cytosol"		"HPA032080: "	"unprognostic (3.09e-1)"	"unprognostic (8.26e-2)"	"unprognostic (5.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.74e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.71e-2)"	0.0	0.1	0.2	0.0	0.2	0.6	0.0	1.8	0.5	0.0	0.5	0.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.1	7.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.0	1.7	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.1	0.2	0.2	1.8	0.5	0.3	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.0	1.1	1.0	0.4	0.3	0.3	0.0	0.6	1.5	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	40.4	0.3	0.9	0.3	0.0	0.0	1.6	0.2	0.3	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.1	5.0	1.4	0.0	0.0	0.6	0.4	44.6	0.3	0.3	0.0	0.0	0.1	0.7	0.0	1.0	1.3	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	1.2	0.0	0.9	0.3	1.2	0.4	0.4	0.4	0.3	0.3	0.1	0.3	0.2
SPTSSA	"C14orf147, ssSPTa"	ENSG00000165389	"Serine palmitoyltransferase small subunit A"	Q969W0	14	34432788-34462240	"Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 405.2;Melanocytes: 435.8;Suprabasal keratinocytes: 443.8;Syncytiotrophoblasts: 512.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 180.0"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.86e-2)"	25.1	71.1	13.5	21.1	13.6	5.7	39.3	13.8	17.9	21.0	13.8	38.4	20.8	16.9	25.6	25.3	21.4	27.1	16.2	12.6	15.8	23.5	46.9	33.6	12.2	18.6	15.4	20.1	13.9	18.2	13.3	28.8	17.0	22.5	36.0	15.3	34.2	24.7	24.4	22.2	21.9	27.3	15.1	13.2	20.5	7.1	14.6	8.5	19.8	19.0	13.0	30.6	26.0	16.2	67.4	38.3	37.6	14.0	61.6	42.8	44.4	44.1	27.2	34.1	41.0	31.3	39.4	56.0	38.8	25.1	25.0	28.2	34.1	37.5	53.7	29.7	21.1	35.2	74.0	153.7	48.5	46.5	19.9	39.8	58.9	25.2	40.8	26.4	40.9	15.7	25.6	58.3	30.4	71.0	19.2	47.0	28.9	32.2	47.4	24.8	180.0	41.2	42.8	29.5	24.6	32.6	100.9	87.7	71.3	29.4	39.9	50.0	43.4	26.8	17.5	27.7	33.4	48.1	34.1	41.0	18.0	40.8	30.4	21.5	36.9	4.9	5.4	29.9	5.3	8.3	4.9	5.3	19.6	7.1	5.1	6.2	2.0	20.8	25.5	7.0	5.3	21.5	13.5	13.6	13.8	17.9	12.6	15.8	18.6	15.4	17.0	15.1	14.6	16.2	51.0	144.2	123.5	14.4	33.1	405.2	166.6	192.0	217.9	40.9	165.5	63.1	33.2	70.1	108.9	88.3	10.4	265.8	31.5	189.6	154.6	257.7	1.3	62.2	165.4	65.5	49.7	66.1	11.2	96.8	126.2	100.9	34.7	100.6	32.4	24.1	50.3	79.1	78.3	40.4	13.5	74.9	120.1	67.1	127.6	2.7	45.7	56.5	435.8	15.0	71.0	43.8	18.6	14.1	30.5	71.0	102.4	60.2	70.9	118.3	75.0	96.7	30.8	31.2	46.0	78.5	98.6	1.9	6.1	167.7	443.8	512.4	33.8	82.9	107.6	153.5
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029686	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 327.3;Late spermatids: 901.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	22.8	33.1	17.1	30.2	18.1	17.4	28.7	19.3	22.5	32.5	20.9	28.1	25.8	23.3	35.8	28.5	22.0	23.2	32.1	17.6	21.3	35.3	61.9	25.0	34.6	19.8	19.2	22.7	55.0	39.7	36.2	29.5	20.5	31.2	29.5	24.2	60.3	28.7	39.8	26.1	26.8	23.5	20.0	28.4	30.4	44.0	18.1	35.5	30.9	33.7	42.6	34.8	23.1	21.4	59.3	66.9	56.7	54.9	62.8	61.3	67.8	83.2	78.3	87.3	107.0	71.3	62.8	75.8	77.5	81.4	75.8	56.1	79.0	66.7	125.6	87.5	37.8	70.9	54.6	184.6	92.7	70.5	65.4	51.5	64.8	63.5	102.3	66.1	88.8	64.9	61.7	82.7	93.1	98.8	81.9	42.4	45.0	96.1	61.3	58.5	72.2	67.4	104.9	89.3	48.9	59.4	59.3	76.7	74.6	71.4	99.4	49.7	66.6	48.7	51.0	62.8	57.1	73.2	108.3	101.1	36.8	45.9	63.5	23.8	27.4	39.2	31.0	35.0	39.6	25.6	31.4	34.0	32.8	25.8	28.7	28.3	27.1	42.1	47.0	21.9	48.2	30.5	17.1	18.1	19.3	22.5	17.6	21.3	19.8	19.2	20.5	20.0	18.1	21.4	40.8	12.8	49.3	25.5	63.2	40.0	56.0	74.6	37.5	37.5	40.7	29.0	41.0	34.3	81.2	40.5	58.4	67.3	59.6	39.4	64.6	73.2	327.3	53.1	43.9	40.7	44.9	36.2	25.4	79.8	75.6	45.8	38.7	64.3	47.5	37.3	36.4	110.0	49.7	26.9	26.8	48.7	87.5	39.0	43.6	901.8	38.5	47.4	28.4	24.4	56.1	44.3	41.2	27.6	54.6	55.1	34.0	37.6	133.1	60.7	39.0	79.2	93.0	50.1	26.3	38.3	46.1	95.4	76.0	36.0	50.3	94.0	64.7	43.0	31.6	64.5
SRXN1	"C20orf139, dJ850E9.2, Npn3, SRX1, YKL086W"	ENSG00000271303	"Sulfiredoxin 1"	Q9BYN0	20	646615-653200	"Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Ductal cells: 4.4;Erythroid cells: 4.8;Excitatory neurons: 4.5;Exocrine glandular cells: 6.8;Inhibitory neurons: 5.8;Pancreatic endocrine cells: 6.5;Squamous epithelial cells: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 12.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"				"unprognostic (7.31e-3)"	"unprognostic (6.08e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.58e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.52e-3)"	20.8	62.7	24.7	10.3	25.1	24.0	12.4	26.7	29.1	18.4	21.8	16.6	18.0	16.5	15.0	63.0	15.3	16.2	37.3	24.1	32.2	23.3	36.7	21.2	5.7	29.2	30.3	16.6	16.0	32.7	22.2	14.0	29.2	15.7	15.1	20.0	18.2	18.3	45.6	11.5	16.7	19.2	25.1	14.5	32.1	8.5	30.5	4.6	26.9	21.7	10.5	26.1	22.7	22.8	119.4	201.0	13.2	26.3	54.5	60.3	30.0	83.6	64.9	58.4	34.2	69.4	63.5	21.8	52.3	133.8	260.2	58.5	50.3	132.9	56.0	23.2	28.2	86.6	43.8	221.7	73.4	37.4	51.4	38.7	121.5	79.3	76.5	47.9	64.3	32.5	76.5	88.5	64.8	35.4	0.2	20.5	26.6	183.8	73.8	0.4	18.1	45.7	41.0	42.3	16.8	32.2	65.5	144.5	98.8	35.8	49.3	23.0	66.0	80.9	56.5	73.5	119.6	23.1	63.7	17.3	51.5	18.0	67.8	2.4	2.0	3.0	2.0	1.8	1.4	0.4	1.0	2.5	1.0	0.0	0.0	0.7	12.3	0.5	2.2	0.1	1.1	0.4	24.7	25.1	26.7	29.1	24.1	32.2	29.2	30.3	29.2	25.1	30.5	22.8	0.2	0.0	0.0	3.3	0.3	0.1	0.1	0.2	1.8	0.7	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.2	2.9	0.0	4.4	0.0	0.2	0.5	0.6	1.2	4.8	4.5	6.8	0.3	0.8	1.5	0.3	0.0	0.1	0.0	0.4	1.0	0.0	5.8	1.4	0.0	0.0	0.3	0.1	0.0	1.3	0.0	3.7	2.1	0.2	0.0	1.0	0.9	6.5	0.8	0.4	2.4	0.3	2.8	0.2	0.1	0.3	0.0	0.1	1.6	0.0	0.0	9.7	0.0	0.0	0.9	0.1	2.0	0.0
SSUH2	"C3orf32, fls485, ssu-2"	ENSG00000125046	"Ssu-2 homolog"	Q9Y2M2	3	8619400-8745040	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.5;intestine: 3.7;testis: 3.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 61.7;Late spermatids: 43.6;Proximal enterocytes: 16.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	27	"Hep G2: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049777	Approved					NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA049777: AB_2680876"	"unprognostic (2.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.65e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.50e-2)"	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.2	0.0	0.5	3.7	0.2	0.0	0.2	0.2	0.4	2.5	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.1	3.3	0.1	0.0	1.6	0.3	3.9	0.0	0.0	0.8	0.1	0.1	0.2	0.2	0.1	0.0	0.5	0.6	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	9.9	0.0	0.0	1.3	0.0	0.3	0.1	0.1	0.0	0.0	0.3	0.8	1.8	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	61.7	1.7	0.1	3.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.2	0.0	0.7	2.2	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.4	43.6	1.2	0.2	1.8	1.0	0.0	0.0	0.0	2.0	1.4	0.1	1.2	0.4	0.0	0.1	16.1	0.9	4.0	0.0	0.0	0.4	0.7	0.5	1.1	0.3	0.1	0.0	0.1	0.5	0.8	0.2
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.9	13.4	8.4	9.3	8.3	10.0	11.6	14.9	11.2	14.0	8.9	16.1	7.3	12.4	13.8	15.3	9.9	12.4	18.5	7.5	16.4	13.9	21.5	10.0	7.5	7.7	9.8	10.1	12.6	13.9	9.3	11.9	7.5	13.7	12.6	14.2	10.3	14.1	39.2	11.7	9.7	18.0	6.0	10.4	11.2	20.9	10.7	9.4	13.7	28.5	9.0	14.7	11.6	10.6	33.7	29.2	31.0	22.0	27.4	20.4	25.8	33.0	23.2	24.9	26.3	37.7	22.4	18.4	22.0	23.2	12.6	18.2	33.5	18.1	37.7	17.5	12.3	19.2	19.6	73.6	28.8	15.6	19.8	19.9	20.8	19.5	24.8	23.9	21.5	16.7	22.8	17.8	25.4	21.5	21.3	16.3	15.3	24.1	25.5	15.0	35.5	4.9	39.2	47.7	19.1	15.5	32.8	23.6	17.7	28.4	27.7	14.5	28.0	24.8	21.3	14.7	12.4	15.7	21.4	17.8	12.7	11.2	20.5	4.1	3.5	4.7	3.3	4.3	4.4	3.4	4.2	3.7	3.1	3.2	4.1	4.8	4.3	4.2	3.5	5.7	3.6	1.3	8.4	8.3	14.9	11.2	7.5	16.4	7.7	9.8	7.5	6.0	10.7	10.6	37.1	22.4	22.4	82.3	19.5	98.1	57.5	17.9	23.9	27.2	37.1	25.1	51.7	28.6	22.1	31.3	27.1	22.1	17.5	34.1	11.7	38.9	21.8	32.7	48.0	36.0	31.9	43.8	110.9	26.3	19.9	39.6	20.4	46.9	8.8	21.7	35.0	43.1	12.8	37.0	119.0	18.8	16.2	23.9	45.7	13.4	26.8	22.9	44.4	92.8	18.9	24.6	11.3	102.1	139.2	40.3	13.2	27.8	31.3	49.6	13.2	43.3	25.2	30.2	26.3	52.3	51.9	59.8	53.6	31.4	96.5	33.2	21.4	26.1	16.3	53.6
SULT1A1	"P-PST, STP, STP1"	ENSG00000196502	"Sulfotransferase family 1A member 1"	P50225	16	28603944-28623625	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 135.0;liver: 248.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 321.6;Hepatocytes: 229.6;Kupffer cells: 214.1;Paneth cells: 309.3;Proximal enterocytes: 926.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 257.6;intermediate monocyte: 212.2;myeloid DC: 116.3;neutrophil: 246.7;non-classical monocyte: 122.6"	"Group enriched"	"Detected in all"	33	"dendritic cells: 116.3;granulocytes: 246.7;monocytes: 257.6"	"Group enriched"	"Detected in many"	4	"EFO-21: 171.0;Hep G2: 353.6"									"HPA049500, HPA051051"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.89e-2)"	30.5	100.1	21.0	10.6	21.5	23.7	15.3	21.2	23.5	8.8	31.0	54.0	135.0	7.2	32.3	5.1	14.2	10.9	26.5	22.5	22.7	30.8	248.9	46.6	15.2	22.8	21.7	7.3	17.8	23.4	24.2	12.4	21.8	8.9	41.7	6.0	26.2	20.3	11.3	3.0	104.3	11.1	21.4	66.2	22.2	13.8	22.2	7.6	35.3	4.8	4.2	13.6	5.1	21.7	6.6	1.5	2.7	10.9	0.0	0.0	23.2	0.0	0.2	0.1	0.0	0.9	42.2	0.3	171.0	0.2	1.6	0.4	3.1	12.1	0.3	0.7	30.8	7.2	13.1	353.6	18.3	0.0	12.6	1.1	0.9	0.0	0.0	0.2	2.9	11.9	4.4	4.2	3.0	39.9	0.7	11.0	2.5	1.8	0.1	11.6	1.3	20.5	2.9	2.9	6.9	0.4	0.4	55.7	1.1	14.1	32.8	32.2	22.5	0.5	7.8	0.4	0.0	5.8	5.5	1.6	2.7	63.1	0.0	32.4	257.6	5.0	1.4	212.2	1.2	1.2	1.9	1.4	116.3	0.3	2.9	1.4	246.7	4.3	122.6	8.6	6.3	129.1	21.0	21.5	21.2	23.5	22.5	22.7	22.8	21.7	21.8	21.4	22.2	21.7	7.1	192.3	97.0	25.1	4.6	1.1	8.0	13.2	9.6	21.8	14.4	9.9	14.2	80.1	17.8	16.5	10.4	2.4	3.0	321.6	129.1	13.4	107.8	18.2	5.9	17.0	19.9	20.2	34.4	19.9	1.4	29.2	23.0	5.2	49.9	15.9	43.9	229.6	38.5	8.4	27.5	63.9	14.2	214.1	8.9	34.4	51.3	45.3	1.8	5.6	37.8	67.8	3.1	18.1	3.6	6.2	309.3	34.6	3.6	3.9	926.9	80.9	40.2	3.8	19.7	11.2	15.2	22.8	5.8	9.6	0.3	1.9	9.0	13.1	79.2	6.8
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597050	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 48.2;liver: 50.1"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 204.8;Paneth cells: 146.1;Proximal enterocytes: 505.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.1;intermediate monocyte: 7.7;myeloid DC: 3.3;neutrophil: 12.4;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 3.3;granulocytes: 12.4;monocytes: 9.1"	"Cell line enriched"	"Detected in many"	4	"Hep G2: 50.2"									"HPA049500, HPA051051"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	2.0	2.9	1.2	0.7	1.0	1.2	1.1	2.2	1.4	0.2	0.6	13.6	48.2	0.4	1.3	0.3	1.0	1.0	2.7	1.2	0.6	3.2	50.1	6.9	0.9	0.8	0.6	0.7	2.1	2.9	1.9	1.7	0.9	0.5	13.0	0.7	1.5	1.0	0.9	0.7	45.4	0.7	0.4	4.3	1.1	0.7	0.8	0.4	7.2	0.2	0.6	2.1	0.2	0.7	1.9	1.1	1.0	0.7	0.3	0.4	9.7	1.0	0.0	0.1	0.1	2.0	5.1	0.3	12.2	0.3	0.1	2.9	0.5	0.6	0.2	1.0	0.5	1.5	2.4	50.2	0.7	1.0	1.9	0.3	0.7	0.8	0.2	0.6	0.3	0.8	1.0	2.3	0.4	1.8	0.3	2.6	1.4	0.3	0.3	1.6	0.3	1.0	0.2	1.5	0.6	1.4	0.3	3.9	0.1	1.6	3.2	0.7	0.6	2.5	1.4	1.9	0.8	2.2	1.6	0.4	0.6	0.7	0.8	1.0	9.1	0.1	0.1	7.7	0.0	0.1	0.1	0.1	3.3	0.1	0.1	0.2	12.4	0.2	3.9	0.8	0.3	4.6	1.2	1.0	2.2	1.4	1.2	0.6	0.8	0.6	0.9	0.4	0.8	0.7	0.6	28.9	15.1	2.0	0.5	0.3	0.4	1.9	0.0	0.3	1.9	3.7	2.4	5.7	7.1	3.7	0.0	0.1	0.1	204.8	15.6	7.8	0.2	2.5	0.5	3.8	3.0	0.0	2.8	4.5	0.2	5.4	4.1	0.8	11.4	1.2	7.5	69.5	1.6	0.0	1.8	20.9	0.0	7.6	0.4	1.4	1.5	1.1	0.0	1.0	1.2	4.4	0.0	1.5	0.6	4.2	146.1	1.5	0.1	0.3	505.6	38.2	2.9	0.5	0.0	0.4	0.8	0.7	0.3	0.1	0.1	0.3	0.5	1.6	14.3	0.9
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 237.2"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 129.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 61.3;intermediate monocyte: 53.2;myeloid DC: 33.7;non-classical monocyte: 25.0"	"Group enriched"	"Detected in all"	11	"dendritic cells: 33.7;monocytes: 61.3"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 166.9;Hep G2: 303.6;Karpas-707: 239.4"									"HPA049500, HPA051051"	Supported					NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	15.7	13.7	53.3	21.9	54.0	36.8	15.7	56.3	72.9	15.4	54.3	57.3	237.2	16.8	18.0	14.3	18.0	14.8	11.0	54.0	53.9	34.6	34.5	26.6	30.3	53.8	53.0	10.8	15.9	17.5	23.8	22.4	54.3	20.1	46.4	23.2	25.8	17.8	11.0	25.7	146.6	24.5	52.0	31.8	22.2	9.6	54.3	16.3	20.2	18.9	29.3	13.5	10.5	55.9	32.6	48.8	30.6	21.3	28.4	19.8	46.0	15.8	16.9	16.7	18.9	21.1	166.9	16.9	150.0	16.0	10.9	45.5	38.8	14.0	16.7	19.9	30.6	93.2	61.2	303.6	11.1	14.2	34.9	21.9	20.9	25.4	5.9	34.2	30.6	21.9	19.0	239.4	12.0	55.4	9.6	62.3	19.1	76.2	20.9	38.6	14.8	32.2	29.4	22.0	15.3	24.7	4.8	43.0	7.8	11.4	23.8	22.1	38.3	34.0	17.4	29.4	11.7	28.8	78.1	8.7	17.4	31.7	20.5	1.9	61.3	0.3	4.3	53.2	0.9	3.4	1.1	1.5	33.7	1.7	0.8	0.7	1.6	1.4	25.0	0.5	0.9	20.4	53.3	54.0	56.3	72.9	54.0	53.9	53.8	53.0	54.3	52.0	54.3	55.9	3.3	12.8	12.0	0.0	4.2	2.0	2.2	1.2	0.6	5.3	2.4	1.3	1.8	4.3	7.6	0.0	8.4	5.3	2.8	13.9	0.0	3.3	1.3	0.9	0.9	5.8	1.2	6.1	0.0	4.0	2.3	4.4	2.6	1.3	1.3	1.7	3.9	2.8	1.5	1.7	0.0	13.4	2.0	5.0	3.7	0.5	0.9	2.6	1.8	0.0	4.9	2.6	4.1	0.0	0.0	6.3	25.3	1.9	1.4	4.3	129.1	0.5	2.3	6.7	0.0	1.7	1.7	0.8	0.3	0.9	2.7	3.0	3.8	1.2	26.8	2.1
SULT1A4		ENSG00000213648	"Sulfotransferase family 1A member 4"	P0DMN0	16	29459913-29464966	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.0;Club cells: 3.7;Distal enterocytes: 1.6;Proximal enterocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 23.1;myeloid DC: 17.2"	"Group enriched"	"Detected in many"	12	"dendritic cells: 17.2;monocytes: 23.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 69.2;Hep G2: 156.6;SK-BR-3: 32.4"									"HPA049500, HPA051051"	Supported					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA049500: AB_2680796, HPA051051: AB_2681327"										"unprognostic (4.14e-2)"				"unprognostic (1.04e-1)"				31.7	4.8	1.7	7.3	2.0	3.2	25.0	1.8	4.3	9.0	0.8	46.0	29.0	7.6	0.7	5.7	11.6	3.4	19.8	2.0	1.1	7.8	7.0	21.0	1.6	2.6	1.4	3.7	3.9	2.0	3.8	2.4	2.1	4.4	7.5	0.7	14.6	3.4	6.3	9.1	61.8	1.9	1.1	34.8	15.5	2.3	2.2	1.2	10.4	0.6	2.6	12.8	9.2	2.4	0.6	0.6	6.7	1.3	0.5	1.2	1.5	3.6	0.2	1.0	0.5	2.5	69.2	0.2	22.2	1.2	2.9	13.3	1.4	0.9	0.6	1.5	2.7	0.9	3.0	156.6	1.6	0.0	5.6	0.4	0.0	1.4	0.6	4.0	4.0	0.5	2.9	4.1	0.4	3.0	1.1	19.3	3.2	2.8	1.1	4.2	0.6	1.5	3.9	4.0	0.8	0.8	0.0	32.4	0.1	0.6	0.6	0.3	1.0	3.0	0.5	0.5	1.2	7.5	9.6	3.2	2.3	2.3	0.3	1.6	7.0	0.0	0.8	23.1	0.1	0.7	0.1	0.1	17.2	0.0	0.4	0.0	0.4	0.1	5.3	0.1	0.1	5.1	1.7	2.0	1.8	4.3	2.0	1.1	2.6	1.4	2.1	1.1	2.2	2.4	0.2	6.4	2.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	3.5	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.0
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870467-47886315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1072.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1578.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	34	"Hep G2: 39.6;RT4: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		1200000	"Cluster 11: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	235.6	0.3	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.5	0.6	59.5	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	1072.1	0.0	0.2	0.2	0.3	0.1	0.1	36.9	0.0	0.1	0.2	0.1	0.9	1.0	0.1	3.1	0.1	0.3	86.6	0.0	0.0	0.4	24.4	4.2	0.2	0.0	0.1	0.0	0.1	2.0	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	39.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	26.7	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.1	2.9	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.4	0.3	0.8	0.5	0.1	0.3	0.2	0.2	0.3	0.2	0.7	0.4	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.3	2.9	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.6	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	18.7	0.3	0.0	0.0	0.3	5.1	0.1	0.0	0.1	30.0	1578.7	0.0	0.0	0.3	2.8	0.0	31.8	0.4	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	8.8	0.4	0.0	0.3	171.7	0.1	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.5	1.8	81.7	2.2	0.3
TAFA5	"FAM19A5, TAFA-5"	ENSG00000219438	"TAFA chemokine like family member 5"	Q7Z5A7	22	48489553-48850912	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 85.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Fibroblasts: 1.1"	"Cancer enhanced"	"Detected in all"		"glioma: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 17.3;HEK 293: 13.6;Hep G2: 32.1;NTERA-2: 12.7;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025629	Approved				"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB025629: "	"unprognostic (2.86e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.94e-2)"	2.7	1.3	50.3	0.8	40.6	0.0	2.0	37.0	51.8	19.7	15.0	8.4	1.0	8.1	4.7	0.9	5.2	2.0	2.5	53.9	43.0	2.4	2.7	2.1	0.4	55.2	85.9	12.1	2.4	4.3	7.0	0.1	51.1	6.8	0.2	3.6	4.9	3.2	1.5	5.4	3.3	0.7	41.5	0.3	2.9	3.3	49.6	1.2	0.8	1.7	0.1	4.0	4.9	28.2	0.0	1.3	2.5	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	17.3	0.1	0.1	1.3	0.0	0.0	0.0	13.6	0.0	0.2	32.1	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.1	0.3	12.7	0.6	0.0	0.6	0.0	7.4	0.0	0.0	7.2	0.2	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	21.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	40.6	37.0	51.8	53.9	43.0	55.2	85.9	51.1	41.5	49.6	28.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS1R1	"GPR70, T1R1, TR1"	ENSG00000173662	"Taste 1 receptor member 1"	Q7RTX1	1	6555307-6579755	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"testis: 4.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.1;Late spermatids: 18.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;Hep G2: 1.6;LHCN-M2: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034579, HPA034580"	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA034579: AB_2674232, HPA034580: AB_10671504"	"unprognostic (2.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.53e-4)"	"unprognostic (3.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.22e-2)"	0.1	0.3	0.2	0.1	0.3	0.6	0.1	0.2	0.5	0.2	0.3	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.8	0.0	0.2	0.5	0.1	0.1	0.3	0.6	0.2	4.3	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.2	0.4	0.5	0.3	0.3	0.3	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	1.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.8	1.9	0.0	0.1	0.0	0.0	1.5	0.0	0.1
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease variant, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 1272.2"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 4164.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.1	58.9	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.4	1272.2	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.1	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.7	6.7	0.0	0.1	0.0	0.0	0.6	95.3	18.7	0.5	72.9	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	1.0	0.3	0.0	3.1	0.0	45.5	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.1	49.6	4164.8	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	2.7	0.2	0.3	1.0	0.0	0.0	0.1	1.3	1.3	0.0	0.0	0.0	3.9	0.0	0.1	0.0
TBC1D22A	C22orf4	ENSG00000054611	"TBC1 domain family member 22A"	Q8WUA7	22	46762617-47175699	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 252.9;Oligodendrocytes: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001173	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA001173: AB_1080212"	"unprognostic (1.62e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (5.95e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.39e-1)"	13.4	12.3	10.5	14.4	9.9	10.4	11.8	9.0	10.5	11.8	7.9	12.5	14.9	10.5	6.8	18.1	12.1	9.3	12.9	10.4	9.2	13.3	11.0	12.7	19.4	11.3	11.5	9.8	14.7	12.0	11.2	12.0	10.7	9.3	9.5	4.9	14.1	7.8	17.9	17.6	15.0	7.6	9.8	19.1	14.8	7.3	11.0	14.7	12.3	11.3	18.4	11.0	12.3	11.4	19.1	13.0	8.1	9.9	11.6	16.1	9.9	12.8	17.2	14.3	15.3	14.8	14.5	16.6	13.9	19.5	8.9	20.7	7.0	20.0	9.9	7.2	19.6	9.5	11.1	28.6	17.7	20.9	7.4	18.9	23.0	9.8	13.6	17.2	23.7	10.4	6.2	17.4	13.1	9.8	9.3	10.7	8.0	17.9	14.6	11.8	9.5	17.9	16.7	9.7	6.6	12.3	11.8	4.5	20.1	10.0	10.5	13.7	19.5	10.9	15.3	11.5	8.2	11.5	3.9	10.5	27.0	10.6	6.9	2.5	10.7	6.3	6.4	15.5	6.0	11.6	5.9	6.1	12.5	13.0	3.9	4.3	15.5	5.5	18.6	6.1	10.2	6.6	10.5	9.9	9.0	10.5	10.4	9.2	11.3	11.5	10.7	9.8	11.0	11.4	20.3	25.6	18.3	81.0	47.0	6.4	12.1	21.1	21.6	18.6	9.9	7.9	8.6	14.3	20.2	7.3	18.8	24.4	22.7	27.9	11.7	25.8	13.9	20.1	14.2	19.0	3.6	13.5	82.0	23.5	19.6	12.2	39.3	14.5	17.1	13.3	23.2	7.9	33.1	21.9	94.2	16.2	18.3	23.0	16.7	3.5	9.9	32.7	10.6	252.9	39.4	13.7	29.9	76.9	113.2	30.2	25.2	11.7	28.8	10.5	39.4	19.8	15.0	27.3	13.1	12.3	11.8	7.9	10.5	18.5	8.0	29.0	22.7	12.7	18.4	11.8
TCEA3	TFIIS.H	ENSG00000204219	"Transcription elongation factor A3"	O75764	1	23380909-23424748	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 513.3"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 214.8;Hepatocytes: 205.9;Intestinal goblet cells: 376.2;Proximal tubular cells: 260.9;Undifferentiated cells: 223.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 8.4;naive CD4 T-cell: 13.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.3;Hep G2: 55.1;OE19: 28.7;SiHa: 18.2;T-47d: 28.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044960, HPA055811"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA044960: AB_10964053, HPA055811: AB_2682932"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-3)"	"unprognostic (9.18e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.77e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-3)"	"unprognostic (7.37e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.58e-2)"	17.5	95.6	4.7	4.6	4.3	0.6	19.6	4.1	4.7	35.7	7.8	87.1	15.8	17.0	7.3	40.5	28.3	11.6	71.6	4.0	4.4	64.9	160.7	20.4	2.4	6.0	4.9	81.9	229.4	16.3	14.9	3.9	5.4	59.9	39.8	3.2	100.3	14.5	513.3	53.4	35.2	9.2	5.2	10.6	75.9	4.7	4.1	1.8	41.2	173.1	4.5	36.2	38.7	5.1	0.0	0.1	0.5	0.5	2.5	15.3	9.0	6.4	4.1	3.2	1.9	4.1	0.5	0.2	0.7	7.9	1.0	9.1	0.5	0.1	2.8	0.0	0.1	0.0	6.9	55.1	1.9	0.8	0.0	10.1	2.8	2.9	0.0	7.1	0.4	0.1	0.0	0.0	1.1	1.5	0.4	6.1	0.0	28.7	1.8	0.1	0.0	0.2	0.0	0.1	0.5	0.1	18.2	0.8	0.8	1.5	28.4	2.8	0.4	0.0	0.2	0.7	0.0	0.5	5.3	0.0	0.5	0.5	0.6	0.0	0.2	0.0	0.4	0.7	0.4	0.0	8.4	1.1	2.9	0.0	13.6	6.1	0.0	0.2	0.2	0.9	0.8	2.3	4.7	4.3	4.1	4.7	4.0	4.4	6.0	4.9	5.4	5.2	4.1	5.1	10.5	125.0	109.5	4.2	1.9	27.4	53.4	30.9	30.7	2.3	46.3	42.4	109.8	100.1	57.2	42.3	2.1	3.3	1.9	158.0	199.6	37.7	6.1	7.7	6.6	13.4	55.9	5.7	2.8	97.9	33.9	45.2	69.3	20.8	9.5	214.8	8.2	205.9	1.5	25.2	4.5	376.2	6.1	7.6	65.4	17.9	17.1	8.4	24.9	3.7	3.2	6.8	3.1	2.0	1.3	25.5	143.0	15.4	0.5	38.8	154.3	260.9	29.4	1.4	19.7	90.1	24.0	0.7	2.6	61.1	54.8	2.2	8.4	52.0	223.5	73.9
TCP10L	PRED77	ENSG00000242220	"T-complex 10 like"	Q8TDR4	21	32497967-32587373	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"testis: 203.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1153.7;Late spermatids: 1940.5;Spermatocytes: 455.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;hTERT-RPE1: 2.0;SCLC-21H: 1.4;THP-1: 1.8"									HPA044709	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA044709: AB_10961410"	"unprognostic (2.31e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.41e-5)"	"unprognostic (4.98e-2)"	"unprognostic (5.94e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-3)"	0.7	0.8	1.3	0.0	1.5	1.4	0.8	3.4	4.1	2.0	0.9	1.1	0.3	0.9	1.9	0.5	1.8	0.4	2.1	1.4	0.9	1.4	18.5	0.6	0.2	1.1	0.7	1.4	0.6	0.2	1.4	0.4	0.6	1.6	0.4	1.9	0.7	0.5	0.7	0.9	0.5	0.0	0.3	0.8	0.6	203.6	1.0	0.4	1.0	0.3	0.4	0.7	1.0	2.0	0.0	0.2	0.3	0.1	0.4	0.2	0.2	0.1	0.4	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.4	2.2	0.2	0.2	0.2	0.2	0.1	0.4	0.0	2.0	0.0	0.1	0.1	0.1	0.3	0.6	0.3	0.8	0.1	0.1	0.0	0.1	0.2	0.3	0.4	0.1	1.4	0.0	0.0	0.0	0.4	0.5	0.3	1.8	0.6	0.4	0.1	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.3	1.5	3.4	4.1	1.4	0.9	1.1	0.7	0.6	0.3	1.0	2.0	1.1	0.0	0.5	2.0	0.3	1.1	0.5	1.2	0.0	1.1	0.8	0.9	2.5	1.5	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.6	1153.7	1.9	0.4	0.9	0.0	0.0	2.9	0.2	0.2	0.8	0.0	0.5	4.5	0.7	0.7	23.0	0.3	0.0	1.7	0.8	2.0	0.8	0.3	1940.5	16.8	1.2	0.0	0.0	0.0	3.8	0.0	0.5	1.6	0.2	0.1	10.1	0.0	0.7	0.0	1.5	1.6	1.1	26.3	0.4	0.6	455.0	9.2	0.0	1.4	0.3	0.1	0.1	0.4	0.2
TECTB		ENSG00000119913	"Tectorin beta"	Q96PL2	10	112283400-112305038	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Late spermatids: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"	NA	NA					"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"						"unprognostic (3.14e-2)"		"unprognostic (2.84e-2)"		"unprognostic (9.75e-3)"				"unprognostic (1.65e-1)"	"unprognostic (1.32e-2)"		"unprognostic (5.54e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.10e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133746040-133796641	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 7525.8;retina: 2433.0"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 7205.2;Muller glia cells: 12965.3"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	48	"Hep G2: 780.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	98000000000	"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	80.9	1.2	186.3	1.0	412.5	2.4	13.3	591.8	274.2	2.0	58.9	2.3	0.9	1.7	1.4	11.0	1.4	1.9	12.1	173.7	287.7	3.4	7525.8	1.9	1.3	786.9	385.4	2.1	4.6	2.2	4.4	1.3	628.2	5.4	1.2	2433.0	55.8	1.8	2.1	4.2	1.6	1.5	484.9	2.9	1.9	14.3	398.1	1.2	2.2	2.7	3.0	1.2	2.8	862.1	1.9	1.4	1.8	1.2	5.5	3.4	0.9	1.9	2.0	1.0	0.8	3.4	1.5	1.7	1.6	1.8	1.2	2.1	1.3	1.8	1.5	1.1	0.7	16.3	2.7	780.9	1.3	4.6	2.7	2.4	3.8	1.0	1.7	1.8	2.2	0.9	6.4	2.1	2.6	1.3	1.1	1.2	1.2	1.2	1.8	1.5	2.9	1.2	1.1	3.1	1.9	1.4	2.4	2.6	7.0	1.3	1.9	1.3	2.9	2.4	1.5	1.6	1.1	1.7	3.0	1.4	2.0	1.5	1.6	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	186.3	412.5	591.8	274.2	173.7	287.7	786.9	385.4	628.2	484.9	398.1	862.1	0.7	16.0	32.4	36.2	11.4	1.0	5.6	0.6	0.0	101.3	5.3	4.3	2.7	117.2	22.9	0.0	91.8	0.2	0.2	0.1	1.9	0.7	5.4	0.8	1.0	16.7	0.0	56.2	34.2	1.1	0.3	3.9	0.0	0.6	17.7	1.3	87.4	7205.2	0.1	47.1	34.7	0.0	0.0	124.7	0.3	3.8	0.3	4.7	0.0	9.4	0.6	12965.3	0.0	45.2	1077.2	1.1	0.0	0.4	0.0	18.7	0.0	0.5	22.1	400.4	0.0	11.6	0.4	0.5	0.4	3.6	0.0	0.3	7.8	0.5	0.0	3.0
TFB1M	"CGI-75, mtTFB"	ENSG00000029639	"Transcription factor B1, mitochondrial"	Q8WVM0	6	155256134-155314493	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029428	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029428: AB_2673038"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.33e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.77e-2)"	4.9	17.3	1.9	3.1	2.8	1.5	5.2	2.9	4.1	6.2	0.6	7.2	5.0	5.0	3.9	9.4	4.8	2.8	10.8	2.8	1.7	6.8	15.0	4.6	5.6	0.8	1.3	6.1	7.1	3.8	7.3	2.1	1.1	5.6	4.8	5.2	6.7	3.1	17.3	7.9	6.4	3.9	1.1	8.5	6.9	11.3	1.9	3.9	7.2	5.5	4.9	7.0	6.9	2.6	7.3	3.5	7.9	12.5	5.9	11.8	6.5	8.9	8.4	8.9	11.9	5.8	6.3	11.6	5.4	3.5	6.5	11.8	5.6	8.8	15.1	11.1	7.3	5.2	4.2	33.2	16.4	6.9	3.8	11.7	3.8	13.3	11.8	10.9	10.6	9.0	13.5	3.1	11.4	4.5	5.2	10.0	8.3	7.3	9.4	6.5	4.7	11.3	9.7	4.9	5.9	14.4	2.4	8.2	8.1	10.6	5.1	9.6	4.2	3.6	7.6	8.5	9.3	5.2	7.0	7.0	12.5	11.8	9.2	5.9	2.8	4.5	4.1	5.0	6.4	7.5	6.3	5.7	6.5	7.0	7.9	6.2	2.5	6.7	5.2	5.3	7.8	3.6	1.9	2.8	2.9	4.1	2.8	1.7	0.8	1.3	1.1	1.1	1.9	2.6	5.9	22.4	12.0	25.8	16.5	6.2	14.1	31.7	16.5	16.2	9.6	10.2	21.6	8.6	14.6	12.9	22.9	19.6	8.9	4.8	31.3	20.9	239.4	7.4	6.2	5.1	6.0	19.1	41.9	17.8	19.0	9.0	11.2	5.1	27.8	10.7	4.2	24.3	14.9	30.3	47.4	8.9	24.4	10.7	5.1	24.6	5.0	9.9	3.6	44.0	13.3	13.4	9.2	42.3	46.3	13.8	8.5	8.6	9.3	8.0	5.9	21.4	11.5	21.6	13.1	7.1	11.6	35.1	17.2	17.1	11.4	7.3	14.2	28.6	13.7	9.6
THPO	"MGDF, MPLLG, TPO"	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 35.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Hepatocytes: 12.7;Late spermatids: 4.0;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.0;Hep G2: 15.6;K-562: 2.8;RPMI-8226: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	1070000			"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (5.57e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.40e-3)"	"unprognostic (4.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.25e-2)"	1.8	2.5	5.2	0.5	3.9	0.0	1.4	4.7	4.8	3.9	2.4	0.7	0.2	3.8	1.3	0.4	2.0	0.4	1.2	4.5	2.8	4.5	35.4	0.8	0.2	3.3	2.9	2.8	1.7	0.1	0.7	0.5	3.0	1.3	0.3	0.0	0.5	0.5	1.9	0.6	0.7	1.5	3.0	1.3	0.9	3.9	2.8	0.0	0.8	0.9	0.1	0.9	1.9	3.6	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	15.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.6	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.9	4.7	4.8	4.5	2.8	3.3	2.9	3.0	3.0	2.8	3.6	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	1.6	0.1	0.0	0.0	2.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	12.7	0.6	0.0	1.3	0.0	0.0	0.8	0.0	4.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	1.1	0.8	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins, Transporters"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 75.5;liver: 33.7"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 231.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in single"							HPA066026	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.2	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.5	1.0	0.4	2.2	75.5	0.6	0.2	0.1	0.3	0.5	0.5	0.2	0.7	3.3	33.7	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.5	0.2	0.6	2.0	0.0	0.1	0.3	0.0	0.1	68.8	0.3	0.1	0.1	2.4	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.8	0.4	0.4	0.5	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.7	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.9	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.8	0.2	0.3	1.2	21.4	0.1	4.5	0.0	1.1	35.6	0.1	0.0	1.1	8.6	0.0	0.3	0.4	0.0	0.6	0.0	1.8	1.0	0.0	0.0	0.0	3.5	0.1	0.1	29.7	0.4	0.0	0.0	231.1	5.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.1	0.1	9.6	0.0
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189149-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA059249: AB_2683959"	"unprognostic (3.27e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	28.0	35.2	7.5	10.5	7.6	3.7	25.6	7.9	7.9	29.2	18.2	23.9	12.7	31.1	31.3	25.4	27.9	17.5	21.7	7.4	7.7	25.1	34.6	26.7	7.7	8.8	9.4	24.8	46.8	36.6	20.0	18.1	8.4	23.4	15.5	5.9	35.6	21.3	19.5	24.2	21.4	18.1	8.5	19.4	29.4	20.2	8.3	8.3	30.7	11.1	12.4	23.8	23.6	8.4	22.0	45.1	17.7	18.0	59.4	40.4	22.4	37.6	55.4	53.7	60.5	19.1	49.0	12.5	25.2	50.3	30.7	50.5	14.9	29.7	39.3	18.4	15.4	9.4	21.3	56.2	41.8	18.5	22.8	41.3	56.1	36.9	50.5	42.3	32.3	7.9	11.2	30.7	43.6	51.2	12.1	15.7	8.4	62.1	39.2	15.6	22.1	24.7	42.5	37.9	16.3	18.6	39.0	44.3	24.5	16.8	28.8	14.1	26.0	47.5	21.2	23.1	28.1	31.0	25.5	7.4	18.1	11.5	39.5	33.4	20.5	25.0	14.1	18.1	15.3	15.0	14.6	12.6	23.4	16.3	13.0	12.9	28.3	23.1	18.5	39.2	17.2	13.5	7.5	7.6	7.9	7.9	7.4	7.7	8.8	9.4	8.4	8.5	8.3	8.4	5.5	16.0	5.3	8.8	11.2	3.3	6.1	7.3	18.8	4.4	6.1	5.0	1.5	7.2	7.6	1.8	14.6	9.8	5.0	4.0	0.0	8.2	13.9	5.2	7.4	8.7	1.8	5.5	6.6	4.9	10.4	14.9	13.7	6.3	2.5	5.3	5.0	4.8	4.1	0.0	7.1	3.5	6.1	2.5	4.5	6.2	5.3	5.6	1.8	4.7	5.3	5.4	4.1	9.0	7.3	5.3	6.1	4.5	54.3	7.7	3.5	3.0	30.0	7.6	6.6	10.1	7.4	7.0	5.4	19.5	4.7	11.9	9.1	5.7	4.1	3.8
TMCC1	KIAA0779	ENSG00000172765	"Transmembrane and coiled-coil domain family 1"	O94876	3	129647792-129893606	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Alveolar cells type 1: 54.5;Astrocytes: 119.1;Excitatory neurons: 206.7;Inhibitory neurons: 201.5;Microglial cells: 127.4;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 209.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 9.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053894	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA053894: AB_2682295"	"unprognostic (4.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (7.75e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (6.82e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.32e-1)"	7.5	6.8	12.9	4.8	13.1	3.2	7.3	23.5	14.8	9.8	1.1	6.7	4.1	7.8	6.7	7.6	6.9	8.6	8.2	10.8	12.1	6.7	34.5	6.7	5.0	10.1	13.1	8.0	4.8	7.8	6.5	9.8	9.9	7.5	5.1	15.2	5.5	6.2	30.1	7.7	4.4	6.8	10.0	6.8	4.0	13.5	16.9	8.3	6.8	21.1	5.5	7.8	6.9	14.5	10.6	11.3	8.8	7.2	12.9	9.1	8.9	4.1	5.4	3.6	3.7	7.3	5.7	6.5	11.4	7.9	4.2	9.6	5.0	8.2	2.6	8.6	1.6	4.3	3.4	26.7	4.4	3.2	2.6	5.3	15.1	2.8	6.7	7.7	11.0	3.9	2.2	4.7	8.2	11.6	5.7	1.9	6.7	7.7	3.6	5.2	7.4	5.5	8.4	12.9	8.2	5.7	14.0	4.8	4.1	8.5	9.2	3.5	9.6	5.7	9.2	5.3	8.5	6.9	5.1	4.8	4.2	3.8	3.0	0.6	0.9	2.1	1.1	0.9	1.2	0.7	0.9	0.9	0.5	1.1	1.1	1.4	9.6	0.8	2.0	1.4	1.9	0.8	12.9	13.1	23.5	14.8	10.8	12.1	10.1	13.1	9.9	10.0	16.9	14.5	14.1	54.5	7.4	119.1	9.4	6.6	12.6	9.9	12.5	37.1	17.4	12.1	23.0	7.2	16.0	22.0	31.3	10.6	8.3	9.0	7.9	15.8	9.6	30.5	14.6	13.2	12.6	4.6	206.7	8.1	20.7	10.9	10.2	38.3	3.8	12.0	9.7	36.8	9.9	35.3	201.5	12.2	10.2	18.6	6.6	10.5	13.1	13.5	1.8	127.4	6.8	27.0	12.3	181.0	209.2	24.9	22.8	8.6	14.5	20.4	4.7	13.1	19.6	29.5	6.6	18.1	12.2	33.5	19.4	15.8	7.0	23.9	8.9	9.6	8.3	25.2
TMED6	"MGC23911, p24g5, p24gamma5"	ENSG00000157315	"Transmembrane p24 trafficking protein 6"	Q8WW62	16	69343250-69351786	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 298.9"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 28.3;Exocrine glandular cells: 36.6;Pancreatic endocrine cells: 12.8;Paneth cells: 10.6;Proximal tubular cells: 19.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.5;OE19: 7.4"									HPA012532	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA012532: AB_1858065"	"unprognostic (6.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.31e-3)"	"prognostic favorable (7.74e-5)"	"unprognostic (9.84e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.52e-3)"	0.5	0.6	0.1	0.7	0.3	1.1	0.6	0.8	0.7	2.5	0.1	4.3	12.5	0.9	18.1	0.4	22.5	0.7	0.4	0.3	0.0	16.1	5.5	1.9	1.3	0.1	0.1	0.6	298.9	0.1	0.2	0.4	0.1	0.7	7.8	1.0	0.5	2.4	0.3	1.0	7.7	0.5	0.1	0.9	61.2	0.4	0.2	0.2	0.5	0.0	0.6	0.3	0.2	0.4	0.6	1.6	1.4	1.0	0.1	0.0	0.9	2.0	0.1	0.0	0.3	2.2	0.8	4.2	0.7	0.0	0.6	1.1	0.2	0.2	0.4	0.6	1.7	2.1	0.6	15.5	0.1	2.7	0.9	0.2	0.8	0.1	0.3	0.8	0.1	1.9	1.4	0.5	0.3	1.6	1.1	2.9	1.9	7.4	1.4	2.3	1.2	1.6	0.4	1.7	3.2	1.3	2.7	0.9	1.0	0.5	0.5	1.7	1.9	2.2	1.3	0.8	1.4	1.4	1.3	4.5	1.2	2.2	0.7	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.7	0.3	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.5	1.3	0.5	0.0	0.1	0.1	0.6	0.5	0.5	0.3	0.2	1.5	0.1	1.8	2.1	0.1	0.0	5.0	0.0	6.6	0.1	28.3	0.7	0.4	8.4	3.2	1.4	36.6	0.0	0.1	9.7	5.0	1.3	0.1	0.4	4.7	0.3	0.0	0.8	2.6	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	1.0	12.8	10.6	0.0	0.3	0.3	8.0	19.1	0.4	0.6	0.0	0.5	0.2	0.1	0.1	0.6	0.0	0.1	0.5	0.1	7.0	0.2
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 237.2;Glandular and luminal cells: 507.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	17.2	19.8	22.6	12.9	26.8	11.5	107.0	23.2	24.0	44.4	24.2	20.6	16.9	63.5	27.6	28.0	37.9	15.9	23.1	22.2	22.7	93.9	24.1	18.7	19.4	24.2	24.0	22.7	39.2	26.4	15.4	21.6	23.2	24.0	16.9	12.1	30.1	111.8	33.3	29.0	17.4	16.1	23.5	20.4	28.8	23.6	23.9	16.5	23.0	24.9	17.7	20.4	23.0	23.4	23.5	56.0	19.7	16.2	45.7	43.9	19.6	24.1	36.1	46.5	43.8	42.0	59.5	26.1	6.5	24.9	36.0	35.3	22.9	41.5	35.2	28.5	46.1	19.5	45.7	86.2	39.3	31.7	32.8	39.4	46.5	32.8	46.3	41.8	40.8	45.0	40.7	50.1	29.2	31.7	34.6	36.6	9.1	25.4	62.6	29.8	42.8	47.4	39.1	18.7	25.3	20.2	14.6	0.5	59.6	24.9	27.3	59.9	24.7	42.1	28.5	18.8	46.9	52.1	38.0	12.0	44.3	29.7	38.2	20.1	42.8	15.3	31.2	43.4	35.7	37.3	39.6	36.4	44.9	39.8	43.2	35.7	15.9	44.1	32.9	44.0	44.6	31.1	22.6	26.8	23.2	24.0	22.2	22.7	24.2	24.0	23.2	23.5	23.9	23.4	22.1	19.2	15.4	0.0	22.8	20.6	31.6	72.0	21.6	10.4	64.2	61.2	27.3	24.3	34.5	40.5	6.2	68.5	19.6	18.5	37.2	36.6	13.1	237.2	70.8	28.2	23.4	33.2	0.0	49.8	47.3	21.1	13.7	507.4	22.9	34.4	36.0	20.6	37.6	11.8	0.0	37.3	28.5	32.4	11.8	11.1	13.1	23.8	33.8	0.0	47.7	17.7	29.9	0.0	0.0	41.8	20.7	12.4	29.4	23.4	27.7	30.2	27.1	11.7	6.6	13.2	19.8	45.8	24.7	26.9	22.6	44.6	20.9	25.6	45.7	25.2
TMEM135	FLJ22104	ENSG00000166575	"Transmembrane protein 135"	Q86UB9	11	87037844-87328824	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 121.8;Excitatory neurons: 99.6;Inhibitory neurons: 93.7;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 88.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056685, HPA069473"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056685: AB_2683208, HPA069473: AB_2686139"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.80e-1)"	26.1	14.9	4.2	5.6	6.0	3.7	14.2	2.8	5.2	5.6	5.8	10.5	15.6	6.4	4.7	4.4	6.0	8.3	6.7	4.9	5.2	12.0	24.7	6.5	5.9	5.0	5.8	7.3	6.2	9.4	5.4	10.2	5.6	10.7	8.5	7.0	10.0	6.4	8.4	3.9	14.5	6.9	2.5	5.8	7.4	10.2	4.3	6.6	10.1	7.5	4.8	5.5	4.4	6.7	8.8	15.7	9.8	13.7	31.3	28.6	9.2	6.5	16.7	7.6	17.0	27.1	39.9	24.2	17.1	8.9	19.9	8.3	13.3	14.9	8.5	22.7	7.5	18.5	14.0	88.5	17.6	10.8	9.2	34.8	9.2	11.0	7.6	10.2	19.5	26.4	19.3	35.9	9.0	5.9	28.3	10.8	11.5	47.2	11.7	12.5	7.5	19.2	17.5	28.1	4.8	11.0	9.6	30.0	13.6	18.8	42.0	9.6	10.3	7.9	10.3	30.6	4.6	13.4	28.2	28.2	6.0	11.5	15.7	0.9	4.8	1.4	7.5	5.1	6.7	4.7	4.7	8.1	5.6	3.4	5.3	5.1	1.5	7.2	2.2	5.7	5.4	4.1	4.2	6.0	2.8	5.2	4.9	5.2	5.0	5.8	5.6	2.5	4.3	6.7	14.4	9.6	7.5	121.8	7.1	4.2	4.0	4.6	8.6	5.6	12.7	7.1	6.3	5.7	6.8	1.8	4.2	2.6	7.7	10.5	5.9	2.8	2.8	5.8	11.0	8.1	3.6	3.8	99.6	3.2	8.6	11.0	8.6	4.2	9.5	11.5	7.9	16.2	4.9	1.7	93.7	6.8	10.2	7.8	6.0	7.7	7.2	5.4	5.4	48.7	4.1	5.0	9.2	123.1	202.4	3.1	10.9	7.2	10.3	6.1	21.8	10.6	8.7	4.2	32.9	5.7	8.4	2.2	3.8	4.8	4.8	1.5	8.3	24.6	8.7	3.8
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040189	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	"Golgi apparatus"	"HPA040189: AB_10793959"	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	14.6	12.4	16.6	12.2	17.0	9.1	18.7	9.7	17.5	27.3	8.3	22.7	24.6	15.2	9.0	13.1	12.7	16.5	10.3	17.6	17.5	7.9	14.9	13.3	9.4	13.3	15.1	10.3	34.3	13.4	11.8	15.0	14.1	20.0	24.8	10.5	52.3	20.9	10.2	16.1	28.5	17.4	12.9	14.3	35.7	21.3	22.3	6.3	21.3	8.7	8.2	20.6	13.4	14.9	22.1	12.6	17.5	27.0	45.1	41.1	33.4	49.1	28.6	25.1	28.4	21.5	26.5	9.3	24.7	41.0	53.5	32.0	26.1	32.4	39.6	13.7	18.7	17.3	18.9	45.6	36.8	21.9	15.8	34.3	31.2	27.9	37.6	37.6	40.7	13.1	33.4	11.3	41.4	13.3	9.7	27.1	13.6	43.8	15.9	9.3	20.1	10.6	23.9	17.1	51.3	35.3	36.0	33.3	24.2	23.9	12.7	30.4	39.1	25.7	17.4	43.1	43.0	6.6	4.9	10.0	31.0	26.8	25.1	5.7	1.1	3.0	2.2	1.1	1.7	0.4	1.2	1.8	0.8	0.4	1.1	1.5	0.7	2.0	1.9	1.0	1.3	0.8	16.6	17.0	9.7	17.5	17.6	17.5	13.3	15.1	14.1	12.9	22.3	14.9	26.7	12.8	33.1	19.9	9.4	20.4	15.6	20.5	17.6	15.6	30.0	18.8	14.2	27.1	23.1	16.5	18.8	8.8	46.0	47.2	3.9	23.3	4.2	16.8	27.7	27.5	44.3	21.5	61.1	32.7	12.5	16.6	49.5	40.5	11.4	36.8	21.0	22.5	10.2	20.2	66.3	35.9	18.3	15.3	16.4	6.7	13.1	14.7	14.2	28.1	13.3	6.0	51.5	43.2	61.7	35.3	25.7	17.7	26.6	37.5	39.4	4.6	25.8	14.6	6.6	12.7	17.8	13.1	22.7	23.6	21.0	5.2	27.0	24.2	30.5	37.1
TMEM190	MDAC1	ENSG00000160472	"Transmembrane protein 190"	Q8WZ59	19	55376826-55378246	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 138.1;testis: 57.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 556.2;Endometrial ciliated cells: 307.5;Late spermatids: 179.0;Respiratory ciliated cells: 1386.5"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 11.5"	"Region enhanced"	"Detected in many"		"cerebellum: 6.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 10.6;SCLC-21H: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-3)"	"unprognostic (3.97e-2)"		"unprognostic (1.42e-1)"	"unprognostic (5.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.38e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.93e-1)"	0.2	1.5	0.3	0.2	0.2	0.2	0.0	6.5	0.8	7.6	0.0	0.3	0.2	0.4	0.0	0.1	138.1	0.2	0.0	0.4	0.1	1.4	0.0	18.2	0.1	1.5	2.8	0.2	0.1	0.0	7.4	0.6	1.4	0.5	0.0	0.2	0.1	0.5	0.0	1.3	0.1	0.1	0.0	0.1	1.0	57.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	1.8	0.0	0.4	0.0	0.0	0.2	0.5	0.2	0.4	0.1	1.3	1.1	1.8	0.1	0.5	0.2	3.3	0.0	0.0	0.0	3.2	0.1	0.0	2.2	10.6	0.6	0.0	0.0	0.2	0.0	0.1	0.0	3.4	0.0	0.1	0.0	2.5	0.0	1.5	0.2	0.0	0.4	1.3	0.5	0.1	1.2	1.1	0.0	0.9	5.0	0.9	1.0	1.3	0.4	0.9	0.5	0.0	0.0	0.1	0.8	0.1	0.5	0.3	2.5	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	6.5	0.8	0.4	0.1	1.5	2.8	1.4	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	63.5	0.0	0.6	0.0	0.0	0.0	0.0	66.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	556.2	307.5	1.8	0.4	8.9	0.0	0.0	0.0	0.1	1.8	0.0	3.7	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	91.6	0.0	0.0	179.0	5.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.2	0.0	0.0	1386.5	0.1	0.0	0.0	28.6	3.4	1.8	0.0	0.0	0.4	0.2	0.0	0.0	0.3
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	140.5	120.1	89.7	60.4	98.6	60.4	88.4	101.9	110.7	108.3	113.6	83.9	62.3	88.9	120.4	57.3	87.1	97.7	101.4	88.2	100.2	145.7	197.8	75.8	81.0	98.9	95.1	97.4	95.1	99.3	89.5	72.5	99.1	105.5	88.7	107.4	78.9	83.1	107.1	34.4	70.2	88.9	95.3	71.8	87.6	49.7	96.0	85.6	135.5	148.3	76.6	93.3	56.6	111.8	157.2	108.1	139.1	105.2	307.1	271.6	105.6	124.0	185.4	119.9	131.4	86.0	152.4	74.8	99.5	180.7	136.6	127.1	104.5	185.2	172.3	83.6	119.6	132.6	31.5	266.3	196.3	154.9	52.8	189.3	202.4	92.2	183.3	167.0	160.1	163.6	126.1	200.3	199.2	44.7	156.9	143.8	106.3	298.8	152.4	100.4	93.2	161.5	182.5	79.4	116.8	141.7	74.6	154.8	270.0	149.0	123.9	145.6	135.7	154.7	90.5	150.1	135.2	133.2	284.3	147.5	62.5	132.2	166.3	128.9	175.4	116.7	136.5	187.1	166.3	170.7	145.8	145.3	163.8	153.1	150.8	148.6	55.7	153.9	180.6	161.2	147.6	349.2	89.7	98.6	101.9	110.7	88.2	100.2	98.9	95.1	99.1	95.3	96.0	111.8	126.6	57.7	64.6	15.3	123.4	70.4	126.7	148.7	65.4	89.6	151.7	133.7	51.3	111.5	95.1	154.5	64.6	173.4	127.8	55.0	502.9	146.6	200.3	77.1	103.2	109.5	95.8	103.7	20.2	111.2	208.8	141.6	59.1	64.1	114.1	82.8	126.7	147.5	212.8	62.2	27.7	123.1	126.1	162.9	172.9	89.5	212.2	121.9	199.3	14.0	215.6	113.9	151.4	13.0	49.6	100.2	130.0	220.4	161.7	129.6	102.0	363.2	81.9	113.3	85.5	100.4	128.0	99.4	97.5	68.1	60.5	148.0	118.2	184.2	125.6	152.1
TMEM88B		ENSG00000205116	"Transmembrane protein 88B"	A6NKF7	1	1426128-1427787	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"brain: 437.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.2;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065743	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"				"HPA065743: AB_2685552"	"unprognostic (3.17e-2)"	"unprognostic (1.42e-2)"		"unprognostic (1.63e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.30e-5)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"			"unprognostic (3.53e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	95.5	0.1	285.1	0.0	0.0	192.8	193.1	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	82.8	125.8	1.0	0.0	0.1	0.0	312.3	232.8	0.1	0.0	0.0	0.0	0.0	199.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	129.9	0.0	0.0	2.2	242.8	0.0	0.0	0.0	0.0	0.3	0.1	437.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	285.1	192.8	193.1	82.8	125.8	312.3	232.8	199.0	129.9	242.8	437.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNNC2	"CFAP85, FAP85"	ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	109	"skeletal muscle: 30416.4;tongue: 8088.6"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 338.7;Skeletal myocytes: 1165.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.2;head and neck cancer: 22.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Hep G2: 10.0;HSkMC: 14.8;SCLC-21H: 11.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 6.1"	"Low region specificity"	"Detected in some"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		No	NA		560000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	6.6	5.5	4.8	0.4	5.7	1.1	8.3	5.2	6.9	2.2	4.4	5.3	2.5	4.2	1.0	128.5	3.0	2.2	4.0	4.8	4.5	1.7	2.5	3.2	0.5	4.4	4.5	6.5	2.2	1.2	3.1	0.2	4.5	44.3	2.2	1.3	176.3	1.3	30416.4	10.1	7.8	1.0	4.1	1.8	2.4	4.6	4.8	6.7	5.1	8088.6	0.7	2.5	3.0	5.5	0.1	0.0	0.2	0.4	1.6	1.0	1.7	0.1	0.4	0.0	0.1	0.2	1.1	0.4	1.1	1.0	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.0	1.0	10.0	0.4	0.3	0.2	14.8	0.2	0.1	0.7	0.3	0.0	1.2	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.4	0.6	0.3	0.6	0.2	0.4	0.1	11.3	0.5	1.6	0.1	0.4	0.5	1.3	0.4	0.5	0.2	0.3	0.9	0.2	1.5	0.4	0.2	1.4	0.1	0.2	0.0	0.6	1.3	0.1	1.1	0.6	5.3	1.3	0.2	0.3	4.6	0.0	0.3	2.0	0.3	0.8	0.8	3.9	8.7	4.8	5.7	5.2	6.9	4.8	4.5	4.4	4.5	4.5	4.1	4.8	5.5	0.9	3.2	0.6	0.3	3.1	0.8	0.5	2.0	0.0	4.2	3.1	1.7	0.5	2.8	3.6	3.7	0.0	2.4	0.5	171.7	3.9	1.5	6.9	37.1	1.0	3.8	22.9	0.0	1.9	5.1	0.4	7.2	0.5	2.3	0.0	13.9	0.0	1.1	0.3	0.0	0.7	108.2	14.2	0.3	1.1	47.0	1.2	22.4	0.0	0.0	2.1	1.4	1.0	0.0	0.6	3.3	92.9	3.0	0.5	0.7	338.7	1.0	4.3	2.4	0.0	1165.3	9.5	2.5	5.5	0.1	8.4	0.1	4.7	7.2	37.0	0.7
TNP1		ENSG00000118245	"Transition protein 1"	P09430	2	216859458-216860064	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1160	"testis: 5953.3"	"Group enriched"	"Detected in some"	205	"Early spermatids: 41424.6;Late spermatids: 136509.6"	"Group enriched"	"Detected in some"	58	"liver cancer: 6.0;testis cancer: 4.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044387	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"			"HPA044387: AB_2678923"															"unprognostic (1.67e-1)"			0.9	0.8	1.4	0.4	4.9	0.0	4.0	1.4	1.4	1.0	0.0	0.9	0.8	0.6	0.0	0.8	0.6	0.0	0.8	1.6	0.0	1.1	2.0	0.6	0.1	0.0	0.0	0.8	1.3	0.0	0.8	0.0	0.0	5.1	0.0	0.0	0.8	0.0	2.3	1.4	1.6	0.0	0.0	0.6	1.0	5953.3	1.0	0.0	2.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.9	1.4	1.4	1.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41424.6	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136509.6	410.1	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	246.7	0.0	0.0	0.0	0.0	0.0	0.0	249.8	0.0	0.1	433.2	234.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 498.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	Cytosol		NA	NA		140000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	26.8	35.4	58.2	12.4	73.5	13.6	25.8	27.5	80.9	35.9	17.6	26.3	25.5	23.5	11.5	93.4	22.4	18.4	31.3	85.0	39.4	43.1	113.3	26.6	14.2	39.9	39.1	24.6	58.2	18.9	54.2	12.1	39.8	31.4	8.2	11.4	31.6	20.5	76.2	75.9	23.4	11.1	32.9	28.8	31.9	73.4	42.7	13.2	24.7	22.7	14.2	33.5	48.8	56.5	31.4	32.6	16.3	18.6	34.0	21.2	14.2	27.2	24.5	31.3	27.7	35.4	19.5	14.6	25.6	25.3	47.9	27.7	14.7	33.4	8.5	30.1	30.1	11.9	6.9	54.2	48.4	22.8	29.0	32.1	38.5	18.6	17.9	17.1	19.7	21.7	19.9	38.5	26.1	26.3	29.1	27.9	20.0	33.9	42.1	21.8	16.6	14.6	20.9	41.3	43.5	25.5	24.4	29.4	30.7	8.3	23.3	25.7	36.0	33.8	14.4	14.4	16.0	38.8	37.8	18.3	53.2	14.9	27.0	45.4	126.6	139.6	33.4	114.0	27.8	38.8	35.3	31.5	99.9	50.0	27.4	26.1	179.1	44.5	108.8	52.4	48.8	77.3	58.2	73.5	27.5	80.9	85.0	39.4	39.9	39.1	39.8	32.9	42.7	56.5	19.5	9.6	19.3	15.0	27.8	66.9	43.9	71.7	23.3	42.6	30.3	24.6	22.8	58.6	30.9	23.9	8.4	49.2	28.0	50.8	70.5	66.3	173.6	11.7	14.8	24.9	51.6	45.0	35.1	69.2	41.1	27.6	19.4	15.8	38.1	20.7	37.9	112.2	92.1	74.0	17.0	30.8	48.8	38.4	33.1	498.2	21.8	48.3	71.2	16.9	50.6	38.1	19.6	10.6	15.0	76.3	53.7	30.9	33.4	55.7	66.6	110.1	15.4	20.6	6.6	18.5	24.5	100.7	39.6	76.3	98.9	104.4	22.0	27.4	29.3	74.0
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.0;intestine: 19.3;stomach 1: 15.0"	"Cell type enriched"	"Detected in many"	30	"Enteroendocrine cells: 1466.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 3.4;midbrain: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Uncertain		Uncertain	Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.6	0.1	0.2	1.2	0.3	1.1	1.3	0.3	0.3	0.6	4.7	9.0	10.2	0.9	0.9	0.2	0.9	0.1	0.3	0.4	3.4	0.5	0.2	0.8	0.5	0.2	9.0	0.7	0.5	0.1	3.0	0.2	1.1	1.4	19.3	1.8	0.5	0.1	0.4	1.4	11.2	0.2	0.2	0.7	15.0	0.9	0.4	0.3	0.5	0.1	0.7	0.4	0.4	0.3	0.1	0.0	0.5	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.0	0.7	0.3	1.1	0.0	1.5	0.3	0.0	0.6	0.0	0.2	0.1	0.2	0.8	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.1	0.4	0.1	0.5	0.0	0.1	0.3	0.0	0.3	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.4	3.4	0.2	9.0	1.1	0.2	0.4	0.3	1.4	0.0	0.0	1.0	1.1	0.4	0.4	0.5	0.0	14.9	1.9	1.0	0.8	0.0	0.1	5.5	2.1	0.2	0.6	1.7	0.0	0.2	0.8	0.1	0.6	0.7	1466.7	0.4	0.5	0.6	0.0	1.2	2.0	0.2	0.0	5.6	0.4	0.2	0.2	1.7	0.4	48.2	0.0	0.3	1.4	0.8	0.9	0.5	0.0	0.0	0.1	1.4	1.0	0.0	0.6	0.4	13.4	1.2	0.3	2.3	1.5	0.3	0.9	5.6	6.6	1.3	1.3	2.8	3.7	0.0	1.4	0.0	1.2	0.0	2.7	0.4
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 96.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 293.9;Late spermatids: 504.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favorable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	21.7	26.0	13.9	10.9	14.4	10.1	21.8	15.0	23.3	20.2	13.5	27.9	10.1	23.7	6.3	23.0	22.2	10.4	46.7	14.8	15.9	22.6	28.0	17.1	16.0	15.9	14.1	21.4	26.2	18.4	26.7	6.6	17.1	20.6	4.7	9.1	25.8	10.0	45.8	35.7	21.2	5.2	14.6	22.1	28.4	96.6	14.8	15.7	24.7	6.4	5.0	26.1	18.9	15.5	16.4	28.0	9.1	10.4	19.9	24.5	23.9	26.6	6.5	7.6	4.2	17.5	13.6	18.8	28.6	9.0	6.7	20.8	10.5	11.9	3.1	22.8	39.5	16.2	8.1	60.8	9.0	20.4	28.0	18.1	9.0	8.5	21.2	5.8	6.7	21.5	25.5	10.0	13.5	22.5	20.6	34.9	22.1	7.3	39.4	15.4	12.4	15.3	8.1	13.5	23.2	37.8	10.6	11.8	18.5	4.0	13.9	16.3	17.2	18.6	10.6	18.7	23.6	28.5	22.4	15.0	21.8	15.9	10.5	0.7	1.0	3.8	0.8	2.5	2.0	0.5	1.3	2.2	1.4	0.5	0.8	1.0	1.0	0.9	3.6	4.3	2.5	0.8	13.9	14.4	15.0	23.3	14.8	15.9	15.9	14.1	17.1	14.6	14.8	15.5	18.8	9.6	12.8	59.4	20.7	11.5	16.2	15.1	14.2	31.8	13.7	16.0	68.4	21.5	11.2	12.9	33.3	21.3	16.9	17.1	58.7	21.7	293.9	20.3	16.4	18.5	3.5	19.1	56.2	18.0	15.2	23.7	23.0	14.5	5.7	22.3	11.0	16.0	25.9	26.9	62.5	17.7	14.2	17.9	10.0	504.5	26.4	20.7	16.0	30.0	28.5	42.6	15.5	52.3	56.4	23.9	11.9	24.0	19.6	16.0	20.3	30.0	19.4	42.0	26.3	20.9	21.7	125.2	26.3	18.8	17.8	17.6	14.4	33.8	15.7	12.2
TRAPPC6B		ENSG00000182400	"Trafficking protein particle complex 6B"	Q86SZ2	14	39147811-39170532	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047928	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum"		"HPA047928: AB_2680214"	"unprognostic (3.89e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.18e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	12.7	15.8	17.0	11.2	19.1	4.8	14.6	18.5	21.9	11.7	14.3	12.9	10.9	12.1	12.2	15.0	9.6	9.5	13.7	20.0	16.8	13.9	24.4	10.4	12.2	13.8	13.7	10.2	10.9	13.9	12.6	12.9	15.9	12.9	10.4	24.6	10.4	13.2	16.6	11.4	10.3	11.8	14.0	12.9	11.0	12.9	14.6	13.5	15.9	18.6	12.2	12.8	12.0	15.6	17.5	7.7	13.0	12.6	18.1	20.4	10.3	22.0	19.4	19.6	19.2	12.7	32.6	10.9	15.2	20.5	9.7	13.4	19.2	14.0	23.8	19.9	9.4	14.9	10.6	37.3	25.8	21.1	19.8	19.4	23.2	16.9	22.4	31.1	17.3	19.8	16.7	22.4	20.5	21.6	15.7	15.2	11.1	13.5	29.7	12.2	24.0	10.7	21.4	34.0	12.7	10.3	26.2	15.9	24.7	13.5	30.2	13.2	24.8	18.0	9.1	15.4	12.1	20.8	30.7	15.9	8.9	12.1	17.4	8.7	3.2	5.6	2.9	6.8	2.6	3.3	4.0	3.3	4.8	2.1	3.4	3.4	3.3	7.7	7.1	4.8	3.6	2.4	17.0	19.1	18.5	21.9	20.0	16.8	13.8	13.7	15.9	14.0	14.6	15.6	20.0	22.4	19.4	24.2	20.3	22.6	19.7	17.9	25.6	25.3	18.2	12.6	24.0	10.0	15.6	18.4	35.5	14.2	28.7	12.4	54.8	14.3	38.8	12.1	17.6	17.5	16.6	27.6	47.0	17.4	13.1	22.0	18.8	18.4	29.2	15.5	23.6	22.8	15.7	23.5	50.6	9.6	26.4	15.0	21.3	16.0	16.1	23.0	17.8	13.1	18.2	16.0	27.8	31.2	45.0	22.2	12.6	17.7	21.4	19.2	11.3	20.7	10.8	39.4	26.3	15.5	21.1	58.9	31.3	29.7	25.1	22.6	22.3	26.8	10.1	30.1
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312536-73328082	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 29.1;parathyroid gland: 33.3;stomach 1: 48.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Gastric mucus-secreting cells: 17.9;Spermatocytes: 5.2;Spermatogonia: 4.2"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"Hep G2: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	6.8	0.3	0.1	0.0	0.1	0.1	0.2	29.1	33.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	0.1	0.4	48.7	8.7	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.2	4.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0
TRIM73	TRIM50B	ENSG00000178809	"Tripartite motif containing 73"	Q86UV7	7	75395063-75410996	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 41.9;Horizontal cells: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 6.0;Hep G2: 10.5"									"HPA047843, HPA051845"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA047843: AB_2680176, HPA051845: AB_2681635"	"unprognostic (1.01e-2)"	"unprognostic (9.85e-5)"	"unprognostic (4.72e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.46e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-3)"	2.8	3.7	1.0	1.3	1.7	2.5	3.5	4.7	2.1	5.0	0.7	2.1	3.6	2.9	0.5	1.4	6.4	1.1	2.0	1.0	1.4	4.2	5.6	1.9	2.3	1.1	1.0	4.3	6.0	1.3	3.6	0.4	1.1	4.5	0.2	0.9	2.1	1.6	2.6	2.4	3.3	0.2	0.8	3.2	21.6	11.3	1.3	1.1	4.6	0.4	0.4	2.2	3.1	1.8	1.0	3.2	1.3	1.9	0.0	0.6	0.5	0.4	0.1	0.0	0.7	0.0	1.5	1.8	0.3	0.2	0.2	1.1	0.3	0.0	0.1	4.1	6.0	1.1	2.8	10.5	0.6	0.6	4.2	1.7	0.0	0.2	0.3	0.9	0.0	2.5	0.6	4.9	0.0	0.7	1.7	2.1	0.1	0.3	1.0	2.8	0.2	0.9	0.3	0.0	1.6	1.2	2.0	0.7	1.9	0.5	0.5	1.9	1.2	0.9	1.4	1.3	0.8	2.3	1.4	1.8	1.2	2.6	1.1	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.3	0.3	0.0	0.2	0.3	0.2	1.0	1.7	4.7	2.1	1.0	1.4	1.1	1.0	1.1	0.8	1.3	1.8	3.8	0.0	0.5	0.0	15.5	0.9	3.2	3.1	4.6	21.9	5.1	4.2	2.5	1.5	3.3	5.5	18.8	2.1	8.7	1.6	5.9	1.8	5.9	9.2	13.4	2.8	4.9	3.4	0.1	4.7	0.7	4.7	16.8	5.6	0.0	41.9	2.9	3.0	3.0	32.0	0.1	3.2	4.1	2.4	1.2	11.4	6.5	3.1	1.8	0.0	2.5	5.8	9.2	0.0	0.1	2.9	4.0	3.8	11.2	3.3	10.0	4.7	5.4	14.5	0.0	14.6	4.1	9.1	2.5	3.3	2.0	1.1	6.8	14.2	3.4	2.6
TTC21B	"FAP60, FLA17, FLJ11457, IFT139B, JBTS11, NPHP12, THM1"	ENSG00000123607	"Tetratricopeptide repeat domain 21B"	Q7Z4L5	2	165857475-165953851	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 67.8;Excitatory neurons: 81.2;Inhibitory neurons: 85.5;Oligodendrocyte precursor cells: 77.9;Oligodendrocytes: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035495, HPA073293"	Supported		Approved	Cytosol		NA	No			"Cluster 38: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA035495: AB_10672866, HPA073293: "	"unprognostic (1.63e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.57e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.84e-2)"	5.5	4.1	3.1	3.1	3.4	2.1	5.3	6.5	4.3	6.8	2.6	5.1	2.6	6.3	2.8	3.0	7.3	2.8	5.2	3.2	3.2	5.2	4.0	4.7	4.1	3.3	3.5	8.0	5.0	4.3	4.6	4.7	3.5	6.1	4.0	7.5	4.6	4.2	9.1	4.7	4.2	4.1	3.2	4.0	4.3	4.4	3.1	5.0	4.3	9.2	3.3	4.7	6.0	3.9	4.1	2.1	11.8	6.2	11.0	7.0	3.6	8.2	5.9	4.9	5.8	4.4	2.5	8.9	3.8	3.2	4.7	5.0	8.2	4.8	6.9	6.4	4.9	6.5	4.4	13.6	6.2	6.7	0.0	4.0	2.9	5.9	5.2	8.4	7.0	5.6	9.6	6.1	9.0	2.4	7.0	7.8	6.9	4.6	6.9	9.5	9.1	3.9	6.2	8.2	9.6	6.9	4.7	1.7	8.6	6.3	2.5	7.2	3.9	12.0	5.1	6.5	5.4	3.5	4.5	5.8	5.2	5.4	7.2	3.2	0.5	0.6	0.8	0.6	1.1	1.2	1.0	0.8	0.9	1.0	1.0	1.3	0.2	1.4	1.0	0.4	1.1	0.5	3.1	3.4	6.5	4.3	3.2	3.2	3.3	3.5	3.5	3.2	3.1	3.9	11.1	3.2	9.8	32.7	12.9	9.2	8.3	5.3	22.8	21.6	7.2	6.9	12.5	4.3	9.4	5.5	33.3	3.8	20.2	4.6	0.0	3.3	2.4	67.8	15.3	8.2	7.2	13.7	81.2	1.8	4.6	11.3	11.2	21.6	6.3	12.8	10.8	8.4	13.1	15.2	85.5	7.7	6.1	8.1	4.9	3.2	10.5	7.2	10.6	44.0	5.7	9.9	9.2	77.9	58.9	1.1	6.5	12.8	14.5	6.3	4.0	7.2	34.7	22.7	6.6	15.9	10.7	7.1	12.1	8.5	3.8	2.9	12.5	8.5	5.8	4.7
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 233.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 134.2;NK-cells: 182.3;Proximal enterocytes: 144.5;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 90.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.9;NK-cells: 38.0;T-cells: 90.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029302, HPA075893"	Approved		Approved	Cytosol		NA	NA		170000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA029302: AB_10601704, HPA075893: "	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favorable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	24.7	23.6	9.5	10.2	11.6	46.9	25.7	10.3	10.7	16.8	12.8	42.1	79.4	13.8	6.4	12.5	17.2	15.5	23.2	9.7	11.0	64.4	233.6	15.6	10.7	13.3	12.3	26.0	35.5	7.6	13.2	7.8	11.9	23.6	31.9	4.7	27.0	7.3	20.6	12.2	80.9	10.3	10.3	22.8	29.1	6.8	12.2	2.5	15.2	12.3	5.9	16.9	13.5	11.3	12.0	13.2	16.4	34.5	15.2	13.1	15.7	17.2	11.5	18.7	14.6	21.8	8.5	0.1	10.8	17.9	7.4	10.8	16.8	13.9	6.8	27.0	36.9	15.6	28.4	76.0	21.0	9.0	59.8	22.6	7.3	8.5	9.7	12.9	15.9	0.2	11.9	19.4	12.2	12.1	0.3	28.2	12.5	22.6	13.1	0.0	8.0	8.0	12.6	13.8	2.9	22.8	23.7	16.3	13.3	7.5	26.1	18.0	18.5	13.0	14.1	10.3	11.0	14.7	9.2	1.7	8.8	13.7	13.8	29.9	11.9	22.5	90.5	11.4	9.7	2.3	8.5	41.0	10.8	1.7	3.5	36.9	7.6	38.0	8.7	4.3	4.5	42.5	9.5	11.6	10.3	10.7	9.7	11.0	13.3	12.3	11.9	10.3	12.2	11.3	9.2	0.0	7.5	13.7	6.5	3.3	5.9	4.3	3.4	2.6	10.2	6.7	9.2	38.6	4.3	9.2	6.2	10.4	69.1	69.0	23.5	10.4	0.3	7.4	9.6	8.9	20.9	10.5	0.3	10.2	9.3	7.5	11.7	6.9	17.2	13.3	9.7	134.2	13.4	5.0	1.8	37.8	4.1	14.9	4.3	0.9	7.5	9.6	5.4	9.4	12.8	9.3	182.3	5.5	5.6	9.7	51.6	13.9	16.2	8.6	144.5	149.6	5.3	5.4	6.6	7.4	5.9	1.8	3.7	5.3	8.2	6.4	29.2	22.7	51.7	4.6
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559732	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 151.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 534.8;Exocrine glandular cells: 273.8;monocytes: 151.9;Pancreatic endocrine cells: 510.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"Hep G2: 63.9;RT4: 52.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	4.2	0.4	0.3	35.6	0.4	0.0	8.6	0.3	0.7	1.7	0.3	13.3	4.2	1.9	1.2	8.3	4.7	0.9	0.6	0.3	0.3	23.2	25.4	10.9	87.5	0.4	0.3	1.2	27.3	1.7	1.4	0.0	0.3	11.9	19.0	0.0	14.6	1.3	0.4	1.8	31.1	1.2	0.3	22.9	27.1	0.8	0.3	90.2	3.0	0.1	151.3	25.8	1.7	0.3	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	63.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.9	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.7	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.2	3.2	3.1	0.0	0.7	0.1	0.1	2.3	16.5	0.0	1.9	1.9	0.0	21.5	13.3	0.0	0.0	0.0	0.1	6.9	1.9	534.8	0.0	0.3	0.2	7.1	3.6	0.0	0.0	273.8	0.0	2.2	13.3	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	5.2	6.1	0.3	0.0	0.0	0.0	1.2	0.0	0.0	151.9	0.0	0.0	0.0	0.0	510.6	8.3	0.0	0.0	0.5	49.1	1.1	9.7	0.0	0.0	0.0	3.4	0.0	0.0	2.2	0.0	0.0	0.2	0.0	11.1	0.1
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.7"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 345.5;Hepatocytes: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 509.6;Hep G2: 595.9;U-2197: 375.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm		Yes	No		1300000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	48.5	27.8	6.2	29.5	7.3	2.4	32.0	9.4	9.2	31.5	18.1	96.5	45.3	29.1	10.6	34.1	29.6	40.5	16.0	5.9	8.3	37.5	137.7	19.0	13.3	7.4	7.7	30.0	33.7	23.1	7.8	38.4	8.0	35.6	73.3	14.3	16.8	14.0	6.7	9.9	41.1	23.5	7.6	11.5	47.4	6.8	8.4	10.3	27.8	9.5	14.5	54.4	17.1	9.7	36.0	509.6	58.4	76.2	181.5	185.3	51.3	102.7	113.8	94.5	84.8	76.2	115.5	25.4	63.0	133.3	94.5	33.5	56.0	29.5	95.8	32.1	13.0	26.2	65.4	595.9	72.7	34.1	25.3	64.4	14.9	160.2	49.8	78.9	59.3	20.9	34.1	17.3	67.9	89.8	29.4	34.4	53.1	194.0	46.4	48.3	95.0	22.0	53.7	120.0	31.2	46.7	69.2	37.9	45.3	41.4	21.0	27.0	85.9	97.9	49.1	375.8	54.2	42.1	33.3	23.3	86.9	25.8	56.6	30.0	20.9	19.7	23.2	18.4	37.8	18.8	18.8	24.9	19.0	18.4	16.1	19.4	3.8	42.3	11.2	22.5	13.5	18.8	6.2	7.3	9.4	9.2	5.9	8.3	7.4	7.7	8.0	7.6	8.4	9.7	19.1	25.6	27.6	4.6	14.1	116.1	73.4	19.5	43.9	7.5	115.8	62.0	8.9	24.3	25.4	20.2	14.6	21.3	12.9	207.8	70.5	54.7	1.1	78.3	53.8	25.4	113.3	9.1	10.6	345.5	78.8	145.7	184.0	64.8	35.5	11.1	20.7	231.3	17.8	10.1	12.6	114.5	12.2	20.2	33.3	1.6	33.2	12.7	30.2	7.5	19.9	7.3	9.2	46.3	12.8	195.8	112.2	29.0	21.3	127.3	81.4	79.6	65.7	9.2	32.9	39.0	57.5	6.5	5.5	102.2	40.1	29.0	11.7	12.4	152.4	86.4
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol		NA	NA		4000000	"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	8.1	8.5	4.2	13.7	4.6	21.8	7.6	4.8	6.5	9.1	5.0	12.4	9.0	7.3	19.9	8.0	6.5	6.5	8.0	4.3	4.6	8.2	14.9	8.4	12.3	4.7	4.4	5.1	14.8	8.7	6.5	8.7	5.0	8.7	10.0	9.7	8.6	6.2	13.2	8.8	10.2	6.2	4.0	9.4	10.7	6.4	4.8	11.7	10.4	13.0	12.6	7.5	6.6	5.6	34.8	11.8	22.0	47.6	28.0	22.3	34.3	39.4	16.7	12.7	11.3	26.0	24.9	49.4	15.4	28.3	11.3	25.3	16.8	16.8	25.5	31.5	8.2	43.4	14.9	82.3	28.0	58.6	25.9	16.3	13.0	25.4	23.0	25.0	29.8	19.8	28.4	25.6	26.9	24.4	23.5	33.5	39.5	24.0	12.4	19.2	21.3	20.9	23.8	25.2	11.7	17.4	27.3	36.0	24.4	22.5	14.4	40.2	43.1	34.6	24.4	20.1	28.4	27.3	40.4	22.3	29.3	31.4	32.6	3.8	2.5	2.5	2.3	2.5	2.3	1.6	1.9	2.1	1.9	3.3	1.6	2.3	3.7	1.9	2.5	3.1	1.6	1.4	4.2	4.6	4.8	6.5	4.3	4.6	4.7	4.4	5.0	4.0	4.8	5.6	14.6	35.3	24.7	24.8	14.3	8.2	6.4	11.1	5.7	19.8	11.2	7.1	16.7	12.8	20.7	3.7	22.9	10.5	22.1	21.5	1.9	14.0	9.2	18.4	27.7	16.5	22.8	31.5	40.6	19.5	20.1	16.6	21.9	22.2	11.4	20.8	17.9	39.7	16.6	20.2	37.6	21.9	8.2	25.4	16.4	2.3	14.9	20.0	14.2	32.8	26.0	7.5	15.5	31.2	46.5	19.4	10.4	13.5	31.5	13.3	25.3	8.4	12.7	20.2	6.6	18.5	13.3	10.0	8.5	9.4	10.7	10.8	18.9	16.0	22.8	10.1
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951804	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 31.4;kidney: 21.0;liver: 13.3;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 91.5;Distal enterocytes: 89.8;Hepatocytes: 53.5;Paneth cells: 54.7;Proximal enterocytes: 248.9;Proximal tubular cells: 130.8;Undifferentiated cells: 101.1"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045108	Supported					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	21.0	13.3	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	91.5	0.0	3.7	0.0	0.0	0.0	89.8	11.7	26.3	0.0	0.0	0.0	0.0	12.2	2.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	53.5	0.0	0.0	0.0	34.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	54.7	0.0	0.0	0.0	248.9	130.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	101.1	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815994-68832023	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"liver: 233.7"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 245.3"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	116	"Hep G2: 12.0"									HPA045108	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	233.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.1	0.0	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	245.3	0.0	0.0	0.0	0.3	0.0	7.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 14.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.6;Early spermatids: 8.3;Late spermatids: 2.3;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 2.6;Spermatogonia: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.8;naive B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"PC-3: 3.3"	"Region enriched"	"Detected in some"	9	"pons and medulla: 11.3"	"Region enriched"	"Detected in single"	46	"spinal cord: 6.0"	HPA026992	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.0	1.2	0.8	0.8	0.5	0.5	1.2	4.1	1.4	0.2	0.0	0.5	5.3	0.7	0.5	0.7	1.0	1.2	0.7	0.7	0.5	0.6	3.2	0.5	1.0	0.7	0.4	1.0	0.5	0.2	0.0	0.4	1.1	0.6	0.4	14.9	0.6	0.2	0.5	1.1	3.2	0.5	0.1	0.6	1.6	2.3	0.6	0.1	0.5	0.0	0.3	0.4	0.1	0.9	0.4	1.0	1.3	0.6	0.3	1.6	0.4	1.0	0.5	0.3	0.2	0.7	0.5	0.7	0.5	0.4	2.6	0.5	0.4	0.0	1.6	0.6	0.5	0.6	1.4	2.9	0.3	0.8	0.4	0.6	0.2	0.2	0.3	0.9	0.3	0.6	0.4	0.6	0.5	0.6	0.2	0.5	0.7	1.3	3.3	0.9	1.5	0.2	0.2	1.6	0.7	0.5	0.6	0.7	0.4	0.5	0.5	0.5	1.4	0.7	0.4	1.3	0.4	1.1	0.6	0.6	0.9	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.5	4.1	1.4	0.7	0.5	0.7	0.4	1.1	0.1	0.6	0.9	0.2	3.2	1.1	0.7	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	8.3	1.4	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.1	0.0	0.7	1.6	0.0	0.2	0.1	1.5	0.0	0.0	0.1	0.2	2.6	2.1	0.0	0.3	0.3	0.0	0.1	0.0	0.1
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54 subunit of GARP complex"	Q9P1Q0	2	63892146-64019428	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	11.7	11.5	8.1	10.6	9.7	15.0	14.5	13.5	9.6	13.5	10.9	11.6	13.0	14.4	12.3	10.8	12.4	10.4	8.4	7.8	8.5	16.0	14.4	13.1	11.1	8.8	8.7	14.6	17.0	28.3	13.0	13.5	8.9	17.4	13.4	17.3	36.8	12.8	9.3	10.9	12.2	12.8	8.5	12.9	14.4	13.4	8.5	13.2	17.7	9.9	11.2	10.9	9.8	11.0	23.3	11.9	22.5	17.4	15.7	17.1	16.6	14.3	21.4	15.0	14.9	22.0	14.9	15.8	10.5	20.1	22.3	10.7	22.1	12.9	27.1	23.0	15.9	14.7	10.0	38.9	15.0	10.3	6.2	16.3	19.8	10.5	22.7	18.0	23.0	11.3	16.6	13.4	19.4	10.1	10.9	11.5	13.8	22.9	9.1	10.8	21.8	9.0	17.1	13.1	13.1	19.6	12.8	16.3	17.8	17.3	11.9	20.6	16.8	19.3	15.3	11.8	23.9	30.8	8.7	20.4	14.3	20.5	16.4	1.0	0.7	0.3	0.5	0.6	0.5	0.6	0.4	0.5	0.4	0.7	0.6	0.5	0.6	0.7	0.5	0.6	0.9	0.2	8.1	9.7	13.5	9.6	7.8	8.5	8.8	8.7	8.9	8.5	8.5	11.0	16.6	16.0	22.3	62.7	5.2	11.1	8.7	6.4	3.4	20.9	11.8	9.8	14.3	15.7	14.2	1.8	12.5	6.5	6.4	11.1	1.9	6.8	53.9	9.3	16.6	13.4	13.2	2.1	71.6	13.2	6.8	11.8	15.8	11.0	2.5	15.2	10.8	15.4	8.1	23.5	81.8	17.4	2.0	9.8	9.3	37.4	18.6	12.2	5.4	76.8	9.6	9.4	3.1	105.6	108.9	11.3	12.8	12.4	7.7	17.3	11.6	9.9	10.6	16.2	19.7	13.4	12.8	14.9	8.3	9.4	10.4	5.5	7.5	15.9	12.9	13.8
VSNL1	"HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1"	ENSG00000163032	"Visinin like 1"	P62760	2	17539126-17657018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 663.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 442.7;Inhibitory neurons: 243.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 663.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 125.9;Hep G2: 124.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053808: AB_2682270"	"unprognostic (1.04e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (4.90e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.14e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.51e-2)"	0.8	27.5	100.4	1.4	143.0	0.1	6.2	12.9	663.3	13.5	0.0	4.6	0.2	1.1	0.0	47.9	2.0	0.2	39.7	105.8	12.3	1.9	20.8	2.9	0.1	21.6	0.0	3.6	1.2	0.2	2.7	5.4	19.7	3.9	5.4	18.6	9.7	0.8	1.3	13.8	0.3	1.1	0.0	0.3	1.4	0.8	4.3	1.1	0.8	2.9	7.3	1.5	26.3	188.8	0.7	0.1	1.4	21.2	2.4	3.0	0.1	0.0	0.0	0.0	0.6	0.3	13.6	0.0	0.0	0.0	0.0	125.9	0.8	4.0	0.0	0.0	0.5	0.0	0.1	124.4	0.0	0.0	0.3	0.9	6.0	0.0	2.9	0.1	0.0	0.0	0.1	0.6	1.6	0.0	0.0	0.1	21.0	6.7	0.0	0.1	0.1	0.0	0.0	0.4	9.3	8.5	0.0	0.0	0.0	4.9	0.0	0.1	0.0	4.2	0.0	0.0	2.4	0.1	0.0	0.0	3.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.4	143.0	12.9	663.3	105.8	12.3	21.6	0.0	19.7	0.0	4.3	188.8	0.1	0.0	0.5	41.1	0.0	18.2	29.8	54.3	59.2	8.8	4.9	19.7	30.8	4.3	18.0	0.0	0.0	0.3	0.1	2.2	1.9	0.1	5.1	0.0	0.1	1.1	1.2	0.0	442.7	0.2	0.2	5.9	0.0	0.1	0.0	0.1	0.0	17.8	0.6	3.3	243.2	7.1	18.3	0.3	0.8	6.5	0.6	0.5	3.6	54.4	0.6	3.7	0.0	36.7	42.9	0.2	1.0	0.0	0.0	15.0	0.0	4.0	0.8	14.7	0.0	0.2	1.3	1.7	0.9	85.5	20.2	0.4	0.8	1.8	5.6	14.2
VWA1	"FLJ22215, VWA-1, WARP"	ENSG00000179403	"Von Willebrand factor A domain containing 1"	Q6PCB0	1	1434861-1442882	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 275.1;Endothelial cells: 142.7;Syncytiotrophoblasts: 290.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 47.2;CACO-2: 46.7;CAPAN-2: 136.6;Hep G2: 84.4;SCLC-21H: 47.6;T-47d: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		250000		"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (2.78e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.52e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (6.71e-2)"	36.2	15.2	55.3	31.5	91.7	0.2	38.4	79.4	76.7	51.0	24.4	114.3	15.3	70.4	11.5	41.3	50.4	22.4	38.0	59.4	58.9	58.6	133.3	29.6	13.7	103.4	81.6	22.5	55.3	12.5	20.0	38.4	87.9	131.3	5.3	2.3	64.0	203.6	10.1	26.2	37.6	20.4	74.2	11.7	52.6	27.1	88.3	3.0	67.4	3.4	5.1	118.5	50.6	151.2	47.2	15.4	2.2	15.7	0.4	1.4	24.5	3.1	0.1	2.2	0.1	46.7	136.6	0.0	43.0	1.3	5.0	12.1	15.9	8.1	0.3	3.0	11.3	1.5	0.1	84.4	3.5	0.0	5.5	2.7	0.4	1.0	0.0	0.4	0.6	0.0	1.6	0.0	0.1	11.7	0.1	0.9	6.1	16.5	4.3	0.6	0.8	2.2	2.7	7.9	47.6	7.4	0.0	41.7	5.8	3.7	61.1	0.6	1.4	0.1	0.6	0.4	15.2	0.3	0.2	0.2	2.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	91.7	79.4	76.7	59.4	58.9	103.4	81.6	87.9	74.2	88.3	151.2	103.4	19.2	36.1	5.9	2.8	6.5	19.1	5.2	12.0	7.6	40.4	59.4	3.6	44.3	14.2	53.3	4.2	275.1	1.4	24.2	7.9	82.0	0.6	16.0	46.2	142.7	12.5	2.7	0.5	65.0	99.2	28.3	16.8	17.7	1.3	2.0	8.2	49.4	22.8	15.2	1.5	8.9	6.1	1.0	4.3	4.0	34.2	1.1	24.9	18.7	2.6	52.1	0.0	13.0	48.7	48.0	11.0	59.0	2.6	21.5	0.8	5.4	10.7	4.3	6.6	62.4	17.2	0.8	2.1	11.9	8.5	290.3	1.3	6.3	10.4	14.9
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295316	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.3;ovary: 7.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2200000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.8	1.1	0.6	0.1	0.9	1.6	1.5	0.3	1.6	2.9	0.0	0.6	0.3	1.3	0.6	0.9	3.5	0.6	0.8	0.7	0.7	0.5	14.3	0.3	0.2	0.5	1.2	7.9	0.3	0.1	0.6	2.4	0.4	1.0	0.4	0.8	0.9	0.5	0.7	0.7	0.4	0.4	0.0	0.4	0.4	1.8	0.5	2.5	0.8	0.4	0.1	0.6	1.2	0.2	0.0	0.1	1.5	0.2	0.2	1.8	0.6	0.2	2.0	0.0	0.3	7.2	0.0	0.5	0.0	0.4	0.1	0.0	2.3	0.0	0.1	0.4	0.0	0.8	0.0	26.3	1.2	0.0	0.3	13.4	0.6	0.7	0.0	0.1	2.3	3.3	0.2	0.3	0.3	0.1	5.5	0.0	2.2	0.0	0.0	14.0	0.2	0.0	0.1	0.1	0.6	1.0	0.0	0.1	0.7	2.4	0.9	0.0	0.8	0.3	0.3	0.5	0.2	0.2	0.6	1.2	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.3	1.6	0.7	0.7	0.5	1.2	0.4	0.0	0.5	0.2	2.1	3.2	1.7	19.2	0.3	1.8	1.8	3.8	3.4	3.6	1.7	0.5	1.0	1.5	2.3	0.0	29.2	1.0	0.5	0.2	0.0	0.1	0.5	2.9	1.0	5.5	1.8	6.1	7.5	0.5	5.0	2.6	0.0	1.8	3.8	6.5	2.5	16.4	1.2	0.0	5.8	0.1	2.0	3.5	2.4	0.8	6.8	2.6	1.8	2.8	2.3	2.3	1.0	2.5	1.4	0.0	0.0	1.9	0.4	1.1	0.1	0.3	5.4	21.1	0.0	0.9	1.1	1.1	3.4	1.3	2.3	4.4	0.9	7.7	0.3	0.7
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 83.1;skeletal muscle: 62.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cone photoreceptor cells: 160.6;Excitatory neurons: 128.5;Inhibitory neurons: 98.8;Intestinal goblet cells: 77.3;Rod photoreceptor cells: 106.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.8;Hep G2: 31.0;SCLC-21H: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	2.0	3.0	14.9	3.3	14.8	0.0	4.9	4.6	39.1	4.7	0.3	36.0	17.9	5.8	4.2	5.7	15.4	1.3	83.1	18.3	7.7	0.8	1.3	0.9	0.5	13.8	6.0	1.1	42.8	2.3	29.6	3.0	8.8	16.7	11.9	28.8	47.3	12.3	62.3	15.8	21.5	4.5	1.9	2.7	14.7	6.6	14.2	7.1	1.8	31.0	1.0	5.5	3.4	10.5	7.4	6.6	4.6	13.2	0.0	0.0	8.8	0.0	0.0	0.1	0.0	2.7	0.2	18.8	2.4	0.0	1.3	0.3	10.4	0.0	0.0	0.0	12.1	0.0	5.8	31.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	12.2	0.0	0.0	9.8	0.2	0.2	11.5	7.2	0.4	0.0	0.0	15.3	0.0	1.1	37.6	14.8	2.4	10.2	0.9	1.3	1.3	2.2	0.1	0.0	4.8	0.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	14.8	4.6	39.1	18.3	7.7	13.8	6.0	8.8	1.9	14.2	10.5	0.3	0.0	0.0	76.4	0.3	1.3	8.5	3.1	0.0	62.0	19.4	18.7	58.1	31.5	14.1	0.0	160.6	15.5	0.2	34.3	0.0	17.1	1.2	7.7	9.2	1.3	32.4	0.0	128.5	9.1	6.7	2.7	3.6	15.8	0.0	8.6	0.4	0.2	3.4	1.7	98.8	77.3	6.1	1.3	2.2	2.6	0.9	0.1	1.8	29.0	0.6	60.3	0.0	9.0	3.2	3.2	57.0	6.0	0.2	11.1	47.7	1.1	6.6	106.8	13.1	3.5	5.0	0.7	7.7	1.1	5.5	15.6	0.4	0.1	59.0	8.9
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.3;Hepatocytes: 49.3;Inhibitory neurons: 35.9;Proximal tubular cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	1.4	2.3	1.3	1.5	1.0	2.2	3.0	5.4	2.0	1.6	0.0	4.1	5.8	1.9	0.8	1.9	1.1	1.6	0.5	0.9	0.7	11.4	33.4	0.7	1.0	0.9	0.2	2.2	2.5	1.1	0.8	0.9	1.1	1.6	4.6	2.1	5.3	0.9	0.6	1.5	6.4	1.4	0.0	1.0	3.5	1.0	0.9	1.6	0.7	0.5	0.8	1.2	1.3	0.6	3.5	6.4	2.8	6.7	4.2	4.3	6.3	5.9	2.0	4.5	4.4	8.2	3.6	3.7	1.4	7.6	5.4	2.5	8.1	2.5	5.6	5.0	6.2	7.5	5.0	24.1	2.2	10.1	7.7	3.0	5.2	5.8	2.7	1.9	4.7	8.5	18.0	6.2	5.0	2.4	8.3	1.4	3.8	8.9	7.9	4.2	5.5	5.0	0.6	6.3	3.6	3.2	3.7	16.0	12.7	2.4	7.2	6.1	2.6	9.0	7.3	15.6	2.5	3.5	6.6	8.5	5.4	9.1	7.2	1.4	0.9	2.0	0.6	1.6	0.5	0.2	0.5	0.3	1.7	0.3	0.6	0.6	1.9	0.5	1.4	0.6	1.5	0.4	1.3	1.0	5.4	2.0	0.9	0.7	0.9	0.2	1.1	0.0	0.9	0.6	1.0	0.0	1.3	14.0	0.9	0.9	2.1	1.8	6.8	3.2	3.0	3.4	1.1	2.8	1.5	0.0	0.0	4.3	1.7	3.8	1.9	1.0	0.5	0.4	3.5	1.8	0.0	3.4	39.3	3.0	3.8	2.3	8.6	1.0	0.0	1.3	1.1	49.3	4.0	0.0	35.9	5.7	2.0	1.0	3.7	1.0	1.5	2.0	0.0	17.8	1.0	0.4	0.0	17.1	17.7	1.3	5.8	1.9	1.6	1.7	13.0	31.7	1.3	5.1	0.0	2.4	1.4	0.5	2.7	4.1	0.9	1.4	0.8	1.8	5.1	2.1
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523025-62587709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 143.8;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	10.7	5.5	6.2	5.8	6.6	26.5	9.1	9.3	8.2	6.7	6.0	7.1	6.7	6.3	5.9	5.5	7.8	8.6	8.5	5.5	6.9	5.5	23.3	10.2	7.0	7.2	6.8	8.0	6.2	5.8	8.0	8.1	6.7	7.3	5.4	10.0	37.2	5.3	12.2	11.6	7.5	5.8	5.3	9.0	6.4	12.0	6.6	7.6	7.3	7.3	6.3	7.9	6.5	11.5	8.0	6.8	5.8	11.5	17.1	7.3	10.9	4.5	6.7	10.5	10.4	3.7	4.8	22.4	5.8	7.4	8.6	13.2	18.6	9.9	4.3	15.5	8.8	5.9	15.6	25.2	5.9	11.4	8.3	7.2	12.6	6.7	12.3	7.6	19.9	9.9	6.4	7.3	3.5	6.5	7.5	4.8	3.7	5.8	6.7	9.7	6.1	0.1	7.3	8.0	7.2	4.5	7.5	16.8	6.6	10.2	5.9	8.9	8.6	10.3	7.0	4.1	6.5	2.8	5.8	9.4	7.6	4.7	3.9	0.0	0.3	0.8	0.5	0.5	0.4	0.1	0.3	0.4	0.1	0.4	0.6	0.4	1.5	0.2	0.1	0.3	0.4	0.1	6.2	6.6	9.3	8.2	5.5	6.9	7.2	6.8	6.7	5.3	6.6	11.5	23.1	25.6	18.8	28.1	10.8	26.6	16.9	7.5	10.8	33.1	15.2	13.2	18.8	20.0	12.4	16.5	54.2	7.4	33.6	10.2	3.9	6.8	143.8	24.1	12.3	28.8	12.6	8.2	48.5	6.2	10.9	9.7	10.2	27.5	2.5	4.4	17.5	35.4	14.1	43.7	33.9	15.5	2.0	44.4	22.0	158.6	8.1	30.6	7.2	29.0	11.9	7.7	9.2	37.2	51.7	5.1	9.1	7.9	10.7	16.5	8.4	5.3	10.8	19.5	6.6	15.6	15.0	16.3	15.2	15.3	18.5	6.8	22.6	5.6	11.5	12.2
ZFAND2A	AIRAP	ENSG00000178381	"Zinc finger AN1-type containing 2A"	Q8N6M9	7	1152071-1160759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 490.1;Paneth cells: 310.4;Prostatic glandular cells: 255.2;Urothelial cells: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019469	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA019469: AB_1859009"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.52e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (5.47e-7)"	"unprognostic (5.44e-3)"	"unprognostic (7.60e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.59e-2)"	27.0	26.0	57.7	10.6	58.9	80.5	24.1	62.8	98.9	18.1	52.7	26.4	17.8	20.7	14.7	21.5	18.8	18.1	18.5	63.0	61.3	30.8	81.1	32.5	15.4	58.7	60.4	20.9	33.8	16.4	22.4	21.1	60.8	23.2	18.1	15.1	19.6	12.1	13.2	20.3	19.9	14.4	60.3	24.3	32.5	26.9	59.3	13.4	27.0	7.9	11.8	25.2	21.7	66.2	44.7	50.6	12.8	29.3	28.6	20.3	20.3	40.1	32.6	40.1	30.6	35.7	35.4	14.5	15.8	33.5	63.3	59.8	10.2	10.6	40.5	11.9	21.1	9.8	22.7	179.8	54.4	29.2	19.3	19.1	34.2	32.9	58.3	28.2	14.0	32.8	56.0	33.0	29.6	69.6	8.3	32.8	51.8	105.8	69.3	25.3	2.4	23.0	16.5	19.0	18.6	19.0	14.3	39.1	50.5	26.7	40.1	58.5	18.2	29.6	23.2	34.3	54.7	40.0	51.2	27.3	29.1	32.5	64.3	71.6	25.8	34.2	31.3	24.7	28.8	32.3	28.1	33.0	18.7	34.5	26.9	23.4	31.8	33.2	25.3	34.6	39.5	30.0	57.7	58.9	62.8	98.9	63.0	61.3	58.7	60.4	60.8	60.3	59.3	66.2	65.4	32.1	17.2	4.2	40.6	22.6	490.1	27.6	46.7	15.6	39.8	34.7	17.9	22.8	17.4	7.3	16.7	18.9	49.1	211.8	23.5	21.6	9.7	46.3	33.4	40.7	126.9	17.2	5.6	39.5	46.6	50.8	54.0	83.8	116.4	9.7	20.3	50.3	40.6	11.8	5.8	207.9	18.3	29.2	119.6	12.6	13.4	121.1	32.0	1.0	31.6	23.7	21.6	2.5	7.4	65.7	310.4	18.0	89.7	255.2	29.3	34.1	13.1	25.6	0.0	16.6	40.5	47.1	39.0	64.8	27.7	65.9	156.4	13.3	123.6	322.2
ZIM2	ZNF656	ENSG00000269699	"Zinc finger imprinted 2"	Q9NZV7	19	56774547-56840729	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;ovary: 7.2;testis: 3.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 25.0;Inhibitory neurons: 19.2;Late spermatids: 33.7;Spermatocytes: 11.7;Spermatogonia: 19.3;Theca cells: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;Hep G2: 2.5"									HPA071856			Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"HPA071856: AB_2686460"	"unprognostic (9.01e-4)"				"unprognostic (8.77e-2)"		"unprognostic (5.09e-2)"			"unprognostic (4.60e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"		0.1	2.3	1.8	0.0	1.2	0.0	0.4	0.9	3.5	0.3	3.2	0.3	0.0	0.4	0.0	0.1	0.6	0.0	0.3	1.1	3.6	0.1	0.1	0.0	0.0	0.8	0.7	7.2	0.1	0.1	0.9	2.0	0.2	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.7	1.7	0.0	0.2	0.0	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	0.9	3.5	1.1	3.6	0.8	0.7	0.2	0.8	1.7	1.8	0.1	0.0	0.0	5.5	0.0	0.1	0.1	0.0	0.6	7.0	0.4	0.9	0.9	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.9	0.1	25.0	0.0	1.2	0.3	0.0	0.0	8.8	0.0	1.2	1.8	0.0	0.1	0.0	7.6	0.0	0.0	0.7	10.1	19.2	0.0	0.0	0.0	0.3	33.7	1.8	0.0	0.0	1.0	0.0	3.8	0.0	6.6	5.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.0	2.4	0.0	1.5	1.0	11.7	19.3	0.3	0.1	9.9	0.0	15.5	0.0	0.0
ZNF114	MGC17986	ENSG00000178150	"Zinc finger protein 114"	Q8NC26	19	48270081-48287608	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 5.9"	"Cell type enhanced"	"Detected in some"		"Spermatogonia: 4.4;Syncytiotrophoblasts: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.2;Hep G2: 27.8;NTERA-2: 13.8;REH: 14.6"									"HPA025019, HPA029553"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA025019: AB_1859080, HPA029553: AB_10603005"	"unprognostic (1.82e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.63e-1)"	0.8	0.4	1.8	0.7	1.6	0.8	0.6	2.1	2.1	1.1	0.8	0.3	0.3	1.1	0.7	0.5	0.9	0.5	0.7	1.7	1.8	0.5	0.2	0.7	0.6	1.4	1.8	0.4	0.8	1.6	0.4	1.4	1.2	0.4	0.2	0.6	0.4	0.5	0.5	1.0	0.1	0.2	0.6	0.6	0.1	0.9	1.8	0.2	5.9	0.4	0.6	0.2	0.3	2.3	3.8	5.9	6.9	0.2	0.0	0.0	22.2	0.4	0.0	2.1	2.8	2.2	5.6	0.0	6.4	0.3	2.4	7.4	9.5	0.1	2.5	0.1	0.6	0.3	1.4	27.8	1.5	3.7	0.5	0.4	0.7	1.1	0.0	0.5	0.1	0.4	0.7	0.0	0.2	10.9	0.3	11.6	13.8	10.3	0.9	14.6	0.0	0.0	0.2	2.7	2.7	3.1	3.7	0.1	3.7	4.2	1.4	7.0	0.9	0.5	2.2	1.7	0.6	0.2	0.2	0.0	0.2	1.8	0.5	1.8	0.3	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.7	1.2	0.1	0.1	2.0	0.7	0.2	1.0	0.1	0.1	1.8	1.6	2.1	2.1	1.7	1.8	1.4	1.8	1.2	0.6	1.8	2.3	2.3	3.2	1.8	0.7	0.2	0.4	1.3	0.5	0.0	1.2	0.3	0.4	0.5	0.0	2.6	0.0	0.0	2.1	0.2	0.0	1.9	0.5	2.6	3.3	1.6	1.4	0.0	1.3	0.2	0.6	2.5	0.6	0.0	3.9	0.0	0.9	2.2	0.8	1.8	0.0	0.9	0.0	0.0	0.3	2.0	0.8	1.2	0.6	0.0	0.0	0.2	1.3	0.0	2.0	0.2	0.3	0.0	0.7	0.1	0.9	0.0	0.4	0.8	0.7	0.0	0.9	0.6	0.8	4.4	0.0	0.1	15.3	0.5	0.7	0.1	1.1
ZNF19	"KOX12, MGC51021"	ENSG00000157429	"Zinc finger protein 19"	P17023	16	71464555-71565089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.9;Spermatocytes: 15.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA063685	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA063685: AB_2685090"	"unprognostic (5.59e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-4)"	"unprognostic (6.02e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.04e-6)"	"unprognostic (3.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.87e-2)"	3.3	3.2	1.7	2.4	3.1	2.6	3.5	2.5	6.0	2.0	3.1	2.4	3.7	3.9	8.3	4.4	8.3	6.5	4.3	4.3	0.6	3.5	2.3	4.3	3.1	0.4	0.1	4.2	6.2	4.3	5.3	1.8	0.0	3.2	2.1	11.3	3.4	2.0	9.7	6.5	3.1	1.5	0.0	2.7	2.9	16.2	1.6	1.1	8.2	1.7	1.4	1.7	0.6	5.7	1.2	1.0	2.9	2.8	1.3	0.9	2.0	1.9	0.9	1.1	1.2	2.1	3.9	1.7	2.1	0.9	2.0	1.4	1.4	1.7	0.4	1.3	1.3	2.3	2.2	3.2	0.8	2.3	1.9	2.1	1.8	1.5	3.2	2.5	0.5	3.0	1.3	2.1	1.4	1.8	1.6	1.5	1.5	0.7	2.5	1.0	2.5	0.6	1.6	2.2	4.0	3.0	3.3	1.1	2.6	1.9	2.2	1.8	1.0	3.3	1.7	2.1	1.8	1.9	1.9	0.4	2.7	1.3	1.8	2.3	0.9	0.8	1.1	0.8	0.3	2.1	1.2	1.1	0.7	2.4	1.5	1.4	1.7	0.9	1.0	1.3	0.5	0.6	1.7	3.1	2.5	6.0	4.3	0.6	0.4	0.1	0.0	0.0	1.6	5.7	1.4	0.0	3.2	3.9	3.7	0.3	2.0	2.1	1.2	3.8	3.1	1.8	1.2	1.5	2.3	1.8	10.4	1.4	2.3	1.8	5.9	4.4	7.3	6.3	1.3	1.6	1.2	3.6	1.7	1.4	0.8	2.1	0.5	1.2	0.0	5.0	2.2	4.1	1.4	10.1	1.6	2.0	2.0	1.0	1.6	4.4	0.6	0.9	0.0	2.8	1.3	3.5	0.0	2.0	2.1	2.2	1.7	1.9	0.8	1.3	3.6	3.3	10.0	25.9	6.6	2.2	2.0	15.3	7.6	0.8	0.6	0.5	1.8	3.4	1.5	1.0
ZNF385C		ENSG00000187595	"Zinc finger protein 385C"	Q66K41	17	42025576-42098479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8;testis: 8.6"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.3;Hep G2: 16.6;MOLT-4: 4.9;SCLC-21H: 8.6"	"Region enriched"	"Detected in many"	12	"cerebellum: 28.2"	"Region enhanced"	"Detected in all"		"cerebellum: 19.7"							NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (1.58e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.05e-2)"	0.5	0.1	2.5	0.3	2.6	0.9	1.6	12.8	3.1	0.8	1.6	0.5	0.1	0.9	1.3	0.6	1.9	0.3	0.3	2.5	3.2	0.9	0.3	0.5	0.5	2.7	3.1	2.5	2.1	0.9	2.5	0.4	3.3	1.2	0.3	4.9	1.5	0.6	2.1	0.7	0.4	0.2	2.1	0.3	0.4	8.6	2.9	1.8	0.5	5.3	0.3	0.4	0.7	2.9	0.3	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.4	1.8	0.0	0.6	0.0	0.0	0.5	0.3	0.1	0.0	4.3	3.2	0.2	0.1	16.6	0.3	0.0	0.4	0.0	2.5	0.0	0.6	0.1	0.0	2.5	0.2	0.0	0.0	0.4	4.9	0.2	0.6	0.8	0.0	0.3	0.0	1.0	0.1	0.2	8.6	0.3	0.1	0.4	0.4	0.9	1.6	1.2	0.0	0.0	0.2	0.1	0.0	1.2	0.4	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	2.5	2.6	12.8	3.1	2.5	3.2	2.7	3.1	3.3	2.1	2.9	2.9	0.6	0.0	0.5	1.6	0.5	0.4	1.9	2.2	0.0	5.0	1.2	2.2	0.5	1.5	1.5	1.8	0.0	0.2	2.7	0.4	1.9	0.5	27.3	0.3	0.3	0.3	0.0	0.0	2.1	0.5	0.1	0.5	0.5	0.7	0.0	0.8	0.0	0.0	0.8	1.7	3.0	0.5	2.0	0.6	0.9	5.1	1.5	0.3	0.0	5.6	0.0	3.0	1.0	3.5	4.2	0.2	0.3	0.0	0.0	4.1	0.6	0.1	0.5	2.2	0.0	1.4	0.5	1.0	1.9	0.0	0.6	0.0	0.2	0.0	0.6	1.3
ZNF517		ENSG00000197363	"Zinc finger protein 517"	Q6ZMY9	8	144798876-144811169	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055337			Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA055337: AB_2682788"	"unprognostic (9.54e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.57e-2)"	2.9	5.9	2.4	2.1	2.0	1.0	3.2	1.9	3.2	5.5	0.4	4.8	2.2	6.8	0.4	3.3	5.5	2.0	3.2	3.2	0.7	4.2	3.6	2.6	2.3	1.8	1.6	7.2	3.5	1.8	5.0	1.4	2.2	5.0	0.3	2.2	4.2	1.0	6.3	6.3	3.4	0.6	0.9	3.4	3.7	4.0	2.0	1.1	4.8	0.8	0.9	4.9	4.0	2.3	1.7	3.2	5.2	5.1	0.8	1.5	2.7	1.4	0.4	0.3	0.2	1.0	1.9	0.9	3.6	0.5	2.2	1.7	0.2	0.6	0.7	3.8	1.4	2.2	2.0	11.7	1.9	0.5	2.2	1.1	1.3	0.2	1.0	2.9	1.2	2.7	2.6	1.4	0.9	2.8	2.3	1.3	3.6	3.5	3.5	3.2	1.6	0.8	0.5	2.1	2.3	6.6	4.3	1.7	1.7	2.5	4.2	2.0	1.5	3.5	5.3	1.8	1.6	2.2	0.4	0.7	3.7	0.9	2.9	0.1	0.3	0.0	0.5	0.7	0.3	1.4	0.4	0.3	0.3	0.1	0.3	0.3	0.1	0.3	0.4	0.1	0.6	0.4	2.4	2.0	1.9	3.2	3.2	0.7	1.8	1.6	2.2	0.9	2.0	2.3	1.8	0.0	0.5	1.3	1.2	0.5	5.8	0.9	0.6	3.9	1.6	1.3	3.3	2.8	1.1	0.0	8.4	0.8	1.2	0.8	1.9	0.8	1.3	1.8	1.5	1.5	1.2	0.8	0.9	0.5	0.7	1.7	1.1	1.3	0.0	2.2	2.2	2.3	1.5	3.3	1.3	1.5	2.0	2.2	0.5	0.0	0.9	1.4	0.0	1.0	0.5	2.5	4.1	1.5	0.6	0.9	0.3	1.2	0.9	1.6	1.3	3.3	0.8	3.6	0.0	1.8	1.5	4.3	3.0	0.9	1.1	0.4	1.5	2.2	0.9	4.1
ZNF556	FLJ11637	ENSG00000172000	"Zinc finger protein 556"	Q9HAH1	19	2867335-2883445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.8;fallopian tube: 2.0;ovary: 5.3;skeletal muscle: 2.4;tongue: 3.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 7.9;granulocytes: 7.6;Skeletal myocytes: 7.5;Theca cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.0;HBEC3-KT: 8.5;Hep G2: 13.4;RH-30: 19.3;THP-1: 7.1"									HPA060593			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 52: Non-specific - Ribosome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA060593: AB_2684328"	"unprognostic (1.36e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.23e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.54e-3)"	0.0	0.0	0.4	0.1	0.3	0.5	0.2	1.8	0.4	0.1	0.2	0.0	0.0	0.4	0.3	0.7	2.0	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.1	0.3	0.2	5.3	0.5	0.4	0.0	0.1	0.3	0.2	0.0	0.2	0.3	0.0	2.4	0.3	0.1	0.1	0.0	0.2	0.1	0.6	0.3	0.2	0.1	3.4	0.1	0.0	0.0	0.8	2.1	0.3	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	8.0	0.1	2.7	1.3	0.2	0.0	0.1	0.0	8.5	0.0	0.1	0.1	0.1	3.4	13.4	0.1	0.1	4.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	2.5	0.1	0.1	0.2	0.0	0.2	0.1	0.0	19.3	1.7	0.0	0.3	0.1	3.1	0.0	0.3	0.0	0.1	4.0	7.1	0.0	0.1	0.1	5.1	0.1	2.3	4.5	0.1	0.2	0.2	0.1	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	1.0	0.5	0.1	14.9	0.1	0.2	0.4	0.3	1.8	0.4	0.3	0.1	0.3	0.2	0.3	0.0	0.3	0.8	0.6	3.2	7.9	0.0	0.3	0.4	2.9	1.5	4.6	2.7	1.1	2.2	0.4	0.0	5.6	3.7	2.1	0.5	1.9	0.1	0.0	0.1	2.1	2.2	4.1	1.0	0.0	0.0	0.5	0.0	0.3	2.7	0.0	4.5	7.6	1.0	1.1	0.2	0.2	3.3	0.6	0.0	0.0	1.3	1.4	0.0	0.6	1.8	0.0	1.0	0.4	0.5	0.0	0.5	0.4	0.1	0.2	0.4	0.3	2.2	0.0	0.7	4.6	5.4	0.0	7.5	1.5	5.0	5.0	4.8	0.1	0.3	1.3	12.9	0.1	2.0
ZNF563	FLJ34797	ENSG00000188868	"Zinc finger protein 563"	Q8TA94	19	12317477-12333720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 14.5"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.2;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.0"									HPA042136	Uncertain		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA042136: AB_10795395"	"unprognostic (1.40e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-2)"	2.5	2.8	1.9	2.0	1.9	1.1	3.8	3.1	1.9	3.3	1.6	2.1	1.4	2.1	2.2	2.4	3.1	1.5	3.9	1.9	1.2	3.8	10.0	1.9	2.8	1.7	1.4	3.5	2.1	2.5	2.2	1.1	1.8	4.9	2.1	2.7	2.7	2.6	1.9	3.9	2.2	2.0	0.9	2.6	1.8	14.5	1.8	3.0	5.5	3.0	3.0	2.7	3.2	2.7	2.0	0.2	0.7	2.7	2.8	1.8	0.2	2.3	4.5	2.8	4.1	2.6	0.7	4.6	2.4	2.9	3.1	1.6	2.4	5.4	2.5	0.1	0.4	0.6	0.5	9.0	2.2	0.4	2.8	3.0	3.7	2.8	1.9	2.1	0.1	2.5	0.9	1.0	2.5	1.3	2.5	0.9	1.1	1.0	2.0	0.1	2.0	0.1	3.0	2.7	0.7	1.3	0.3	0.5	0.3	3.1	2.2	0.2	0.3	4.4	0.8	5.1	1.4	4.4	3.8	0.3	0.8	0.4	1.6	0.8	1.1	0.7	2.7	1.2	1.6	3.2	4.6	2.5	1.4	4.2	8.9	5.2	0.8	1.5	1.4	1.4	3.9	2.2	1.9	1.9	3.1	1.9	1.9	1.2	1.7	1.4	1.8	0.9	1.8	2.7	3.2	3.2	1.7	2.3	4.6	1.3	2.0	3.0	4.6	8.4	2.4	3.4	5.5	5.7	2.1	1.8	0.0	0.3	2.6	1.1	1.9	4.7	200.4	3.6	2.3	3.7	0.0	19.4	4.2	4.9	0.2	2.6	2.0	2.0	0.0	9.5	3.3	8.3	2.2	5.0	2.6	2.4	2.0	1.9	0.4	32.3	7.8	1.7	5.4	3.7	1.8	13.9	8.2	3.5	2.7	2.6	4.5	5.7	1.5	2.0	2.6	7.8	4.9	3.4	13.1	3.1	3.3	15.8	6.3	2.8	2.0	0.1	4.7	3.3	2.5	0.9
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883572-29057488	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Astrocytes: 504.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	2.8	7.1	11.3	1.3	11.2	0.3	2.6	8.1	13.8	4.4	1.0	3.9	3.0	5.1	13.4	3.4	4.8	2.1	2.6	12.1	5.5	8.2	6.6	4.3	0.5	13.2	9.2	5.9	3.3	8.7	2.7	5.0	4.2	7.2	3.4	1.1	7.5	7.7	3.8	5.3	2.7	4.6	5.1	1.2	4.4	5.0	13.6	1.3	4.1	1.9	0.6	3.2	3.3	6.2	5.8	13.7	12.5	3.5	2.3	2.6	23.7	3.5	1.7	2.7	2.6	20.8	3.2	0.1	5.4	1.8	4.9	9.8	8.7	5.5	3.3	7.8	8.9	2.3	2.5	46.1	2.0	6.9	2.3	2.7	5.0	4.3	4.3	2.3	2.4	4.1	5.0	3.2	3.9	5.6	0.2	3.5	4.6	7.3	5.4	6.9	8.2	5.3	11.6	8.5	20.6	7.6	6.2	6.1	3.5	3.8	4.1	3.1	2.3	10.3	8.8	8.2	5.8	4.3	6.3	8.1	4.4	3.9	5.5	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	11.3	11.2	8.1	13.8	12.1	5.5	13.2	9.2	4.2	5.1	13.6	6.2	4.2	12.8	23.6	504.1	0.3	12.6	5.2	4.9	15.9	3.7	5.7	9.5	7.5	8.6	5.3	12.9	0.0	28.1	0.5	2.1	1.9	5.0	12.7	8.0	8.0	5.8	8.4	4.0	62.9	2.5	2.5	5.8	5.6	15.5	0.0	5.4	2.2	17.6	3.5	1.7	37.4	9.4	0.0	1.0	3.1	15.0	10.8	0.8	0.0	82.4	0.0	6.0	0.0	54.8	34.4	3.7	2.1	12.8	0.6	9.6	2.4	11.6	4.9	3.9	0.0	16.0	6.6	4.6	3.2	7.8	7.5	7.7	0.7	14.5	12.9	2.8
ZSWIM5	KIAA1511	ENSG00000162415	"Zinc finger SWIM-type containing 5"	Q9P217	1	45016399-45306209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Astrocytes: 96.9;Excitatory neurons: 84.3;Granulosa cells: 36.3;Inhibitory neurons: 133.8;Microglial cells: 54.4;Oligodendrocyte precursor cells: 144.8;Oligodendrocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.2;Hep G2: 6.1;SCLC-21H: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018211	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA018211: AB_1859502"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.12e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.16e-1)"	1.0	12.1	2.8	0.9	3.4	0.2	1.7	5.4	3.1	2.2	0.9	4.1	4.4	3.0	2.4	1.3	2.4	1.1	1.5	2.6	3.3	2.9	0.6	2.1	1.1	3.0	3.2	8.0	2.9	6.0	6.0	0.9	2.9	3.1	4.9	8.5	2.9	2.3	1.2	1.5	6.8	3.0	2.2	1.6	1.9	3.0	3.5	0.7	4.1	1.1	0.9	2.6	1.3	2.5	0.4	1.3	3.1	5.2	0.4	0.1	0.7	0.1	4.2	0.8	0.6	0.4	0.5	0.3	0.1	0.1	2.3	0.1	2.2	0.0	0.9	2.2	3.9	0.2	4.6	6.1	0.0	0.6	0.6	0.1	0.1	0.2	0.0	0.4	0.9	1.0	0.2	0.2	0.1	1.8	0.4	0.2	2.8	3.7	1.5	1.4	0.1	0.2	0.0	1.0	7.2	3.7	2.0	0.7	0.3	0.9	1.5	0.1	0.2	0.7	0.4	0.2	0.8	1.4	0.2	0.1	2.8	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.8	3.4	5.4	3.1	2.6	3.3	3.0	3.2	2.9	2.2	3.5	2.5	0.3	0.0	3.1	96.9	0.4	0.5	0.5	0.1	1.2	9.3	1.5	1.4	1.4	2.8	1.3	0.0	10.4	0.1	0.2	5.7	1.9	0.3	1.2	0.4	0.7	1.9	6.7	0.0	84.3	1.3	0.0	1.0	1.5	0.7	0.0	36.3	1.8	0.3	0.1	8.4	133.8	3.9	0.0	0.0	0.3	1.5	0.3	0.2	0.0	54.4	0.6	1.8	0.0	144.8	106.1	0.8	3.7	1.5	0.2	0.5	6.1	1.8	0.7	4.9	0.0	1.1	1.1	1.3	2.3	0.5	0.9	0.1	0.9	0.7	4.4	0.3